fp0006512_497.htm
 
Filed Pursuant to Rule 497
File No. 333-184803
PROSPECTUS SUPPLEMENT
(to Prospectus dated February 13, 2013)
$70,000,000
 
7.25% Senior Notes due 2023
 
We are an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "1940 Act").  We are managed by The Tokarz Group Advisers LLC, a registered investment adviser.  Our investment objective is to seek to maximize total return from capital appreciation and/or income. We seek to achieve our investment objective primarily by providing debt and equity financing to small and middle-market companies. No assurances can be given that we will achieve our objective.
 
We are offering $70,000,000 in aggregate principal amount of 7.25% senior notes due 2023, or the “Notes.” The Notes will mature on January 15, 2023. We will pay interest on the Notes on January 15, April 15, July 15 and October 15 of each year, beginning on April 15, 2013.  We may redeem the Notes in whole or in part at any time or from time to time on or after April 15, 2016, at the redemption price set forth under “Description of the Notes—Redemption and Payment” in this prospectus supplement. The Notes will be issued in minimum denominations of $25 and integral multiples of $25 in excess thereof.
 
The Notes will be our direct senior unsecured obligations and rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by MVC Capital, Inc.
We intend to apply to list the Notes on the New York Stock Exchange (the “NYSE”) under the symbol “MVCB”. If the application is approved, we expect trading in the Notes on the NYSE to begin within 30 days of the original issue date. The Notes are expected to trade “flat,” which means that purchasers will not pay, and sellers will not receive, any accrued and unpaid interest on the Notes that is not reflected in the trading price. Currently, there is no public market for the Notes.
An investment in the Notes involves a high degree of risk and should be considered highly speculative. See “Supplementary Risk Factors” beginning on page S-7 in this prospectus supplement and “Risk Factors” beginning on page 15 of the accompanying prospectus to read about factors you should consider, including the risk of leverage, before investing in our Notes.
This prospectus supplement and the accompanying prospectus contain important information about us that a prospective investor should know before investing in the Notes. Please read this prospectus supplement and the accompanying prospectus before investing and keep them for future reference. We file periodic reports, current reports, proxy statements and other information with the Securities and Exchange Commission (the “SEC”). This information is available free of charge by contacting us at 287 Bowman Avenue, 2nd Floor, Purchase, New York 10577 or by telephone at (914) 510-9400 or on our website at http://www.mvccapital.com. Information contained on our website is not incorporated by reference into this prospectus supplement or the accompanying prospectus, and you should not consider that information to be part of this prospectus supplement or the accompanying prospectus. The SEC also maintains a website at www.sec.gov that contains information about us.
 
 

 
 
     
Per Note
Total
Public offering price
   
100.00%
$70,000,000
Underwriting discount (sales load)
   
3.15%
$2,205,000
Proceeds, before expenses, to us(1)
   
96.85%
$67,795,000
 
(1)
We estimate that we will incur approximately $564,000 of expenses relating to this offering, resulting in net proceeds, after sales load (underwriting discount) and expenses, to us of approximately $67,231,000.
 
The public offering price set forth above does not include accrued interest, if any. Interest on the Notes will accrue from February 26, 2013 and must be paid by the purchaser if the Notes are delivered after February 26, 2013.
 
The underwriters may also purchase up to an additional $10,500,000 total aggregate amount of Notes to cover overallotments, if any, within 30 days of the date of this prospectus supplement.  If the underwriters exercise this option in full, the total public offering price will be $80,500,000, the total underwriting discount (sales load) paid by us will be $2,535,750, and total proceeds, before expenses, will be $77,964,250.
 
THE NOTES ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF A BANK AND ARE NOT INSURED BY THE FEDERAL DEPOSIT INSURANCE CORPORATION OR ANY OTHER GOVERNMENT AGENCY.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Delivery of the Notes in book-entry form only through The Depository Trust Company will be made on or about February 26, 2013.
 
Joint Book-Running Managers
UBS Investment Bank
Morgan Stanley
 
Co-Managers
BB&T Capital Markets JMP Securities  MLV & Co.  Sterne Agee
The date of this prospectus supplement is February 19, 2013.
 
 

 
 
TABLE OF CONTENTS
PROSPECTUS SUPPLEMENT
 
ABOUT THIS PROSPECTUS SUPPLEMENT
S-ii
PROSPECTUS SUPPLEMENT SUMMARY
S-1
THE OFFERING
S-4
SUPPLEMENTARY RISK FACTORS
S-7
USE OF PROCEEDS
S-10
RATIO OF EARNINGS TO FIXED CHARGES
S-11
CAPITALIZATION
S-12
DESCRIPTION OF THE NOTES
S-13
UNDERWRITING
S-23
MATERIAL U.S. FEDERAL TAX CONSIDERATIONS
S-26
LEGAL MATTERS
S-30
WHERE YOU CAN FIND ADDITIONAL INFORMATION
S-31
 
PROSPECTUS
 
PROSPECTUS SUMMARY
1
WHERE YOU CAN FIND ADDITIONAL INFORMATION
11
FEES AND EXPENSES
12
SELECTED CONSOLIDATED FINANCIAL DATA
13
RISK FACTORS
15
DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS
30
USE OF PROCEEDS
30
PRICE RANGE OF COMMON STOCK AND DISTRIBUTIONS
31
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
31
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
66
SENIOR SECURITIES
66
PORTFOLIO COMPANIES
80
DETERMINATION OF COMPANY'S NET ASSET VALUE
87
MANAGEMENT
90
COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS
95
ADVISORY AGREEMENT
97
CONTROL PERSONS AND PRINCIPAL HOLDERS OF SECURITIES
103
FEDERAL INCOME TAX MATTERS
104
CERTAIN GOVERNMENT REGULATIONS
109
DIVIDEND REINVESTMENT PLAN
111
DESCRIPTION OF SECURITIES
112
PLAN OF DISTRIBUTION
114
LEGAL COUNSEL
115
SAFEKEEPING, TRANSFER AND DIVIDEND PAYING AGENT AND REGISTRAR
115
BROKERAGE ALLOCATION AND OTHER PRACTICES
115
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
115
   
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
F-1
 
 
S-i

 
 
ABOUT THIS PROSPECTUS SUPPLEMENT
You should rely only on the information contained in this prospectus supplement and the accompanying prospectus. Neither we nor the underwriters have authorized any other person to provide you with different information from that contained in this prospectus supplement or the accompanying prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. Neither this prospectus supplement nor the accompanying prospectus constitutes an offer to sell, or a solicitation of an offer to buy, the Notes by any person in any jurisdiction where it is unlawful for that person to make such an offer or solicitation or to any person in any jurisdiction to whom it is unlawful to make such an offer or solicitation. The information contained in this prospectus supplement and the accompanying prospectus is complete and accurate only as of their respective dates, regardless of the time of their delivery or sale of the Notes. Our financial condition, results of operations and prospects may have changed since those dates. To the extent required by law, we will amend or supplement the information contained in this prospectus supplement and the accompanying prospectus to reflect any material changes to such information subsequent to the date of this prospectus supplement and the accompanying prospectus and prior to the completion of any offering pursuant to this prospectus supplement and the accompanying prospectus.
 
This document is in two parts. The first part is this prospectus supplement, which describes the terms of the Notes and this offering and also adds to and updates information contained in the accompanying prospectus. The second part is the accompanying prospectus, which gives more general information and disclosure. To the extent the information contained in this prospectus supplement differs from or is additional to the information contained in the accompanying prospectus, you should rely only on the information contained in this prospectus supplement. You should read this prospectus supplement and the accompanying prospectus together with the additional information described under the heading “Where You Can Find Additional Information” before investing in the Notes.
 
Forward-Looking Statements
 
Information contained in this prospectus supplement and the accompanying prospectus may contain forward-looking statements. In addition, forward-looking statements can generally be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “anticipate,” “estimate,” or “continue” or the negative thereof or other variations thereon or comparable terminology. The matters described in “Supplementary Risk Factors” in this prospectus supplement, and in “Risk Factors” in the accompanying prospectus, and certain other factors noted throughout this prospectus supplement and the accompanying prospectus constitute cautionary statements identifying important factors with respect to any such forward-looking statements, including certain risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The forward-looking statements contained in this prospectus supplement and the accompanying prospectus are excluded from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended (the “Securities Act”). For a list of factors that could affect these forward-looking statements, see “Supplementary Risk Factors” in this prospectus supplement, and “Risk Factors” and “Disclosure Regarding Forward-Looking Statements” in the accompanying prospectus.
 
 
S-ii

 
 
PROSPECTUS SUPPLEMENT SUMMARY
This summary highlights some of the information in this prospectus supplement and the accompanying prospectus. It is not complete and may not contain all of the information that is important to you. To understand the terms of the Notes offered pursuant to this prospectus supplement and the accompanying prospectus, you should read the entire prospectus supplement and the accompanying prospectus carefully. Together, these documents describe the specific terms of the Notes we are offering. Except as otherwise noted, all information in this prospectus supplement and the accompanying prospectus assumes no exercise of the underwriters’ option to purchase additional Notes.
In this prospectus supplement and the accompanying prospectus, unless otherwise indicated, "MVC Capital," "we," "us," "our" or the "Company" refer to MVC Capital, Inc. and its subsidiary, MVC Financial Services, Inc. ("MVCFS"), and "TTG Advisers" or the "Adviser" refers to The Tokarz Group Advisers LLC.
MVC Capital, Inc.
MVC Capital provides debt and equity investment capital to fund growth, acquisitions and recapitalizations of small and middle-market companies in a variety of industries primarily located in the United States. Our investments can take the form of common and preferred stock and warrants or rights to acquire equity interests, senior and subordinated loans, or convertible securities. The Company is externally managed by TTG Advisers, the Company's investment adviser, which is headed by Michael Tokarz, who has over 35 years of lending and investment experience. TTG Advisers has a dedicated originations and transaction development investment team with significant experience in private equity, leveraged finance, investment banking, distressed debt transactions and business operations.
 
We were organized on December 2, 1999. Prior to July 2004, our name was meVC Draper Fisher Jurvetson Fund I, Inc. In September 2003, the Company's shareholders voted to elect a new Chairman and Portfolio Manager, Michael Tokarz. While the Company has been in operation since 2000, fiscal year 2004 marked a new beginning for the Company as this period reflects when Mr. Tokarz and his management team assumed portfolio management responsibilities for the Company. We are a Delaware corporation and a non-diversified closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act. In addition, we have elected to be treated, and intend to qualify annually, as a “regulated investment company” (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
 
We seek to implement our investment objective (i.e., to maximize total return from capital appreciation and/or income) through making a broad range of private investments in a variety of industries. We are concentrating our investment efforts on small and middle-market companies that, in our view, provide opportunities to maximize total return from capital appreciation and/or income. Under our investment approach, we are permitted to invest, without limit, in any one portfolio company, subject to any diversification limits required in order for us to continue to qualify as a RIC under Subchapter M of the Code. Due to our asset growth and composition, compliance with the RIC requirements currently restricts our ability to make additional investments that represent more than 5% of our total assets or more than 10% of the outstanding voting securities of an issuer. As a RIC, the Company generally is not subject to corporate-level federal income tax on any net ordinary income or realized net capital gains for its taxable year that it timely distributes to its stockholders.
 
We participate in the private equity business generally by providing privately negotiated long-term equity and/or debt investment capital to small and middle-market companies. Our financing is generally used to fund growth, buyouts, acquisitions, recapitalizations, note purchases and/or bridge financings. Although we generally invest in private companies, from time to time we may invest in public companies that may lack adequate access to public capital.
 
We recently signed an agreement to sell one of our portfolio companies, Summit Research Labs, a specialty chemical company that manufactures and markets antiperspirant actives globally. The sale is subject to the satisfaction of customary closing conditions and regulatory approvals. Assuming full realization of all closing conditions, we should receive gross proceeds of $63 million, an approximate gain of $47 million that results in an
 
 
S-1

 
 
estimated gross IRR of 31% (calculated as of August 2006, the time of the original investment). As part of the sale, we will provide Summit with a $22 million second lien loan.
 
In seeking to achieve our investment objective, we established subsidiaries to sponsor, and provide services to, a private equity fund, MVC Private Equity Fund, L.P. (the “PE Fund”). Specifically, on October 29, 2010, the Company committed to invest approximately $20.1 million in the PE Fund. We may continue to establish additional subsidiaries for similar purposes and/or sponsor additional private equity or other investment funds in seeking to achieve our investment objective.
 
Prior to the adoption of our current investment objective (i.e., to maximize total return from capital appreciation and/or income), our investment objective had been to achieve long-term capital appreciation from venture capital investments in information technology companies. Our investments had thus previously focused on investments in equity and debt securities of information technology companies. As of October 31, 2012, 2.36% of our assets consisted of investments made by our former management team pursuant to the prior investment objective (the “Legacy Investments”). We are, however, managing these Legacy Investments to try and realize maximum returns. At October 31, 2012, the fair value of portfolio investments of the Legacy Investments was $10.8 million. We generally seek to capitalize on opportunities to realize cash returns on these investments when presented with a potential “liquidity event,” i.e., a sale, public offering, merger or other reorganization.
 
As a business development company, we are required to comply with regulatory requirements, including limitations on our use of debt. We are permitted to, and expect to, finance various investments through borrowings. However, as a business development company, we are only generally allowed to borrow amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowing. The amount of leverage that we employ will depend on our assessment of market conditions and other factors at the time of any proposed borrowing, such as the maturity, covenant package and rate structure of the proposed borrowings, our ability to raise funds through the issuance of shares of our common stock and the risks of such borrowings within the context of our investment outlook. Ultimately, we only intend to use leverage if the expected returns from borrowing to make investments will exceed the cost of such borrowing.
 
Other Corporate Information
Our principal executive office is located at 287 Bowman Avenue, 2nd Floor, Purchase, New York 10577 and our telephone number is (914) 510-9400. Our Internet website address is http://www.mvccapital.com. Information contained on our website is not incorporated by reference into this prospectus supplement or the accompanying prospectus, and you should not consider information contained on our website to be part of this prospectus supplement or the accompanying prospectus unless otherwise indicated.
 
Use of Proceeds
 
The net proceeds from our sale of the $70,000,000 aggregate principal amount of Notes in this offering are estimated to be approximately $67,231,000, or $77,400,250 if the underwriters fully exercise their overallotment option, after deducting an underwriting discount of approximately $2,205,000 (or approximately $2,535,750 if the underwriters fully exercise their overallotment option) payable by us and estimated offering expenses of approximately $564,000 payable by us.
 
We intend to use the net proceeds from this offering, together with proceeds from any subsequent offering or offerings of additional Notes directly by the Company and cash on hand as needed, to repay debt outstanding under a credit facility first entered into by the Company and MVCFS with Guggenheim Corporate Funding, LLC (“Guggenheim”) on April 27, 2006 (the “Guggenheim Facility”). On April 13, 2010, the Company renewed the Guggenheim Facility for three years. The Guggenheim Facility consists of a $50 million term loan with an interest rate of LIBOR plus 450 basis points with a 1.25% LIBOR floor. As of October 31, 2012, there was $50 million in term debt outstanding under the Guggenheim Facility and approximately $9,000 of interest payable. The Guggenheim Facility will expire on April 27, 2013, at which time the outstanding amount under the Guggenheim Facility will be due and payable. During the year ended October 31, 2012, the Company requested Guggenheim's consent (which was granted) to waive compliance with a particular covenant of the Guggenheim Facility relating to interest and asset coverage ratios. In order to obtain this waiver, the Company agreed to increase the interest rate on
 
 
S-2

 
 
the Guggenheim Facility if the Company did not meet a newly established covenant level relating to asset coverage that was more stringent than required in the Company’s Guggenheim Facility documents. The covenant level for an event of default remained unchanged. As of October 31, 2012, the Company has met all of its original covenant levels and is not in default, but was unable to meet the increased covenant level required by Guggenheim as part of the waiver obtained earlier in the year and an interest rate penalty was triggered. As a result, the interest rate on the Guggenheim Facility has increased to LIBOR plus 525 basis points with a 1.25% LIBOR floor. The increased rate will be effective until the Company demonstrates that it has met the higher covenant level.  Guggenheim has provided its consent under the Guggenheim Facility to the Notes offering. The Company paid a closing fee, legal and other costs associated with obtaining and renewing the Guggenheim Facility. These costs are being amortized evenly over the life of the facility. The prepaid expenses on the consolidated balance sheet include the unamortized portion of these costs and will be written off when the loan is repaid. Borrowings under the Guggenheim Facility are secured, by among other things, cash, cash equivalents, debt investments, accounts receivable, equipment, instruments, general intangibles, the capital stock of MVCFS, and any proceeds from all the aforementioned items, as well as all other property except for equity investments made by the Company.
 
If there are any excess net proceeds from the sale of the Notes after the repayment of the Guggenheim Facility, we intend to use such excess net proceeds for general corporate purposes, including, for example, investing in portfolio companies in accordance with our investment objective and strategy, funding distributions, funding our subsidiaries' activities and/or repurchasing our shares pursuant to the share repurchase program adopted by our Board of Directors on April 23, 2010 and expanded on July 19, 2011.
 
Pending the use of net proceeds contemplated above, we will hold the net proceeds from the sale of the Notes in cash or invest all or a portion of such net proceeds in short term, liquid investments.
 
Subsequent Offerings of Additional Notes
 
After the offering of the Notes contemplated by this prospectus supplement, we may issue additional Notes directly to certain purchasers in a subsequent offering or offerings. We expect that such additional Notes (if issued) will be consolidated and form a single series with the Notes being offered pursuant to this prospectus supplement. The amount of additional Notes that may be issued in any subsequent offering or offerings may be significant. The completion of the offering of the Notes contemplated hereby is not contingent on the success of any subsequent offering or offerings of additional Notes. This prospectus supplement is not, and should not be construed as, an offering of any Notes other than the Notes being offered by this prospectus supplement.
 
 
S-3

 
 
THE OFFERING
This section summarizes the principal legal and financial terms of the Notes. You should read this section together with the more detailed description of the Notes in this prospectus supplement under the heading “Description of the Notes” and the more general description found in the prospectus under the heading “Description of Securities–Debt Securities” before investing in the Notes. Capitalized terms used in this prospectus supplement and not otherwise defined shall have the meanings ascribed to them in the accompanying prospectus or the indenture governing the Notes.
  
Issuer
MVC Capital, Inc., a Delaware corporation
 
Title of the securities
7.25% Senior Notes due 2023
 
Initial aggregate principal amount being offered
$70,000,000
 
Overallotment option
The underwriters may also purchase from us up to an additional $10,500,000 aggregate principal amount of Notes to cover overallotments, if any, within 30 days of the date of this prospectus supplement.
 
Initial public offering price
100% of the aggregate principal amount.
 
Listing
We intend to apply to list the Notes on the NYSE under the symbol “MVCB”. If the application is approved, we expect trading in the Notes on the NYSE to begin within 30 days of the original issue date.
 
Interest rate
7.25% per year
 
Stated maturity date
January 15, 2023, unless redeemed prior to maturity.
 
Interest payment dates
Each January 15, April 15, July 15, and October 15, commencing April 15, 2013. If an interest payment date falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment.
 
Additional Notes
We may from time to time, without notice to or the consent of the registered holders of the Notes, create and issue further notes ranking equally and ratably with the Notes in all respects, including having the same CUSIP number, so that such further notes shall be consolidated and form a single series of notes and shall have the same terms as to status or otherwise as the Notes.
 
Ranking of Notes
The Notes will be our direct unsecured obligations and will rank:
 
 
 
pari passu with our future senior unsecured indebtedness;
 
 
 
senior to any of our future indebtedness that expressly provides it is subordinated to the Notes; and
 
 
 
structurally subordinated to all existing and future indebtedness and other obligations of any of our subsidiaries, financing vehicles or similar facilities, including senior debt outstanding under the Guggenheim Facility.
 
 
S-4

 
 
Denominations
We will issue the Notes in denominations of $25 and integral multiples of $25 in excess thereof.
 
Optional redemption
The Notes may be redeemed in whole or in part at any time or from time to time at our option on or after April 15, 2016, upon not less than 30 days nor more than 60 days written notice by mail prior to the date fixed for redemption thereof, at a redemption price of $25 per Note plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to but not including the date fixed for redemption.
 
Repayment at option of Holders
Holders will not have the option to have the Notes repaid prior to the stated maturity date.
 
Governing Law
New York
 
Trustee, Paying Agent, Registrar and Transfer Agent
U.S. Bank National Association
 
Certain covenants
In addition to the covenants described in the prospectus attached to this prospectus supplement, the following covenants shall apply to the Notes:
 
We have agreed to provide to holders of the Notes and the trustee, if at any time when the Notes are outstanding and we are not subject to the reporting requirements of Sections 13 or 15(d) of the Exchange Act to file any periodic reports with the SEC, our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements will be prepared, in all material respects, in accordance with applicable United States generally accepted accounting principles.

We agree that for the period of time during which the Notes are outstanding, we will not violate Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC. These provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.
 
 
S-5

 
 
 
We have agreed that for the period of time during which the Notes are outstanding, we will not violate Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, giving effect to any exemptive relief granted to us by the SEC. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.
 
 
S-6

 
 
SUPPLEMENTARY RISK FACTORS
Investing in the Notes involves a high degree of risk. In addition to the other information contained in this prospectus supplement and the accompanying prospectus, you should carefully consider the following supplementary risk factors together with the risk factors set forth in the accompanying prospectus before making an investment in the Notes. The risks set out below and in the accompanying prospectus are not the only risks we face. Additional risks and uncertainties not presently known to us might also impair our operations and performance. If any of the events described herein or in the accompanying prospectus occur, our business, financial condition and results of operations could be materially and adversely affected. In such case, our net asset value and the market price of the Notes could decline, and you may lose part or all of your investment.
 
The Notes will be unsecured and therefore will be effectively subordinated to any secured indebtedness we have currently incurred or may incur in the future.
 
The Notes will not be secured by any of our assets or any of the assets of our subsidiaries. As a result, the Notes are effectively subordinated to any secured indebtedness we or our subsidiaries have currently incurred and may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the Notes. As of October 31, 2012, we had $50 million of outstanding borrowings under the Guggenheim Facility. The Guggenheim Facility will expire on April 27, 2013, at which time the outstanding borrowing amount will be due and payable. We intend to use proceeds of this offering, together with proceeds from any subsequent offering or offerings of additional Notes directly by the Company and cash on hand as needed, to repay the Guggenheim Facility. However, we may borrow other secured indebtedness in the future. We had no other secured indebtedness outstanding as of October 31, 2012.
 
The Notes will be structurally subordinated to the indebtedness and other liabilities of our subsidiaries.
 
The Notes are obligations exclusively of MVC Capital, Inc. and not of any of our subsidiaries. None of our subsidiaries is a guarantor of the Notes, and the Notes are not required to be guaranteed by any subsidiaries we may acquire or create in the future.
 
Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors (including trade creditors) and holders of preferred stock, if any, of our subsidiaries will have priority over our equity interests in such subsidiaries (and therefore the claims of our creditors, including holders of the Notes) with respect to the assets of such subsidiaries. Even if we are recognized as a creditor of one or more of our subsidiaries, our claims would still be effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently, the Notes will be structurally subordinated to all indebtedness and other liabilities (including trade payables) of any of our subsidiaries and any subsidiaries that we may in the future acquire or establish as financing vehicles or otherwise. As of October 31, 2012, we had $50 million of outstanding borrowings under the Guggenheim Facility. We and our subsidiaries had no other senior indebtedness outstanding as of October 31, 2012. All of such indebtedness would be structurally senior to the Notes. In addition, our subsidiaries may incur substantial additional indebtedness in the future, all of which would be structurally senior to the Notes.
 
The indenture under which the Notes will be issued will contain limited protection for holders of the Notes.
 
The indenture under which the Notes will be issued offers limited protection to holders of the Notes. The terms of the indenture and the Notes do not restrict our or any of our subsidiaries’ ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have a material adverse impact on your investment in the Notes. In particular, the terms of the indenture and the Notes will not place any restrictions on our or our subsidiaries’ ability to:
 
 
S-7

 
 
 
issue securities or otherwise incur additional indebtedness or other obligations, including (1) any indebtedness or other obligations that would be equal in right of payment to the Notes, (2) any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the Notes to the extent of the values of the assets securing such debt, (3) indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore is structurally senior to the Notes and (4) securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to the Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC (these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings);
 
 
pay dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the Notes, including subordinated indebtedness, in each case other than dividends, purchases, redemptions or payments that would cause a violation of Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions giving effect to any exemptive relief granted to us by the SEC (these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase);
 
 
sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);
 
 
enter into transactions with affiliates;
 
 
create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;
 
 
make investments; or
 
 
create restrictions on the payment of dividends or other amounts to us from our subsidiaries.
 
In addition, the indenture will not require us to offer to purchase the Notes in connection with a change of control or any other event.
 
Furthermore, the terms of the indenture and the Notes do not protect holders of the Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, if any, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity.
 
Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the Notes may have important consequences for you as a holder of the Notes, including making it more difficult for us to satisfy our obligations with respect to the Notes or negatively affecting the trading value of the Notes.
 
Other debt that we may issue or incur in the future could contain more protections for its holders than the indenture and the Notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the Notes.
 
 
S-8

 
 
There is no existing trading market for the Notes and, even if the NYSE approves the listing of the Notes, an active trading market for the Notes may not develop, which could limit your ability to sell the Notes or the market price of the Notes.
 
The Notes will be a new issue of debt securities for which there initially will not be a trading market. We intend to list the Notes on the NYSE within 30 days of the original issue date under the symbol ‘‘MVCB.’’ However, there is no assurance that the Notes will be approved for listing on the NYSE. Moreover, even if the listing of the Notes is approved, we cannot provide any assurances that an active trading market will develop for the Notes or that you will be able to sell your Notes. If the Notes are traded after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. The underwriters have advised us that they may make a market in the Notes, but they are not obligated to do so. The underwriters may discontinue any market-making in the Notes at any time at their sole discretion. Accordingly, we cannot assure you that the Notes will be approved for listing on the NYSE, that a liquid trading market will develop for the Notes, that you will be able to sell your Notes at a particular time or that the price you receive when you sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for the Notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the Notes for an indefinite period of time.
 
If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the Notes.
 
Any default under the agreements governing our indebtedness, including a default under the Guggenheim Facility or other indebtedness to which we may be a party that is not waived by the required lenders or holders, and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the Notes and substantially decrease the market value of the Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lenders under the Guggenheim Facility or other debt we may incur in the future could elect to terminate their commitments, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. Further, we may in the future need to seek to obtain waivers from the required lender under the Guggenheim Facility, Guggenheim, or other debt that we may incur in the future to avoid being in default. The Company has previously obtained Guggenheim’s consent to waive compliance with certain covenants contained in the Guggenheim Facility, and we may require such consents in the future from Guggenheim or other future lenders, but there can be no assurance that such future consents will be granted. If this occurs, we would be in default, and Guggenheim and any other future lender or debt holder could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations, including Guggenheim, could proceed against the collateral securing the debt. Because the Guggenheim Facility has, and any future credit facilities will likely have, customary cross-default provisions, if the indebtedness thereunder or under any future credit facility is accelerated, we may be unable to repay or finance the amounts due. Additionally, although it is our intent to use the proceeds from the offering of the Notes to pay down the Guggenheim Facility, if sufficient proceeds are not raised, the outstanding debt under the Guggenheim Facility may still be outstanding in part or full. See “Description of the Notes”.
The Notes have not been rated.
We have not sought to obtain a rating for the Notes. No assurance can be given, however, that one or more rating agencies might not independently determine to issue such a rating or that such a rating, if issued, would not adversely affect the market price of the Notes. In addition, we may elect in the future to obtain a rating of the Notes, which could impact the market price of the Notes. Ratings only reflect the views of the rating agency or agencies issuing the ratings and such ratings could be revised or withdrawn entirely at the discretion of the issuing rating agency if in its judgment circumstances so warrant. Any such revision or withdrawal of a rating could have an effect on the market price of the Notes.
 
S-9

 
 
USE OF PROCEEDS
The net proceeds from our sale of the $70,000,000 aggregate principal amount of Notes in this offering are estimated to be approximately $67,231,000, or $77,400,250 if the underwriters fully exercise their overallotment option, after deducting an underwriting discount of approximately $2,205,000 (or approximately $2,535,750 if the underwriters fully exercise their overallotment option) payable by us and estimated offering expenses of approximately $564,000 payable by us.
 
We intend to use the net proceeds from this offering, together with proceeds from any subsequent offering or offerings of additional Notes directly by the Company and cash on hand as needed, to repay debt outstanding under the Guggenheim Facility. The Guggenheim Facility consists of a $50 million term loan with an interest rate of LIBOR plus 450 basis points with a 1.25% LIBOR floor. As of October 31, 2012, there was $50 million in term debt outstanding under the Guggenheim Facility and approximately $9,000 of interest payable. The Guggenheim Facility will expire on April 27, 2013, at which time the outstanding amount under the Guggenheim Facility will be due and payable. During the year ended October 31, 2012, the Company requested Guggenheim's consent (which was granted) to waive compliance with a particular covenant of the Guggenheim Facility relating to interest and asset coverage ratios. In order to obtain this waiver, the Company agreed to increase the interest rate on the Guggenheim Facility if the Company did not meet a newly established covenant level relating to asset coverage that was more stringent than required in the Company’s Guggenheim Facility documents. The covenant level for an event of default remained unchanged. As of October 31, 2012, the Company has met all of its original covenant levels and is not in default, but was unable to meet the increased covenant level required by Guggenheim as part of the waiver obtained earlier in the year and an interest rate penalty was triggered. As a result, the interest rate on the Guggenheim Facility has increased to LIBOR plus 525 basis points with a 1.25% LIBOR floor. The increased rate will be effective until the Company demonstrates that it has met the higher covenant level. Guggenheim has provided its consent under the Guggenheim Facility to the Notes offering. The Company paid a closing fee, legal and other costs associated with obtaining and renewing the Guggenheim Facility. These costs are being amortized evenly over the life of the facility. The prepaid expenses on the consolidated balance sheet include the unamortized portion of these costs and will be written off when the loan is repaid. Borrowings under the Guggenheim Facility are secured, by among other things, cash, cash equivalents, debt investments, accounts receivable, equipment, instruments, general intangibles, the capital stock of MVCFS, and any proceeds from all the aforementioned items, as well as all other property except for equity investments made by the Company.
 
If there are any excess net proceeds from the sale of the Notes after the repayment of the Guggenheim Facility, we intend to use such excess net proceeds for general corporate purposes, including, for example, investing in portfolio companies in accordance with our investment objective and strategy, funding distributions, funding our subsidiaries' activities and/or repurchasing our shares pursuant to the share repurchase program adopted by our Board of Directors on April 23, 2010 and expanded on July 19, 2011.
 
Pending the use of the net proceeds contemplated above, we will hold the net proceeds from the sale of the Notes in cash or invest all or a portion of such net proceeds in short term, liquid investments.
 
 
S-10

 
 
RATIO OF EARNINGS TO FIXED CHARGES
The following table contains our ratio of earnings to fixed charges for the periods indicated, computed as set forth below. You should read these ratios of earnings to fixed charges together with our consolidated financial statements, including the notes to those statements, included in the accompanying prospectus.
 
 
For the Year
Ended
October 31, 2012
(Proforma for Notes Offering)
For The Year Ended October 31, 2012
For The Year Ended October 31, 2011
For The Year Ended October 31, 2010
For The Year Ended October 31, 2009
For The Year Ended October 31, 2008
Earnings to Fixed Charges
(3.60)
(5.43)
3.27
6.71
6.00
15.12
 
For purposes of computing the ratios of earnings to fixed charges, earnings represent net increase (decrease) in net assets resulting from operations plus (or minus) income tax expense (benefit) including excise tax expense plus fixed charges. Fixed charges include interest, credit facility fees and amortized capitalized expenses related to indebtedness.
 
 
S-11

 
 
CAPITALIZATION
The following table sets forth our capitalization as of October 31, 2012:
 
 
·
on an actual basis; and

 
·
on an as adjusted basis to reflect the sale of $70,000,000 aggregate principal amount of Notes in this offering and the use of proceeds therefrom (assuming no exercise of the overallotment option and without reflecting the issuance of any additional Notes in any subsequent offering or offerings by the Company and the use of proceeds therefrom), after deducting the underwriting discounts and commissions of $2,205,000 payable by us and estimated offering expenses of approximately $564,000 payable by us.
 
   
Actual
   
As Adjusted
 
Cash and cash equivalents
  $ 36,160,558     $
53,391,532
 
Restricted cash and cash equivalents
    6,480,000       6,480,000  
Total cash and cash equivalents
  $ 42,640,558     $
59,871,532
 
                 
Long-term debt, including current maturities:
               
Term loan
  $ 50,000,000     $ -  
Notes offered hereby
    -       70,000,000  
Total long-term debt
  $ 50,000,000     $ 70,000,000  
                 
Net assets:
               
Common stock, $0.01 par value; (150,000,000 shares
               
     authorized; 23,916,982 shares outstanding)
  $ 283,044     $ 283,044  
Additional paid-in-capital
    425,651,660       425,651,660  
Accumulated earnings
    64,524,665       64,524,665  
Dividends paid to stockholders
    (92,010,775 )     (92,010,775 )
Accumulated net realized loss
    (46,401,983 )     (46,401,983 )
Net unrealized appreciation
    71,738,767       71,738,767  
Treasury stock, at cost, (4,387,466 shares held)
    (37,769,245 )     (37,769,245 )
                 
Total net assets
  $ 386,016,133     $ 386,016,133  
                 
Total Capitalization
  $ 436,016,133     $
456,016,133
 
 
 
S-12

 
 
DESCRIPTION OF THE NOTES
This prospectus supplement sets forth certain terms of the Notes that we are offering pursuant to this prospectus supplement. This description supplements, and to the extent inconsistent therewith, replaces the descriptions of the general terms and provisions contained in “Description of Securities–Debt Securities” in the accompanying prospectus.
 
The Notes will be issued under an indenture to be dated as of the closing date, entered into between us and U.S. Bank National Association, as trustee, as supplemented by the first supplemental indenture to be dated as of the closing date, entered into between us and U.S. Bank National Association, as trustee. The terms of the Notes include those stated in the Indenture and those made a part of the Indenture by reference to the Trust Indenture Act of 1939, as amended. As used in this section, all references to “Indenture” mean the indenture as supplemented by the first supplemental indenture, and all references to “we,” “our” and “us” mean MVC Capital, Inc., a Delaware corporation, exclusive of our subsidiaries, unless we specify otherwise.
 
Because this section is a summary, it does not describe every aspect of the Notes and the Indenture. We urge you to read the Indenture because it, and not this description, defines your rights as a holder of the Notes. For example, in this section, we use capitalized words to signify terms that are specifically defined in the Indenture. Some of the definitions are repeated in this prospectus supplement, but for the rest you will need to read the Indenture. You may obtain a copy of the Indenture from us without charge. See “Where You Can Find Additional Information” in the accompanying prospectus.
 
General
 
The Notes:
  
 
 
will be issued in an initial principal amount of $70,000,000 ($80,500,000 if the underwriters’ option to purchase Notes to cover overallotments, if any, is exercised in full);
 
 
 
will mature on January 15, 2023, unless redeemed prior to maturity;
 
 
 
will be issued in denominations of $25 and integral multiples of $25 in excess thereof;
 
 
 
will be redeemable in whole or in part at any time or from time to time on and after April 15, 2016, at a redemption price of $25 per Note plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to the date fixed for redemption as described under “—Redemption and Repayment” below;
 
 
 
are expected to be listed on The New York Stock Exchange within 30 days of the original issue date.
 
The Notes will be our direct unsecured obligations and will rank:
  
 
 
pari passu with future senior unsecured indebtedness;
 
 
 
senior to any of our future indebtedness that expressly provides it is subordinated to the Notes;
 
 
 
effectively subordinated to all of our existing and future secured indebtedness (including indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness; and
 
 
 
structurally subordinated to all existing and future indebtedness and other obligations of any of our subsidiaries, financing vehicles or similar facilities.
 
Our subsidiaries are separate and distinct legal entities and have no obligation, contingent or otherwise, to pay any amounts due on the Notes or to make any funds available for payment on the Notes, whether by dividends, loans or other payments. In addition, the payment of dividends and the making of loans and advances to us by our subsidiaries may be subject to statutory, contractual or other restrictions, may depend on the earnings or financial condition of all of the foregoing and are subject to various business considerations. As a result, we may be unable to gain significant, if any, access to the cash flow or assets of our subsidiaries.
 
 
S-13

 
 
The Indenture does not limit the amount of debt (secured and unsecured) that we and our subsidiaries may incur or our ability to pay dividends, sell assets, enter into transactions with affiliates or make investments. In addition, the Indenture does not contain any provisions that would necessarily protect holders of Notes if we become involved in a highly leveraged transaction, reorganization, merger or other similar transaction that adversely affects us or them.
 
The Notes will be issued in fully registered form only, without coupons, in minimum denominations of $25 and integral multiples thereof. The Notes will be represented by one or more global notes deposited with or on behalf of The Depository Trust Company (“DTC”), or a nominee thereof. Except as otherwise provided in the Indenture, the Notes will be registered in the name of that depositary or its nominee, and you will not receive certificates for the Notes. We will make payments on a global security in accordance with the applicable policies of the depositary as in effect from time to time. Under those policies, we will make payments directly to the depositary, or its nominee, and not to any indirect holders who own beneficial interests in the global security. An indirect holder’s right to those payments will be governed by the rules and practices of the depositary and its participants.
 
We are permitted, under specified conditions, to issue multiple classes of indebtedness if our asset coverage, as defined in the 1940 Act, is at least equal to 200% immediately after each such issuance. In addition, while any indebtedness and senior securities remain outstanding, we must make provisions to prohibit the distribution to our stockholders or the repurchase of such securities or shares unless we meet the applicable asset coverage ratios at the time of the distribution or repurchase. Specifically, we may be precluded from declaring dividends or repurchasing shares of our common stock unless our asset coverage is at least 200%. We may also borrow amounts up to 5% of the value of our total assets for temporary or emergency purposes without regard to asset coverage. For a discussion of the risks associated with leverage, see “Risk Factors—Business Risks— We have borrowed and may continue to borrow money, which magnifies the potential for gain or loss on amounts invested and may increase the risk of investing in us.” in the prospectus.
 
Interest Provisions Related to the Notes
 
Interest on the Notes will accrue at the rate of 7.25% per annum and will be payable quarterly on each January 15, April 15, July 15 and October 15 commencing on April 15, 2013. The initial interest period will be the period from and including the original issue date to, but excluding, the initial interest payment date, and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be. We will pay interest to those persons who were holders of record of such Notes on the 1st day of the month during which each interest payment date occurs: each January, April, July and October, commencing April 1, 2013.
 
Interest on the Notes will accrue from the date of original issuance and will be computed on the basis of a 360-day year comprised of twelve 30-day months. We will not provide a sinking fund for the Notes.
 
Interest payments will be made only on a business day, defined in the Indenture as each Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which banking institutions in New York City are authorized or required by law or executive order to close. If any interest payment is due on a non-business day, we will make the payment on the next day that is a business day. Payments made on the next business day in this situation will be treated under the Indenture as if they were made on the original due date. Such payment will not result in a default under the Notes or the Indenture, and no interest will accrue on the payment amount from the original due date to the next day that is a business day.
 
Book-entry and other indirect holders should consult their banks or brokers for information on how they will receive payments on their Notes.
 
Redemption and Repayment
 
The Notes may be redeemed in whole or in part at any time or from time to time at our option on or after April 15, 2016, upon not less than 30 days nor more than 60 days written notice by mail prior to the date fixed for redemption thereof, at a redemption price of 100% of the outstanding principal amount thereof plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to the date fixed for redemption.
 
 
S-14

 
 
You may be prevented from exchanging or transferring the Notes when they are subject to redemption. In case any Notes are to be redeemed in part only, the redemption notice will provide that, upon surrender of such Note, you will receive, without a charge, a new Note or Notes of authorized denominations representing the principal amount of your remaining unredeemed Notes.
 
Any exercise of our option to redeem the Notes will be done in compliance with the 1940 Act and the rules, regulations and interpretations promulgated thereunder, to the extent applicable.
 
If we redeem only some of the Notes, the Trustee or DTC, as applicable, will determine the method for selection of the particular Notes to be redeemed, in accordance with the Indenture, and in accordance with the rules of any national securities exchange or quotation system on which the Notes are listed and the 1940 Act to the extent applicable. Unless we default in payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the Notes called for redemption.
 
Holders will not have the option to have the Notes repaid prior to the stated maturity date.
 
Listing
 
We intend to apply to list the Notes on the New York Stock Exchange under the symbol “MVCB”. If the application is approved, we expect trading in the Notes to begin within 30 days of the original issue date.
 
Trading Characteristics
 
We expect the Notes to trade at a price that takes into account the value, if any, of accrued and unpaid interest. This means that purchasers will not pay, and sellers will not receive, accrued and unpaid interest on the Notes that is not included in their trading price. Any portion of the trading price of a note that is attributable to accrued and unpaid interest will be treated as a payment of interest for U.S. federal income tax purposes and will not be treated as part of the amount realized for purposes of determining gain or loss on the disposition of the Notes. See “Material U.S. Federal Tax Considerations.”
 
Certain Covenants
 
Reporting.  We have agreed to provide to holders of the Notes and the trustee (if at any time when Notes are outstanding we are not subject to the reporting requirements of Sections 13 or 15(d) of the Exchange Act to file any periodic reports with the SEC), our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements will be prepared, in all material respects, in accordance with applicable United States generally accepted accounting principles.
 
1940 Act Compliance.  We have agreed that for the period of time during which the Notes are outstanding, we will not violate Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC. These provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.
 
We have agreed that for the period of time during which the Notes are outstanding, we will not violate Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, giving effect to any exemptive relief granted to us by the SEC. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.
 
 
S-15

 
 
Events of Default
 
You will have rights if an Event of Default occurs in respect of the Notes and is not cured, as described later in this subsection.
 
The term “Event of Default” in respect of the Notes means any of the following:
  
 
 
We do not pay the principal of, or any premium on, the Notes when due, whether at maturity, upon redemption or otherwise.
 
 
 
We do not pay interest on the Notes when due, and such default is not cured within 30 days.
 
 
 
We remain in breach of a covenant in respect of the Notes for 60 days after we receive a written notice of default stating we are in breach. The notice must be sent by either the trustee or holders of at least 25% of the principal amount of the Notes.
 
 
 
We file for bankruptcy, or certain other events of bankruptcy, insolvency or reorganization occur.
 
 
 
On the last business day of each of twenty-four consecutive calendar months, we have an asset coverage of less than 100%.
 
The trustee may withhold notice to the holders of the Notes any default, except in the payment of principal, premium or interest, if it considers the withholding of notice to be in the best interests of the holders.
 
Remedies if an Event of Default Occurs.  If an Event of Default, other than an Event of Default referred to in the second to last bullet point above with respect to us, has occurred and has not been cured, the trustee or the holders of at least 25% in principal amount of Notes may declare the entire principal amount of all the Notes to be due and immediately payable. If an Event of Default referred to in the second to last bullet point above with respect to us has occurred, the entire principal amount of all the Notes will automatically become due and immediately payable. This is called a declaration of acceleration of maturity. In certain circumstances, a declaration of acceleration of maturity may be canceled by the holders of a majority in principal amount of the Notes.
 
The trustee is not required to take any action under the Indenture at the request of any holders unless the holders offer the trustee indemnification satisfactory to it from expenses and liability (called an “indemnity”) (Section 315 of the Trust Indenture Act of 1939). If indemnity satisfactory to the trustee is provided, the holders of a majority in principal amount of the Notes may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy available to the trustee. The trustee may refuse to follow those directions in certain circumstances. No delay or omission in exercising any right or remedy will be treated as a waiver of that right, remedy or Event of Default.
 
Before you are allowed to bypass your trustee and bring your own lawsuit or other formal legal action or take other steps to enforce your rights or protect your interests relating to the Notes, the following must occur:
  
 
 
You must give your trustee written notice that an Event of Default has occurred and remains uncured.
 
 
 
The holders of at least 25% in principal amount of all outstanding Notes must make a written request that the trustee take action because of the default and must offer indemnity satisfactory to the trustee against the cost and other liabilities of taking that action.
 
 
 
The trustee must not have taken action for 60 calendar days after receipt of the above notice and offer of indemnity.
 
 
 
The holders of a majority in principal amount of the Notes must not have given the trustee a direction inconsistent with the above notice during that 60 calendar day period.
 
However, you are entitled at any time to bring a lawsuit for the payment of money due on your Notes on or after the due date.
 
Holders of a majority in principal amount of the Notes may waive any past defaults other than:
  
 
 
in respect of the payment of principal, any premium or interest; or
 
 
 
in respect of a covenant that cannot be modified or amended without the consent of each holder.
 
 
S-16

 
 
Book-entry and other indirect holders should consult their banks or brokers for information on how to give notice or direction to or make a request of the trustee and how to declare or cancel an acceleration of maturity.
 
Each year, we will furnish to the trustee a written statement of certain of our officers certifying that to their knowledge we are in compliance with the Indenture, or else specifying any default.
 
Merger or Consolidation
 
Under the terms of the Indenture, we are generally permitted to consolidate or merge with another entity. We are also permitted to sell all or substantially all of our assets to another entity. However, we may not consolidate with or into any other corporation or convey or transfer all or substantially all of our property or assets to any person unless all the following conditions are met:
  
 
 
Where we merge out of existence or sell our assets, the resulting entity must agree to be legally responsible for all of our obligations under the Notes and the Indenture.
 
 
 
Immediately after giving effect to such transaction, no Default or Event of Default shall have happened and be continuing. For purposes of this no-default test, a default would include an Event of Default that has occurred and has not been cured, as described under “Events of Default” above. A default for this purpose would also include any event that would be an Event of Default if the requirements for giving us notice of default or our default having to exist for a specified period of time were disregarded.
 
 
 
We must deliver certain certificates and documents to the trustee.
 
Modification or Waiver
 
There are three types of changes we can make to the Indenture and the Notes.
 
Changes Requiring Your Approval.  First, there are changes that we cannot make to your Notes without your specific approval. The following is a list of those types of changes:
  
 
 
change the stated maturity of the principal of or interest on the Notes;
 
 
 
reduce any amounts due on the Notes;
 
 
 
reduce the amount of principal payable upon acceleration of the maturity of the Notes following a default;
 
 
 
adversely affect any right of repayment at the holder’s option;
 
 
 
change the place or currency of payment on the Notes;
 
 
 
impair your right to sue for payment;
 
 
 
reduce the percentage of holders of Notes whose consent is needed to modify or amend the Indenture;
 
 
 
reduce the percentage of holders of Notes whose consent is needed to waive compliance with certain provisions of the Indenture or to waive certain defaults; and
 
 
 
modify any other aspect of the provisions of the Indenture dealing with supplemental indentures, modification and waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants.
 
Changes Not Requiring Approval.  The second type of change does not require any vote by the holders of the Notes. This type is limited to clarifications and certain other changes that would not adversely affect holders of the Notes in any material respect. We also do not need any approval to make any change that affects only debt securities to be issued under the indenture after the change takes effect.
 
Changes Requiring Majority Approval. Any other change to the Indenture and the Notes would require the following approval:  
 
 
If the change affects only the Notes, it must be approved by the holders of a majority in principal amount of the Notes outstanding at such time.
 
 
S-17

 
 
 
 
If the change affects more than one series of debt securities issued under the indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by the change, with all affected series voting together as one class for this purpose.
 
The holders of a majority in principal amount of all of the series of debt securities issued under an indenture, voting together as one class for this purpose, may waive our compliance with some of our covenants in that indenture. However, we cannot obtain a waiver of a payment default or of any of the matters covered by the bullet points included above under “—Changes Requiring Your Approval.”
 
Further Details Concerning Voting. When taking a vote, we will use the principal amount that would be due and payable on the voting date if the maturity of the Notes were accelerated to that date because of a default, to decide how much principal to attribute to the Notes.
 
The Notes will not be considered outstanding, and therefore not eligible to vote, if we have deposited or set aside in trust money for their payment or redemption. The Notes will also not be eligible to vote if they have been fully defeased as described later under “Full Defeasance.”
 
We will generally be entitled to set any day as a record date for the purpose of determining the holders of the Notes that are entitled to vote or take other action under the indenture. If we set a record date for a vote or other action to be taken by holders of the Notes, that vote or action may be taken only by persons who are holders of the Notes on the record date and must be taken within eleven months following the record date.
 
Book-entry and other indirect holders should consult their banks or brokers for information on how approval may be granted or denied if we seek to change the Indenture or the Notes or request a waiver.
 
Defeasance
 
Covenant Defeasance. If certain conditions are satisfied, we can make the deposit described below and be released from some of the restrictive covenants in the Indenture under which the Notes were issued. This is called “covenant defeasance.” In that event, you would lose the protection of those restrictive covenants but would gain the protection of having money and government securities set aside in trust to repay your Notes. In order to achieve covenant defeasance, we must do the following:  
  
 
we must irrevocably deposit in trust for the benefit of all holders of such Notes a combination of money and United States government or United States government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the Notes on their various due dates. No Default or Event of Default with respect to the Notes shall have occurred and be continuing on the date of such deposit, or in the case of a bankruptcy Event of Default, at any time during the period ending on the 91st day after the date of such deposit.
 
 
 
We must deliver to the trustee a legal opinion of our counsel that, under current U.S. federal income tax law, we may make the above deposit without causing you to be taxed on the Notes any differently than if we did not make the deposit and just repaid the Notes ourselves at maturity.
 
We must deliver to the trustee a legal opinion of our counsel stating that the above deposit does not require registration by us under 1940 Act and a legal opinion and officers’ certificate stating that all conditions precedent to covenant defeasance have been complied with.
 
If we accomplish covenant defeasance, you can still look to us for repayment of the Notes if there were a shortfall in the trust deposit or the trustee is prevented from making payment. For example, if one of the remaining Events of Default occurred (such as our bankruptcy) and the Notes became immediately due and payable, there might be a shortfall. Depending on the event causing the default, you may not be able to obtain payment of the shortfall.
 
Full Defeasance. If there is a change in U.S. federal tax law, as described below, we can legally release ourselves from all payment and other obligations on the Notes (called “full defeasance”) if we put in place the following other arrangements for you to be repaid:
 
S-18

 
 
  
 
we must deposit in trust for the benefit of all holders of such Notes a combination of money and United States government or United States government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the Notes. No Default or Event of Default with respect to the Notes shall have occurred and be continuing on the date of such deposit, or in the case of a bankruptcy Event of Default, at any time during the period ending on the 91st day after the date of such deposit.
 
 
 
We must deliver to the trustee a legal opinion confirming that there has been a change in current U.S. federal tax law or an IRS revenue ruling that allows us to make the above deposit without causing you to be taxed on the Notes any differently than if we did not make the deposit and just repaid the Notes ourselves at maturity. Under current U.S. federal tax law, the deposit and our legal release from the Notes would be treated as though we paid you your share of the cash and notes or bonds at the time the cash and notes or bonds were deposited in trust in exchange for your Notes and you would recognize gain or loss on the Notes at the time of the deposit.
 
 
 
We must deliver to the trustee a legal opinion of our counsel stating that the above deposit does not require registration by us under the 1940 Act and a legal opinion and officers’ certificate stating that all conditions precedent to defeasance have been complied with.
 
If we ever did accomplish full defeasance, as described above, you would have to rely solely on the trust deposit for repayment of the Notes. You could not look to us for repayment in the unlikely event of any shortfall. Conversely, the trust deposit would most likely be protected from claims of our lenders and other creditors if we ever became bankrupt or insolvent.
 
No service charge will be made for any registration of transfer or any exchange of Notes, but we may require payment of a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith.
 
Satisfaction and Discharge
 
The Indenture will be discharged and will cease to be of further effect with respect to the Notes when either:
  
 
 
all the Notes that have been authenticated have been delivered to the trustee for cancellation; or
 
 
 
all the Notes that have not been delivered to the trustee for cancellation:
 
 
 
have become due and payable,
 
 
 
will become due and payable at their stated maturity within one year, or
 
 
 
are to be called for redemption within one year,
 
and we, in the case of the first, second and third sub-bullets above, have irrevocably deposited or caused to be deposited with the trustee as trust funds in trust solely for the benefit of the holders of the Notes, in amounts as will be sufficient, without consideration of any reinvestment of interest, to pay and discharge the entire indebtedness (including all principal, premium, if any, and interest) on such Notes delivered to the trustee for cancellation (in the case of notes that have become due and payable on or prior to the date of such deposit) or to the stated maturity or redemption date, as the case may be,
  
  
 
we have paid or caused to be paid all other sums payable by us under the Indenture with respect to the Notes; and
 
 
 
we have delivered to the trustee an officers’ certificate and legal opinion, each stating that all conditions precedent provided for in the Indenture relating to the satisfaction and discharge of the Indenture and the Notes have been complied with.
 
Additional Notes and Additional Series of Notes
 
We may from time to time, without notice to or the consent of the registered holders of the Notes, create and issue further notes ranking equally and ratably with the Notes in all respects, including having the same CUSIP number, so that such further notes shall be consolidated and form a single series of notes and shall have the same terms as to status or otherwise as the Notes. No additional notes may be issued if an event of default has occurred
 
 
S-19

 
 
and is continuing with respect to the Notes. The indenture also allows for the issuance of additional series of debt securities from time to time.
 
The Trustee Under the Indenture
 
U.S. Bank National Association will serve as the trustee under the Indenture.
Resignation of Trustee
The trustee may resign or be removed with respect to the Notes provided that a successor trustee is appointed to act with respect to the Notes. In the event that two or more persons are acting as trustee with respect to different series of indenture securities under the indenture, each of the trustees will be a trustee of a trust separate and apart from the trust administered by any other trustee.
 
Payment, Paying Agent, Registrar and Transfer Agent
 
The principal amount of each Note will be payable on the stated maturity date at the office of the Paying Agent, Registrar and Transfer Agent for the Notes or at such other office in New York City as we may designate. The trustee will initially act as Paying Agent, Registrar and Transfer Agent for the Notes.
 
Governing Law
 
The Indenture and the Notes will be governed by the laws of the State of New York.
 
Book-Entry Debt Securities
 
The Notes will be represented by global securities that will be deposited and registered in the name of The Depository Trust Company (“DTC”) or its nominee. This means that, except in limited circumstances, you will not receive certificates for the Notes. Beneficial interests in the Notes will be represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and indirect participants in DTC. Investors may elect to hold interests in the Notes through either DTC, if they are a participant, or indirectly through organizations that are participants in DTC.
The Notes will be issued as fully registered securities registered in the name of Cede & Co. (DTC’s partnership nominee) or such other name as may be requested by an authorized representative of DTC. One fully-registered certificate will be issued for the Notes, in the aggregate principal amount of such issue, and will be deposited with DTC. Interests in the Notes will trade in DTC’s Same Day Funds Settlement System, and any permitted secondary market trading activity in such Notes will, therefore, be required by DTC to be settled in immediately available funds. None of the Company, the Trustee or the Paying Agent will have any responsibility for the performance by DTC or its participants or indirect participants of their respective obligations under the rules and procedures governing their operations.
 
DTC is a limited-purpose trust company organized under the New York Banking Law, a “banking organization” within the meaning of the New York Banking Law, a member of the Federal Reserve System, a “clearing corporation” within the meaning of the New York Uniform Commercial Code, and a “clearing agency” registered pursuant to the provisions of Section 17A of the Exchange Act. DTC holds and provides asset servicing for over 3.5 million issues of U.S. and non-U.S. equity, corporate and municipal debt issues, and money market instruments from over 100 countries that DTC’s participants (“Direct Participants”) deposit with DTC. DTC also facilitates the post-trade settlement among Direct Participants of sales and other securities transactions in deposited securities through electronic computerized book-entry transfers and pledges between Direct Participants’ accounts. This eliminates the need for physical movement of securities certificates. Direct Participants include both U.S. and non-U.S. securities brokers and dealers, banks, trust companies, clearing corporations, and certain other organizations. DTC is a wholly owned subsidiary of The Depository Trust & Clearing Corporation (“DTCC”).
 
DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned by the users of its regulated
 
 
S-20

 
 
subsidiaries. Access to the DTC system is also available to others such as both U.S. and non-U.S. securities brokers and dealers, banks, trust companies and clearing corporations that clear through or maintain a custodial relationship with a Direct Participant, either directly or indirectly (“Indirect Participants”). DTC has Standard & Poor’s Ratings Services’ highest rating: AAA. The DTC Rules applicable to its participants are on file with the SEC. More information about DTC can he found at www.dtcc.com and www.dtc.org.
 
Purchases of debt securities under the DTC system must be made by or through Direct Participants, which will receive a credit for the debt securities on DTC’s records. The ownership interest of each actual purchaser of each security (“Beneficial Owner”) is in turn to be recorded on the Direct and Indirect Participants’ records. Beneficial Owners will not receive written confirmation from DTC of their purchase. Beneficial Owners are, however, expected to receive written confirmations providing details of the transaction, as well as periodic statements of their holdings, from the Direct or Indirect Participant through which the Beneficial Owner entered into the transaction. Transfers of ownership interests in the debt securities are to be accomplished by entries made on the books of Direct and Indirect Participants acting on behalf of Beneficial Owners. Beneficial Owners will not receive certificates representing their ownership interests in debt securities, except in the event that use of the book-entry system for the debt securities is discontinued.
 
To facilitate subsequent transfers, all debt securities deposited by Direct Participants with DTC are registered in the name of DTC’s partnership nominee, Cede & Co. or such other name as may be requested by an authorized representative of DTC. The deposit of debt securities with DTC and their registration in the name of Cede & Co. or such other DTC nominee do not effect any change in beneficial ownership. DTC has no knowledge of the actual Beneficial Owners of the debt securities; DTC’s records reflect only the identity of the Direct Participants to whose accounts such debt securities are credited, which may or may not be the Beneficial Owners. The Direct and Indirect Participants will remain responsible for keeping account of their holdings on behalf of their customers.
 
Conveyance of notices and other communications by DTC to Direct Participants, by Direct Participants to Indirect Participants, and by Direct Participants and Indirect Participants to Beneficial Owners will he governed by arrangements among them, subject to any statutory or regulatory requirements as may be in effect from time to time.
 
Redemption notices shall be sent to DTC. If less than all of the debt securities within an issue are being redeemed, DTC’s practice is to determine by lot the amount of the interest of each Direct Participant in such issue to be redeemed.
 
Neither DTC nor Cede & Co. (nor such other DTC nominee) will consent or vote with respect to the Notes unless authorized by a Direct Participant in accordance with DTC’s Procedures. Under its usual procedures, DTC mails an Omnibus Proxy to us as soon as possible after the record date. The Omnibus Proxy assigns Cede & Co.’s consenting or voting rights to those Direct Participants to whose accounts the Notes are credited on the record date (identified in a listing attached to the Omnibus Proxy).
 
Redemption proceeds, distributions, and dividend payments on the Notes will be made to Cede & Co., or such other nominee as may be requested by an authorized representative of DTC. DTC’s practice is to credit Direct Participants’ accounts upon. DTC’s receipt of funds and corresponding detail information from us or the trustee on the payment date in accordance with their respective holdings shown on DTC’s records. Payments by Participants to Beneficial Owners will be governed by standing instructions and customary practices, as is the case with securities held for the accounts of customers in bearer form or registered in “street name,” and will be the responsibility of such Participant and not of DTC nor its nominee, the trustee, or us, subject to any statutory or regulatory requirements as may be in effect from time to time. Payment of redemption proceeds, distributions, and dividend payments to Cede & Co. (or such other nominee as may be requested by an authorized representative of DTC) is the responsibility of us or the trustee, but disbursement of such payments to Direct Participants will be the responsibility of DTC, and disbursement of such payments to the Beneficial Owners will be the responsibility of Direct and Indirect Participants.
 
DTC may discontinue providing its services as securities depository with respect to the Notes at any time by giving reasonable notice to us or to the trustee. Under such circumstances, in the event that a successor securities depository is not obtained, certificates are required to be printed and delivered. We may decide to discontinue use of
 
 
S-21

 
 
the system of book-entry-only transfers through DTC (or a successor securities depository). In that event, subject to DTC’s internal procedures, certificates will be printed and delivered to DTC.
 
The information in this section concerning DTC and DTC’s book-entry system has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy thereof.
 
 
S-22

 
 
UNDERWRITING
UBS Securities LLC and Morgan Stanley & Co. LLC are acting as joint book running managers of the offering and representatives of the underwriters named below. Subject to the terms and conditions stated in the underwriting agreement dated February 19, 2013 the Company agrees to sell, and each underwriter named below severally agrees to purchase, the aggregate principal amount of Notes indicated opposite its respective name in the following table:
 
Underwriters
 
Principal
Amount
 
UBS Securities LLC
  $ 28,000,000  
Morgan Stanley & Co. LLC
  $ 28,000,000  
BB&T Capital Markets, a division of BB&T Securities, LLC
  $ 3,500,000  
JMP Securities LLC
  $ 3,500,000  
MLV & Co. LLC
  $ 3,500,000  
Sterne, Agee & Leach, Inc.
  $ 3,500,000  
Total
  $ 70,000,000  
 
The underwriters are committed to take and pay for all of the Notes being offered, if any are purchased.
Overallotment Option
If the underwriters sell more Notes than the total number set forth in the table above, the underwriters have an option to buy up to an additional $10,500,000 aggregate principal amount of the Notes from us. They may exercise that option for 30 days from the date of this prospectus supplement.  If any Notes are purchased pursuant to this option, the underwriters will severally purchase such Notes in approximately the same proportion as set forth in the table above.
Commissions and Discounts
The following table shows the per Note and total underwriting discounts and commissions to be paid by us to the underwriters. These amounts are shown assuming both no exercise and full exercise of the underwriters’ option to purchase additional Notes.
 
Paid by MVC Capital, Inc.
 
No
Exercise
   
Full
Exercise
 
Per Note
    3.15 %     3.15 %
Total
  $ 2,205,000     $ 2,535,750  
 
Notes sold by the underwriters to the public will initially be offered at the public offering price set forth on the cover of this prospectus supplement and to certain dealers at a price less a concession not in excess of $0.50 per Note. The underwriters may allow, and the dealers may reallow, a discount from the concession not in excess of $0.45 per Note to certain broker dealers. If all the Notes are not sold at the public offering price, the representative may change the offering price and the other selling terms. The offering of the Notes by the underwriters is subject to receipt and acceptance and subject to the underwriters’ right to reject any order in whole or in part.
 
We estimate that our share of the total expenses of the offering, excluding underwriting discounts, will be approximately $564,000.
We have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act.
No Sales of Similar Securities
Subject to certain exceptions, we have agreed not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of any debt securities issued or guaranteed by the Company or any securities convertible into or exercisable or exchangeable for debt securities issued or guaranteed by the Company or file any registration statement under the Securities Act with respect to any of the foregoing for a period
 
 
S-23

 
 
of 30 days after the date of this prospectus supplement without first obtaining the prior written consent of UBS Securities LLC and Morgan Stanley & Co. LLC.
Listing
The Notes are a new issue of securities with no established trading market. We intend to apply to list the Notes on the NYSE under the symbol “MVCB”. If the application is approved, we expect trading in the Notes on the NYSE to begin within 30 days after the original issue date. Currently there is no public market for the Notes and we can provide no assurance that the Notes will be approved for listing on the NYSE or that an active trading market will develop for the Notes.
We have been advised by the underwriters that they presently intend to make a market in the Notes after completion of the offering as permitted by applicable laws and regulations. The underwriters are not obligated, however, to make a market in the Notes and any such market-making may be discontinued at any time in the sole discretion of the underwriters without any notice. Accordingly, no assurance can be given as to the liquidity of, or development of a public trading market for, the Notes. If an active public trading market for the Notes does not develop, the market price and liquidity of the Notes may be adversely affected.
Price Stabilizations and Short Positions
 
In connection with the offering, the underwriters may purchase and sell Notes in the open market. Purchases and sales in the open market may include short sales, purchases to cover short positions and stabilizing purchases.
 
 
Short sales involve secondary market sales by the underwriters of a greater number of Notes than they are required to purchase in the offering.
 
 
Covering transactions involve purchases of Notes in the open market after the distribution has been completed in order to cover short positions.
 
 
Stabilizing transactions involve bids to purchase Notes so long as the stabilizing bids do not exceed a specified minimum.
 
The underwriters also may impose a penalty bid. Penalty bids permit the underwriters to reclaim a selling concession from a syndicate member when the underwriters, in covering short positions or making stabilizing purchases, repurchase Notes originally sold by that syndicate member in order to cover short positions or make stabilizing purchases.
 
Purchases to cover short positions and stabilizing purchases, as well as other purchases by the underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of the Notes. They may also cause the price of the Notes to be higher than the price that would otherwise exist in the open market in the absence of these transactions. The underwriters may conduct these transactions on the NYSE, in the over-the-counter market or otherwise. If the underwriters commence any of these transactions, they may discontinue them at any time.
 
Additional Underwriter Compensation
The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for the issuer, for which they received or will receive customary fees and expenses, including acting as underwriters for our securities offerings. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.
 
 
S-24

 
 
Settlement
We expect that delivery of the Notes will be made against payment therefor on or about February 26, 2013, which will be the fifth business day following the date of the pricing of the Notes (such settlement being herein referred to as “T+5”). Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), trades in the secondary market generally are required to settle in three business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to the date of delivery hereunder will be required, by virtue of the fact that the Notes initially will settle in T+5 business days, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement.
Other Jurisdictions
Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the Notes offered by this prospectus supplement in any jurisdiction where action for that purpose is required. The Notes offered by this prospectus supplement may not be offered or sold, directly or indirectly, nor may this prospectus supplement or any other offering material or advertisements in connection with the offer and sale of any such Notes be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus supplement comes are advised to inform themselves about and to observe any restriction relating to the offering and the distribution of this prospectus supplement. This prospectus supplement and the accompanying prospectus do not constitute an offer to sell or a solicitation of an offer to buy the Notes offered by this prospectus supplement and the accompanying prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.
 
The addresses of the underwriters are: UBS Securities LLC, 677 Washington Boulevard, Stamford, CT 06901; Morgan Stanley & Co. LLC, 180 Varick Street, New York, NY 10014; BB&T Capital Markets, a division of BB&T Securities, LLC, 901 East Byrd Street, Richmond, VA 23219; JMP Securities LLC, 450 Park Avenue, New York, NY 10022; MLV & Co. LLC, 1251 Avenue of the Americas, New York, NY 10020 and Sterne, Agee & Leach, Inc., 277 Park Avenue, New York, NY 10172.
 
 
S-25

 
 
MATERIAL U.S. FEDERAL TAX CONSIDERATIONS
The following discussion is a general summary of the material United States federal income tax considerations (and, in the case of a non-U.S. holder (as defined below), the material United States federal estate tax considerations) applicable to an investment in the Notes. This summary does not purport to be a complete description of the tax considerations applicable to such an investment. The discussion is based upon the Internal Revenue Code of 1986, as amended (the “Code”), Treasury Regulations, and administrative and judicial interpretations, each as of the date of this prospectus supplement and all of which are subject to change, potentially with retroactive effect. You should consult your own tax advisor with respect to tax considerations that pertain to your purchase of our Notes.
 
This discussion deals only with Notes held as capital assets within the meaning of Section 1221 of the Code and does not purport to deal with persons in special tax situations or special classes of taxpayers, such as financial institutions, insurance companies, controlled foreign corporations, passive foreign investment companies and regulated investment companies (and shareholders of such corporations), dealers in securities or currencies, traders in securities, former citizens of the United States, persons holding the Notes as a hedge against currency risks or as a position in a “straddle,” “hedge,” “constructive sale transaction” or “conversion transaction” for tax purposes, entities that are tax-exempt for United States federal income tax purposes, retirement plans, individual retirement accounts, tax-deferred accounts, persons subject to the alternative minimum tax, pass-through entities (including partnerships and entities and arrangements classified as partnerships for United States federal income tax purposes) and beneficial owners of pass-through entities, or U.S. holders (as defined below) whose functional currency is not the U.S. dollar. It also does not deal with beneficial owners of the Notes other than original purchasers of the Notes who acquire the Notes in this offering for a price equal to their original issue price (i.e., the first price at which a substantial amount of the Notes is sold other than to bond houses, brokers, or similar persons or organizations acting in the capacity of underwriters, placement agents or wholesalers). This discussion does not address any aspects of foreign, state or local tax laws. If you are considering purchasing the Notes, you should consult your own tax advisor concerning the application of the United States federal tax laws to you in light of your particular situation, as well as any consequences to you of purchasing, owning and disposing of the Notes under the laws of any other taxing jurisdiction.
 
For purposes of this discussion, the term “U.S. holder” means a beneficial owner of a Note that is, for United States federal income tax purposes, (i) an individual citizen or resident of the United States, (ii) a corporation or other entity treated as a corporation for United States federal income tax purposes, created or organized in or under the laws of the United States or of any political subdivision thereof, (iii) a trust (a) if one or more United States persons have the authority to control all of its substantial decisions and a court in the United States is able to exercise primary supervision over its administration, or (b) that existed on August 20, 1996 and has in effect a valid election (under applicable Treasury Regulations) to be treated as a domestic trust for United States federal income tax purposes, or (iv) an estate the income of which is subject to United States federal income taxation regardless of its source. The term “non-U.S. holder” means a beneficial owner of a Note that is neither a U.S. holder nor a partnership (including an entity or arrangement treated as a partnership for United States federal income tax purposes). An individual may, subject to exceptions, be deemed to be a resident alien, as opposed to a non-resident alien, by, among other ways, being present in the United States (i) on at least 31 days in the calendar year, and (ii) for an aggregate of at least 183 days during a three-year period ending in the current calendar year, counting for such purposes all of the days present in the current year, one-third of the days present in the immediately preceding year, and one-sixth of the days present in the second preceding year. Resident aliens are subject to United States federal income tax as if they were United States citizens.
 
If a partnership (including an entity or arrangement treated as a partnership for United States federal income tax purposes) holds any Notes, the United States federal income tax treatment of a partner of the partnership generally will depend upon the status of the partner, the activities of the partnership and certain determinations made at the partner level. Partners of partnerships holding Notes should consult their own tax advisors.
 
Taxation of Note Holders
 
We are of the opinion that, under present law, the Notes will constitute our indebtedness for United States federal income tax purposes, and the discussion below assumes that the Notes will be so treated. We intend to treat all payments made with respect to the Notes consistent with this characterization.
 
 
S-26

 
 
Payments or accruals of interest on a Note generally will be taxable to a U.S. holder as ordinary interest income at the time they are received (actually or constructively) or accrued, in accordance with the U.S. holder’s regular method of tax accounting.
 
Upon the sale, exchange, redemption, retirement or other taxable disposition of a Note, a U.S. holder generally will recognize capital gain or loss equal to the difference between the amount realized on the sale, exchange, redemption, retirement or other taxable disposition (excluding amounts representing accrued and unpaid interest, which are treated as ordinary income) and the U.S. holder’s adjusted tax basis in the Note. A U.S. holder’s adjusted tax basis in a Note generally will equal the amount of the U.S. holder’s initial investment in the Note. Capital gain or loss generally will be long-term capital gain or loss if the Note was held for more than one year. Long-term capital gains recognized by individuals and certain other non-corporate U.S. holders generally are eligible for reduced rates of taxation. A U.S. holder’s ability to offset capital losses against ordinary income is subject to limitation.
 
A tax of 3.8% will be imposed on the amount of “net investment income,” in the case of an individual, or undistributed “net investment income,” in the case of an estate or trust (other than a charitable trust), which exceeds certain threshold amounts. “Net investment income” as defined for this purpose generally includes interest payments and gain recognized from the sale or other disposition of the Notes. Qualified pension trusts, which are not subject to income taxes generally, and non-U.S. individuals will not be subject to this tax. U.S. holders should consult their own tax advisors regarding the effect, if any, of this tax on their ownership and disposition of the Notes.
 
Taxation of Non-U.S. Holders.  A non-U.S. holder generally will not be subject to United States federal income tax or withholding of such tax on payments of interest on a Note provided that (i) interest on the Note is not effectively connected with the conduct by the non-U.S. holder of a trade or business within the United States (or, if it is so effectively connected, is not attributable to a United States “permanent establishment” maintained by the non-U.S. holder, if required by an applicable treaty), (ii) the non-U.S. holder is not a controlled foreign corporation related to the Company through sufficient stock ownership (as provided in the Code), (iii) the non-U.S. holder is not a bank receiving interest described in Section 881(c)(3)(A) of the Code, (iv) the non-U.S. holder does not own (actually or constructively) 10% or more of the total combined voting power of all classes of stock of the Company entitled to vote within the meaning of Section 871(h)(3) of the Code and the Treasury Regulations thereunder, and (v) the non-U.S. holder provides to the applicable withholding agent a statement in the year in which a payment occurs or in the preceding 3 years, on an Internal Revenue Service (IRS) Form W-8BEN (or other applicable form), signed under penalties of perjury, that includes its name and address and certifies, in compliance with applicable requirements that the non-U.S. holder is the beneficial owner and is not a United States person, or satisfies documentary evidence requirements for establishing that it is not a United States person.
 
A non-U.S. holder that is not exempt from tax under these rules generally will be subject to withholding of United States federal income tax on payments of interest on the Notes at a rate of 30% unless (i) the interest is effectively connected with the non-U.S. holder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, is attributable to a United States “permanent establishment” maintained by the non-U.S. holder), so long as the non-U.S. holder has provided to the applicable withholding agent an IRS Form W-8ECI (or substantially similar substitute form) stating that the interest on the Notes is effectively connected with the non-U.S. holder’s conduct of a trade or business within the United States, in which case the interest will be subject to United States federal income tax on a net income basis at the regular graduated rates and in the manner applicable to U.S. holders generally (unless an applicable income tax treaty provides otherwise), or (ii) an applicable income tax treaty provides for a lower rate of, or exemption from, this withholding.
 
To claim the benefit of an income tax treaty or to claim exemption from withholding because interest is effectively connected with a United States trade or business, a non-U.S. holder must timely provide the appropriate, properly executed IRS forms to the applicable withholding agent. The non-U.S. holder must inform this withholding agent of any changes on these forms within 30 days of such change. These forms may be required to be periodically updated.
 
Generally, a non-U.S. holder will not be subject to United States federal income tax or withholding of such tax on any amount that constitutes capital gain upon the sale, exchange, redemption, retirement or other taxable
 
 
S-27

 
 
disposition of a Note, unless (i) the gain is effectively connected with the conduct of a trade or business in the United States by the non-U.S. holder (and, if required by an applicable income tax treaty, is attributable to a United States “permanent establishment” maintained by the non-U.S. holder), in which case the gain will be subject to United States federal income tax on a net income basis at the regular graduated rates and in the manner applicable to U.S. holders generally or (ii) the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of the sale, exchange, redemption, retirement or other taxable disposition and meets certain other conditions, in which case, except as otherwise provided by an applicable income tax treaty, the gain, which may be offset by certain U.S.-source capital losses, generally will be subject to a flat 30% United States federal income tax, even though the non-U.S. holder is not considered a resident alien under the Code. Certain other exceptions may be applicable, and a non-U.S. holder should consult its tax advisor in this regard.
 
A non-U.S. holder that is a corporation for United States federal income tax purposes and that receives interest on, or recognizes capital gain on the disposition of, the Notes that is effectively connected with the non-U.S. holder’s conduct of a trade or business within the United States may also be subject to a branch profits tax (which is generally imposed on a non-U.S. corporation on the actual or deemed repatriation from the United States of earnings and profits, including such interest or gain, attributable to a United States trade or business) at a 30% rate. The non-U.S. holder may be exempt from the branch profits tax or subject to the branch profits tax at a reduced rate, if the non-U.S. holder is a qualified resident of a country with which the United States has an income tax treaty.
 
A Note that is held by an individual who, at the time of death, is not a citizen or resident of the United States (as specially defined for United States federal estate tax purposes) generally will not be subject to the United States federal estate tax, unless, at the time of death, (i) such individual actually or constructively owns 10% or more of the total combined voting power of all classes of our stock entitled to vote within the meaning of Section 871(h)(3) of the Code and the Treasury Regulations thereunder or (ii) such individual’s interest in the Notes is effectively connected with the individual’s conduct of a trade or business within the United States.
 
Information Reporting and Backup Withholding.  A U.S. holder (other than an “exempt recipient,” including a corporation and certain other persons who, when required, demonstrate their exempt status) may be subject to backup withholding at a rate of 28% on, and to information reporting requirements with respect to, payments of interest on, and proceeds from the sale, exchange, redemption, retirement or other taxable disposition of, the Notes. In general, if a non-corporate U.S. holder subject to information reporting fails to furnish a correct taxpayer identification number or otherwise fails to comply with applicable backup withholding requirements, backup withholding at the applicable rate may apply.
 
In addition, backup withholding tax and certain other information reporting requirements apply to payments of interest on, and proceeds from the sale, exchange, redemption, retirement or other taxable disposition of, the Notes held by a non-U.S. holder, unless an exemption applies. Backup withholding and information reporting will not apply to such payments made to a non-U.S. holder if such non-U.S. holder has provided to the applicable withholding agent under penalties of perjury the required certification that the non-U.S. holder is not a United States person as discussed above (and the applicable withholding agent does not have actual knowledge or reason to know that the non-U.S. holder is a United States person) or if the non-U.S. holder is an exempt recipient. However, the amount of interest we pay to a non-U.S. holder on the Notes will be reported to such non-U.S. holder and to the IRS annually on an IRS Form 1042-S even if the non-U.S. holder is exempt from the 30% withholding tax described above. Copies of the information returns reporting those payments and the amounts withheld may also be made available to the tax authorities in the country where the non-U.S. holder is resident under provisions of an applicable income tax treaty or agreement.
 
If a non-U.S. holder sells or redeems a Note through a U.S. office of a U.S. or non-U.S. broker, the proceeds from such sale or redemption will be subject to information reporting and backup withholding unless such non-U.S. holder provides to the broker a withholding certificate or other appropriate documentary evidence establishing that such non-U.S. holder is not a United States person and such broker does not have actual knowledge or reason to know that such non-U.S. holder is a United States person, or the non-U.S. holder is an exempt recipient eligible for an exemption from information reporting and backup withholding. If a non-U.S. holder sells or redeems a Note through the non-U.S. office of a broker who is a United States person or has certain enumerated connections with the United States, the proceeds from such sale or redemption will be subject to information reporting unless the non-U.S. holder provides to such broker a withholding certificate or other documentary evidence establishing that
 
 
S-28

 
 
the non-U.S. holder is not a United States person and such broker does not have actual knowledge or reason to know that such non-U.S. holder is a United States person, or the non-U.S. holder is an exempt recipient eligible for an exemption from information reporting. In circumstances where information reporting by the non-U.S. office of such a broker is required, backup withholding will be required only if the broker has actual knowledge that the non-U.S. holder is a United States person.
 
You should consult your tax advisor regarding the qualification for an exemption from backup withholding and information reporting and the procedures for obtaining such an exemption, if applicable. Backup withholding is not an additional tax, and any amounts withheld under the backup withholding rules from a payment to a beneficial owner generally will be allowed as a refund or a credit against such beneficial owner’s United States federal income tax liability provided the required information is timely furnished to the IRS.
 
Foreign Account Tax Compliance Act
 
Legislation enacted in 2010 imposes a withholding tax of 30% on payments of interest or gross proceeds from the disposition of a debt instrument paid after December 31, 2012 to certain non-U.S. entities, including certain non-U.S. financial institutions and investment funds, unless such non-U.S. entity complies with certain reporting requirements regarding its United States account holders and its United States owners. However, the new withholding obligations will not apply to obligations, such as the Notes, that are outstanding on January 1, 2014. Prospective purchasers of the Notes should consult their own tax advisors regarding the new withholding and reporting provisions.
 
You should consult your own tax advisor with respect to the particular tax consequences to you of an investment in the Notes, including the possible effect of any pending legislation or proposed regulations.
 
 
S-29

 
 
LEGAL MATTERS
The validity of the Notes offered by this prospectus supplement and certain other legal matters will be passed upon for us by Kramer Levin Naftalis & Frankel LLP, New York, New York. Certain legal matters related to the offering will be passed upon for the underwriters by Fried, Frank, Harris, Shriver & Jacobson LLP, New York, New York.
 
 
S-30

 
 
WHERE YOU CAN FIND ADDITIONAL INFORMATION
We have filed with the SEC a registration statement on Form N-2, together with all amendments and related exhibits, under the Securities Act, with respect to the Notes offered by this prospectus supplement. The registration statement contains additional information about us and the Notes being offered by this prospectus supplement. Please also read the accompanying prospectus.
 
We file with or furnish to the SEC annual, quarterly and current reports, proxy statements and other information meeting the informational requirements of the Exchange Act. You may inspect and copy these reports, proxy statements and other information, as well as the registration statement and related exhibits and schedules, at the Public Reference Room of the SEC at 100 F Street, N.E., Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements and other information filed electronically by us with the SEC, which are available on the SEC’s website at www.sec.gov. Copies of these reports, proxy and information statements and other information may be obtained, after paying a duplicating fee, by electronic request at the following e-mail address: publicinfo@sec.gov, or by writing the SEC’s Public Reference Section, 100 F Street, N.E., Washington, D.C. 20549.
 
 
S-31

 
 
$250,000,000
 
 
Common Stock
Preferred Stock
Warrants
Debt Securities
 
MVC Capital, Inc. is a closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "1940 Act"). Our investment objective is to seek to maximize total return from capital appreciation and/or income. We seek to achieve our investment objective primarily by providing debt and equity financing to small and middle-market companies that are, for the most part, privately owned. No assurances can be given that we will achieve our objective.
 
We are managed by The Tokarz Group Advisers LLC, a registered investment adviser.
 
We may offer, from time to time, in one or more offerings or series, together or separately, up to $250,000,000 of our common stock, preferred stock, debt securities or warrants representing rights to purchase shares of our common stock, preferred stock or debt securities, which we refer to, collectively, as the "securities." The securities may be offered at prices and on terms to be described in one or more supplements to this prospectus.
 
Our common stock is traded on the New York Stock Exchange under the symbol "MVC."
 
This prospectus, and the accompanying prospectus supplement, if any, sets forth information about us that a prospective investor should know before investing. It includes the information required to be included in a prospectus and statement of additional information. Please read it before you invest and keep it for future reference. You may request a free copy of this prospectus, and the accompanying prospectus supplement, if any, annual and quarterly reports, and other information about us, and make shareholder inquiries by calling (914) 510-9400, by writing to us or from our website at www.mvccapital.com. Additional information about us has been filed with the Securities and Exchange Commission and is available on the Securities and Exchange Commission's website at www.sec.gov.
________________
 
We invest in securities that generally are not rated by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are commonly referred to as “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.
________________
 
Our shares have historically traded at a discount to net asset value, which may create an additional risk of loss of your investment.
________________
 
Investing in our securities involves a high degree of risk. Before buying any securities, you should read the discussion of the material risks of investing in our securities, including the risk of leverage, in "Risk Factors" beginning on page 15 of this prospectus.
________________
 
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
________________
 
This prospectus may not be used to consummate sales of securities unless accompanied by a prospectus supplement.
________________
 
Prospectus dated February 13, 2013

 
 

 

TABLE OF CONTENTS
 
You should rely only on the information contained in this prospectus and the accompanying prospectus supplement, if any. We have not authorized anyone to provide you with additional information, or information different from that contained in this prospectus and the accompanying prospectus supplement, if any. If anyone provides you with different or additional information, you should not rely on it. We are offering to sell, and seeking offers to buy, securities only in jurisdictions where offers and sales are permitted. The information contained in or incorporated by reference in this prospectus and the accompanying prospectus supplement, if any, is accurate only as of the date of this prospectus or such prospectus supplement; however, the prospectus and such supplement will be updated to reflect any material changes.  Our business, financial condition, results of operations and prospects may have changed since then.
 
PROSPECTUS SUMMARY
1
WHERE YOU CAN FIND ADDITIONAL INFORMATION
11
FEES AND EXPENSES
12
SELECTED CONSOLIDATED FINANCIAL DATA
13
RISK FACTORS
15
DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS
30
USE OF PROCEEDS
30
PRICE RANGE OF COMMON STOCK AND DISTRIBUTIONS
31
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
31
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
66
SENIOR SECURITIES
66
PORTFOLIO COMPANIES
80
DETERMINATION OF COMPANY'S NET ASSET VALUE
87
MANAGEMENT
90
COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS
95
ADVISORY AGREEMENT
97
CONTROL PERSONS AND PRINCIPAL HOLDERS OF SECURITIES
103
FEDERAL INCOME TAX MATTERS
104
CERTAIN GOVERNMENT REGULATIONS
109
DIVIDEND REINVESTMENT PLAN
111
DESCRIPTION OF SECURITIES
112
PLAN OF DISTRIBUTION
114
LEGAL COUNSEL
115
SAFEKEEPING, TRANSFER AND DIVIDEND PAYING AGENT AND REGISTRAR
115
BROKERAGE ALLOCATION AND OTHER PRACTICES
115
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
115
   
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
F-1
 
 
i

 
 
ABOUT THIS PROSPECTUS
 
This prospectus is part of a registration statement that we have filed with the Securities and Exchange Commission, or SEC, using the "shelf" registration process. Under the shelf registration process, we may offer, from time to time, up to an aggregate of $250,000,000 of our common stock, preferred stock, debt securities or warrants representing rights to purchase shares of our common stock, preferred stock or debt securities on the terms to be determined at the time of the offering. The securities may be offered at prices and on terms described in one or more supplements to this prospectus.  This prospectus provides you with a general description of the securities that we may offer. Each time we use this prospectus to offer securities, we will provide a prospectus supplement that will contain specific information about the terms of that offering. The prospectus supplement may also add, update or change information contained in this prospectus. Please carefully read this prospectus and any prospectus supplement together with any exhibits and the additional information described under the heading "Where You Can Find Additional Information" and the section under the heading "Risk Factors" before you make an investment decision.
 
 
ii

 

PROSPECTUS SUMMARY
 
The following summary highlights some of the information in this prospectus. It is not complete and may not contain all the information that you may want to consider. We encourage you to read this entire document and the documents to which we have referred.
 
In this prospectus and any accompanying prospectus supplement, unless otherwise indicated, "MVC Capital," "we," "us," "our" or the "Company" refer to MVC Capital, Inc. and its subsidiary, MVC Financial Services, Inc. ("MVCFS"), and "TTG Advisers" or the "Adviser" refers to The Tokarz Group Advisers LLC.
 
ABOUT MVC CAPITAL
 
Overview
 
MVC Capital is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act. MVC Capital provides debt and equity investment capital to fund growth, acquisitions and recapitalizations of small and middle-market companies in a variety of industries primarily located in the United States.  Our investments can take the form of common and preferred stock and warrants or rights to acquire equity interests, senior and subordinated loans, or convertible securities.  Our common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "MVC."
 
Our Corporate History
 
From 2000 through 2003, the Company experienced significant valuation declines from investments made by the original management team.  During fiscal 2002, the Company's largest shareholder at the time launched a proxy contest against the former management.  In late February 2003, a shareholder meeting was held which replaced the entire Board of Directors who then removed the former management of the Company.
 
In September 2003, the Company's shareholders voted to implement the Board of Director's long-term plan  to adopt and amend the investment objective and strategy of the Company,  seeking to maximize total return from more traditional mezzanine investments, senior and subordinated loans and other private equity investments and to elect a new Chairman and Portfolio Manager, Michael Tokarz.  Also as part of the long-term plan of the Board, the Company decided to conduct a tender offer for 25% of the Company's outstanding shares at a price of 95% of the net asset value of the Company.
 
While the Company has been in operation since 2000, fiscal 2004 marked a new beginning for the Company as this period reflects when Mr. Tokarz and his management team assumed portfolio management responsibilities for the Company.  As part of this change, Mr. Tokarz and his team determined to manage the existing investments made by the prior management which we refer to as our Legacy Investments.  After only three quarters of operations under the new management team, the Company posted a profitable third quarter for fiscal year 2004, reversing a trend of 12 consecutive quarters of net investment losses and earned a profit for the entire fiscal year.
 
As described above, the current management team determined to manage the Legacy Investments, which were comprised of all the remaining portfolio investments made by the original management team.  At the time that the current management team took over the portfolio responsibilities of the Company, the fair market value of the Legacy Investments was $24.1 million.  Through active management of these assets, current management was able to realize $58.6 million of cash from the Legacy Investments, providing more than $34 million of value to the  Company’s shareholders.  As of October 31, 2012, the Legacy Investments represent 2.36% of the Company's assets.
 
During fiscal 2006, the Company found itself being presented with a number of opportunities to manage and invest in various private funds and offshore enterprises.  Under the internal management structure, due to regulatory and tax constraints on the Company, due to its status as a business development company and regulated investment company, the Company was restricted in its ability to participate in many of these opportunities.  During fiscal 2006, the Board developed a structure that would allow the Company's stockholders to benefit from a broader range of investment and management opportunities and, in this connection, determined to externalize the Company's management.  The Board proposed the externalization to shareholders for a vote, which was overwhelmingly approved in September 2006.  As a result, beginning on November 1, 2006, TTG Advisers began serving as the Company's external investment adviser.  (All of the employees of the Company immediately prior to that date became employees of TTG Advisers.)
 
 
 

 
 
Our Management
 
The Company is managed by TTG Advisers, the Company's investment adviser, which is headed by Michael Tokarz, who has over 35 years of lending and investment experience. TTG Advisers has a dedicated originations and transaction development investment team with significant experience in private equity, leveraged finance, investment banking, distressed debt transactions and business operations. The members of the investment team have invested in and managed businesses during both recessionary and expansionary periods, through interest rate cycles and a variety of financial market conditions. TTG Advisers has 12 full-time investment professionals and two part-time investment professionals. TTG Advisers also uses the services of other investment professionals with whom it has developed long-term relationships, on an as-needed basis. In addition, TTG Advisers employs seven other full-time professionals and two part-time professionals who manage the operations of the Company and provide investment support functions both directly and indirectly to our portfolio companies. As TTG Advisers grows, it expects to hire, train, supervise and manage new employees at various levels, many of whom would be expected to provide services to the Company.
 
When the current management team began managing the Company in fiscal 2004, total assets after the tender offer were $108.3 million.  Since then and through October 31, 2012, the Company generated over $230 million of bottom line performance (net change in net assets resulting from operations).  The current management team has also earned approximately $186.8 million in realized and unrealized gains (net of realized and unrealized losses) thus far on the portfolio (through October 31, 2012) and has repurchased approximately $37.0 million of stock below NAV, including the shares purchased during the 2004 tender offer.
 
Beginning in fiscal 2004, after nearly three years of not paying a dividend under the previous management team, the Company began paying a $0.12 per share dividend, with an average annual distribution rate of $0.42 per share since that time. From fiscal 2004 through fiscal 2012, the Company paid over $85 million in dividends, of which $79.5 million was paid from ordinary income, $2.2 million was paid from capital gains and $3.9 million represented a return of capital on a tax basis.  During fiscal 2012, the Company paid $0.495 per share in dividends.  Recently, the Company declared a 13.5 cent per share dividend for each of the fourth fiscal quarter of 2012 and the first fiscal quarter of 2013.  The most recent distribution represents the thirty-first consecutive quarterly dividend paid by the Company since implementing a dividend policy in July 2005.
 
Our Portfolio
 
We continue to perform due diligence and seek new investments that are consistent with our objective of maximizing total return from capital appreciation and/or income. We believe that we have extensive relationships with private equity firms, investment banks, business brokers, commercial banks, accounting firms, law firms, hedge funds, other investment firms, industry professionals and management teams of several companies, which can continue to provide us with investment opportunities.
 
We are currently working on an active pipeline of potential new investment opportunities with a view to move the composition of our portfolio to a more yielding portfolio, over time.  As of October 31, 2012, our portfolio is currently comprised of approximately 78% equity and 22% debt investments.  Our goal is that, over time, yielding investments (i.e., investments that produce regular income or cash distributions) will comprise the majority of our portfolio.  During fiscal 2012, two of the Company's largest investments (based upon fair market value), U.S. Gas & Electric, Inc. and Summit Research Labs, Inc. paid dividends to the Company, totaling approximately $14.4 million. Although the majority of the current portfolio is comprised of equity investments, the Company expects to continue seeking to earn income distributions from certain portfolio companies, thereby enhancing our opportunity to generate yield for our shareholders.
 
We recently signed an agreement to sell one of our portfolio companies, Summit Research Labs, a specialty chemical company that manufactures and markets antiperspirant actives globally. The sale is subject to the satisfaction of customary closing conditions and regulatory approvals. Assuming full realization of all closing conditions, we should receive gross proceeds of $63 million, an approximate gain of $47 million that results in an estimated gross IRR of 31% (calculated as of August 2006, the time of the original investment). As part of the sale, we will provide Summit with a $22 million second lien loan.
 
 
2

 
 
We expect that our loan and equity investments will generally range between $3 million and $25 million each, although we may occasionally invest smaller or greater amounts of capital depending upon the particular investment. While the Company does not adhere to a specific equity and debt asset allocation mix, no more than 25% of the value of our total assets may be invested in the securities of one issuer (other than U.S. government securities), or of two or more issuers that are controlled by us and are engaged in the same or similar or related trades or businesses, determined as of the close of each quarter. Our portfolio company investments are typically illiquid and are made through privately negotiated transactions.  We generally target companies with annual revenues of between $10.0 million and $150.0 million and annual EBITDA (earnings before net interest expense, income tax expense, depreciation and amortization) of between $3.0 million and $25.0 million.  We generally seek to invest in companies with a history of strong, predictable, positive EBITDA.
 
Due to our asset growth and composition, compliance with the RIC (as defined below) requirements currently restricts our ability to make to make additional investments that represent more than 5% of our total assets or more than 10% of the outstanding voting securities of the issuer (“Non-Diversified Investments”).  Among the key factors resulting in this current restriction is that, at the time of original investment, certain portfolio investments were “Diversified” because they represented (on a cost basis) significantly less than 5% of the Company’s total assets.  However, since then, the fair values of certain of these investments (e.g., U.S. Gas) have grown significantly thereby causing the investment to be reclassified as “Non-Diversified” as it surpassed the 5% threshold.  Accordingly, to maintain adherence to the diversification requirements, the Company currently is restricted from making additional Non-Diversified Investments.  This restriction causes us to forgo certain investment opportunities that we may otherwise deem attractive (including in existing portfolio companies that are deemed “Non-Diversified”).  See the discussion on the Company's diversification compliance in "Federal Income Tax Matters" on page 104 and the "Risk Factors" on page 15 for more information (including the risk that complying with this limitation can cause us to forego otherwise attractive opportunities).
 
As of October 31, 2012, the Company's net assets were approximately $386 million compared with net assets of approximately $137 million at October 31, 2003 (immediately prior to Mr. Tokarz assuming portfolio management responsibilities for the Company), an approximate $144.9 million or 106% cumulative increase (this increase does not include $104.1 million in net capital contributions since the beginning of fiscal 2004).  Since Mr. Tokarz and his team assumed portfolio management control of the Company through October 31, 2012, the Company's market value per share increased from $8.10 to $12.36, a return of 52.6%.  Over the same period, the net asset value per share increased from $8.48 as of October 31, 2003 to $16.14 as of October 31, 2012 (which includes the effects of the capital contributions mentioned above).  At the same time, the Company's common stock price discount to NAV was (4.5)% as of October 31, 2003 and (23.4)% as of October 31, 2012, with an average annual market discount rate of (14.1)% based on the common stock price and NAV per share on the last day of each fiscal year from 2004 to 2012.  The Company's average annual yield was 2.8% based on net assets per share as of the last day of each fiscal year from 2004 to 2012 and 3.4% based on common stock price on the last day of each fiscal year from 2004 to 2012.
 
Fiscal year 2012 represented a year where we increased our liquidity, continued to allocate capital at a deliberate pace into new opportunities while supporting our existing portfolio companies.  The Company made two new investments in Freshii USA, Inc. ("Freshii") and Biovation Holdings, Inc. ("Biovations") and nine follow-on investments in the following five existing portfolio companies: MVC Partners, LLC ("MVC Partners") Limited Partnership interest, MVCFS' General Partnership interest, Centile Holdings B.V. ("Centile"), SGDA Sanierungsgesellschaft fur Deponien und Altasten GmbH ("SGDA") and SHL Group Limited.  The total capital committed in fiscal year 2012 was $11.3 million compared to $43.2 million committed in fiscal year 2011 and $8.3 million committed in fiscal year 2010.
 
MVC Private Equity Fund, L.P.. In seeking to achieve our investment objective, we established subsidiaries to sponsor, and provide services to, a private equity fund, MVC Private Equity Fund, L.P. (the “PE Fund”). Specifically, on October 29, 2010, the Company committed to invest approximately $20.1 million in the PE Fund.  MVC GP II, LLC, an indirect wholly-owned subsidiary of the Company, serves as the general partner of the PE Fund (the “GP”).  Substantially all of the Company's commitment was made by our wholly-owned subsidiary, MVC Partners, as a limited partner investor in the Fund.  Additionally, pursuant to the direction of the Company and the GP, MVC Partners, as the anchor investor and sponsor of the PE Fund, was designated as the “Carried Interest Partner,” entitling it to up to 30% of the carried interest generated by the PE Fund.  The GP’s general partnership interest capital commitment is nominal – approximately $500,000 of the total $20.1 million capital commitment attributable to the Company.  The Company’s capital commitment (i.e., its investment in the Fund) was made mostly through MVC Partners’ limited partnership interest for tax efficiency reasons, including that, for tax purposes, MVC Partners is a partnership (i.e., a look through vehicle), which can help limit the Company’s taxable income associated with its investment in the PE Fund.  The PE Fund has closed on approximately $104 million of capital commitments.  As of October 31, 2012, the Company has contributed to the PE Fund $8.0 million of its $19.6 million limited partner capital commitment, and the GP has contributed $200,000 of its general partner capital commitment.  As of October 31, 2012, the PE Fund has invested in Plymouth Rock Energy, LLC, Gibdock Limited and Focus Pointe Holdings, Inc.  We may continue to establish additional subsidiaries for similar purposes and/or sponsor additional private equity or other investment funds in seeking to achieve our investment objective. 
 
 
3

 
 
Our portfolio company investments currently consist of common and preferred stock, other forms of equity interest and warrants or rights to acquire equity interests, senior and subordinated loans, and convertible securities in addition to our interest in the PE Fund. At October 31, 2012, the value of all investments in portfolio companies was approximately $404.2 million and our gross assets were approximately $456.4 million.
 
We expect that our investments in senior loans, subordinated debt, mezzanine debt and other yielding instruments will generally have stated terms of three to ten years. However, there is no limit on the maturity or duration of any security in our portfolio. Our debt investments are not, and typically will not be, rated by any rating agency, but we believe that if such investments were rated, they would be below investment grade (rated lower than "Baa3" by Moody's or lower than "BBB-" by Standard & Poor's). We may invest without limit in debt of any rating and debt that has not been rated by any nationally recognized statistical rating organization.
 
Our Board of Directors (the "Board") has the authority to change any of the strategies described in this prospectus without seeking the approval of our shareholders. However, the 1940 Act prohibits us from altering or changing our investment objective, strategies or policies such that we cease to be a business development company and prohibits us from voluntarily withdrawing our election to be regulated as a business development company, without the approval of the holders of a "majority of the outstanding voting securities," as defined in the 1940 Act, of the Company.
 
COMPETITIVE ADVANTAGES
 
We believe that the following capabilities provide us with a competitive advantage over various other capital providers to small- and middle-market companies:
 
Our Team's Experience and Expertise.  The investment team of TTG Advisers is headed by Michael Tokarz, who has over 35 years of lending and investment experience, 17 of which were with Kohlberg Kravis Roberts & Co., and Warren Holtsberg who has extensive investment experience, including as Corporate Vice President of Equity Investments and as Founder and Head of Motorola Ventures where he spent 13 years, including eight years actively managing the corporate venture group.
 
TTG Advisers has a dedicated originations and investment team comprised of 12 investment professionals with over 15 years average experience in private equity, leveraged finance, investment banking, distressed debt transactions and business operations. The members of the investment team have experience managing investments and businesses during both recessionary and expansionary periods, through interest rate cycles and a variety of financial market conditions.  TTG Advisers also retains the services of other investment and industry professionals with whom it has developed long-term relationships, on an as-needed basis. In addition, TTG Advisers employs seven other professionals who manage our operations and provide investment support functions both directly and indirectly to our portfolio companies.
 
Proprietary Deal Flow.  We have relationships with various private equity firms, investment banks, business brokers, commercial banks, accounting firms, law firms, hedge funds, other investment firms, industry professionals and management teams of several companies, all of which provide us with access to a variety of investment opportunities. Because of these relationships, we often have the first or exclusive opportunity to provide investment capital and thus may be able to avoid competitive situations. As of October 31, 2012, over 90% of our portfolio was comprised of investments where we were either the lead or sole investor.
 
 
4

 
 
Creative and Extensive Transaction Structuring.  We are flexible in the types of securities in which we invest and their structures, and can invest across a company's capital structure. We believe that the investment team's creativity and flexibility in structuring investments, coupled with our ability to invest in companies across various industries, gives us the ability to identify investment opportunities and provides us with the opportunity to be a "one-stop" capital provider to small- and mid-sized companies.
 
Efficient/Collaborative Organizational Structure.  In contrast to traditional private equity and mezzanine funds, which typically have a limited life, the perpetual nature of our corporate structure provides us with a permanent capital base. We believe this greater flexibility with respect to our investment horizon affords us greater investment opportunities and is also attractive to our investors and potential investee companies, as our structure enables us to be a long-term partner for our portfolio companies.
 
Counsel to Portfolio Companies.  We provide valuable support to our portfolio companies in different ways including: offering advice to senior management on strategies for realizing their objectives, advising or participating on their boards of directors, offering ideas to help increase sales, offering advice on improving margins and operating more efficiently, helping to augment the management team, capital structure assistance and providing access to external resources (e.g., financial, legal, accounting, or technology).
 
Existing Investment Platform: As of October 31, 2012, we had approximately $456.4 million in gross assets under management. During the 2011 fiscal year, the Company made six new investments and seven follow-on investments pursuant to its strategy of maximizing capital appreciation and/or income.  In fiscal 2012, , the Company made two new investments and nine follow-on investments.  The total capital committed in fiscal year 2012 was $11.3 million compared to $43.2 million in fiscal 2011. We believe that our current investment platform provides us with the ability to, among other things, identify investment opportunities and conduct marketing activities and extensive due diligence for potential investments.
 
Oversight: The public nature of the Company allows for oversight not normally found in a typical private investment firm. This oversight is provided by the SEC, the NYSE, the Company's Board and, most importantly, the Company's shareholders. The Company, through its periodic filings with the SEC, provides transparency into its investment portfolio and operations thus allowing shareholders access to information about the Company on a regular basis.
 
Diverse Industry Knowledge: We provide financing to companies in a variety of industries. We generally look at companies with secure market niches and a history of predictable or dependable cash flows in which members of the investment team have prior investment experience. We believe that the ability to invest in portfolio companies in various industries has the potential to give our portfolio greater diversity.
 
Disciplined and Opportunistic Investment Philosophy: Our investment philosophy and method of portfolio construction involves an assessment of the overall macroeconomic environment, financial markets and company-specific research and analysis. While the composition of our portfolio may change based on our opportunistic investment philosophy, we continue to seek to provide long-term debt and equity investment capital to small and middle-market companies that we believe will provide us strong returns on our investments while taking into consideration the overall risk profile of the specific investment.
 
Tax Status and Capital Loss Carry Forwards: The Company has elected to be taxed as a "regulated investment company" ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code").  It is the policy of the Company to continue to meet the requirements for RIC status. As a RIC, the Company is not subject to federal income tax to the extent that it distributes all of its investment company taxable income and net realized capital gains for its taxable year (see "Federal Income Tax Matters"). This allows us to attract different kinds of investors than other publicly held corporations. The Company is also exempt from excise tax if it distributes at least (1) 98% of its ordinary income during each calendar year, (2) 98.2% of its capital gains realized in the period from November 1 of the prior year through October 31 of the current year, and (3) all such ordinary income and capital gains for previous years that were not distributed during those years. On October 31, 2012, the Company had a net capital loss carry forward of approximately $45.1 million, of which approximately $26.3 million will expire in the year 2019 and $18.8 million has no expiration. To the extent future capital gains are offset by capital loss carry forwards, such gains need not be distributed.
 
 
5

 
 
OPERATING AND REGULATORY STRUCTURE
 
Our tax status generally allows us to "pass-through" our income to our shareholders as dividends without the imposition of corporate level taxation, if certain requirements are met. See "Federal Income Tax Matters."
 
As a business development company, we are required to meet certain regulatory tests, the most significant relating to our investments and borrowings. We are required to have at least 70% of the value of our total assets invested in "eligible portfolio companies" or cash or cash equivalents. Generally, U.S.-based, privately held or thinly-traded public companies are deemed "eligible portfolio companies" under the 1940 Act. A business development company must also maintain a coverage ratio of assets to borrowings of at least 200%. See "Certain Government Regulations."
 
As a business development company, we must make available significant managerial assistance to our portfolio companies. We provide support for our portfolio companies in several different ways including: offering advice to senior management on strategies for realizing their objectives, advising or participating on their boards of directors, offering ideas to help increase sales, reviewing monthly/quarterly financial statements, offering advice on improving margins and saving costs, helping to augment the management team, providing capital structure expertise and providing access to external resources (e.g., financial, legal, accounting, or technology). We may receive fees for these services.
 
PLAN OF DISTRIBUTION
 
We may offer, from time to time, up to $250,000,000 of our common stock, preferred stock, debt securities or warrants representing rights to purchase shares of our common stock, preferred stock or debt securities, on terms to be determined at the time of the offering.
 
Securities may be offered at prices and on terms described in one or more supplements to this prospectus directly to one or more purchasers, through agents designated from time to time by us, or to or through underwriters or dealers. The supplement to this prospectus relating to the offering will identify any agents or underwriters involved in the sale of our securities, and will set forth any applicable purchase price, fee and commission or discount arrangement or the basis upon which such amount may be calculated.
 
We may not sell securities pursuant to this prospectus without delivering a prospectus supplement describing the method and terms of the offering of such securities. See "Plan of Distribution."
 
USE OF PROCEEDS
 
We intend to use the net proceeds from the sale of our securities for general corporate purposes, including, for example, investing in portfolio companies in accordance with our investment objective and strategy, repaying debt, funding distributions, funding our subsidiaries' activities and/or repurchasing our shares pursuant to the share repurchase program adopted by the Board on April 23, 2010 and expanded on July 19, 2011.  Pending such uses, we will hold the net proceeds from the sale of our securities in cash or invest all or a portion of such net proceeds in short term, liquid investments.  The supplement to this prospectus relating to an offering will more fully identify the use of the proceeds from such offering.
 
DETERMINATION OF COMPANY'S NET ASSET VALUE
 
Pursuant to the requirements of the 1940 Act and in accordance with ASC 820, we value our portfolio securities at their current market values or, if market quotations are not readily available, at their estimates of fair values. Because our portfolio company investments generally do not have readily ascertainable market values, we record these investments at fair value in accordance with our Valuation Procedures adopted by the Board of Directors which are consistent with ASC 820. As permitted by the SEC, the Board of Directors has delegated the responsibility of making fair value determinations to the Valuation Committee, subject to the Board of Directors’ supervision and pursuant to our Valuation Procedures. Our Board of Directors may also hire independent consultants to review our Valuation Procedures or to conduct an independent valuation of one or more of our portfolio investments although it has not done so in the past and has no current intention to do so.
 
 
6

 
 
Pursuant to our Valuation Procedures, the Valuation Committee (which is comprised of three Independent Directors) determines fair values of portfolio company investments on a quarterly basis (or more frequently, if deemed appropriate under the circumstances).  During the process, the Valuation Committee carefully evaluates the valuation of each portfolio investment.  Any changes in valuation are recorded in the consolidated statements of operations as “Net change in unrealized appreciation (depreciation) on investments.” Currently, our NAV per share is calculated and published on a quarterly basis. The Company calculates our NAV per share by subtracting all liabilities from the total value of our portfolio securities and other assets and dividing the result by the total number of outstanding shares of our common stock on the date of valuation.
 
At October 31, 2012, approximately 88.77% of our total assets represented portfolio investments and escrow receivables recorded at fair value.
 
Under most circumstances, at the time of acquisition, fair value investments are carried at cost (absent the existence of conditions warranting, in management’s and the Valuation Committee’s view, a different initial value). During the period that an investment is held by the Company, its original cost may cease to approximate fair value as the result of market and investment specific factors. No pre-determined formula can be applied to determine fair value. Rather, the Valuation Committee analyzes fair value measurements based on the value at which the securities of the portfolio company could be sold in an orderly disposition over a reasonable period of time between willing parties, other than in a forced or liquidation sale. The liquidity event whereby the Company ultimately exits an investment is generally the sale, the merger, the recapitalization or, in some cases, the initial public offering of the portfolio company.
 
There is no one methodology to determine fair value and, in fact, for any portfolio security, fair value may be expressed as a range of values, from which the Company derives a single estimate of fair value. To determine the fair value of a portfolio security, the Valuation Committee analyzes the portfolio company’s financial results and projections, publicly traded comparable companies when available, comparable private transactions when available, precedent transactions in the market when available, third-party real estate and asset appraisals if appropriate and available, discounted cash flow analysis, if appropriate, as well as other factors. The Company generally requires, where practicable, portfolio companies to provide annual audited and more regular unaudited financial statements, and/or annual projections for the upcoming fiscal year.
 
The fair value of our portfolio securities is inherently subjective. Because of the inherent uncertainty of fair valuation of portfolio securities and escrow receivables that do not have readily ascertainable market values, our estimate of fair value may significantly differ from the fair value that would have been used had a ready market existed for the securities. Such values also do not reflect brokers’ fees or other selling costs, which might become payable on disposition of such investments.
 
Our investments are carried at fair value in accordance with the 1940 Act and Accounting Standards Codification, Fair Value Measurements and Disclosures (“ASC 820”). In accordance with the 1940 Act, unrestricted minority-owned publicly traded securities for which market quotations are readily available are valued at the closing market quote on the valuation date and majority-owned publicly traded securities and other privately held securities are valued as determined in good faith by the Valuation Committee of our Board of Directors. For legally or contractually restricted securities of companies that are publicly traded, the value is based on the closing market quote on the valuation date minus a discount for the restriction. At October 31, 2012, we did not hold restricted or unrestricted securities of publicly traded companies for which we have a majority-owned interest.
 
ASC 820 provides a framework for measuring the fair value of assets and liabilities and provides guidance regarding a fair value hierarchy which prioritizes information used to measure value. In determining fair value, the Valuation Committee primarily uses the level 3 inputs referenced in ASC 820.  See "Determination of Company's Net Asset Value — Valuation Methodology" on page 88.
 
DISTRIBUTIONS
 
Currently, the Company has a policy of seeking to pay quarterly dividends to shareholders. Our quarterly dividends, if any, will be determined by our Board. Most recently, on December 17, 2012 our Board declared a quarterly dividend of $0.135 per share, which will be paid on January 7, 2013 to shareholders of record on December 31, 2012.
 
 
7

 
 
We intend to continue to qualify for treatment as a RIC under Subchapter M of the Code. In order to permit us to deduct from our taxable income dividends we distribute to our shareholders, in addition to meeting other requirements, we must distribute for each taxable year at least 90% of (i) our investment company taxable income (consisting generally of net investment income from interest and dividends and net realized short term capital gains) and (ii) our net tax-exempt interest, if any. See "Federal Income Tax Matters" on page 104.
 
DIVIDEND REINVESTMENT PLAN
 
All of our shareholders who hold shares of common stock in their own name will automatically be enrolled in our dividend reinvestment plan (the "Plan"). All such shareholders will have any cash dividends and distributions automatically reinvested by Computershare Ltd. (the "Plan Agent") in additional shares of our common stock. Any shareholder may, of course, elect to receive his or her dividends and distributions in cash. Currently, the Company has a policy of seeking to pay quarterly dividends to shareholders. For any of our shares that are held by banks, brokers or other entities that hold our shares as nominees for individual shareholders, the Plan Agent will administer the Plan on the basis of the number of shares certified by any nominee as being registered for shareholders that have not elected to receive dividends and distributions in cash. To receive your dividends and distributions in cash, you must notify the Plan Agent.  You can contact Computershare Ltd. by calling toll free 1-800-426-5523 or by mail using the following principal business office:  250 Royall Street, Canton, Massachusetts 02021.
 
The Plan Agent serves as agent for the shareholders in administering the Plan. If we declare a dividend or distribution payable in cash or in additional shares of our common stock, those shareholders participating in the Plan will receive their dividend or distribution in additional shares of our common stock. Such shares will be either newly issued by us or purchased in the open market by the Plan Agent. If the market value of a share of our common stock on the payment date for such dividend or distribution equals or exceeds the net asset value per share on that date, we will issue new shares at the net asset value. If the net asset value exceeds the market price of our common stock, the Plan Agent will purchase in the open market such number of shares as is necessary to complete the distribution.
 
CORPORATE INFORMATION
 
Our principal executive office is located at 287 Bowman Avenue, 2nd Floor, Purchase, New York 10577 and our telephone number is (914) 510-9400.
 
Our Internet website address is http://www.mvccapital.com. Information contained on our website is not incorporated by reference into this prospectus and you should not consider information contained on our website to be part of this prospectus unless otherwise indicated.
 
RISK FACTORS
 
An investment in MVC Capital involves certain significant risks relating to our business and investment objective. We have identified below a summary of these risks. For a more complete description of the risk factors impacting an investment in our securities, we urge you to read the "Risk Factors" section.  There can be no assurance that we will achieve our investment objective and an investment in the Company should not constitute a complete investment program for an investor.
 
Business Risks
 
·
We depend on key personnel of TTG Advisers, especially Mr. Tokarz, in seeking to achieve our investment objective.
 
·
Our returns may be substantially lower than the average returns historically realized by the private equity industry as a whole.
 
·
Substantially all of our portfolio investments and escrow receivables are recorded at “fair value” and, as a result, there is a degree of uncertainty regarding the carrying values of our portfolio investments.
 
 
8

 
 
·
Economic recessions or downturns, including the current economic instability in Europe and the United States, could impair our portfolio companies and have a material adverse impact on our business, financial condition and results of operations.
 
·
We may not realize gains from our equity investments.
 
·
The market for private equity investments can be highly competitive. In some cases, our status as a regulated business development company may hinder our ability to participate in investment opportunities.
 
·
Our ability to use our capital loss carry forwards and certain other losses may be subject to limitations.
 
·
Loss of pass-through tax treatment would substantially reduce net assets and income available for dividends.
 
·
There are certain risks associated with the Company holding debt obligations that are treated under applicable tax rules as having original issue discount.
 
·
Our ability to grow depends on our ability to raise capital.
 
·
Complying with the RIC requirements may cause us to forego otherwise attractive opportunities.
 
·
Regulations governing our operation as a business development company affect our ability to, and the way in which we, raise additional capital.
 
·
Any failure on our part to maintain our status as a business development company would reduce our operating flexibility.
 
·
Changes in the law or regulations that govern business development companies and RICs, including changes in tax law or regulations, may significantly impact our business.
 
·
Results may fluctuate and may not be indicative of future performance.
 
·
Our common stock price can be volatile.
 
·
We are subject to market discount risk.
 
·
We have not established a minimum dividend payment level and we cannot assure you of our ability to make distributions to our shareholders in the future.
 
·
During certain periods, our distribution proceeds have exceeded and may, in the future, exceed our earnings. Therefore, during those times, portions of the distributions that we make may represent a return of capital to you for tax purposes, which will reduce your tax basis in your shares.
 
·
We have borrowed and may continue to borrow money, which magnifies the potential for gain or loss on amounts invested and may increase the risk of investing in us.
 
·
Changes in interest rates may affect our cost of capital and net operating income and our ability to obtain additional financing.
 
·
We may be unable to meet our covenant obligations under our credit facility, which could adversely affect our business.
 
·
A small portion of our existing investment portfolio was not selected by the investment team of TTG Advisers.
 
·
Under the Advisory Agreement, TTG Advisers is entitled to compensation based on our portfolio’s performance. This arrangement may result in riskier or more speculative investments in an effort to maximize incentive compensation.  Additionally, because the base management fee payable under the Advisory Agreement is based on total assets, TTG Advisers may have an incentive to increase portfolio leverage in order to earn higher base management fees.
 
 
9

 
 
·
There are potential conflicts of interest that could impact our investment returns.
 
·
Our relationship with any investment vehicle we or TTG Advisers manage could give rise to conflicts of interest with respect to the allocation of investment opportunities between us on the one hand and the other vehicles on the other hand.
 
·
Wars, terrorist attacks, and other acts of violence may affect any market for our common stock, impact the businesses in which we invest and harm our operations and our profitability.
 
·
Our financial condition and results of operations will depend on our ability to effectively manage our future growth.
 
Investment Risks
 
·
Investing in private companies involves a high degree of risk.
 
·
Our investments in portfolio companies are generally illiquid.
 
·
Our investments in small and middle-market privately-held companies are extremely risky and the Company could lose its entire investment.
 
·
Our borrowers may default on their payments, which may have an effect on our financial performance.
 
·
Our investments in mezzanine and other debt securities may involve significant risks.
 
·
We are a non-diversified investment company within the meaning of the 1940 Act, and therefore may invest a significant portion of our assets in a relatively small number of portfolio companies, which subjects us to a risk of significant loss should the performance or financial condition of one or more portfolio companies deteriorate.
 
·
As a result of our significant portfolio investment in Summit Research Labs, Inc., we are particularly subject to the risks of that company and the specialty chemical industry.
 
·
As a result of our significant portfolio investment in U.S. Gas & Electric, Inc., we are particularly subject to the risks of that company and the energy services industry.
 
·
When we are a debt or minority equity investor in a portfolio company, we may not be in a position to control the entity, and management of the company may make decisions that could decrease the value of our portfolio holdings.
 
·
We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies.
 
·
Our portfolio companies may incur obligations that rank equally with, or senior to, our investments in such companies. As a result, the holders of such obligations may be entitled to payments of principal or interest prior to us, preventing us from obtaining the full value of our investment in the event of an insolvency, liquidation, dissolution, reorganization, acquisition, merger or bankruptcy of the relevant portfolio company.
 
·
Investments in foreign debt or equity may involve significant risks in addition to the risks inherent in U.S. investments.
 
·
Our investments in private equity funds, including the PE Fund, are subject to substantial risk, including a complete loss of investment.
 
 
10

 
 
Offering Risks
 
·
Our common stock price can be volatile.
 
·
Our common stock has historically traded at prices below our net asset value per share.
 
·
Investing in our securities may involve a high degree of risk.
 
·
We may allocate the net proceeds from this offering in ways with which you may not agree.
 
·
Sales of substantial amounts of our securities may have an adverse effect on the market price of our securities.
 
·
Future offerings of debt securities, which would be senior to our common stock upon liquidation, or equity securities, which could dilute our existing shareholders and be senior to our common stock for the purposes of distributions, may harm the value of our common stock.
 
WHERE YOU CAN FIND ADDITIONAL INFORMATION
 
We have filed with the Securities and Exchange Commission (the "SEC") a registration statement on Form N-2 together with all amendments and related exhibits under the Securities Act of 1933, as amended (the "Securities Act"). The registration statement contains additional information about us and the common stock being offered by this prospectus. You may inspect the registration statement and the exhibits without charge at the SEC at 100 F Street, NE, Washington, DC 20549. You may obtain copies from the SEC at prescribed rates.
 
We file annual, quarterly and current reports, proxy statements and other information with the SEC. You can inspect our SEC filings, without charge, at the public reference facilities of the SEC at 100 F Street, NE, Washington, DC 20549. The SEC also maintains a web site at http://www.sec.gov that contains our SEC filings. You can also obtain copies of these materials from the public reference section of the SEC at 100 F Street, NE, Washington, DC 20549, at prescribed rates. Please call the SEC at 1-202-551-8090 for further information on the public reference room. Copies may also be obtained, after paying a duplicating fee, by electronic request to publicinfo@sec.gov or by written request to Public Reference Section, Washington, DC 20549-0102. You can also inspect reports and other information we file at the offices of the NYSE, and you are able to inspect those at 20 Broad Street, New York, NY 10005.
 
 
11

 
 
FEES AND EXPENSES
 
This table describes the various costs and expenses that an investor in our common stock will bear directly or indirectly.
 
Shareholder Transaction Expenses (as a percentage of the offering price)
Sales load
    % (1)
Offering expenses borne by us
    % (2)
Total shareholder transaction expenses
    % (3)
Estimated Annual Expenses (as a percentage of consolidated net assets attributable to common stock) (4)
       
Management fees
    2.12 %(5)
Incentive fees payable under Advisory Agreement (20% of net realized capital gains (on investments made after November 1, 2003) and 20% of pre-incentive fee net operating income)
    3.87 %(5)
Other expenses
    1.31 %(6)
    Acquired fund fees and expenses
    0.01 %
Interest payments on borrowed funds
    0.90 %(7)
Total annual expenses
    8.21 %(8)

Example
 
The following example, required by the SEC, demonstrates the projected dollar amount of total cumulative expenses that would be incurred over various periods with respect to a hypothetical investment in us.  In calculating the following expense amounts, we assumed we would have $50 million of leverage and that our operating expenses would remain at the levels set forth in the table above.
 
 
1 Year 
3 Years 
5 Years 
10 Years 
You would pay the following cumulative expenses on a $1,000 investment, assuming a 5.0% annual return
$81
$235
$379
$701

Although the example assumes (as required by the SEC) a 5.0% annual return, our performance will vary and may result in a return of greater or less than 5.0%.  In addition, while the example assumes reinvestment of all dividends and distributions at net asset value, participants in the dividend reinvestment plan may receive shares of common stock that we issue at net asset value or are purchased by the administrator of the dividend reinvestment plan, at the market price in effect at the time, which may be at or below net asset value. See "Dividend Reinvestment Plan."
 
The example should not be considered a representation of future expenses, and the actual expenses may be greater or less than those shown.
____________

(1)
In the event that the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load.
 
(2)
The related prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by us as a percentage of the offering price.
 
(3)
The related prospectus supplement will disclose the offering price and the total shareholder transaction expenses as a percentage of the offering price.
 
(4)
"Consolidated net assets attributable to common stock" equals the weighted average of the Company's consolidated net assets (i.e., total consolidated assets less total consolidated liabilities) estimated for the current fiscal year, including the anticipated net proceeds from an offering in the current fiscal year.
 
 
12

 
 
(5)
Pursuant to our Amended and Restated Investment Advisory and Management Agreement (the "Advisory Agreement"), the Company pays TTG Advisers a management fee and an incentive fee.  The management fee is calculated at an annual rate of 2% of our total assets (excluding cash and the value of any investment by the Company not made in a portfolio company ("Non-Eligible Assets") but including assets purchased with borrowed funds that are not Non-Eligible Assets).  (Although the Company's investments in the PE Fund may, as a technical matter, not be deemed a "Non-Eligible Asset," such investments, due to a separate provision in the Advisory Agreement, are excluded from any management fee or incentive fee calculation and thus are not subject to fees paid under the Advisory Agreement.  See "Advisory Agreement" for more information.)  The incentive fee, which has two parts – an incentive fee on income and an incentive fee on capital gains, is payable to TTG Advisers based on our performance, may not be paid unless we achieve certain goals and remains unpaid until certain realization events occur.  Because the example above assumes a 5.0% return, as required by the SEC, no incentive fee on income would be payable during the current fiscal year.  The amount of the incentive fee in the table is based on the actual realized gains and losses for the fiscal year ended October 31, 2012 and the unrealized appreciation of our investments as of such date and assumes that all such unrealized appreciation is converted to realized capital gains during the current fiscal year.  For a more complete description of the management and incentive fees, see "Advisory Agreement" on page 97 below.
 
(6)
"Other expenses" are based on estimated amounts for the current fiscal year.  Included in other expenses is estimated current or deferred tax expense incurred by the Company and its consolidated subsidiaries.
 
(7)
The estimate is based on borrowings outstanding as of October 31, 2012 and our assumption is that our borrowings will remain similar to the amounts outstanding as of that date.  We had outstanding borrowings of $50 million at October 31, 2012.  The estimate also includes expected interest expense on borrowings during the current fiscal year.
 
(8)
TTG Advisers agreed to an expense cap for the fiscal years 2011 and 2012 pursuant to which it absorbs or reimburses operating expenses of the Company (promptly following the completion of such year), to the extent necessary to limit the Company's expense ratio (the consolidated expenses of the Company, including any amounts payable to TTG Advisers under the base management fee, but excluding the amount of any interest and other direct borrowing costs, taxes, incentive compensation, payments made by the general partner ("GP") of the MVC Private Equity Fund, L.P. to TTG Advisers pursuant to the Portfolio Management Agreement between the GP and TTG Advisers and extraordinary expenses taken as a percentage of the Company's average net assets) for such year to 3.5%.  TTG Advisers has also voluntarily agreed to extend the expense cap of 3.5% through the fiscal year 2013.  In addition, for the 2010 through 2012 fiscal years, TTG Advisers voluntarily agreed to waive $150,000 of expenses that the Company is obligated to reimburse to TTG Advisers under the Advisory Agreement (TTG Advisers has also voluntarily agreed to an extension of this waiver for fiscal 2013). TTG Advisers has also voluntarily agreed that any assets of the Company that were invested in exchange-traded funds and Octagon High Income Cayman Fund Ltd. ("Octagon Fund") would not be taken into account in the calculation of the base management fee due to TTG Advisers under the Advisory Agreement.  The expense cap and voluntary waivers are described further in "Advisory Agreement" on page 97 below.  If the expense cap and voluntary waivers were taken into account in the fee table, the Company's expense ratio for the current fiscal year would be 8.17%.
 
SELECTED CONSOLIDATED FINANCIAL DATA
 
You should read the condensed consolidated financial information below with the Consolidated Financial Statements and Notes thereto included in this prospectus.  Financial information for the fiscal years ended October 31, 2012, 2011, 2010, 2009 and 2008 are derived from the consolidated financial statements, which have been audited by the Company's current independent registered public accounting firm. Quarterly financial information is derived from unaudited financial data, but in the opinion of management, reflects all adjustments (consisting only of normal recurring adjustments), which are necessary to present fairly the results for such interim periods.  See "Management's Discussion and Analysis of Financial Condition and Results of Operations" on page 31 for more information.
 
 
13

 
 
Selected Consolidated Financial Data
 
   
Year Ended October 31,
 
   
2012
   
2011
   
2010
   
2009
   
2008
 
   
(In thousands, except per share data)
 
Operating Data:
                                       
Interest and related portfolio income:
                                       
Interest and dividend income
 
$
25,205
  
 
$
11,450
  
 
$
19,315
  
 
$
21,755
  
 
$
26,047
  
Fee income
   
1,940
  
   
2,784
  
   
3,696
  
   
4,099
  
   
3,613
  
Fee income — asset management
   
2,300
  
   
396
  
                       
Other income
   
442
  
   
1,341
  
   
510
  
   
255
  
   
367
  
                                         
Total operating income
   
29,887
  
   
15,971
  
   
23,521
  
   
26,109
  
   
30,027
  
Expenses:
                                       
Management fee
   
8,588
  
   
8,845
  
   
9,330
  
   
9,843
  
   
8,989
  
Portfolio fees — asset management
   
968
  
   
  
   
  
   
  
   
  
Management fee — asset management
   
757
  
   
297
  
   
  
   
  
   
  
Administrative
   
3,573
  
   
4,320
  
   
3,395
  
   
3,519
  
   
3,620
  
Interest and other borrowing costs
   
3,367
  
   
3,082
  
   
2,825
  
   
3,128
  
   
4,464
  
Net Incentive compensation (Note 5)
   
(5,937
   
1,948
  
   
2,479
  
   
3,717
  
   
10,822
  
                                         
Total operating expenses
   
11,316
  
   
18,492
  
   
18,029
  
   
20,207
  
   
27,895
  
                                         
Total waiver by adviser
   
(2,554
   
(251
   
(150
   
  
   
  
                                         
Total net operating expenses
   
8,762
  
   
18,241
  
   
17,879
  
   
20,207
  
   
27,895
  
                                         
Net operating (loss) income before taxes
   
21,125
  
   
(2,270
   
5,642
  
   
5,902
  
   
2,132
  
Tax expense (benefit), net
   
4
  
   
14
  
   
8
  
   
1,377
  
   
(936
                                         
Net operating (loss) income
   
21,121
  
   
(2,284
   
5,634
  
   
4,525
  
   
3,068
  
Net realized and unrealized gain (loss):
                                       
Net realized (loss) gain on investments and foreign currency
   
(20,518
   
(26,422
   
32,188
  
   
(25,082
   
1,418
  
Net change in unrealized appreciation (depreciation) on investments
   
(22,257
   
35,677
  
   
(21,689
   
34,804
  
   
59,465
  
                                         
Net realized and unrealized (loss) gain on investments and foreign currency
   
(42,775
   
9,255
  
   
10,499
  
   
9,722
  
   
60,883
  
                                         
Net (decrease) increase in net assets resulting from operations
 
$
(21,654
 
$
6,971
  
 
$
16,133
  
 
$
14,247
  
 
$
63,951
  
                                         
Per Share:
                                       
Net (decrease) increase in net assets per share resulting from operations
 
$
(0.90
 
$
0.30
  
 
$
0.66
  
 
$
0.59
  
 
$
2.63
  
Dividends per share
 
$
0.495
  
 
$
0.480
  
 
$
0.480
  
 
$
0.480
  
 
$
0.480
  
Balance Sheet Data:
                                       
Portfolio at value
 
$
404,171
  
 
$
452,215
  
 
$
433,901
  
 
$
502,803
  
 
$
490,804
  
Portfolio at cost
   
332,432
  
   
358,219
  
   
375,582
  
   
422,794
  
   
445,600
  
Total assets
   
456,431
  
   
497,107
  
   
500,373
  
   
510,846
  
   
510,711
  
Shareholders’ equity
   
386,016
  
   
419,510
  
   
424,994
  
   
424,456
  
   
421,871
  
Shareholders’ equity per share (net asset value)
 
$
16.14
  
 
$
17.54
  
 
$
17.71
  
 
$
17.47
  
 
$
17.36
  
Common shares outstanding at period end
   
23,917
  
   
23,917
  
   
23,991
  
   
24,297
  
   
24,297
  
Other Data:
                                       
Number of Investments funded in period
   
11
  
   
13
  
   
5
  
   
6
  
   
15
  
Investments funded ($) in period
 
$
11,300
  
 
$
43,235
  
 
$
8,332
  
 
$
6,293
  
 
$
126,300
  

 
14

 
 
   
2012
   
2011
   
2010
 
   
Qtr 4
   
Qtr 3
   
Qtr 2
   
Qtr 1
   
Qtr 4
   
Qtr 3
   
Qtr 2
   
Qtr 1
   
Qtr 4
   
Qtr 3
   
Qtr 2
   
Qtr 1
 
   
(In thousands, except per share data)
 
Quarterly Data (Unaudited):
                                                                                               
Total operating income
   
6,148
  
   
3,931
  
   
16,164
  
   
3,644
  
   
3,421
  
   
3,482
  
   
4,544
  
   
4,524
  
   
5,130
  
   
5,257
  
   
5,336
  
   
7,798
  
Management fee
   
2,027
  
   
2,127
  
   
2,177
  
   
2,257
  
   
2,155
  
   
2,183
  
   
2,022
  
   
2,485
  
   
2,232
  
   
2,176
  
   
2,467
  
   
2,455
  
Portfolio fees — asset management
   
106
  
   
338
  
   
462
  
   
62
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  
Management fee — asset management
   
140
  
   
41
  
   
188
  
   
388
  
           
  
   
227
  
   
70
  
   
  
   
  
   
  
   
  
Administrative
   
862
  
   
971
  
   
817
  
   
923
  
   
1,105
  
   
1,049
  
   
990
  
   
1,176
  
   
777
  
   
910
  
   
938
  
   
770
  
Interest, fees and other borrowing costs
   
886
  
   
854
  
   
832
  
   
795
  
   
783
  
   
784
  
   
745
  
   
770
  
   
770
  
   
767
  
   
647
  
   
641
  
Net Incentive compensation
   
(1,410
   
(2,415
   
(175
   
(1,937
   
3,483
  
   
(463
   
531
  
   
(1,603
   
2,504
  
   
(3,270
   
2,225
  
   
1,020
  
Total waiver by adviser
   
(38
   
(37
   
(2,383
   
(96
   
(38
   
(37
   
(38
   
(138
   
(50
   
(50
   
(50
   
  
Tax expense
   
3
  
   
  
   
  
   
1
  
   
2
  
   
  
   
2
  
   
10
  
   
2
  
   
  
   
1
  
   
5
  
Net operating income (loss) before net realized and unrealized gains
   
3,572
  
   
2,052
  
   
14,246
  
   
1,251
  
   
(4,069
   
(34
   
65
  
   
1,754
  
   
(1,105
   
4,724
  
   
(892
   
2,907
  
Net (decrease) increase in net assets resulting from operations
   
(3,556
   
(10,595
   
1,515
  
   
(9,018
   
13,282
  
   
(2,369
   
2,302
  
   
(6,244
   
11,307
  
   
(11,281
   
8,969
  
   
7,138
  
Net (decrease) increase in net assets resulting from operations per share
   
(0.14
   
(0.45
   
0.06
  
   
(0.37
   
0.56
  
   
(0.10
   
0.10
  
   
(0.26
   
0.47
  
   
(0.47
   
0.37
  
   
0.29
  
Net asset value per share
   
16.14
  
   
16.42
  
   
16.99
  
   
17.04
  
   
17.54
  
   
17.1
  
   
17.32
  
   
17.33
  
   
17.71
  
   
17.35
  
   
17.89
  
   
17.64
  
 
RISK FACTORS
 
Investing in MVC Capital involves a number of significant risks relating to our business and investment objective. As a result, there can be no assurance that we will achieve our investment objective. In addition to the other information contained in this prospectus, you should consider carefully the following information before making an investment in our common stock. The Company's risk factors include those directly related to the Company's business, its investments, and potential offerings.
 
BUSINESS RISKS
 
Business risks are risks that are associated with general business conditions, the economy, and the operations of the Company. Business risks are not risks associated with our specific investments or an offering of our securities.
 
We depend on key personnel of TTG Advisers, especially Mr. Tokarz, in seeking to achieve our investment objective.
 
We depend on the continued services of Mr. Tokarz and certain other key management personnel of TTG Advisers. If we were to lose access to any of these personnel, particularly Mr. Tokarz, it could negatively impact our operations and we could lose business opportunities. There is a risk that Mr. Tokarz’s expertise may be unavailable to the Company, which could significantly impact the Company’s ability to achieve its investment objective.
 
Our returns may be substantially lower than the average returns historically realized by the private equity industry as a whole.
 
Past performance of the private equity industry is not necessarily indicative of that sector’s future performance, nor is it necessarily a good proxy for predicting the returns of the Company. We cannot guarantee that we will meet or exceed the rates of return historically realized by the private equity industry as a whole. Additionally, our overall returns are impacted by certain factors related to our structure as a publicly-traded business development company, including:
 
 
·
The lower return we are likely to realize on short-term liquid investments during the period in which we are identifying potential investments, and
 
 
·
The periodic disclosure required of business development companies, which could result in the Company being less attractive as an investor to certain potential portfolio companies.
 
 
15

 
 
Substantially all of our portfolio investments and escrow receivables are recorded at “fair value” and, as a result, there is a degree of uncertainty regarding the carrying values of our portfolio investments.
 
Pursuant to the requirements of the 1940 Act, because our portfolio company investments do not have readily ascertainable market values, we record these investments at fair value in accordance with our Valuation Procedures adopted by our Board of Directors. As permitted by the SEC, the Board of Directors has delegated the responsibility of making fair value determinations to the Valuation Committee, subject to the Board of Directors’ supervision and pursuant to the Valuation Procedures.
 
At October 31, 2012, approximately 88.77% of our total assets represented portfolio investments and escrow receivables recorded at fair value.
 
There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. In determining the fair value of a portfolio investment, the Valuation Committee analyzes, among other factors, the portfolio company’s financial results and projections and publicly traded comparable companies when available, which may be dependent on general economic conditions. We specifically value each individual investment and record unrealized depreciation for an investment that we believe has become impaired, including where collection of a loan or realization of an equity security is doubtful. Conversely, we will record unrealized appreciation if we have an indication (based on a significant development) that the underlying portfolio company has appreciated in value and, therefore, our equity security has also appreciated in value, where appropriate. Without a readily ascertainable market value and because of the inherent uncertainty of fair valuation, fair value of our investments may differ significantly from the values that would have been used had a ready market existed for the investments, and the differences could be material.
 
Pursuant to our Valuation Procedures, our Valuation Committee (which is currently comprised of three Independent Directors) reviews, considers and determines fair valuations on a quarterly basis (or more frequently, if deemed appropriate under the circumstances). Any changes in valuation are recorded in the consolidated statements of operations as “Net change in unrealized appreciation (depreciation) on investments.”
 
Economic recessions or downturns, including the current economic instability in Europe and the United States, could impair our portfolio companies and have a material adverse impact on our business, financial condition and results of operations.
 
Many of the companies in which we have made or will make investments may be susceptible to adverse economic conditions. Adverse economic conditions may affect the ability of a company to engage in a liquidity event. These conditions could lead to financial losses in our portfolio and a decrease in our revenues, net income and assets. Conditions in the public debt and equity markets have been volatile and pricing levels have performed similarly. As a result, depending on market conditions, we could incur substantial realized losses and suffer unrealized losses in future periods, which could have a material adverse impact on our business, financial condition and results of operations. If current market conditions continue, or worsen, it may adversely impact our ability to deploy our investment strategy and achieve our investment objective.
 
Our overall business of making loans or private equity investments may be affected by current and future market conditions. The absence of an active mezzanine lending or private equity environment may slow the amount of private equity investment activity generally. As a result, the pace of our investment activity may slow, which could impact our ability to achieve our investment objective. In addition, significant changes in the capital markets could have an effect on the valuations of private companies and on the potential for liquidity events involving such companies. This could affect the amount and timing of any gains realized on our investments and thus have a material adverse impact on our financial condition.
 
Depending on market conditions, we could incur substantial realized losses and suffer unrealized losses in future periods, which could have a material adverse impact on our business, financial condition and results of operations. In addition, the global financial markets have not fully recovered from the global financial crisis and the economic factors which gave rise to the crisis. The continuation of current global market conditions, uncertainty or further deterioration, including the economic instability in Europe, could result in further declines in the market values of the Company investments. Such declines could also lead to diminished investment opportunities for the Company, prevent the Company from successfully executing its investment strategies or require the Company to dispose of investments at a loss while such adverse market conditions prevail.
 
 
16

 
 
We may not realize gains from our equity investments.
 
When we invest in mezzanine and senior debt securities, we may acquire warrants or other equity securities as well. We may also invest directly in various equity securities. Our goal is ultimately to dispose of such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive or invest in may not appreciate in value and, in fact, may decline in value. In addition, the equity securities we receive or invest in may be subject to restrictions on resale during periods in which it would be advantageous to sell. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.
 
The market for private equity investments can be highly competitive. In some cases, our status as a regulated business development company may hinder our ability to participate in investment opportunities.
 
We face competition in our investing activities from private equity funds, other business development companies, investment banks, investment affiliates of large industrial, technology, service and financial companies, small business investment companies, wealthy individuals and foreign investors. As a regulated business development company, we are required to disclose quarterly the name and business description of portfolio companies and the value of any portfolio securities. Many of our competitors are not subject to this disclosure requirement. Our obligation to disclose this information could hinder our ability to invest in certain portfolio companies. Additionally, other regulations, current and future, may make us less attractive as a potential investor to a given portfolio company than a private equity fund not subject to the same regulations. Furthermore, some of our competitors have greater resources than we do. Increased competition would make it more difficult for us to purchase or originate investments at attractive prices. As a result of this competition, sometimes we may be precluded from making certain investments.
 
Our ability to use our capital loss carry forwards and certain other losses may be subject to limitations.
 
On October 31, 2012, the Company had a net capital loss carry forward of approximately $45.1 million of which approximately $26.3 million will expire in the year 2019 and $18.8 million has no expiration. To the extent future capital gains are offset by capital loss carry forwards, such gains need not be distributed.  If, over a three year period, we experience an aggregate shift of more than 50% in the ownership of our common stock attributable to transactions involving one or more "5% shareholders" (e.g., if a shareholder acquires 5% or more of our outstanding shares of common stock, or if a shareholder who owns 5% or more of our outstanding shares of common stock significantly increases or decreases its investment in the Company), our ability to utilize our capital loss carry forwards and losses from Legacy Investments to offset future capital gains may be severely limited.  Further, in the event that we are deemed to have failed to meet the requirements to qualify as a RIC, our ability to use our capital loss carry forwards could be adversely affected.
 
Loss of pass-through tax treatment would substantially reduce net assets and income available for dividends.
 
We have operated so as to qualify as a RIC. If we meet source of income, diversification and distribution requirements, we will qualify for effective pass-through tax treatment. We would cease to qualify for such pass-through tax treatment if we were unable to comply with these requirements. In addition, we may have difficulty meeting the requirement to make distributions to our shareholders because in certain cases we may recognize income before or without receiving cash representing such income, such as in the case of debt obligations that are treated as having original issue discount.  If we fail to qualify as a RIC, we will have to pay corporate-level taxes on all of our income whether or not we distribute it, which would substantially reduce the amount of income available for distribution to our shareholders. Even if we qualify as a RIC, we generally will be subject to a corporate-level income tax on the income we do not distribute. Moreover, if we do not distribute at least (1) 98% of our ordinary income during each calendar year, (2) 98.2% of our capital gains realized in the period from November 1 of the prior year through October 31 of the current year, and (3) all such ordinary income and capital gains for previous years that were not distributed during those years, we generally will be subject to a 4% excise tax on certain undistributed amounts.
 
 
17

 
 
There are certain risks associated with the Company holding debt obligations that are treated under applicable tax rules as having original issue discount.
 
For federal income tax purposes, we may be required to recognize taxable income in circumstances in which we do not receive a corresponding payment in cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount ("OID") (such as debt instruments with payment-in-kind, or PIK, interest or, in certain cases, increasing interest rates or debt instruments that were issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. We anticipate that a portion of our income may constitute original issue discount or other income required to be included in taxable income prior to receipt of cash. Further, we may elect to amortize market discounts and include such amounts in our taxable income in the current year, instead of upon disposition, as an election not to do so would limit our ability to deduct interest expenses for tax purposes.
 
Any original issue discount or other amounts accrued will be included in our investment company taxable income for the year of the accrual.  Therefore, we may be required to make a distribution to our shareholders in order to satisfy the annual distribution requirement necessary to qualify for and maintain RIC tax treatment under Subchapter M of the Code, even though we will not have received any corresponding cash amount. As a result, we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may fail to qualify for or maintain RIC tax treatment and thus become subject to corporate-level income tax, as described in the previous risk factor regarding loss of pass-through tax treatment.
 
Additionally, the higher interest rates of OID instruments reflect the payment deferral and increased credit risk associated with these instruments, and OID instruments generally represent a significantly higher credit risk than coupon loans.  Even if the accounting conditions for income accrual are met, the borrower could still default when the Company's actual collection is supposed to occur at the maturity of the obligation.
 
OID instruments may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral.  OID income may also create uncertainty about the source of the Company's cash distributions.  For accounting purposes, any cash distributions to shareholders representing OID income are not treated as coming from paid-in capital, even though the cash to pay them comes from the offering proceeds.  Thus, despite the fact that a distribution of OID income comes from the cash invested by the shareholders, the 1940 Act does not require that shareholders be given notice of this fact by reporting it as a return of capital.  PIK interest has the effect of generating investment income and potentially increasing the incentive fees payable to TTG Advisers at a compounding rate.  In addition, the deferral of PIK interest also reduces the loan-to-value ratio at a compounding rate.  Furthermore, OID creates the risk that fees will be paid to TTG Advisers based on non-cash accruals that ultimately may not be realized, while TTG Advisers will be under no obligation to reimburse the Company for these fees.
 
Our ability to grow depends on our ability to raise capital.
 
To fund new investments, we may need to issue periodically equity securities, borrow from financial and other institutions or obtain debt sources of capital. Unfavorable economic conditions could increase our funding costs, limit our access to the public markets or result in a decision by lenders not to extend credit to us. If we fail to obtain capital to fund our investments, it could limit both our ability to grow our business and our profitability. With certain limited exceptions, we are only allowed to borrow amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowing. The amount of leverage that we employ depends on TTG Advisers’ and our Board's assessment of market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to maintain our current facility or obtain other lines of credit at all or on terms acceptable to us.
 
 
18

 
 
Complying with the RIC requirements may cause us to forego otherwise attractive opportunities.
 
In order to qualify as a RIC for U.S. federal income tax purposes, we must satisfy tests concerning the sources of our income, the nature and diversification of our assets and the amounts we distribute to our shareholders. We may be unable to pursue investments that would otherwise be advantageous to us in order to satisfy the source of income or asset diversification requirements for qualification as a RIC. In particular, to qualify as a RIC, at least 50% of our assets must be in the form of cash and cash items, Government securities, securities of other RICs, and other securities that represent not more than 5% of our total assets and not more than 10% of the outstanding voting securities of the issuer. We have from time to time held a significant portion of our assets in the form of securities that exceed 5% of our total assets or more than 10% of the outstanding voting securities of an issuer, and compliance with the RIC requirements currently restricts us from making additional investments that represent more than 5% of our total assets or more than 10% of the outstanding voting securities of the issuer. Thus, compliance with the RIC requirements may hinder our ability to take advantage of investment opportunities believed to be attractive, including potential follow-on investments in certain of our portfolio companies. Furthermore, as a result of the foregoing restrictions, the Board has approved an amended policy for the allocation of investment opportunities, which requires TTG Advisers to give first priority to the PE Fund only for all equity investments that would represent more than 5% of our total assets or more than 10% of the outstanding voting securities of the issuer.  For a further discussion of this allocation policy, please see "MVC Capital – Our Investment Strategy – Allocation of Investment Opportunities" below.
 
Regulations governing our operation as a business development company affect our ability to, and the way in which we, raise additional capital.
 
We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock or warrants at a price below the then-current net asset value per share of our common stock if our Board determines that such sale is in the best interests of the Company and its stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you might experience dilution.
 
Any failure on our part to maintain our status as a business development company would reduce our operating flexibility.
 
We intend to continue to qualify as a business development company (“BDC”) under the 1940 Act. The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their total assets in specified types of securities, primarily in private companies or thinly-traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high quality debt investments that mature in one year or less. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a business development company. If we decide to withdraw our election, or if we otherwise fail to qualify as a business development company, we may be subject to the substantially greater regulation under the 1940 Act as a closed-end investment company. Compliance with such regulations would significantly decrease our operating flexibility, and could significantly increase our costs of doing business.
 
Changes in the law or regulations that govern business development companies and RICs, including changes in tax regulations, may significantly impact our business.
 
We and our portfolio companies are subject to regulation by laws at the local, state and federal levels, including federal securities law and federal taxation law. These laws and regulations, as well as their interpretation, may change from time to time. A change in these laws or regulations may significantly affect our business.
 
Results may fluctuate and may not be indicative of future performance.
 
Our operating results will fluctuate and, therefore, you should not rely on current or historical period results to be indicative of our performance in future reporting periods. In addition to many of the above-cited risk factors, other factors could cause operating results to fluctuate including, among others, variations in the investment origination volume and fee income earned, variation in timing of prepayments, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions.
 
 
19

 
 
Our common stock price can be volatile.
 
The trading price of our common stock may fluctuate substantially. The price of the common stock may be higher or lower than the price you pay for your shares, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include the following:
 
 
·
Price and volume fluctuations in the overall stock market from time to time;
 
 
·
Significant volatility in the market price and trading volume of securities of business development companies or other financial services companies;
 
 
·
Volatility resulting from trading by third parties in derivative instruments that use our common stock as the referenced asset, including puts, calls, long-term equity participation securities, or LEAPs, or short trading positions;
 
 
·
Changes in regulatory policies or tax guidelines with respect to business development companies or RICs;
 
 
·
Our adherence to applicable regulatory and tax requirements, including the current restriction on our ability to make Non-Diversified Investments;
 
 
·
Actual or anticipated changes in our earnings or fluctuations in our operating results or changes in the expectations of securities analysts;
 
 
·
General economic conditions and trends;
 
 
·
Loss of a major funding source, which would limit our liquidity and our ability to finance transactions; or
 
 
·
Departures of key personnel of TTG Advisers.
 
We are subject to market discount risk.
 
As with any stock, the price of our shares will fluctuate with market conditions and other factors. If shares are sold, the price received may be more or less than the original investment. Whether investors will realize gains or losses upon the sale of our shares will not depend directly upon our NAV, but will depend upon the market price of the shares at the time of sale. Since the market price of our shares will be affected by such factors as the relative demand for and supply of the shares in the market, general market and economic conditions and other factors beyond our control, we cannot predict whether the shares will trade at, below or above our NAV. Although our shares, from time to time, have traded at a premium to our NAV, currently, our shares are trading at a discount to NAV, which discount may fluctuate over time.  Our common stock has historically traded at prices below our net asset value per share and was trading as of October 31, 2012 at an approximately 23.4% discount to NAV. Therefore, shareholders selling their shares will likely have to sell at a significant discount to their purchase price.
 
We have not established a minimum dividend payment level and we cannot assure you of our ability to make distributions to our shareholders in the future.
 
We cannot assure that we will achieve investment results that will allow us to make cash distributions or year-to-year increases in cash distributions. Our ability to make distributions is impacted by, among other things, the risk factors described in this prospectus. In addition, the asset coverage test applicable to us as a business development company can limit our ability to make distributions. Any distributions will be made at the discretion of our Board and will depend on our earnings, our financial condition, maintenance of our RIC status and such other factors as our Board may deem relevant from time to time. We cannot assure you of our ability to make distributions to our shareholders.
 
 
20

 
 
During certain periods, our distribution proceeds have exceeded and may, in the future, exceed our earnings. Therefore, during those times, portions of the distributions that we make may represent a return of capital to you for tax purposes, which will reduce your tax basis in your shares.
 
During certain periods, our distribution proceeds have exceeded and may, in the future, exceed our earnings.  For example, in the event that we encounter delays in locating suitable investment opportunities, we may pay all or a portion of our distributions from the proceeds of any securities offering, from borrowings in anticipation of future cash flow or from available funds.  Therefore, portions of the distributions that we make may be a return of the money that you originally invested and represent a return of capital to you for tax purposes.  A return of capital generally is a return of your investment rather than a return of earnings or gains derived from our investment activities and will be made after deducting the fees and expenses payable in connection with the offering.  Such a return of capital is not immediately taxable, but reduces your tax basis in your shares, which may result in higher taxes for you even if your shares are sold at a price below your original investment.
 
We have borrowed and may continue to borrow money, which magnifies the potential for gain or loss on amounts invested and may increase the risk of investing in us.
 
We have borrowed and may continue to borrow money (subject to the 1940 Act limits) in seeking to achieve our investment objective going forward. Borrowings, also known as leverage, magnify the potential for gain or loss on amounts invested and, therefore, can increase the risks associated with investing in our securities.
 
Under the provisions of the 1940 Act, we are permitted, as a business development company, to borrow money or “issue senior securities” only in amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy this test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous.
 
We may borrow from, and issue senior debt securities to, banks, insurance companies and other private and public lenders. Lenders of these senior securities have fixed dollar claims on our assets that are superior to the claims of our common shareholders. If the value of our assets increases, then leveraging would cause the NAV attributable to our common stock to increase more sharply than it would had we not used leverage. Conversely, if the value of our consolidated assets decreases, leveraging would cause the NAV to decline more sharply than it otherwise would had we not used leverage. Similarly, any increase in our consolidated income in excess of consolidated interest expense on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our consolidated income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could negatively affect our ability to make common stock dividend payments. Leverage is generally considered a speculative investment technique.
 
At October 31, 2012, we had $50.0 million in term debt on the revolving credit facility outstanding under the Credit Facility (defined below). We may incur additional debt in the future. If our portfolio of investments fails to produce adequate returns, we may be unable to make interest or principal payments on our indebtedness when they are due. The following table is designed to illustrate the effect on return to a holder of our common stock of the leverage created by our use of borrowing, at the weighted annualized average interest rate of 6.73% for the twelve month period ended October 31, 2012 and assuming hypothetical annual returns on our portfolio of minus 20 to plus 20 percent. As shown in the table, leverage generally increases the return to stockholders when the portfolio return is positive and decreases the return to stockholders when the portfolio return is negative. Actual returns to stockholders may be greater or less than those appearing in the table.
 
Assumed Return on Our Portfolio
 
Assumed Return on Portfolio (net of expenses) (1)
-20%
-10%
-5%
0%
5%
10%
20%
Corresponding Return to Common Stockholders (2)
-24.5%
-12.7%
-6.7%
-0.8%
5.1%
11.0%
22.9%

 
21

 
 
(1)
The assumed portfolio return is required by regulation of the SEC and is not a prediction of, and does not represent, our projected or actual performance.
 
(2)
In order to compute the "Corresponding Return to Common Stockholders," the "Assumed Return on Portfolio" is multiplied by the total value of our assets at the beginning of the period to obtain an assumed return to us. From this amount, all interest expense accrued during the period is subtracted to determine the return available to stockholders. The return available to stockholders is then divided by the total value of our net assets as of the beginning of the period to determine the "Corresponding Return to Common Stockholders."
 
Changes in interest rates may affect our cost of capital and net operating income and our ability to obtain additional financing.
 
Because we have borrowed and may continue to borrow money to make investments, our net investment income before net realized and unrealized gains or losses, or net investment income, may be dependent upon the difference between the rate at which we borrow funds and the rate at which we invest these funds. As a result, there can be no assurance that a significant change in market interest rates would not have a material adverse effect on our net investment income. In periods of declining interest rates, we may have difficulty investing our borrowed capital into investments that offer an appropriate return. In periods of sharply rising interest rates, our cost of funds would increase, which could reduce our net investment income. We may use a combination of long-term and short-term borrowings and equity capital to finance our investing activities. We may utilize our short-term credit facility as a means to bridge to long-term financing. Our long-term fixed-rate investments are financed primarily with equity and intermediate or long-term debt. We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. Such techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. Additionally, we cannot assure you that financing will be available on acceptable terms, if at all. Recent turmoil in the credit markets has greatly reduced the availability of debt financing. Deterioration in the credit markets, which could delay our ability to sell certain of our loan investments in a timely manner, could also negatively impact our cash flows.
 
We may be unable to meet our covenant obligations under our credit facility or renew such facility, which could adversely affect our business.
 
On April 27, 2006, the Company and MVCFS, as co-borrowers, entered into a four-year, $100 million revolving credit facility (the “Credit Facility”) with Guggenheim Corporate Funding, LLC (“Guggenheim”) as administrative agent to the lenders. On April 13, 2010, the Company renewed the Credit Facility for three years. The Credit Facility consists of a $50.0 million term loan with an interest rate of LIBOR plus 450 basis points with a 1.25% LIBOR floor. As of October 31, 2012, there was $50.0 million in term debt outstanding under the Credit Facility. The Credit Facility contains covenants that we may not be able to meet. If we cannot meet these covenants, events of default would arise, which could result in payment of the applicable indebtedness being accelerated and may limit our ability to execute on our investment strategy, as would be the case if we were unable to renew such facility. As such, from time to time, due to investment activity, changing cash positions and the need to execute against certain corporate strategies, the Company has obtained Guggenheim’s consent to waive compliance with certain covenants contained in the Credit Facility and may require such consents in the future and there can be no assurance that such future consents will be granted. The Credit Facility will expire on April 27, 2013, at which time the outstanding amount under the Credit Facility will be due and payable. Although not currently expected, in the event we are unable to renew such facility (or enter into a similar facility), our business could be adversely affected by, among other things, being forced to sell a portion of our investments quickly and prematurely to meet outstanding financing obligations and/or support working capital requirements at what may be disadvantageous prices.
 
In addition, if we require working capital greater than that provided by the Credit Facility or are unable to renew the Credit Facility, we may be required to obtain other sources of funds, which, if available, may result in increased borrowing costs for the Company and/or additional covenant obligations.
 
 
22

 
 
A small portion of our existing investment portfolio was not selected by the investment team of TTG Advisers.
 
As of October 31, 2012, 2.36% of the Company’s assets were represented by Legacy Investments. These investments were made pursuant to the Company’s prior investment objective of seeking long-term capital appreciation from venture capital investments in information technology companies.
 
Generally, a cash return may not be received on these investments until a “liquidity event,” i.e., a sale, public offering or merger, occurs. Until then, these Legacy Investments remain in the Company’s portfolio. The Company is managing them to seek to realize maximum returns.
 
Under the Advisory Agreement, TTG Advisers is entitled to compensation based on our portfolio’s performance. This arrangement may result in riskier or more speculative investments in an effort to maximize incentive compensation.  Additionally, because the base management fee payable under the Advisory Agreement is based on total assets, TTG Advisers may have an incentive to increase portfolio leverage in order to earn higher base management fees.
 
The way in which the compensation payable to TTG Advisers is determined may encourage the investment team to recommend riskier or more speculative investments and to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would adversely affect our shareholders, including investors in this offering. In addition, key criteria related to determining appropriate investments and investment strategies, including the preservation of capital, might be under-weighted if the investment team focuses exclusively or disproportionately on maximizing returns.
 
There are potential conflicts of interest that could impact our investment returns.
 
Our officers and directors, and members of the TTG Advisers investment team, may serve other entities, including the PE Fund and others that operate in the same or similar lines of business as we do. Accordingly, they may have obligations to those entities, the fulfillment of which might not be in the best interests of us or our shareholders. It is possible that new investment opportunities that meet our investment objective may come to the attention of one of the management team members or our officers or directors in his or her role as an officer or director of another entity or as an investment professional associated with that entity, and, if so, such opportunity might not be offered, or otherwise made available, to us.
 
Additionally, as an investment adviser, TTG Advisers has a fiduciary obligation to act in the best interests of its clients, including us. To that end, if TTG Advisers manages any additional investment vehicles or client accounts (which includes its current management of the PE Fund), TTG Advisers will endeavor to allocate investment opportunities in a fair and equitable manner. When the investment professionals of TTG Advisers identify an investment, they will have to choose which investment fund should make the investment. As a result, there may be times when the management team of TTG Advisers has interests that differ from those of our shareholders, giving rise to a conflict. In an effort to mitigate situations that give rise to such conflicts, TTG Advisers adheres to a policy (which was approved by our Board of Directors) relating to allocation of investment opportunities, which generally requires, among other things, that TTG Advisers continue to offer the Company investment opportunities in mezzanine and debt securities as well as non-control equity investments in small and middle market U.S. companies.  For a further discussion of this allocation policy, please see "MVC Capital – Our Investment Strategy – Allocation of Investment Opportunities" below.
 
Our relationship with any investment vehicle we or TTG Advisers manage could give rise to conflicts of interest with respect to the allocation of investment opportunities between us on the one hand and the other vehicles on the other hand.
 
Our subsidiaries are authorized to and serve as a general partner or managing member to a private equity or other investment vehicle(s) (“Other Vehicles”).  We or TTG Advisers may serve as an investment manager, sub-adviser or portfolio manager to the Other Vehicles.  This raises a potential conflict of interest with respect to allocation of investment opportunities to us, on the one hand and to the Other Vehicles on the other hand.  In fact, our Board has authorized the establishment of the PE Fund that would have the ability, among other things, to make Non-Diversified Investments.  (See discussion on PE Fund in “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”)  The Board and TTG Advisers have adopted an allocation policy (referenced above) to help mitigate potential conflicts of interest among us and similarly managed vehicles. The PE Fund has generally been given priority only on all Non-Diversified Investments, which investments would otherwise have been made available to us.  (We are currently restricted from making Non-Diversified Investments.)
 
 
23

 
 
Wars, terrorist attacks, and other acts of violence may affect any market for our common stock, impact the businesses in which we invest and harm our operations and our profitability.
 
Wars, terrorist attacks and other acts of violence are likely to have a substantial impact on the U.S. and world economies and securities markets. The nature, scope and duration of the unrest, wars and occupation cannot be predicted with any certainty. Furthermore, terrorist attacks may harm our results of operations and your investment. We cannot assure you that there will not be further terrorist attacks against the United States or U.S. businesses. Such attacks and armed conflicts in the United States or elsewhere may impact the businesses in which we invest directly or indirectly, by undermining economic conditions in the United States. Losses resulting from terrorist events are generally uninsurable.
 
Our financial condition and results of operations will depend on our ability to effectively manage our future growth.
 
Our ability to achieve our investment objective can depend on our ability to sustain continued growth. Accomplishing this result on a cost-effective basis is largely a function of our marketing capabilities, our management of the investment process, our ability to provide competent, attentive and efficient services and our access to financing sources on acceptable terms. As we grow, TTG Advisers may need to hire, train, supervise and manage new employees. Failure to effectively manage our future growth could have a material adverse effect on our business, financial condition and results of operations.
 
INVESTMENT RISKS
 
Investment risks are risks associated with our determination to execute on our business objective. These risks are not risks associated with general business conditions or those relating to an offering of our securities.
 
Investing in private companies involves a high degree of risk.
 
Our investment portfolio generally consists of loans to, and investments in, private companies. Investments in private businesses involve a high degree of business and financial risk, which can result in substantial losses and, accordingly, should be considered speculative. There is generally very little publicly available information about the companies in which we invest, and we rely significantly on the due diligence of the members of the investment team to obtain information in connection with our investment decisions.
 
Our investments in portfolio companies are generally illiquid.
 
We generally acquire our investments directly from the issuer in privately negotiated transactions. Most of the investments in our portfolio (other than cash or cash equivalents and certain other investments made pending investments in portfolio companies such as investments in exchange-traded funds) are typically subject to restrictions on resale or otherwise have no established trading market. We may exit our investments when the portfolio company has a liquidity event, such as a sale, recapitalization or initial public offering. The illiquidity of our investments may adversely affect our ability to dispose of equity and debt securities at times when it may be otherwise advantageous for us to liquidate such investments. In addition, if we were forced to immediately liquidate some or all of the investments in the portfolio, the proceeds of such liquidation could be significantly less than the current fair value of such investments.
 
Our investments in small and middle-market privately-held companies are extremely risky and the Company could lose its entire investment.
 
Investments in small and middle-market privately-held companies are subject to a number of significant risks including the following:
 
 
24

 
 
 
·
Small and middle-market companies may have limited financial resources and may not be able to repay the loans we make to them. Our strategy includes providing financing to companies that typically do not have capital sources readily available to them. While we believe that this provides an attractive opportunity for us to generate profits, this may make it difficult for the borrowers to repay their loans to us upon maturity.
 
 
·
Small and middle-market companies typically have narrower product lines and smaller market shares than large companies. Because our target companies are smaller businesses, they may be more vulnerable to competitors’ actions and market conditions, as well as general economic downturns. In addition, smaller companies may face intense competition, including competition from companies with greater financial resources, more extensive development, manufacturing, marketing and other capabilities, and a larger number of qualified managerial and technical personnel.
 
 
·
There is generally little or no publicly available information about these privately-held companies. There is generally little or no publicly available operating and financial information about privately-held companies. As a result, we rely on our investment professionals to perform due diligence investigations of these privately-held companies, their operations and their prospects. We may not learn all of the material information we need to know regarding these companies through our investigations. It is difficult, if not impossible, to protect the Company from the risk of fraud, misrepresentation or poor judgment by our portfolio companies.
 
 
·
Small and middle-market companies generally have less predictable operating results. We expect that our portfolio companies may have significant variations in their operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, may require substantial additional capital to support their operations, finance expansion or maintain their competitive position, may otherwise have a weak financial position or may be adversely affected by changes in the business cycle. Our portfolio companies may not meet net income, cash flow and other coverage tests typically imposed by their senior lenders.
 
 
·
Small and middle-market businesses are more likely to be dependent on one or two persons. Typically, the success of a small or middle-market company also depends on the management talents and efforts of one or two persons or a small group of persons. The death, disability or resignation of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us.
 
 
·
Small and middle-market companies are likely to have greater exposure to economic downturns than larger companies. We expect that our portfolio companies will have fewer resources than larger businesses and an economic downturn may thus more likely have a material adverse effect on them.
 
 
·
Small and middle-market companies may have limited operating histories. We may make debt or equity investments in new companies that meet our investment criteria. Portfolio companies with limited operating histories are exposed to the operating risks that new businesses face and may be particularly susceptible to, among other risks, market downturns, competitive pressures and the departure of key executive officers.
 
Our borrowers may default on their payments, which may have an effect on our financial performance.
 
We may make long-term unsecured, subordinated loans, which may involve a higher degree of repayment risk than conventional secured loans. We primarily invest in companies that may have limited financial resources and that may be unable to obtain financing from traditional sources. In addition, numerous factors may adversely affect a portfolio company’s ability to repay a loan we make to it, including the failure to meet a business plan, a downturn in its industry or operating results, or negative economic conditions. Deterioration in a borrower’s financial condition and prospects may be accompanied by deterioration in any related collateral.
 
 
25

 
 
Our investments in mezzanine and other debt securities may involve significant risks.
 
Our investment strategy contemplates investments in mezzanine and other debt securities of privately held companies. “Mezzanine” investments typically are structured as subordinated loans (with or without warrants) that carry a fixed rate of interest. We may also make senior secured and other types of loans or debt investments. Our debt investments are not, and typically will not be, rated by any rating agency, but we believe that if such investments were rated, they would be below investment grade quality (rated lower than “Baa3” by Moody’s or lower than “BBB-” by Standard & Poor’s, commonly referred to as “junk bonds”). Loans of below investment grade quality have predominantly speculative characteristics with respect to the borrower’s capacity to pay interest and repay principal. Our debt investments in portfolio companies may thus result in a high level of risk and volatility and/or loss of principal.
 
We are a non-diversified investment company within the meaning of the 1940 Act, and therefore may invest a significant portion of our assets in a relatively small number of portfolio companies, which subjects us to a risk of significant loss should the performance or financial condition of one or more portfolio companies deteriorate.
 
We are classified as a non-diversified investment company within the meaning of the 1940 Act, and therefore we may invest a significant portion of our assets in a relatively small number of portfolio companies in a limited number of industries. As of October 31, 2012, the fair values of our two largest investments, Summit Research Labs, Inc. (“Summit”) and U.S. Gas & Electric, Inc. (“U.S. Gas”), comprised 19.3% and 23.5% of our net assets, respectively. Beyond the asset diversification requirements associated with our qualification as a RIC, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, relatively few industries may continue to be significantly represented among our investments. To the extent that we have large positions in the securities of a small number of portfolio companies, we are subject to an increased risk of significant loss should the performance or financial condition of these portfolio companies or their respective industries deteriorate. We may also be more susceptible to any single economic or regulatory occurrence as a result of holding large positions in a small number of portfolio companies. See the risk factors below regarding the industries in which Summit and U.S. Gas operate.
 
As a result of our significant portfolio investment in Summit, we are particularly subject to the risks of that company and the specialty chemical industry.
 
Given the extent of our investment in Summit, the Company is particularly subject to the risks impacting Summit and the specialty chemical industry. See page 2 for a discussion of our agreement to sell Summit, subject to satisfaction of closing conditions and regulatory approvals.
 
Summit operates in a competitive marketplace. Competition is based on several key criteria, including product performance and quality, product price, product availability and security of supply, responsiveness of product development in cooperation with customers and customer service. Summit's competitors may be larger than it is and may have greater financial resources.  These competitors may also be able to maintain significantly greater operating and financial flexibility than it does. As a result, these competitors may be better able to withstand changes in conditions within the industry, changes in the prices of raw materials and energy and in general economic conditions. Additionally, competitors’ pricing decisions could compel Summit to decrease its prices, which could affect its margins and profitability adversely.  Summit's ability to maintain or increase its profitability is, and will continue to be, dependent upon its ability to offset changes in the prices and margins of its products by improving production efficiency and volume, shifting to higher margin chemical products and improving existing products through innovation and research and development. If it is unable to do so or to otherwise maintain its competitive position, it could lose market share to its competitors.
 
Additionally, downturns in the businesses that use Summit's specialty chemicals will adversely affect its sales. Historically, downturns in general economic conditions have resulted in diminished product demand, excess manufacturing capacity and lower average selling prices, and Summit may experience similar problems in the future. A decline in economic conditions in Summit's customers’ cyclical industries may have a material adverse effect on its sales and profitability.  Furthermore, increases in the price of the raw materials or energy utilized for Summit's products, or any disruption in the availability of such raw materials or energy, may have a material adverse effect on Summit's operating results.
 
Summit, like others in its industry, is subject to extensive federal, state, local and foreign environmental, health and safety laws and regulations concerning, among other things, emissions in the air, discharges to land and water and the generation, handling, treatment and disposal of hazardous waste and other materials.  These requirements, and enforcement of these requirements, may become more stringent in the future.  In addition, future regulatory or other developments could also restrict or eliminate the use of, or require Summit to make modifications to, its products, packaging, manufacturing processes and technology, which could have a significant adverse impact on its financial condition, results of operations and cash flows.
 
 
26

 
 
As a result of our significant portfolio investment in U.S. Gas, we are particularly subject to the risks of that company and the energy services industry.
 
Given the extent of our investment in U.S. Gas, the Company is particularly subject to the risks impacting U.S. Gas and the energy services industry.
 
As with others in its industry, U.S. Gas's operating results may fluctuate on a seasonal or quarterly basis and with general economic conditions. Weather conditions and other natural phenomena can also have an adverse impact on earnings and cash flows.  Unusually mild weather in the future could diminish U.S. Gas's results of operations and harm its financial condition.
 
U.S. Gas enters into contracts to purchase and sell electricity and natural gas as part of its operations. With respect to such transactions, the rate of return on its capital investments is not determined through mandated rates, and its revenues and results of operations are likely to depend, in large part, upon prevailing market prices for power in its regional markets and other competitive markets. These market prices can fluctuate substantially over relatively short periods of time.  Trading margins may erode as markets mature and there may be diminished opportunities for gain should volatility decline. Fuel prices may also be volatile, and the price U.S. Gas can obtain for power sales may not change at the same rate as changes in fuel costs. These factors could reduce U.S. Gas's margins and therefore diminish its revenues and results of operations.
 
U.S. Gas, like others in its industry, relies on a firm supply source to meet its energy management obligations for its customers. Should U.S. Gas's suppliers fail to deliver supplies of natural gas and electricity, there could be a material impact on its cash flows and statement of operations.  U.S. Gas depends on natural gas pipelines and other storage and transportation facilities owned and operated by third parties to deliver natural gas to wholesale markets and to provide retail energy services to customers. If transportation or storage of natural gas is disrupted, including for reasons of force majeure, the ability of U.S. Gas to sell and deliver its services may be hindered. As a result, it may be responsible for damages incurred by its customers, such as the additional cost of acquiring alternative supply at then-current market rates.  Additionally, U.S. Gas depends on transmission facilities owned and operated by other unaffiliated power companies to deliver the power it sells at wholesale. If transmission is disrupted, or transmission capacity is inadequate, U.S. Gas may not be able to sell and deliver its wholesale power.
 
U.S. Gas is subject to substantial regulation from federal, state and local regulatory authorities. It is required to comply with numerous laws and regulations and to obtain numerous authorizations, permits, approvals and certificates from governmental agencies. U.S. Gas cannot predict the impact of any future revisions or changes in interpretations of existing regulations or the adoption of new laws and regulations applicable to it. Changes in regulations or the imposition of additional regulations could influence its operating environment and may result in substantial costs to U.S. Gas.
 
When we are a debt or minority equity investor in a portfolio company, we may not be in a position to control the entity, and management of the company may make decisions that could decrease the value of our portfolio holdings.
 
We anticipate making debt and minority equity investments; therefore, we will be subject to the risk that a portfolio company may make business decisions with which we disagree, and the shareholders and management of such company may take risks or otherwise act in ways that do not serve our interests. Due to the lack of liquidity in the markets for our investments in privately held companies, we may not be able to dispose of our interests in our portfolio companies as readily as we would like. As a result, a portfolio company may make decisions that could decrease the value of our portfolio holdings.
 
 
27

 
 
We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies.
 
Some of our loans to our portfolio companies may be structured to include customary business and financial covenants placing affirmative and negative obligations on the operation of each company’s business and its financial condition. However, from time to time, we may elect to waive breaches of these covenants, including our right to payment, or waive or defer enforcement of remedies, such as acceleration of obligations or foreclosure on collateral, depending upon the financial condition and prospects of the particular portfolio company. These actions may reduce the likelihood of our receiving the full amount of future payments of interest or principal and be accompanied by a deterioration in the value of the underlying collateral as many of these companies may have limited financial resources, may be unable to meet future obligations and may go bankrupt. This could negatively impact our ability to pay dividends and cause you to lose all or part of your investment.
 
Our portfolio companies may incur obligations that rank equally with, or senior to, our investments in such companies. As a result, the holders of such obligations may be entitled to payments of principal or interest prior to us, preventing us from obtaining the full value of our investment in the event of an insolvency, liquidation, dissolution, reorganization, acquisition, merger or bankruptcy of the relevant portfolio company.
 
Our portfolio companies may have other obligations that rank equally with, or senior to, the securities in which we invest. By their terms, such other securities may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments in respect of the securities in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of securities ranking senior to our investment in the relevant portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying investors that are more senior than us, the portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of other securities ranking equally with securities in which we invest, we would have to share on an equal basis any distributions with other investors holding such securities in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company. As a result, we may be prevented from obtaining the full value of our investment in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.
 
Investments in foreign debt or equity may involve significant risks in addition to the risks inherent in U.S. investments.
 
Our investment strategy has resulted in some investments in debt or equity of foreign companies (subject to applicable limits prescribed by the 1940 Act). Investing in foreign companies can expose us to additional risks not typically associated with investing in U.S. companies. These risks include exchange rates, changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. A portion of our investments are located in countries that use the euro as their official currency.  The USD/euro exchange rate, like foreign exchange rates in general, can be volatile and difficult to predict.  This volatility could materially and adversely affect the value of the Company’s shares and our interests in affected portfolio companies.
 
Our investments in private equity funds, including the PE Fund, are subject to substantial risk, including a complete loss of investment.
 
The PE Fund is not, and other private equity funds in which the Company may invest, will not be registered as an investment company under the 1940 Act.  Therefore, with respect to its investments in such funds, the Company will not have the benefit of the protections afforded by the 1940 Act to investors in registered investment companies, such as the limitations applicable to the use of leverage and the requirements concerning custody of assets, composition of boards of directors and approvals of investment advisory arrangements.  Additionally, the interests in the PE Fund are privately placed and are not registered under the Securities Act, and the PE Fund is not a reporting company under the Securities Exchange Act of 1934.  Accordingly, the amount of information available to investors about the PE Fund will be limited.
 
 
28

 
 
Investment in a private equity fund involves the same types of risks associated with an investment in any operating company.  However, the investments made by private equity funds will entail a high degree of risk and in most cases be highly illiquid and difficult to value since no ready market typically exists for the securities of companies held in a private equity fund's portfolio.  (See "Determination of Company's Net Asset Value — Valuation Methodology" on page 88, which discusses our valuation policy respecting our interest in the PE Fund.)  Investing in private equity investments is intended for long-term investment by investors who can accept the risks associated with making highly speculative, primarily illiquid investments in privately negotiated transactions, and who can bear the risk of loss of their entire investment.  Attractive investment opportunities in private equity may occur only periodically, if at all.  Furthermore, private equity has generally been dependent on the availability of debt or equity financing to fund the acquisitions of their investments.  Due to recent market conditions, however, the availability of such financing has been reduced dramatically, limiting the ability of private equity to obtain the required financing.
 
OFFERING RISKS
 
Offering risks are risks that are associated with an offering of our securities.

Our common stock price can be volatile.

The trading price of our common stock may fluctuate substantially. The price of the common stock may be higher or lower than the price you pay for your shares, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include the following:
 
 
·
price and volume fluctuations in the overall stock market from time to time;
 
 
·
significant volatility in the market price and trading volume of securities of business development companies or other financial services companies;
 
 
·
volatility resulting from trading in derivative securities related to our common stock including puts, calls, long-term equity participation securities, or LEAPs, or short trading positions;
 
 
·
changes in regulatory policies or tax guidelines with respect to business development companies or RICs;
 
 
·
actual or anticipated changes in our earnings or fluctuations in our operating results or changes in the expectations of securities analysts;
 
 
·
general economic conditions and trends;
 
 
·
loss of a major funding source; or
 
 
·
departures of key personnel of TTG Advisers.
 
Our common stock has historically traded at prices below our net asset value per share.
 
It is not possible to predict whether any common stock offered under this offering will trade at, above or below net asset value. Our common stock has historically traded at prices below our net asset value per share and was trading as of October 31, 2012 at an approximately 23.4%  discount to NAV. Therefore, shareholders selling their shares will likely have to sell at a significant discount to their purchase price.
 
Investing in our securities may involve a high degree of risk.
 
The investments we make in accordance with our investment objective may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive, and therefore, an investment in our securities may not be suitable for someone with a low risk tolerance.
 
We may allocate the net proceeds from this offering in ways with which you may not agree.
 
We have significant flexibility in investing the net proceeds of an offering of our securities and may use the net proceeds from the offering in ways with which you may not agree.
 
 
29

 
 
Sales of substantial amounts of our securities may have an adverse effect on the market price of our securities.
 
Sales of substantial amounts of our securities, or the availability of such securities for sale, could adversely affect the prevailing market prices for our securities. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.
 
Future offerings of debt securities, which would be senior to our common stock upon liquidation, or equity securities, which could dilute our existing shareholders and be senior to our common stock for the purposes of distributions, may harm the value of our common stock.
 
In the future, we may attempt to increase our capital resources by making additional offerings of equity or debt securities, including medium-term notes, senior or subordinated notes and classes of preferred stock or common stock. Upon the liquidation of our Company, holders of our debt securities and shares of preferred stock and lenders with respect to other borrowings will receive a distribution of our available assets prior to the holders of our common stock. Additional equity offerings by us may dilute the holdings of our existing shareholders or reduce the value of our common stock, or both. Any preferred stock we may issue would have a preference on distributions that could limit our ability to make distributions to the holders of our common stock. Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings. However, it is the Company's current expectation that, in the current fiscal year, it may issue debt securities that would be senior to the Company's common stock.  Our shareholders bear the risk of our future offerings reducing the market price of our common stock and diluting their stock holdings in us.

DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS
 
Information contained in this prospectus may contain "forward-looking statements" which can be identified by the use of forward-looking terminology such as "may," "will," "expect," "intend," "anticipate," "estimate" or "continue" or the negative thereof or other variations or similar words or phrases. The matters described in "Risk Factors" and certain other factors noted throughout this prospectus and in any exhibits to the registration statement of which this prospectus is a part, constitute cautionary statements identifying important factors with respect to any such forward-looking statements, including certain risks and uncertainties, that could cause actual results to differ materially from those in such forward-looking statements.
 
Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be incorrect. Important assumptions include our ability to originate new investments, maintain certain margins and levels of profitability, access the capital markets for equity and debt capital, the ability to meet regulatory requirements and the ability to maintain certain debt to asset ratios. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this prospectus should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described in "Risk Factors" and elsewhere in this prospectus and any exhibits of the registration statement of which this prospectus is a part. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this prospectus.  The forward-looking statements contained in this prospectus and any accompanying prospectus supplement are excluded from the safe harbor protection provided by Section 27A of the Securities Act.
 
USE OF PROCEEDS
 
We intend to use the net proceeds from the sale of our securities for general corporate purposes, including, for example, investing in portfolio companies in accordance with our investment objective and strategy, repaying debt, funding distributions, funding our subsidiaries' activities and/or repurchasing our shares pursuant to the most recent share repurchase program adopted by the Board on July 19, 2011.  Pending such uses, we will hold the net proceeds from the sale of our securities in cash or invest all or a portion of such net proceeds in short term, liquid investments.  The supplement to this prospectus relating to an offering will more fully identify the use of the proceeds from such offering.
 
 
30

 
 
PRICE RANGE OF COMMON STOCK AND DISTRIBUTIONS
 
Our common stock is traded on the NYSE under the symbol "MVC."  The following table lists the high and low closing sales prices for our common stock, and the closing sales price as a percentage of net asset value.  On February 14, 2013, the last reported sale price on the NYSE for our common stock was $12.66 and on October 31, 2012, the Company's net asset value per share was $16.14.*  To view the Company's latest net asset value per share, visit the Company's Internet website address at http://www.mvccapital.com.
 
 
NAV
Closing Sale Price High
Closing Sale Price Low
Premium/(Discount) of High Sales Price to NAV
 
Premium/(Discount) of Low Sales Price to NAV
Declared Dividends
               
Fiscal Year ending October 31, 2009
First Quarter
17.28
12.59
9.15
-27.14%
 
-47.05%
0.12
Second Quarter
16.84
10.86
6.38
-35.51%
 
-62.11%
0.12
Third Quarter
16.46
9.41
7.79
-42.83%
 
-52.67%
0.12
Fourth Quarter
17.47
9.69
8.67
-44.53%
 
-50.37%
0.12
Fiscal Year ending October 31, 2010
First Quarter
17.64
12.27
9.22
-30.44%
 
-47.73%
0.12
Second Quarter
17.89
14.71
10.98
-17.78%
 
-38.62%
0.12
Third Quarter
17.35
14.80
12.55
-14.70%
 
-27.67%
0.12
Fourth Quarter
17.71
13.44
12.32
-24.11%
 
-30.43%
0.12
Fiscal Year ending October 31, 2011
First Quarter
17.33
15.12
13.07
-12.75%
 
-24.58%
0.12
Second Quarter
17.32
14.74
12.96
-14.90%
 
-25.17%
0.12
Third Quarter
17.10
13.70
12.51
-19.88%
 
-26.84%
0.12
Fourth Quarter
17.54
13.14
10.23
-25.09%
 
-41.68%
0.12
Fiscal Year ending October 31, 2012
First Quarter
17.04
12.98
11.01
-23.83%
 
-35.39%
0.12
Second Quarter
16.99
13.30
12.28
-21.72%
 
-27.72%
0.12
Third Quarter
16.42
13.13
12.33
-20.04%
 
-24.91%
0.12
Fourth Quarter
16.14
12.86
12.26
-20.32%
 
-24.04%
0.135
Fiscal Year ending October 31, 2013
First Quarter __.__* 12.40 11.65 __.__*   __.__* 0.135
 
*
The NAV calcuation for the fiscal quarter ended January 31, 2013 is not yet available.
 
Our common stock price per share has generally traded at a significant discount to our net asset value per share. We cannot predict whether our shares of common stock will trade at a premium or discount to net asset value in the future.
 
Currently, the Company has a policy of seeking to pay quarterly dividends to shareholders. Our quarterly dividends, if any, will be determined by our Board.  Recently, on October 15, 2012, our Board declared a quarterly dividend of $0.135 per share, which was paid on October 31, 2012 to shareholders of record on October 25, 2012 and a quarterly dividend of $0.135 per share, which will be paid on January 7, 2013 to shareholders of record on December 31, 2012.
 
We maintain a dividend reinvestment plan for our registered shareholders. As a result, if our Board  declares a dividend or distribution, certain shareholders can have any cash dividends and distributions automatically reinvested in additional shares of our common stock. See "Dividend Reinvestment Plan."
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
OVERVIEW
 
The Company is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act. The Company's investment objective is to seek to maximize total return from capital appreciation and/or income.
 
 
31

 
 
On November 6, 2003, Mr. Tokarz assumed his positions as Chairman and Portfolio Manager of the Company. He and the Company's management team are seeking to implement our investment objective (i.e., to maximize total return from capital appreciation and/or income) through making a broad range of private investments in a variety of industries.
 
The investments can include senior or subordinated loans, convertible debt and convertible preferred securities, common or preferred stock, equity interests, warrants or rights to acquire equity interests and other private equity transactions. During the fiscal year ended October 31, 2011, the Company made six new investments and made seven additional investments in four existing portfolio companies committing a total of $43.2 million of capital to these investments.  During the fiscal year ended October 31, 2012, the Company made two new investments and made nine additional investments in five existing portfolio companies committing a total of $11.3 million of capital to these investments.
 
Prior to the adoption of our current investment objective, the Company's investment objective had been to achieve long-term capital appreciation from venture capital investments in information technology companies. The Company's investments had thus previously focused on investments in equity and debt securities of information technology companies. As of October 31, 2012, 2.36% of the current fair value of our assets consisted of Legacy Investments. We are, however, seeking to manage these Legacy Investments to try and realize maximum returns. We generally seek to capitalize on opportunities to realize cash returns on these investments when presented with a potential "liquidity event," i.e., a sale, public offering, merger or other reorganization.
 
Our portfolio investments are made pursuant to our objective and strategy. We are concentrating our investment efforts on small and middle-market companies that, in our view, provide opportunities to maximize total return from capital appreciation and/or income. Under our investment approach, we are permitted to invest, without limit, in any one portfolio company, subject to any diversification limits required in order for us to continue to qualify as a RIC under Subchapter M of the Code.  Due to our asset growth and composition, compliance with the RIC requirements currently restricts our ability to make Non-Diversified Investments.
 
We participate in the private equity business generally by providing privately negotiated long-term equity and/or debt investment capital to small and middle-market companies. Our financing is generally used to fund growth, buyouts, acquisitions, recapitalizations, note purchases and/or bridge financings. We generally invest in private companies, though, from time to time, we may invest in public companies that may lack adequate access to public capital.
 
We may also seek to achieve our investment objective by establishing a subsidiary or subsidiaries that would serve as general partner to a private equity or other investment fund(s).  In fact, during fiscal year 2006, we established MVC Partners, LLC (“MVC Partners”) for this purpose.  Furthermore, the Board of Directors authorized the establishment of a PE Fund, for which an indirect wholly-owned subsidiary of the Company serves as the GP and which may raise up to $250 million.  On October 29, 2010, through MVC Partners and MVCFS, the Company committed to invest approximately $20.1 million in the PE Fund.  The PE Fund closed on approximately $104 million of capital commitments.  The Company's Board of Directors authorized the establishment of, and investment in, the PE Fund for a variety of reasons, including the Company's ability to make Non-Diversified Investments through the PE Fund. As previously disclosed, the Company is currently restricted from making Non-Diversified Investments.  For services provided to the PE Fund, the GP and MVC Partners are together entitled to receive 25% of all management fees and other fees paid by the PE Fund and its portfolio companies and up to 30% of the carried interest generated by the PE Fund.  Further, at the direction of the Board of Directors, the GP retained TTG Advisers to serve as the portfolio manager of the PE Fund.  In exchange for providing those services, and pursuant to the Board of Directors' authorization and direction, TTG Advisers is entitled to receive the balance of the fees and any carried interest generated by the PE Fund and its portfolio companies.  Given this separate arrangement with the GP and the PE Fund, under the terms of the Company's Advisory Agreement with TTG Advisers, TTG Advisers is not entitled to receive from the Company a management fee or an incentive fee on assets of the Company that are invested in the PE Fund. During the fiscal year ended October 31, 2012, MVC Partners was consolidated with the operations of the Company as MVC Partners’ limited partnership interest in the PE Fund is a substantial portion of MVC Partners operations.  Previously, MVC Partners was presented as a Portfolio Company on the Schedule of Investments.  The consolidation of MVC Partners has not had any material effect on the financial position or net results of operations of the Company.  There are additional disclosures resulting from this consolidation. Please see Note 2 of our consolidated financial statements “Consolidations” for more information.
 
 
32

 
 
As a result of the closing of the PE Fund, consistent with the Board-approved policy concerning the allocation of investment opportunities, the PE Fund will receive a priority allocation of all private equity investments that would otherwise be Non-Diversified Investments for the Company during the PE Fund's investment period.  For a further discussion of this allocation policy, please see "Our Investment Strategy – Allocation of Investment Opportunities" above.
 
Additionally, in pursuit of our objective, we may acquire a portfolio of existing private equity or debt investments held by financial institutions or other investment funds should such opportunities arise.
 
Furthermore, pending investments in portfolio companies pursuant to the Company’s principal investment strategy, the Company may invest in certain securities on a short-term or temporary basis.  In addition to cash-equivalents and other money market-type investments, such short-term investments may include exchange-traded funds and private investment funds offering periodic liquidity.
 
OPERATING INCOME
 
For the Fiscal Years Ended October 31, 2012, 2011 and 2010. Total operating income was $29.9 million for the fiscal year ended October 31, 2012 and $16.0 million for the fiscal year ended October 31, 2011, an increase of $13.9 million.  Fiscal year 2011 operating income decreased by $7.5 million compared to fiscal year 2010 operating income of $23.5 million.
 
For the Fiscal Year Ended October 31, 2012
 
Total operating income was $29.9 million for the fiscal year ended October 31, 2012. The increase in operating income over the same period last year was primarily due to an increase in dividend income and fee income from asset management offset by a decrease in fees from portfolio companies and other income.  The main components of operating income for the year ended October 31, 2012, was dividend income from portfolio companies and the interest earned on loans.  The Company earned approximately $25.2 million in interest and dividend income from investments in portfolio companies, of which $12.0 million was a non-recurring dividend.  Of the $25.2 million recorded in interest/dividend income, approximately $3.1 million was “payment in kind” interest/dividends.  The “payment in kind” interest/dividends are computed at the contractual rate specified in each investment agreement and added to the principal balance of each investment. The Company’s debt investments yielded rates from 6% to 14%, excluding those investments, which interest is being reserved against.  The Company also received fee income from asset management of the PE Fund and its portfolio companies totaling approximately $2.3 million and fee income from portfolio companies of approximately $1.9 million, totaling approximately $4.2 million.  Of the $2.3 million of fee income from asset management, 75% of the income is obligated to be paid to TTG Advisers.  However, under the PE Fund's agreements, a significant portion of the portfolio fees that are paid by the PE Fund’s portfolio companies to the GP and TTG Advisers is subject to recoupment by the PE Fund in the form of an offset to future management fees paid by the PE Fund.
 
For the Fiscal Year Ended October 31, 2011
 
Total operating income was $16.0 million for the fiscal year ended October 31, 2011. The decrease in operating income over the same period last year was primarily due to the repayment of investments that provided the Company with current income, reserves against non-performing loans and a decrease in dividend income from the sale of portfolio companies.  The main components of operating income were the interest earned on loans and the receipt of closing, monitoring and termination fees from certain portfolio companies by the Company and MVCFS.  The Company earned approximately $11.5 million in interest and dividend income from investments in portfolio companies.  Of the $11.5 million recorded in interest/dividend income, approximately $3.2 million was “payment in kind” interest/dividends.  The “payment in kind” interest/dividends are computed at the contractual rate specified in each investment agreement and added to the principal balance of each investment. The Company’s debt investments yielded rates from 3% to 15%, excluding those investments which interest is being reserved against.  The Company received fee income and other income from portfolio companies and other entities totaling approximately $4.5 million.
 
 
33

 
 
For the Fiscal Year Ended October 31, 2010
 
Total operating income was $23.5 million for the fiscal year ended October 31, 2010.  The decrease of $2.6 million in operating income over the same period last year was primarily due to the repayment of investments that provided the Company with current income, reserves against non-performing loans and a decrease in fee income because of fewer new investments closed.  The main components of investment income were the interest earned on loans and dividend income from portfolio companies and the receipt of closing and monitoring fees from certain portfolio companies by the Company and MVCFS. The Company earned approximately $19.3 million in interest and dividend income from investments in portfolio companies. Of the $19.3 million recorded in interest/dividend income, approximately $5.6 million was "payment in kind" interest/dividends. The "payment in kind" interest/dividends are computed at the contractual rate specified in each investment agreement and added to the principal balance of each investment. The Company's debt investments yielded rates from 1.3% to 17% excluding those investments in which accrued interest is being reserved against.  The Company received fee income and other income from portfolio companies and other entities totaling approximately $4.2 million.
 
OPERATING EXPENSES
 
For the Fiscal Years Ended October 31, 2012, 2011 and 2010.  Net Operating expenses were $8.8 million for the fiscal year ended October 31, 2012 and $18.2 million for the fiscal year ended 2011, a decrease of $9.4 million.  Fiscal year 2011 operating expenses increased by approximately $300,000 compared to fiscal year 2010 operating expenses of $17.9 million.
 
For the Fiscal Year Ended October 31, 2012
 
Operating expenses, net of the Voluntary Waivers (as described below), were approximately $8.8 million or 2.17% of the Company's average net assets, when annualized, for the year ended October 31, 2012.  Significant components of operating expenses for the year ended October 31, 2012 were management fee expense totaling approximately $9.3 million, which includes management fees related to the Company of approximately $8.6 million and the PE Fund of approximately $757,000, and interest and other borrowing costs of approximately $3.4 million.
 
The $9.4 million decrease in the Company’s net operating expenses for the year ended October 31, 2012 compared to the year ended October 31, 2011, was primarily due to the $7.9 million decrease in the estimated provision for incentive compensation expense and the $2.3 million voluntary waiver of the income incentive fee payment, which were offset by the addition of approximately $968,000 in portfolio fees – asset management expense.  The portfolio fees are payable to TTG Advisers for monitoring and other customary fees received by the GP from portfolio companies of the PE Fund.  To the extent the GP or TTG Advisers receives advisory, monitoring organization or other customary fees from any portfolio company of the PE Fund, 25% of such fees shall be paid to or retained by the GP and 75% of such fees shall be paid to or retained by TTG Advisers.  For the 2010 through 2012 fiscal years, TTG Advisers voluntarily agreed to waive $150,000 of expenses that the Company is obligated to reimburse to TTG Advisers under the Advisory Agreement (the "Voluntary Waiver"). On October 23, 2012, TTG Advisers and the Company entered into an agreement to extend the expense cap of 3.5% and the Voluntary Waiver to the 2013 fiscal year.  TTG Advisers had also voluntarily agreed that any assets of the Company that were invested in exchange-traded funds and the Octagon Fund would not be taken into account in the calculation of the base management fee due to TTG Advisers under the Advisory Agreement.  For fiscal year 2011 and fiscal year 2012, the Company’s expense ratio was 3.18% and 2.95%, respectively, (taking into account the same carve outs as those applicable to the expense cap).
 
Pursuant to the terms of the Advisory Agreement, during the year ended October 31, 2012, the provision for incentive compensation was decreased by a net amount of approximately $8.3 million to approximately $15.7 million.  The net decrease in the provision for incentive compensation during the year ended October 31, 2012 reflects the Valuation Committee’s determination to decrease the fair values of eleven portfolio investments (BP, HH&B, MVC Automotive Group B.V. (“MVC Automotive”), Security Holdings, SGDA Europe, NPWT, SIA Tekers Invest (“Tekers”), Velocitius B.V. (“Velocitius”), BPC II, LLC (“BPC”), Centile and Ohio Medical Corporation (“Ohio Medical”)) by a total of $35.4 million and the dividend distribution of $12.0 million received from Summit Research Labs, Inc. (“Summit”).  The net decrease in the provision also reflects the Valuation Committee’s determination to increase the fair values of five portfolio investments (Octagon Fund, Vestal Manufacturing Enterprises, Inc. (“Vestal”), Octagon Credit Investors, LLC ("Octagon"), Turf Products, LLC (“Turf”) and RuMe) by a total of approximately $5.7 million.  The Valuation Committee also increased the fair value of the Company’s escrow receivable related to Vitality by $130,000.  For the year ended October 31, 2012, a provision of approximately $2.3 million was recorded for the net operating income portion of the incentive fee as pre-incentive fee net operating income exceeded the hurdle rate for the quarter ended April 30, 2012.  TTG Advisers has voluntarily agreed to waive the income-related incentive fee payment of approximately $2.3 million that the Company would otherwise be obligated to pay to TTG Advisers under the Advisory Agreement.  Please see Note 5 of our consolidated financial statements “Incentive Compensation” for more information.
 
 
34

 
 
For the Fiscal Year Ended October 31, 2011
 
Operating expenses, net of the Voluntary Waiver defined below, were approximately $18.2 million or 4.38% of the Company's average net assets for the fiscal year ended October 31, 2011.  Significant components of operating expenses for the fiscal year ended October 31, 2011 were management fee expense of $9.1 million and interest and other borrowing costs of approximately $3.1 million.
 
The $300,000 increase in the Company’s operating expenses for the fiscal year ended October 31, 2011 compared to the fiscal year ended October 31, 2010, was primarily due to the increases in interest and other borrowing costs, legal and other expenses totaling approximately $1.0 million offset by the decreases in management fee and the estimated provision for incentive compensation expense of approximately $700,000.  For the 2010 and 2011 fiscal years, TTG Advisers voluntarily agreed to waive $150,000 of expenses that the Company is obligated to reimburse to TTG Advisers under the Advisory Agreement (the "Voluntary Waiver"). On October 26, 2010, TTG Advisers and the Company entered into an agreement to extend the expense cap of 3.5% to the 2011 fiscal year.  On October 25, 2011, TTG Advisers and the Company entered into an agreement to extend the expense cap of 3.5% and the Voluntary Waiver to the 2012 fiscal year.  TTG Advisers has also voluntarily agreed that any assets of the Company that are invested in exchange-traded funds would not be taken into account in the calculation of the base management fee due to TTG Advisers under the Advisory Agreement.  For fiscal year 2010 and fiscal year 2011, the Company’s expense ratio was 2.95% and 3.18%, respectively, (taking into account the same carve outs as those applicable to the expense cap).
 
Pursuant to the terms of the Advisory Agreement, during the fiscal year ended October 31, 2011, the provision for incentive compensation was increased by a net amount of approximately $1.9 million to approximately $23.9 million.  The increase in the provision for incentive compensation during the fiscal year ended October 31, 2011 reflects both increases and decreases by the Valuation Committee in the fair values of certain portfolio companies.  The provision also reflects the sale of the SPDR Barclays Capital High Yield Bond Fund and the iShares S&P U.S. Preferred Stock Index Fund for a realized gain of approximately $106,000, realized gains of approximately $55,000 and $317,000 from the Octagon Fund and LHD Europe Holding, Inc. ("LHD Europe"), respectively, and a realized loss from the sale of HuaMei of $2.0 million.  Specifically, it reflects the Valuation Committee’s determination to increase the fair values of six of the Company’s portfolio investments (Summit, SHL Group Limited, Security Holdings, Total Safety U.S., Inc. (“Total Safety”), U.S. Gas, and Velocitius) by a total of approximately $39.7 million.  The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $1.9 million due to PIK distributions, which were treated as a return of capital.  The net increase in the provision also reflects the Valuation Committee’s determination to decrease the fair values of eleven of the Company’s portfolio investments (BP, Ohio Medical common and preferred stock, MVC Automotive, HuaMei Capital Company, Inc. (“HuaMei”), Tekers, Octagon Fund, NPWT, SGDA Europe, Vestal and HH&B) by a total of $32.1 million.  During the fiscal year ended October 31, 2011, there was no provision recorded for the net operating income portion of the incentive fee as pre-incentive fee net operating income did not exceed the hurdle rate. Please see Note 5 of our consolidated financial statements “Incentive Compensation” for more information.
 
For the Fiscal Year Ended October 31, 2010
 
Operating expenses, net of the Voluntary Waiver, were $17.9 million or 4.19% of the Company's average net assets for the fiscal year ended October 31, 2010.  Significant components of operating expenses for the fiscal year ended October 31, 2010, included the management fee of $9.3 million, interest and other borrowing costs of approximately $2.8 million and incentive compensation expense of approximately $2.5 million.  The estimated provision for incentive compensation expense is a non-cash, not yet payable, provisional expense relating to the Advisory Agreement.
 
 
35

 
 
The $2.2 million decrease in the Company's operating expenses for the fiscal year ended October 31, 2010 compared to the fiscal year ended October 31, 2009, was primarily due to the $1.2 million decrease in the estimated provision for incentive compensation expense, an approximately $500,000 decrease in management fee expense and an approximately $300,000 decrease in interest and other borrowing costs.  The Advisory Agreement extended the expense cap applicable to the Company for an additional two fiscal years (fiscal years 2009 and 2010) and increased the expense cap from 3.25% to 3.5%.  For fiscal year 2009 and fiscal year 2010, the Company's expense ratio was 3.23% and 2.95%, respectively, (taking into account the same carve outs as those applicable to the expense cap).  For the 2010 fiscal year, TTG Advisers voluntarily agreed to waive $150,000 of expenses that the Company is obligated to reimburse to TTG Advisers under the Advisory Agreement (the "Voluntary Waiver").  On October 26, 2010, TTG Advisers and the Company entered into an agreement to extend the expense cap of 3.5% and the Voluntary Waiver to the 2011 fiscal year.
 
Pursuant to the terms of the Advisory Agreement, during the fiscal year ended October 31, 2010, the provision for incentive compensation was increased by a net amount of $2.5 million to $22.0 million.  The increase in the provision for incentive compensation reflects both increases and decreases by the Valuation Committee in the fair values of certain portfolio companies and the sale of Vitality for a realized gain of $13.9 million.  The difference between the amount received from the sale and Vitality's carrying value at October 31, 2009 was an increase of $3.0 million.  The amount of the provision also reflects the Valuation Committee's determination to increase the fair values of eight of the Company's portfolio investments (Octagon, Summit, Velocitius, LHD Europe, PreVisor, Inc. ("PreVisor"), U.S. Gas, Vestal and Dakota Growers Pasta Company, Inc. ("Dakota Growers")) by a total of $54.2 million.  The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $6.8 million due to PIK distributions, which were treated as a return of capital.  The net increase in the provision also reflects the Valuation Committee's determination to decrease the fair values of ten of the Company's portfolio investments (Amersham Corporation (“Amersham”), BP, Ohio Medical, MVC Automotive, Security Holdings, Harmony Pharmacy, GDC Acquisition, LLC ("GDC"), SGDA Europe, Turf and SGDA) by a total of $50.5 million and the Valuation Committee determination not to increase the fair values of the Amersham loan, the BP second lien loan and the GDC senior subordinated loan for the accrued PIK interest totaling approximately $732,000.  As of October 31, 2010, the Company does not anticipate an incentive compensation payment being made to TTG Advisers for fiscal year 2010 based on the terms of the Advisory Agreement.  During the fiscal year ended October 31, 2010, there was no provision recorded for the net operating income portion of the incentive fee as pre-incentive fee net operating income did not exceed the hurdle rate.  Please see Note 5 of the consolidated financial statements, "Incentive Compensation" for more information.
 
REALIZED GAINS AND LOSSES ON PORTFOLIO SECURITIES
 
For the Fiscal Years Ended October 31, 2012, 2011 and 2010. Net realized losses for the fiscal year ended October 31, 2012 were $20.5 million and for the fiscal year ended October 31, 2011 were $26.4 million, a decrease of approximately $5.9 million.  Net realized gains for the fiscal year ended October 31, 2010 were $32.2 million.
 
For the Fiscal Year Ended October 31, 2012
 
Net realized losses for the year ended October 31, 2012 were approximately $20.5 million.  The significant components of the Company’s net realized losses for the year ended October 31, 2012 were primarily due to the reorganization of BP, the sale of Safestone Technologies Limited (“Safestone”), and the realization of the losses on GDC and MVC Partners, which were partially offset by the realized gain from the sale of SHL Group Limited.
 
On December 12, 2011, BP filed for Chapter 11 protection in New York with agreement to turn ownership over to secured lenders under a bankruptcy reorganization plan.  On June 20, 2012, BP completed the bankruptcy process, which resulted in a realized loss of approximately $23.4 million on the Company’s second lien loan, term loan A and term loan B.
 
On March 23, 2012, the Company sold its shares in the Octagon Fund for approximately $3.0 million resulting in a realized gain of approximately $18,000.  Also during the year ended October 31, 2012, the Company received distributions from the Octagon Fund of approximately $45,000, which were treated as realized gains.
 
On July 10, 2012, the Company sold its 21,064 common shares of Safestone, a Legacy Investment.  The amount received from the sale was approximately $50,000 and resulted in a realized loss of approximately $2.0 million.
 
 
36

 
 
On August 9, 2012, the Company sold its common shares of SHL Group Limited and received gross proceeds of approximately $15.3 million, resulting in a realized gain of approximately $9.2 million.  The $15.3 million in proceeds includes all transaction expenses and approximately $225,000 held in escrow, which was fair valued at $135,000 as of October 31, 2012.
 
On October 31, 2012, the Company realized the loss of approximately $3.2 million on GDC because GDC was no longer doing business due to alleged accounting discrepancies, which has resulted in an investigation by the U.S. Department of Justice.
 
During the year ended October 31, 2012, MVC Partners and MVCFS’ General Partnership interest received distributions totaling approximately $41,000 from the PE Fund, which were treated as realized gains.
 
During fiscal year ended October 31, 2012, the Company realized a loss on its investment in MVC Partners of approximately $1.4 million.  Please see Note 2 of our consolidated financial statements “Consolidation” for more information.
 
During the year ended October 31, 2012, the Valuation Committee determined to increase the fair values of the Vitality and Vendio escrows by a combined amount of approximately $143,000, which were recorded as realized gains.
 
For the Fiscal Year Ended October 31, 2011
 
Net realized losses for the fiscal year ended October 31, 2011 were $26.4 million.  The significant components of the Company’s net realized losses for the fiscal year ended October 31, 2011 was primarily due to the loss on the sale of Harmony Pharmacy common stock, demand notes and revolving credit facility, the dissolution of Amersham, the dissolution of Sonexis and the sale of HuaMei common stock.  A portion of these losses were offset by the gains on the sale of LHD Europe common stock, SPDR Barclays Capital High Yield Bond Fund, the iShares S&P U.S. Preferred Stock Index Fund, and distributions from the Octagon Fund.
 
On November 30, 2010, a public Uniform Commercial Code (“UCC”) sale of Harmony Pharmacy’s assets took place.  Prior to this sale, the Company formed a new entity, Harmony Health & Beauty, Inc. (“HH&B”).  The Company assigned its secured debt interest in Harmony Pharmacy of approximately $6.4 million to HH&B in exchange for a majority of the economic ownership.  At the UCC sale, HH&B submitted a successful credit bid of approximately $5.9 million for all of the assets of Harmony Pharmacy.  On December 21, 2010, Harmony Pharmacy filed for dissolution in the states of California, New Jersey and New York.  As a result, the Company realized an $8.4 million loss on its investment in Harmony Pharmacy.
 
On December 1, 2010, Amersham filed for dissolution in the State of California as all operating divisions were sold in 2010.  As a result, the Company realized a $6.5 million loss on its investment in Amersham.  The Company may be eligible to receive proceeds from an earnout related to the sale of an operating division once the senior lender is repaid in full.  At this time, it is not likely that any proceeds will be received by the Company.
 
On January 25, 2011, the Company sold its common stock in LHD Europe, receiving approximately $542,000 in proceeds, which resulted in a realized gain of approximately $317,000.
 
On August 1, 2011, as part of a restructuring of the Company’s investment in HuaMei, the Company sold its shares to HuaMei, resulting in a realized loss of $2.0 million.
 
On August 31, 2011, Sonexis, Inc., a Legacy Investment, completed the dissolution of its operations and the sales of its assets.  The Company realized a loss of $10.0 million as a result of this dissolution.
 
During the fiscal year ended October 31, 2011, the Company received distributions from Octagon Fund of approximately $55,000 which were treated as realized gains.
 
During the fiscal year ended October 31, 2011, the Company sold its shares in the SPDR Barclays Capital High Yield Bond Fund and the iShares S&P U.S. Preferred Stock Index Fund, which resulted in a realized gain of approximately $106,000.
 
 
37

 
 
For the Fiscal Year Ended October 31, 2010
 
Net realized gains for the fiscal year ended October 31, 2010 were $32.2 million.  The significant components of the Company's net realized gains for the fiscal year ended October 31, 2010 were primarily due to the gains on the sale of Vitality Foodservice, Inc. (Vitality”) common and preferred stock and warrants and the sale of Dakota Growers common and preferred stock which were offset by the losses on the sale of Vendio common and preferred stock and Phoenix Coal common stock.
 
On December 29, 2009, the Company sold its common stock, preferred stock and warrants of Vitality.  The amount received from the sale of the 556,472 common shares was approximately $10.0 million, for the 1 million preferred shares was approximately $14.0 million, and for the 1 million warrants was approximately $3.8 million.  As part of this transaction, there was approximately $2.9 million deposited in an escrow account subject to a reduction over a three year period in accordance with a specified schedule.  On March 9, 2010, the Company received its first scheduled disbursement from the Vitality escrow totaling approximately $522,000. There were no claims against the escrow, so 100% of the expected proceeds of the first scheduled disbursement were released. At the same time, the Company received its portion of a working capital adjustment paid to Vitality.  The Company's share of the proceeds from the working capital adjustment totaled approximately $471,000 and was recorded as additional long-term capital gain. The total proceeds received from the escrow disbursement and working capital adjustment was approximately $993,000.  The value of the escrow was increased by $150,000 by the Valuation Committee during the fiscal year ended October 31, 2010.  This escrow is currently valued at approximately $1.9 million on the Company's consolidated balance sheet as of October 31, 2010.  The total amount received from the sale as of October 31, 2010 was approximately $30.6 million resulting in a realized gain of approximately $13.9 million, which was treated as a long-term capital gain.
 
On March 10, 2010, the Company announced that its portfolio company, Dakota Growers had signed a definitive merger agreement with Viterra Inc. (TSX: VT) (“Viterra”), Canada's leading agri-business that provides premium quality ingredients to leading global food manufacturers, under which Dakota Growers would be acquired by a subsidiary of Viterra for approximately $240 million in cash.  Under the terms of the agreement, Viterra would commence a tender offer to acquire all of the outstanding shares of Dakota Growers' common stock at a price of $18.28 per share resulting in anticipated proceeds of approximately $37.9 million.  The acquisition closed shortly after completion of a tender of a majority (50.1%) of the outstanding shares of Dakota Growers common stock, the receipt of various regulatory approvals and the satisfaction of other customary closing conditions and contingencies.  On May 3, 2010, the Company converted its 1,065,000 preferred shares of Dakota Growers to 1,065,000 common shares of Dakota Growers.  On May 6, 2010, the Company tendered its shares in Dakota Growers for approximately $37.9 million, resulting in a realized gain of approximately $22.0 million.
 
On July 2, 2010, the Company sold its common and preferred stock of Vendio Services, Inc. (“Vendio”), a legacy investment.  The amount received from the sale of the 10,476 common shares was approximately $2,900 and for the 6,443,188 preferred shares was approximately $2.9 million, which resulted in a realized loss of approximately $3.5 million, including proceeds held in escrow.  As part of this transaction, there was approximately $465,205 deposited in an escrow account, subject to a reduction over an eighteen month period.  This escrow is valued at approximately $180,000 on the Company's consolidated balance sheet as of October 31, 2010.
 
During the fiscal year ended October 31, 2010, the Company sold the remaining 666,667 shares of Phoenix Coal Corporation (“Phoenix Coal”) common stock.  The total amount received from the sale net of commission was approximately $295,000, resulting in a realized loss of approximately $205,000.
 
UNREALIZED APPRECIATION AND DEPRECIATION ON PORTFOLIO SECURITIES
 
For the Fiscal Years Ended October 31, 2012, 2011 and 2010. The Company had a net change in unrealized depreciation on portfolio investments of $22.3 million for the fiscal year ended October 31, 2012 and a net change in unrealized appreciation of $35.7 million for the fiscal year ended October 31, 2011, a decrease of $58.0 million.  The Company had a net change in unrealized depreciation on portfolio investments of $21.7 million for the fiscal year ended October 31, 2010.
 
 
38

 
 
For the Fiscal Year Ended October 31, 2012
 
The Company had a net change in unrealized depreciation on portfolio investments of approximately $22.3 million for the year ended October 31, 2012.  The change in unrealized depreciation for the year ended October 31, 2012 primarily resulted from the $12.0 million cash dividend received from Summit, the reclassification from unrealized to realized, caused by the sale of SHL Group Limited of approximately $9.2 million and the Valuation Committee’s decision to decrease the fair values of the Company’s investments in BP term loan A by $100,000, HH&B common stock by $900,000, MVC Automotive equity interest by approximately $8.9 million, SGDA Europe equity interest by approximately $2.6 million, Security Holdings equity interest by approximately $9.2 million, BPC equity interest by $180,000, MVC Partners equity interest by approximately $1.1 million, NPWT common and preferred stock by approximately $31,000 and $560,000, respectively, Tekers common stock by $278,000, Velocitius equity interest by approximately $3.4 million, Ohio Medical preferred stock by $8.4 million, Centile equity interest by approximately $34,000 and value the liability associated with the Ohio Medical guarantee at $825,000.  These changes in unrealized depreciation were partially off-set by the reclassifications from unrealized depreciation to realized losses caused by BP, Safestone, MVC Partners and GDC of approximately $29.9 million and the Valuation Committee decision to increase the fair values of the Company's investments in Octagon Fund by approximately $227,000, RuMe preferred stock by approximately $417,000, Turf equity interest by approximately $153,000, MVCFS’ General Partnership interest in the PE Fund by approximately $1,000, Octagon equity interest by $700,000 and Vestal common stock by approximately $4.2 million.
 
For the Fiscal Year Ended October 31, 2011
 
The Company had a net change in unrealized appreciation on portfolio investments of approximately $35.7 million for the fiscal year ended October 31, 2011.  The change in unrealized appreciation on investment transactions for the fiscal year ended October 31, 2011 primarily resulted from the increase in unrealized appreciation reclassification from unrealized to realized, caused by the sales of Harmony Pharmacy and HuaMei and the dissolutions of Amersham and Sonexis of approximately $26.9 million. The other components in the change in unrealized appreciation are the Valuation Committee’s decision to increase the fair value of the Company’s investments in Summit common stock by $14.5 million, SHL Group Limited common stock by $4.9 million, Security Holdings equity interest by approximately $17.6 million, Total Safety first lien loan by approximately $74,000, U.S. Gas preferred stock by $2.5 million and Velocitius equity interest by $200,000.  The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $1.9 million due to PIK distributions which were treated as a return of capital.  The Valuation Committee also decreased the fair value of the Company's investments in MVC Automotive equity interest by approximately $1.7 million, Tekers common stock by approximately $2.3 million, Octagon Fund by $209,000, BP second lien loan by $3.9 million and term loan A and B by a combined $3.2 million, Ohio Medical common stock by $500,000 and preferred stock by approximately $8.0 million, NPWT common and preferred stock by a net amount of $200,000, HuaMei common stock by approximately $1.5 million, SGDA Europe equity interest by approximately $4.3 million, Vestal common stock by $745,000 and HH&B by $5.7 million during the fiscal year ended October 31, 2011.
 
For the Fiscal Year Ended October 31, 2010
 
The Company had a net change in unrealized depreciation on portfolio investments of approximately $21.7 million for the fiscal year ended October 31, 2010.  The change in unrealized depreciation on investment transactions for the fiscal year ended October 31, 2010 primarily resulted from the increase in unrealized depreciation due to the reclassification from unrealized to realized, caused by the sale of Vitality, Dakota Growers, and Vendio, of approximately $29.2 million. The other components in the change in unrealized depreciation are the Valuation Committee's decision to increase the fair value of the Company's investments in Dakota Growers common stock by approximately $3.4 million and preferred stock by approximately $3.6 million, Octagon equity interest by $1.5 million, Summit common stock by $22.0 million, Velocitius equity interest by $1.7 million, PreVisor common stock by $3.4 million, U.S. Gas preferred stock by $17.8 million, Vestal common stock by $600,000 and LHD Europe series A common stock by approximately $166,000 and series B common stock by approximately $58,000.  The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $6.8 million due to PIK distributions which were treated as a return of capital.  The Valuation Committee also decreased the fair value of the Company's investments in Amersham second lien notes by $2.4 million, BP second lien loan by $14.1 million, Ohio Medical common stock by $8.6 million, SGDA preferred equity interest by approximately $2.4 million, MVC Automotive equity interest by $2.4 million, Security Holdings equity interest by approximately $6.4 million, SGDA Europe equity interest by approximately $4.1 million, Harmony Pharmacy demand notes and revolving credit facility by a net amount of $6.4 million, Turf equity interest by $500,000, GDC senior subordinated loan by approximately $3.2 million and Vendio preferred stock by approximately $1.9 million and common stock by $5,500 during the fiscal year ended October 31, 2010.  The net decrease of $6.4 million in Harmony Pharmacy was a result of the Valuation Committee determination to decrease the value of the unsecured demand notes by $7.5 million and ascribed value of $1.1 million to the capitalized PIK interest on the revolving credit facility which had no previous value.  The Valuation Committee also determined not to increase the fair values of the Amersham loan, BP second lien loan, and GDC senior subordinated loan for the accrued PIK interest totaling approximately $732,000.
 
 
39

 
 
PORTFOLIO INVESTMENTS
 
For the Fiscal Years Ended October 31, 2012 and 2011. The cost of the portfolio investments held by the Company at October 31, 2012 and 2011 was $332.4 million and $358.2 million, respectively, representing a decrease of $25.8 million. The primary reasons for the decrease in the cost of the portfolio investments are the realizations on investments and repayment of debt investments, as well as other factors.  The aggregate fair value of portfolio investments at October 31, 2012 and at October 31, 2011 was $404.2 million and $452.2 million, respectively, representing a decrease of $48.0 million.  The cost and aggregate market value of cash and cash equivalents held by the Company at October 31, 2012 and 2011 was $42.6 million and $35.2 million, respectively, representing an increase of approximately $7.4 million.
 
For the Fiscal Year Ended October 31, 2012
 
During the fiscal year ended October 31, 2012, the Company made two new investments, committing capital totaling $2.5 million.  The investments were made in Freshii ($1.0 million) and Biovation ($1.5 million).
 
During the fiscal year ended October 31, 2012, the Company made nine follow-on investments in five existing portfolio companies totaling approximately $8.8 million. The Company through MVC Partners Limited Partnership interest and MVCFS’ General Partnership interest contributed approximately $8.2 million of its $20.1 million capital commitment to the PE Fund, which as of October 31, 2012, has invested in Plymouth Rock Energy, LLC, Gibdock Limited and Focus Pointe Holdings, Inc.  On February 1, 2012, the Company made an equity investment in SHL Group Limited of approximately $48,000 for an additional 9,568 shares of common stock.  On September 17, 2012, the Company loaned SGDA $360,000, increasing the term loan to approximately $6.5 million at October 31, 2012 and extended the maturity date to August 31, 2014.  On October 3, 2012, the Company increased its common equity interest in Centile by approximately $173,000, which was fair valued at $3.1 million as of October 31, 2012.
 
On November 30, 2011, as part of the Ohio Medical debt refinancing, the Company agreed to guarantee a series B preferred stock tranche of equity.  As of October 31, 2012, the amount guaranteed was approximately $21.1 million and the guarantee obligation was fair valued at $825,000 by the Valuation Committee.
 
On December 12, 2011, BP filed for Chapter 11 protection in New York with agreement to turn ownership over to secured lenders under a bankruptcy reorganization plan.  On June 20, 2012, BP completed the bankruptcy process which resulted in a realized loss of approximately $23.4 million on the Company’s second lien loan, term loan A and term loan B.  As a result of the bankruptcy process, the Company received a limited liability company interest in BPC.
 
On December 28, 2011, the Company received its third scheduled disbursement from the Vitality escrow of approximately $585,000.  The escrow was fair valued at approximately $472,000 as of October 31, 2012.
 
On March 7, 2012, the Board of Directors of Summit approved a recapitalization and declared a $15.0 million dividend, of which $12.0 million was paid to the Company, resulting in a $12.0 million reduction in the fair value of the common stock.
 
On March 23, 2012, the Company sold its shares in the Octagon Fund for approximately $3.0 million resulting in a realized gain of approximately $18,000.  The Company received approximately $2.9 million of the $3.0 million with the remaining proceeds of approximately $152,000 to be distributed when the Octagon Fund’s fiscal year audit is complete.  The Company received additional proceeds of approximately $86,000 over the life of the investment.
 
 
40

 
 
On June 27, 2012, IPC completed the liquidation process filed under Chapter 7.  There was no realized gain or loss as a result of the liquidation.
 
On July 10, 2012, the Company sold its 21,064 common shares of Safestone Limited, a Legacy Investment, which had a fair value of $0.  The amount received from the sale was approximately $50,000 and resulted in a realized loss of approximately $2.0 million.
 
On August 9, 2012, the Company sold its common shares of SHL Group Limited and received gross proceeds of approximately $15.3 million, resulting in a realized gain of approximately $9.2 million.  The $15.3 million in proceeds includes all transaction expenses and approximately $225,000 held in escrow, which had a fair value of $135,000 as of October 31, 2012.
 
On October 12, 2012, the Company received a dividend from U.S. Gas of approximately $2.4 million.  U.S. Gas’ board approved an initial dividend to its shareholders, with future distributions projected to be paid quarterly. The Company anticipates receiving dividends from U.S. Gas for as long as it maintains its equity investment in U.S. Gas, and its cash flows can support the dividend. Each quarterly dividend must be approved by U.S. Gas's board of directors and be permissible under its gas and electric supply credit agreement.
 
During the fiscal year ended October 31, 2012, Marine Exhibition Corporation (“Marine”) made principal payments totaling $600,000 on its senior subordinated loan.  As of October 31, 2012, the balance of the loan was approximately $11.8 million.
 
During the fiscal year ended October 31, 2012, Pre-Paid Legal made principal payments on its tranche A term loan totaling approximately $976,000.  The outstanding balance of the tranche A term loan was approximately $3.0 million.
 
During fiscal year ended October 31, 2012, the Company realized a loss on its investment in MVC Partners of approximately $1.4 million.  Please see Note 2 of our consolidated financial statements “Consolidation” for more information.
 
During the quarter ended January 31, 2012, the Valuation Committee increased the fair value of the Company’s investments in Octagon Fund by approximately $84,000, SGDA Europe equity interest by $265,000, Turf equity interest by $500,000 and Security Holdings equity interest by $205,000.  The Valuation Committee also increased the fair values of the Company’s escrow receivables related to Vitality by $130,000 and Vendio by approximately $13,000.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $759,466.  The Valuation Committee also decreased the fair value of the Company's investments in BP term loan A by $100,000, HH&B common stock by $500,000, MVC Automotive equity interest by approximately $7.5 million, MVC Partners equity interest by approximately $326,000, MVCFS’ General Partnership interest in the PE Fund by approximately $8,000, NPWT common and preferred stock by approximately $6,000 and $120,000, respectively, Tekers common stock by $280,000, Velocitius equity interest by approximately $1.9 million.  The Valuation Committee also determined to value the liability associated with the Ohio Medical guarantee at $700,000.  Also, during the quarter ended January 31, 2012, the undistributed allocation of flow through losses from the Company’s equity investment in Octagon decreased the cost basis and fair value of this investment by approximately $112,000.
 
During the quarter ended April 30, 2012, the Valuation Committee increased the fair value of the Company’s investments in Vestal common stock by $1.2 million, MVC Automotive equity interest by $106,000, Security Holdings equity interest by $101,000, SGDA Europe equity interest by $33,000, Tekers common stock by $4,000 and Octagon Fund by approximately $143,000.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit, U.S. Gas, Freshii and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $775,585.  The Valuation Committee also decreased the fair value of the Company's investments in HH&B common stock by $100,000, MVC Partners equity interest by approximately $113,000, MVCFS’ General Partnership interest in the PE Fund by approximately $3,000, and Velocitius equity interest by approximately $2.1 million.  Also, during the quarter ended April 30, 2012, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $94,000.
 
 
41

 
 
During the quarter ended July 31, 2012, the Valuation Committee increased the fair value of the Company’s investments in Vestal common stock by approximately $1.2 million and RuMe preferred stock by approximately $417,000.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit, U.S. Gas, Freshii and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $759,887.  The Valuation Committee also decreased the fair value of the Company's investments in BPC equity interest by $180,000, HH&B common stock by $150,000, MVC Automotive equity interest by approximately $1.1 million, MVC Partners equity interest by approximately $565,000, Security Holdings equity interest by approximately $6.5 million, SGDA Europe equity interest by approximately $3.1 million, Tekers common stock by $141,000, Turf equity interest by $618,000 and Velocitius equity interest by approximately $1.9 million.  Also, during the quarter ended July 31, 2012, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $107,000.
 
During the quarter ended October 31, 2012, the Valuation Committee increased the fair value of the Company’s investments in Vestal common stock by approximately $1.8 million, Octagon equity interest by $700,000, Velocitius equity interest by approximately $2.5 million, Turf equity interest by $271,000, SGDA Europe equity interest by $239,000, Tekers common stock by $139,000 and MVCFS’ General Partnership interest in the PE Fund by approximately $13,000.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit, U.S. Gas, Freshii and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $836,104.  The Valuation Committee also decreased the fair value of the Company's investments in HH&B common stock by $150,000, MVC Automotive equity interest by $362,000, MVC Partners equity interest by approximately $71,000, Security Holdings equity interest by approximately $3.0 million, Ohio Medical preferred stock and guarantee by $8.4 million and $125,000, respectively, NPWT common and preferred stock by approximately $25,000 and $440,000, respectively, and Centile equity interest by approximately $34,000.  Also, during the quarter ended October 31, 2012, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $99,000.
 
During the fiscal year ended October 31, 2012, the Valuation Committee increased the fair value of the Company’s investments in Octagon Fund by approximately $227,000, RuMe preferred stock by approximately $417,000, Turf equity interest by approximately $153,000, MVCFS’ General Partnership interest in the PE Fund by approximately $1,000, Octagon equity interest by $700,000 and Vestal common stock by approximately $4.2 million.  The Valuation Committee also increased the fair values of the Company’s escrow receivables related to Vitality by $130,000 and Vendio by approximately $13,000.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit U.S. Gas, and Freshii and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $3,131,042.  The Valuation Committee also decreased the fair value of the Company's investments in BP term loan A by $100,000, HH&B common stock by $900,000, MVC Automotive equity interest by approximately $8.9 million, SGDA Europe equity interest by approximately $2.6 million, Security Holdings equity interest by approximately $9.2 million, BPC equity interest by $180,000, MVC Partners equity interest by approximately $1.1 million, NPWT common and preferred stock by approximately $31,000 and $560,000, respectively, Tekers common stock by $278,000, Velocitius equity interest by approximately $3.4 million, Ohio Medical preferred stock by $8.4 million, Centile equity interest by approximately $34,000 and valued the liability associated with the Ohio Medical guarantee at $825,000.  Also, during the fiscal year ended October 31, 2012, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $188,000.
 
At October 31, 2012, the fair value of all portfolio investments, exclusive of short-term investments, was $404.2 million with a cost basis of $332.4 million.  At October 31, 2012, the fair value and cost basis of portfolio investments of the Legacy Investments were $10.8 million and $30.3 million, respectively, and the fair value and cost basis of portfolio investments made by the Company’s current management team were $393.4 million and $303.5 million, respectively.  At October 31, 2011, the fair value of all portfolio investments, exclusive of short-term securities, was $452.2 million, with a cost basis of $358.2 million.  At October 31, 2011, the fair value and cost basis of portfolio investments of the Legacy Investments was $10.8 million and $32.3 million, respectively, and the fair value and cost basis of portfolio investments made by the Company's current management team was $441.4 million and $325.9 million, respectively.
 
 
42

 
 
For the Fiscal Year Ended October 31, 2011
 
During the fiscal year ended October 31, 2011, the Company made six new investments, committing capital totaling approximately $26.1 million.  The investments were made in Octagon Fund ($3.0 million), JSC Tekers ($4.0 million), Teleguam ($7.0 million), Pre-Paid Legal ($8.0 million), RuMe ($1.2 million) and Centile ($3.0 million).
 
During the fiscal year ended October 31, 2011, the Company made seven follow-on investments in four existing portfolio companies totaling approximately $17.1 million. On January 27, 2011, the Company invested $3.3 million in Security Holdings in the form of an additional equity interest.  On January 28, 2011, the Company loaned an additional $5.0 million to Security Holdings in the form of a bridge loan with an annual interest rate of 3%.  This bridge loan allowed Security Holdings to secure project guarantees.  On May 4, 2011, the Company invested $500,000 in NPWT to acquire 5,000 shares of convertible preferred stock.  On May 26, 2011 and September 14, 2011, the Company invested an additional $150,000 on each date into HH&B to acquire an additional 47,612 shares of common stock.   On September 6, 2011, the Company invested $7.0 million in Security Holdings in the form of an additional equity interest.  On October 17, 2011, the Company invested $1.0 million in SGDA Europe in the form of additional equity interest.  In addition, during the fiscal year ended October 31, 2011, the Company invested approximately $10.0 million in the SPDR Barclays Capital High Yield Bond Fund and approximately $10.0 million in the iShares S&P U.S. Preferred Stock Index Fund.  These investments were sold during the fiscal year ended October 31, 2011, resulting in a realized gain of approximately $106,000.  The investments in these exchange traded funds were intended to provide the Company with higher yielding investments than cash and cash equivalents while awaiting deployment into portfolio companies pursuant to the Company’s principal investment strategy.  TTG Advisers had voluntarily agreed that any assets of the Company that are invested in exchange-traded funds would not be subject to the base management fee due to TTG Advisers under the Advisory Agreement.
 
Effective November 4, 2010, the interest rate on the Turf senior subordinated loan was reduced from 15% to 13% and the maturity date on the senior subordinated loan and junior revolving note was extended to January 31, 2014.
 
On November 30, 2010, the Company loaned an additional $700,000 to Harmony Pharmacy, which was the remaining portion of the $1.3 million demand note committed on September 23, 2010.
 
On November 30, 2010, a public Uniform Commercial Code (“UCC”) sale of Harmony Pharmacy’s assets took place.  Prior to this sale, the Company formed a new entity, HH&B.  The Company assigned its secured debt interest in Harmony Pharmacy of approximately $6.4 million to HH&B in exchange for a majority of the economic ownership.  At the UCC sale, HH&B submitted a successful credit bid of approximately $5.9 million for all of the assets of Harmony Pharmacy.  On December 21, 2010, Harmony Pharmacy filed for dissolution in the states of California, New Jersey and New York.  As a result, the Company realized an $8.4 million loss on its investment in Harmony Pharmacy.
 
On December 1, 2010, Amersham filed for dissolution in the State of California as all operating divisions were sold in 2010.  As a result, the Company realized a $6.5 million loss on its investment in Amersham.  The Company may be eligible to receive proceeds from an earnout related to the sale of an operating division once the senior lender is repaid in full.  At this time, it is not likely that any proceeds will be received by the Company.
 
On January 11, 2011, SHL Group Limited, which provides workplace talent assessment solutions, including ability and personality tests, and psychometric assessments, acquired the Company’s portfolio company PreVisor.  The Company received 1,518,762 common shares of SHL Group Limited for its investment in PreVisor.  The cost basis and market value of the Company’s investment remained unchanged at the time as a result of the transaction.
 
On January 25, 2011, the Company sold its common stock in LHD Europe and received approximately $542,000 in proceeds, which resulted in a realized gain of approximately $317,000.
 
On March 1, 2011, SP Industries, Inc. (“SP”) repaid its first lien and second lien loans in full including all accrued interest.  The Company received a $500,000 termination fee associated with the repayment of the loans.
 
On April 29, 2011, assets from a division of Ohio Medical were distributed to Ohio Medical shareholders on a pro-rata basis.  The Company received 281 shares of common stock in NPWT as a result of this transaction.
 
 
43

 
 
On May 26, 2011, Security Holdings repaid its bridge loan in full, including all accrued interest.
 
On August 1, 2011, as part of a restructuring of the Company’s investment in HuaMei, the Company sold its shares to HuaMei, resulting in a realized loss of $2.0 million.
 
On August 31, 2011, Sonexis, a Legacy Investment, completed the dissolution of its operations and the sales of its assets.  The Company realized a loss of $10.0 million as a result of this dissolution.
 
On October 3, 2011, Storage Canada, LLC (“Storage Canada”) repaid its term loan in full including all accrued interest.
 
On October 17, 2011, the Company converted SGDA Europe’s $1.5 million senior secured loan and all accrued interest to additional common equity interest.
 
On October 28, 2011, Total Safety repaid its first and second lien loans in full including all accrued interest.
 
On October 31, 2011, the Company received a distribution from NPWT of $500,000, which was treated as a return of capital and returned all cash invested into NPWT to the Company.
 
During the fiscal year ended October 31, 2011, Marine made principal payments totaling $450,000 on its senior subordinated loan.  The balance of the loan as of October 31, 2011 was approximately $12.0 million.
 
During the fiscal year ended October 31, 2011, Octagon borrowed and repaid $1.5 million on its revolving line of credit.  Octagon cancelled the revolving line of credit effective June 30, 2011.  As of October 31, 2011, the revolving credit facility was no longer a commitment of the Company.
 
During the quarter ended January 31, 2011, the Valuation Committee increased the fair value of the Company’s investments in Summit common stock by $7.5 million and U.S. Gas preferred stock by $2.5 million.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, SP, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of payment in kind ("PIK") interest/dividends totaling $980,119.  The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $1.9 million due to PIK distributions, which were treated as a return of capital.  Also, during the quarter ended January 31, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $229,000.  The Valuation Committee also decreased the fair value of the Company's investments in BP second lien loan by $3.9 million and term loan A and B by a combined $2.0 million, Ohio Medical common stock by $500,000 and preferred stock by $8.2 million, MVC Automotive equity interest by $3.1 million, HuaMei stock by $325,000 and HH&B by $1.9 million during the quarter ended January 31, 2011.
 
During the quarter ended April 30, 2011, the Valuation Committee increased the fair value of the Company’s investments in Summit common stock by $2.0 million, MVC Automotive equity interest by $3.0 million, SHL Group Limited common stock by $2.5 million, Security Holdings equity interest by approximately $2.0 million, Tekers common stock by $590,000, Total Safety first lien loan by approximately $74,000 and Velocitius equity interest by $2.6 million.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, SP, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $714,247.  In addition, during the quarter ended April 30, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $28,000.  The Valuation Committee also decreased the fair value of the Company's investments in BP term loan A by approximately $1.2 million, Ohio Medical preferred stock by approximately $164,000, HuaMei common stock by approximately $1.0 million, SGDA Europe equity interest by $3.9 million and HH&B by $3.8 million during the quarter ended April 30, 2011.
 
During the quarter ended July 31, 2011, the Valuation Committee increased the fair value of the Company’s investments in SHL Group Limited common stock by $1.0 million, Octagon Fund by approximately $25,000 and Security Holdings equity interest by approximately $2.5 million.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $731,374.  In addition, during the quarter ended July 31, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $139,000.  The Valuation Committee also decreased the fair value of the Company's investments in HuaMei common stock by $250,000, SGDA Europe equity interest by $400,000, MVC Automotive by $2.3 million, Tekers common stock by $180,000, Velocitius equity interest by $2.3 million and Vestal common stock by $670,000 during the quarter ended July 31, 2011.
 
 
44

 
 
During the quarter ended October 31, 2011, the Valuation Committee increased the fair value of the Company’s investments in SHL Group Limited common stock by $1.4 million, Security Holdings equity interest by approximately $13.1 million, Summit common stock by $5.0 million, Ohio Medical preferred stock by $400,000 and MVC Automotive equity interest by $750,000.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $748,981.  In addition, during the quarter ended October 31, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $193,000.  The Valuation Committee also decreased the fair value of the Company's investments in Octagon Fund by approximately $234,000, Tekers common stock by $2.7 million, NPWT common and preferred stock by a net amount of approximately $200,000, Velocitius equity interest by $100,000 and Vestal common stock by $75,000 during the quarter ended October 31, 2011.
 
During the fiscal year ended October 31, 2011, the Valuation Committee increased the fair value of the Company’s investments in Summit common stock by $14.5 million, SHL Group Limited common stock by $4.9 million, Security Holdings equity interest by approximately $17.6 million, Total Safety first lien loan by approximately $74,000, U.S. Gas preferred stock by $2.5 million and Velocitius equity interest by $200,000.  In addition, increases in the cost basis and fair value of the loans to Custom Alloy, SP, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $3,174,721.  The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $1.9 million due to PIK distributions, which were treated as a return of capital.  Also, during the fiscal year ended October 31, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $589,000.  The Valuation Committee also decreased the fair value of the Company's investments in MVC Automotive equity interest by approximately $1.7 million, Tekers common stock by approximately $2.3 million, Octagon Fund by $209,000, BP second lien loan by $3.9 million and term loan A and B by a combined $3.2 million, Ohio Medical common stock by $500,000 and preferred stock by approximately $8.0 million, NPWT common and preferred stock by a net amount of $200,000, HuaMei common stock by approximately $1.5 million, SGDA Europe equity interest by approximately $4.3 million, Vestal common stock by $745,000 and HH&B by $5.7 million during the fiscal year ended October 31, 2011.
 
At October 31, 2011, the fair value of all portfolio investments, exclusive of short-term investments, was $452.2 million with a cost basis of $358.2 million.  At October 31, 2011, the fair value and cost basis of portfolio investments of the Legacy Investments was $10.8 million and $32.3 million, respectively, and the fair value and cost basis of portfolio investments made by the Company’s current management team was $441.4 million and $325.9 million, respectively.  At October 31, 2010, the fair value of all portfolio investments, exclusive of short-term securities, was $433.9 million, with a cost basis of $375.6 million.  At October 31, 2010, the fair value and cost basis of portfolio investments of the Legacy Investments was $10.8 million and $42.3 million, respectively, and the fair value and cost basis of portfolio investments made by the Company's current management team was $423.1 million and $333.3 million, respectively.
 
PORTFOLIO COMPANIES
 
During the fiscal year ended October 31, 2012, the Company had investments in the following portfolio companies:
 
Actelis Networks, Inc.
 
Actelis Networks, Inc. ("Actelis"), Fremont, California, a Legacy Investment, provides authentication and access control solutions designed to secure the integrity of e-business in Internet-scale and wireless environments.
 
 
45

 
 
At October 31, 2011 and October 31, 2012, the Company's investment in Actelis consisted of 150,602 shares of Series C preferred stock at a cost of $5.0 million.  The investment has been fair valued at $0.
 
Biovation Holdings Inc.
 
Biovation, Mankato, Minnesota, is a manufacturer and marketer of environmentally friendly, organic and sustainable laminate materials and composites.
 
On May 22, 2012, the Company invested $1.5 million in Biovation in the form of a loan.  The loan bears annual interest at 12% and matures on February 28, 2014.
 
At October 31, 2012, the Company’s investment in Biovation had an outstanding balance, cost basis and fair value of approximately $1.5 million.
 
Peter Seidenberg, Chief Financial Officer of the Company, and Jim Lynch, a representative of the Company, serve as directors of Biovation.
 
BP Clothing, LLC
 
BP, Pico Rivera, California, is a company that designs, manufactures, markets and distributes women’s apparel under several brand names.
 
At October 31, 2011, the Company's investment in BP consisted of a $20.4 million second lien loan, a $2.0 million term loan A, and a $2.0 million term loan B.  The second lien loan bears annual interest at 16.5%.  The second lien loan had a $17.5 million principal face amount and was issued at a cost basis of $17.5 million. The second lien loan's cost basis was subsequently discounted to reflect loan origination fees received.  The maturity date of the second lien loan is July 18, 2012.  The principal balance is due upon maturity.  The term loan A bears annual interest at LIBOR plus 7.75% or Prime Rate plus 6.75%.  The term loan B bears annual interest at LIBOR plus 10.75% or Prime Rate plus 9.75%.  The interest rate option on the loan assignments is at the borrower's discretion.  Both term loans matured on July 18, 2011.  The combined cost basis and fair value of the investments at October 31, 2011 was $23.6 million and $280,000, respectively.
 
On December 12, 2011, BP filed for Chapter 11 protection in New York with agreement to turn ownership over to secured lenders under a bankruptcy reorganization plan.  Secured lenders, including the Company, agreed to support a Chapter 11.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the term loan A by $100,000.
 
On June 20, 2012, BP completed the bankruptcy process which resulted in a realized loss of approximately $23.4 million on the Company’s second lien loan, term loan A and term loan B.  As a result of the bankruptcy process, the Company received a limited liability company interest in BPC.
 
At October 31, 2012, the Company no longer held an investment in BP.
 
BPC II, LLC
 
BPC, Arcadia, California, is a company that designs, manufactures, markets and distributes women’s apparel under several brand names.
 
On December 12, 2011, BP filed for Chapter 11 protection in New York with agreement to turn ownership over to secured lenders under a bankruptcy reorganization plan.  Secured lenders, including the Company, agreed to support a Chapter 11.
 
On June 20, 2012, BP completed the bankruptcy process which resulted in a realized loss of approximately $23.4 million on the second lien loan, term loan A and term loan B.  As a result of the bankruptcy process, the Company received limited liability company interest in BPC.
 
 
46

 
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the limited liability company interest in BPC by $180,000.
 
At October 31, 2012, the equity investment had a cost basis of $180,000 and a fair value of $0.
 
Centile Holding B.V.
 
Centile, Sophia-Antipolis, France, is a leading European innovator of unified communications, network platforms, hosted solutions, applications and tools that help mobile, fixed and web-based communications service providers serve the needs of enterprise end users.
 
At October 31, 2011, the Company’s investment in Centile consisted of common equity interest at a cost and fair value of approximately $3.0 million.
 
On October 3, 2012, the Company increased its common equity interest in Centile by approximately $173,000.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the common equity interest by approximately $34,000.
 
At October 31, 2012, the Company’s investment in Centile consisted of common equity interest at a cost of $3.2 million and a fair value of approximately $3.1 million.
 
Christopher Sullivan, a representative of the Company, serves as a director of Centile.
 
Custom Alloy Corporation
 
Custom Alloy, High Bridge, New Jersey, manufactures time sensitive and mission critical butt-weld pipe fittings for the natural gas pipeline, power generation, oil/gas refining and extraction, and nuclear generation markets.
 
At October 31, 2011, the Company's investment in Custom Alloy consisted of nine shares of convertible series A preferred stock at a cost and fair value of $44,000 and 1,991 shares of convertible series B preferred stock at a cost and fair value of approximately $10.0 million.  The unsecured subordinated loan, which bears annual interest at 14% and was to mature on September 18, 2012, had a cost of $14.5 million and a fair value of $14.6 million.
 
At October 31, 2012, the Company's investment in Custom Alloy consisted of nine shares of convertible series A preferred stock at a cost and fair value of $44,000 and the 1,991 shares of convertible series B preferred stock had a cost and fair value of approximately $10.0 million.  The unsecured subordinated loan had a cost basis, outstanding balance and fair value of approximately $15.6 million.  The Company extended the maturity date of the loan to June 18, 2013.  The increase in the cost basis and fair value of the loan is due to the amortization of loan origination fees and the capitalization of "payment in kind" interest.  These increases were approved by the Company's Valuation Committee.
 
Michael Tokarz, Chairman of the Company, and Shivani Khurana, representative of the Company, serve as directors of Custom Alloy.
 
DPHI, Inc. (formerly DataPlay, Inc.)
 
DPHI, Inc. ("DPHI"), Boulder, Colorado, a Legacy Investment, is trying to develop new ways of enabling consumers to record and play digital content.
 
At October 31, 2011 and October 31, 2012, the Company's investment in DPHI consisted of 602,131 shares of Series A-1 preferred stock with a cost of $4.5 million. This investment has been fair valued at $0.
 
Foliofn, Inc.
 
Foliofn, Vienna, Virginia, a Legacy Investment, is a financial services technology company that offers investment solutions to financial services firms and investors.
 
 
47

 
 
At October 31, 2011 and October 31, 2012, the Company's investment in Foliofn consisted of 5,802,259 shares of Series C preferred stock with a cost of $15.0 million and a fair value of $10.8 million.
 
Bruce Shewmaker, an officer of the Company, serves as a director of Foliofn.
 
Freshii USA, Inc.
 
Freshii, Chicago, Illinois, is a chain of “fast casual” restaurants serving fresh and healthy food for breakfast, lunch and dinner.  Freshii currently has 33 locations in 21 cities and four countries.
 
On January 13, 2012, the Company invested $1.0 million in Freshii in the form of a senior secured loan with an annual interest rate of 12% and a maturity date of January 11, 2017, and received a warrant at no cost to the Company.  The Company allocated a portion of the cost basis in the senior secured loan to the warrant at the time the investment was made.
 
At October 31, 2012, the Company’s investment in Freshii consisted of a senior secured loan with an outstanding balance, cost basis and fair value of approximately $1.0 million.  The warrant had a cost and fair value of approximately $34,000.  The increase in cost and fair value of the loan is due to the amortization of loan origination fees, the capitalization of "payment in kind" interest and the discount associated with the warrant.  These increases were approved by the Company's Valuation Committee.
 
GDC Acquisitions, LLC d/b/a JDC Lighting, LLC
 
GDC is the holding company of JDC Lighting, LLC ("JDC").  GDC, New York, New York, was a distributor of commercial lighting and electrical products.
 
At October 31, 2011, the Company's investment in GDC consisted of a $3.3 million senior subordinated loan, bearing annual interest at 17% and matured on August 31, 2011. The loan had an outstanding balance of approximately $3.3 million, a cost basis of approximately $3.2 million and was fair valued at $0.  The warrant was fair valued at $0.
 
On October 31, 2012, the Company realized the loss of approximately $3.2 million because GDC was no longer doing business due to alleged accounting discrepancies, which has resulted in an investigation by U.S. Department of Justice.
 
At October 31, 2012, the Company no longer held an investment in GDC.
 
Harmony Health & Beauty, Inc.
 
Harmony Health & Beauty, Purchase, New York, purchased the assets of Harmony Pharmacy on November 30, 2010, during a public UCC sale for approximately $6.4 million.  HH&B now operates the health and beauty stores previously owned by Harmony Pharmacy in John F. Kennedy International Airport and San Francisco International Airport.  The Company’s initial investment consisted of 100,010 shares of common stock.
 
At October 31, 2011, the Company's investment in HH&B consisted of 147,621 shares of common stock with a cost of $6.7 million and fair value of $1.0 million.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the common stock by $900,000.
 
At October 31, 2012, the Company's investment in HH&B consisted of 147,621 shares of common stock with a cost of $6.7 million and fair value of $100,000.
 
Michael Tokarz, Chairman of the Company, serves as a director of HH&B.
 
Integrated Packaging Corporation
 
IPC, New Brunswick, New Jersey, is a manufacturer of corrugated boxes and packaging material.
 
 
48

 
 
At October 31, 2011, the Company's investment in IPC consisted of a warrant, which was received in exchange for services provided to another investor in IPC.  The warrant had a zero cost basis and has been fair valued at $0.
 
On June 27, 2012, IPC completed the liquidation process filed under Chapter 7.  There was no realized gain or loss as a result of the liquidation.
 
At October 31, 2012, the Company no longer held an investment in IPC.
 
JSC Tekers Holdings
 
JSC Tekers, Latvia, is an acquisition company focused on real estate management.
 
At October 31, 2011 and October 31, 2012, the Company's investment in JSC Tekers consisted of a secured loan with an outstanding balance, a cost basis and a fair value of $4.0 million and 2,250 shares of common stock with a cost basis and fair value of $4,500.  The secured loan has an interest rate of 8% and a maturity date of June 30, 2014.
 
Lockorder Limited (formerly Safestone Technologies PLC)
 
Lockorder, located in Old Amersham, United Kingdom, a Legacy Investment, provides organizations with technology designed to secure access controls, enforcing compliance with security policies and enabling effective management of corporate IT and e-business infrastructure.
 
At October 31, 2011 and October 31, 2012, the Company's investment in Lockorder consisted of 21,064 shares of common stock with a cost of $2.0 million.  The investment has been fair valued at $0 by the Company's Valuation Committee.
 
Mainstream Data, Inc.
 
Mainstream Data, Inc. ("Mainstream"), Salt Lake City, Utah, a Legacy Investment, builds and operates satellite, internet and wireless broadcast networks for information companies. Mainstream networks deliver text news, streaming stock quotations and digital images to subscribers around the world.
 
At October 31, 2011 and October 31, 2012, the Company's investment in Mainstream consisted of 5,786 shares of common stock with a cost of $3.75 million. The investment has been fair valued at $0.
 
Marine Exhibition Corporation
 
Marine, Miami, Florida, owns and operates the Miami Seaquarium.  The Miami Seaquarium is a family-oriented entertainment park.
 
At October 31, 2011, the Company's investment in Marine consisted of a senior secured loan and 20,000 shares of preferred stock.  The senior secured loan had an outstanding balance of approximately $12.0 million and a cost basis of approximately $11.9 million.  The senior secured loan bears annual interest at 11% and matures on August 30, 2017.  The senior secured loan was fair valued at approximately $12.0 million.  The preferred stock was fair valued at approximately $3.0 million.  The dividend rate on the preferred stock is 12% per annum.
 
During the fiscal year ended October 31, 2012, Marine made principal payments totaling $600,000 on its senior secured loan.
 
At October 31, 2012, the Company's senior secured loan had an outstanding balance, cost basis and fair value of approximately $11.8 million.  The preferred stock had a cost and fair value of approximately $3.3 million.  The increase in the outstanding balance, cost and fair value of the loan and preferred stock is due to the amortization of loan origination fees and the capitalization of "payment in kind" interest/dividends.  These increases were approved by the Company's Valuation Committee.
 
 
49

 
 
MVC Automotive Group B.V.
 
MVC Automotive, an Amsterdam-based holding company, owns and operates ten Ford, Jaguar, Land Rover, Mazda, and Volvo dealerships located in Austria, Belgium, and the Czech Republic.
 
At October 31, 2011, the Company's investment in MVC Automotive consisted of an equity interest with a cost of approximately $34.7 million and a fair value of approximately $42.5 million.  The bridge loan, which bears annual interest at 10% and matures on December 31, 2012, had a cost and fair value of approximately $3.6 million.  The guarantees for MVC Automotive were equivalent to approximately $13.7 million at October 31, 2011.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the equity interest by approximately $8.9 million.
 
At October 31, 2012, the Company's investment in MVC Automotive consisted of an equity interest with a cost of approximately $34.7 million and a fair value of approximately $33.5 million.  The bridge loan had a cost and fair value of approximately $3.6 million.  The mortgage guarantee for MVC Automotive was equivalent to approximately $5.2 million at October 31, 2012.  This guarantee was taken into account in the valuation of MVC Automotive.
 
Michael Tokarz, Chairman of the Company, and Christopher Sullivan, a representative of the Company, serve as directors of MVC Automotive.
 
MVC Partners LLC
 
MVC Partners, Purchase, New York, a wholly-owned portfolio company, is a private equity firm established primarily to serve as the general partner, managing member or anchor investor of private or other investment vehicles.
 
On October 29, 2010, through MVC Partners and MVCFS, the Company committed to invest approximately $20.1 million in the PE Fund, for which an indirect wholly-owned subsidiary of the Company serves as the GP.  Of the $20.1 million total commitment, the Company, via MVC Partners, has committed $19.6 million to the PE Fund as its anchor limited partner.  See MVC Private Equity Fund, L.P. for more information on the PE Fund. The PE Fund has closed on approximately $104 million of capital commitments.
 
At October 31, 2011, the Company's equity investment in MVC Partners had a cost basis of approximately $1.4 million and fair value of approximately $1.1 million.
 
During the fiscal year ended October 31, 2012, the Company made three follow-on investments in MVC Partners totaling approximately $8.0 million, which was used to fund MVC Partners’ limited partnership commitment to the PE Fund.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the equity interest in MVC Partners by approximately $1.1 million.
 
During the fiscal year ended October 31, 2012, MVC Partners was consolidated with the operations of the Company as MVC Partners’ limited partnership interest in the PE Fund is a substantial portion of MVC Partners operations.  Previously, MVC Partners was presented as a Portfolio Company on the Schedule of Investments.  See MVC Private Equity Fund, L.P. below for more information.
 
MVC Private Equity Fund, L.P.
 
MVC Private Equity Fund, L.P., Purchase, New York, is a private equity fund focused on control equity investments in the lower middle market.  MVC GP II, an indirect wholly-owned subsidiary of the Company, serves as the GP to the PE Fund and is exempt from the requirement to register with the Securities and Exchange Commission as an investment adviser under Section 203 of the Investment Advisers Act of 1940.  MVC GP II is wholly-owned by MVCFS, a subsidiary of the Company.  The Company's Board of Directors authorized the establishment of, and investment in, the PE Fund for a variety of reasons, including the Company's ability to participate in Non-Diversified Investments made by the PE Fund. As previously disclosed, the Company is currently restricted from making Non-Diversified Investments.  For services provided to the PE Fund, the GP and MVC Partners are together entitled to receive 25% of all management fees and other fees paid by the PE Fund and its portfolio companies and up to 30% of the carried interest generated by the PE Fund.  Further, at the direction of the Board of Directors, the GP retained TTG Advisers to serve as the portfolio manager of the PE Fund.  In exchange for providing those services, and pursuant to the Board of Directors' authorization and direction, TTG Advisers is entitled to the remaining 75% of the management and other fees generated by the PE Fund and its portfolio companies and any carried interest generated by the PE Fund.  A significant portion of the portfolio fees that are paid by the PE Fund’s portfolio companies to the GP and TTG Advisers is subject to recoupment by the PE Fund in the form of an offset to future management fees paid by the PE Fund.  Given this separate arrangement with the GP and the PE Fund, under the terms of the Company's Advisory Agreement with TTG Advisers, TTG Advisers is not entitled to receive from the Company a management fee or an incentive fee on assets of the Company that are invested in the PE Fund.  The PE Fund's term will end on October 29, 2016; unless the GP, in its sole discretion, extends the term of the PE Fund for two additional periods of one year each. 
 
 
50

 
 
On October 29, 2010, through MVC Partners and MVCFS, the Company committed to invest approximately $20.1 million in the PE Fund.  Of the $20.1 million total commitment, MVCFS, via its wholly-owned subsidiary MVC GP II, has committed $500,000 to the PE Fund as its general partner.  See MVC Partners for more information on the other portion of the Company’s commitment to the PE Fund. The PE Fund has closed on approximately $104 million of capital commitments.
 
During the fiscal year ended October 31, 2012, the Company, via MVCFS, made three investments in MVC PE Fund totaling approximately $204,000 in the form of a general partnership interest.
 
During the fiscal year ended October 31, 2012, the Valuation Committee increased the fair value of the general partnership interest in the PE Fund by approximately $1,000.
 
During the fiscal year ended October 31, 2012, MVC Partners was consolidated with the operations of the Company as MVC Partners’ limited partnership interest in the PE Fund is a substantial portion of MVC Partners operations.  At October 31, 2012, the cost basis of the limited partnership interest in the PE Fund was equal to the investments made in the PE Fund of approximately $8.0 million and had a fair value of approximately $8.1 million.
 
At October 31, 2012, the Company's general partnership interest in the PE Fund had a cost basis of approximately $204,000 and fair value of approximately $206,000.
 
NPWT Corporation
 
NPWT, Gurnee, Illinois, is a medical device manufacturer and distributor of negative pressure wound therapy products.
 
During October of 2011 NPWT completed the sale of all of its assets to Invacare Corporation (“Invacare”).  NPWT received an upfront payment as well as a limited five year royalty based on the sales of eligible product lines.  On October 31, 2011, the Company received a distribution from NPWT of $500,000, which was treated as a return of capital and returned all cash invested into NPWT to the Company.  This distribution was paid from the upfront payment mentioned previously.
 
At October 31, 2011, the Company’s investment in NPWT consisted of 281 shares of common with a cost basis of approximately $1.2 million and a fair value of approximately $56,000 and 5,000 shares of convertible preferred stock with a cost basis of $0 and a fair value of $1.0 million.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the common stock by approximately $31,000 and the preferred stock by approximately $560,000.
 
At October 31, 2012, the common stock had a cost basis of approximately $1.2 million and a fair value of $25,000.  The convertible preferred stock had a cost basis of $0 and a fair value of $440,000.
 
Scott Schuenke, an officer of the Company, serves as a director of NPWT.
 
 
51

 
 
Octagon Credit Investors, LLC
 
Octagon, is a New York-based asset management company that manages leveraged loans and high yield bonds through collateralized debt obligations ("CDO") funds.
 
At October 31, 2011, the Company's investment in Octagon consisted of an equity investment with a cost basis of approximately $2.2 million and a fair value of approximately $5.3 million.
 
During the fiscal year ended October 31, 2012, the cost basis and fair value of the equity investment was increased by approximately $188,000 because of an allocation of flow through income by the Company’s Valuation Committee.
 
During the fiscal year ended October 31, 2012, the Valuation Committee increased the fair value of the equity investment by $700,000.
 
At October 31, 2012, the equity investment had a cost basis of approximately $2.4 million and a fair value of $6.2 million.
 
Octagon High Income Cayman Fund Ltd.
 
Octagon Fund, is a private fund that seeks to maximize current income consistent with the preservation of capital through the leveraged loan market.  This fund is managed by Octagon, a current portfolio company.
 
At October 31, 2011, the Company's investment in Octagon Fund consisted of 3,014 shares of series 1 participating non-voting shares with a cost basis of approximately $3.0 million and a fair value of approximately $2.8 million.
 
During the fiscal year ended October 31, 2012, the Valuation Committee increased the fair value of the investment by approximately $227,000.
 
On March 23, 2012, the Company sold its shares in the Octagon Fund for approximately $3.0 million resulting in a realized gain of approximately $18,000.  The Company received approximately $2.9 million of the $3.0 million with the remaining proceeds of approximately $152,000 to be distributed when the Octagon Fund’s fiscal year audit is complete.  The Company received additional proceeds of approximately $86,000 over the life of the investment.
 
At October 31, 2012, the Company no longer held an investment in Octagon Fund.
 
Ohio Medical Corporation
 
Ohio Medical, Gurnee, Illinois, is a manufacturer and supplier of suction and oxygen therapy products, medical gas equipment, and input devices.
 
At October 31, 2011, the Company's investment in Ohio Medical consisted of 5,620 shares of common stock with a cost basis and fair value of approximately $15.8 million and $0, respectively, and 18,102 shares of convertible preferred stock with a cost basis of $30.0 million and a fair value of $39.5 million.
 
On November 30, 2011, as part of Ohio Medical’s refinancing of their debt, the Company agreed to guarantee a series B preferred stock tranche of equity, with a 12% coupon for the first 18 months it is outstanding.  After that initial period, the rate increases by 400bps to 16% for the next 6 months and increases by 50 bps (.5%) each 6 month period thereafter.  The amount guaranteed was approximately $19.0 million and initially fair valued at $700,000 by the Valuation Committee.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the preferred stock by $8.4 million and increased the guarantee obligation by $125,000.
 
At October 31, 2012, the Company's investment in Ohio Medical consisted of 5,620 shares of common stock with a cost basis of approximately $15.8 million and a fair value of $0 and 21,176 shares of convertible preferred stock with a cost basis of $30.0 million and a fair value of $31.1 million.  The guarantee obligation had a fair value of negative $825,000.
 
 
52

 
 
Michael Tokarz, Chairman of the Company, Peter Seidenberg, Chief Financial Officer of the Company, and Jim O'Connor, a representative of the Company, serve as directors of Ohio Medical.
 
Pre-Paid Legal Services, Inc.
 
Pre-Paid Legal, Ada, Oklahoma, is the leading marketer of legal counsel and identity theft solutions to families and small businesses in the U.S. and Canada.
 
At October 31, 2011, the Company’s investment in Pre-Paid Legal consisted of a $4.0 million tranche A term loan and a $4.0 million tranche B term loan, both purchased at a discount.  The tranche A term loan bears annual interest at LIBOR, with a 1.5% floor, plus 6% and matures on January 1, 2017 and the tranche B term loan bears annual interest at LIBOR, with a 1.5% floor, plus 9.5% and matures on January 1, 2017.  At October 31, 2011, the loans had a combined outstanding balance of $8.0 million and a cost basis and fair value of approximately $7.8 million.
 
During the fiscal year ended October 31, 2012, Pre-Paid Legal made principal payments on its tranche A term loan totaling approximately $976,000.
 
At October 31, 2012, the loans had a combined outstanding balance of $7.0 million and a cost basis and fair value of approximately $6.9 million.  The increases in the costs of the term loans are due to the amortization of the original issue discount.
 
RuMe, Inc.
 
RuMe, Denver, Colorado, produces functional, affordable and responsible products for the environmentally and socially-conscious consumer reducing dependence on single-use products.
 
At October 31, 2011, the Company’s investment in RuMe consisted of 999,999 shares of common stock with a cost basis and fair value of approximately $160,000 and 4,999,076 shares of series B-1 preferred stock with a cost basis and fair value of approximately $1.0 million.
 
During the fiscal year ended October 31, 2012, the Valuation Committee increased the fair value of the preferred stock by approximately $417,000.
 
At October 31, 2012, the Company’s investment in RuMe consisted of 999,999 shares of common stock with a cost basis and fair value of approximately $160,000 and 4,999,076 shares of series B-1 preferred stock with a cost basis of approximately $1.0 million and a fair value of approximately $1.4 million.
 
Christopher Sullivan, a representative of the Company, serves as a director of RuMe.
 
SafeStone Technologies Limited (formerly Safestone Technologies PLC)
 
SafeStone Limited, Old Amersham, United Kingdom, a Legacy Investment, provides organizations with technology designed to secure access controls across the extended enterprise, enforcing compliance with security policies and enabling effective management of the corporate IT and e-business infrastructure.
 
At October 31, 2011, the Company's investment in SafeStone Limited consisted of 21,064 shares of common stock with a cost of $2.0 million.  The investment has been fair valued at $0 by the Company's Valuation Committee.
 
On July 10, 2012, the Company sold its 21,064 common shares of Safestone Limited.  The amount received from the sale was approximately $50,000 and resulted in a realized loss of approximately $2.0 million.
 
At October 31, 2012, the Company no longer held an investment in Safestone Limited.
 
 
53

 
 
Security Holdings, B.V.
 
Security Holdings is an Amsterdam-based holding company that owns FIMA, a Lithuanian security and engineering solutions company.
 
On April 26, 2011, the Company agreed to collateralize a 5.0 million Euro letter of credit from JPMorgan Chase Bank, N.A., which is classified as restricted cash on the Company’s consolidated balance sheet.  This letter of credit is being used as collateral for a project guarantee by AB DnB NORD bankas to Security Holdings.
 
At October 31, 2011, the Company's common equity interest in Security Holdings had a cost basis of approximately $40.2 million and a fair value of $33.2 million.
 
On August 29, 2012, TTG Advisers extended a short-term, below market interest rate loan to FIMA.  Our Board of Directors, including all of the Independent Directors, approved the loan (Mr. Tokarz recused himself from making a determination or recommendation on this matter).
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the common equity interest by $9.2 million.
 
At October 31, 2012, the Company's common equity interest in Security Holdings had a cost basis of approximately $40.2 million and a fair value of approximately $24.0 million.
 
Christopher Sullivan, a representative of the Company, serves as a director of Security Holdings.
 
SGDA Europe B.V.
 
SGDA Europe is an Amsterdam-based holding company that pursues environmental and remediation opportunities in Romania.
 
At October 31, 2011, the Company's equity investment had a cost basis of approximately $20.1 million and a fair value of $10.5 million.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the common equity interest by approximately $2.6 million.
 
At October 31, 2012, the Company's equity investment had a cost basis of approximately $20.1 million and a fair value of approximately $7.9 million.
 
Christopher Sullivan, a representative of the Company, serves as a director of SGDA Europe.
 
SGDA Sanierungsgesellschaft fur Deponien und Altasten GmbH
 
SGDA, Zella-Mehlis, Germany, is a company that is in the business of landfill remediation and revitalization of contaminated soil.
 
At October 31, 2011, the Company's investment in SGDA consisted of a term loan with an outstanding balance and cost basis of approximately $6.2 million.  The term loan bears annual interest at 7.0% and matures on August 31, 2012.  The term loan was fair valued at approximately $6.2 million.
 
On September 17, 2012, the Company loaned SGDA $360,000, increasing the term loan to approximately $6.5 million and extended the maturity date to August 31, 2014.
 
At October 31, 2012, the Company's investment in SGDA consisted of a term loan with an outstanding balance and cost basis of approximately $6.5 million.  The term loan bears annual interest at 7.0%.  The term loan was fair valued at approximately $6.5 million.
 
SHL Group Limited (formerly PreVisor, Inc.)
 
SHL Group Limited, London, United Kingdom, provides workplace talent assessment solutions including ability and personality tests, and psychometric assessments in more than 50 countries and in 30 languages.
 
 
54

 
 
On May 31, 2006, the Company invested $6.0 million in PreVisor in the form of 9 shares of common stock.  Mr. Tokarz, our Chairman and Portfolio Manager, is a minority non-controlling shareholder of PreVisor.  Our Board of Directors, including all of the Independent Directors, approved the transaction (Mr. Tokarz recused himself from making a determination or recommendation on this matter).
 
At October 31, 2011, the Company’s investment in SHL Group Limited consisted of 1,518,762 shares of common stock with a cost basis and fair value of $6.0 million and $15.3 million, respectively.
 
On February 1, 2012, the Company made an equity investment in SHL Group Limited of approximately $48,000 for an additional 9,568 shares of common stock.
 
On August 9, 2012, the Company sold its common shares of SHL Group Limited and received gross proceeds of approximately $15.3 million, resulting in a realized gain of approximately $9.2 million.  The $15.3 million in proceeds includes all transaction expenses and approximately $225,000 held in escrow, which had a fair value of $135,000 as of October 31, 2012.
 
At October 31, 2012, the Company no longer held an investment in SHL Group Limited.
 
SIA Tekers Invest
 
Tekers, Riga, Latvia, is a port facility used for the storage and servicing of vehicles.
 
At October 31, 2011, the Company's investment in Tekers consisted of 68,800 shares of common stock with a cost of $2.3 million and a fair value of approximately $1.5 million.  The Company guaranteed a 1.4 million Euro mortgage for Tekers.  The guarantee was equivalent to approximately $348,000 at October 31, 2011 for Tekers.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the common stock by $278,000.
 
At October 31, 2012, the Company's investment in Tekers consisted of 68,800 shares of common stock with a cost of $2.3 million and a fair value of approximately $1.2 million.  The guarantee for Tekers had a commitment of 150,000 euros at October 31, 2012, equivalent to approximately $194,000.  This guarantee was taken into account in the valuation of Tekers.
 
Summit Research Labs, Inc.
 
Summit, Huguenot, New York, is a specialty chemical company that manufactures antiperspirant actives.
 
At October 31, 2011, the Company's investment in Summit consisted of a second lien loan and 1,115 shares of common stock.  The second lien loan bears annual interest at 14% and matures on August 31, 2013.  The second lien loan had an outstanding balance of $11.1 million with a cost of $11.0 million.  The second lien loan was fair valued at $11.1 million.  The common stock had been fair valued at $74.5 million with a cost basis of $16.0 million.
 
On March 7, 2012, the Board of Directors of Summit approved a recapitalization and declared a $15.0 million dividend, of which $12.0 million was paid to the Company, resulting in a $12.0 million reduction in the fair value of the common stock.
 
At October 31, 2012, the Company's second lien loan had an outstanding balance of approximately $11.9 million with a cost of approximately $11.8 million.  The second lien loan was fair valued at approximately $11.9 million.  The maturity date for the second lien loan was extended to September 30, 2017.  The 1,115 shares of common stock were fair valued at $62.5 million and had a cost basis of $16.0 million.  The increase in cost and fair value of the loan is due to the amortization of loan origination fees and the capitalization of "payment in kind" interest.  These increases were approved by the Company's Valuation Committee.
 
Michael Tokarz, Chairman of the Company, and Puneet Sanan and Shivani Khurana, representatives of the Company, serve as directors of Summit.
 
 
55

 
 
Teleguam Holdings LLC
 
Teleguam, Guam, is a rural local exchange carrier providing broadband services, and local, long-distance and wireless phone services on the island of Guam.
 
At October 31, 2011, the Company’s investment in Teleguam consisted of a $7.0 million second lien loan, which was purchased at a discount, with an annual interest of LIBOR plus 8%, with a 1.75% LIBOR floor, and a maturity date of June 9, 2017.  The loan had an outstanding balance of $7.0 million and a cost basis and fair value of approximately $6.9 million.
 
At October 31, 2012, the loan had an outstanding balance of $7.0 million and a cost basis and fair value of approximately $6.9 million.  The increase in the cost and fair value of the second lien loan is due to the amortization of the original issue discount.
 
Turf Products, LLC
 
Turf, Enfield, Connecticut, is a wholesale distributor of golf course and commercial turf maintenance equipment, golf course irrigation systems and consumer outdoor power equipment.
 
At October 31, 2011, the Company's investment in Turf consisted of a senior subordinated loan, bearing interest at 13% per annum with a maturity date of January 31, 2014, a junior revolving note, bearing interest at 6% per annum with a maturity date of January 31, 2014, LLC membership interest, and warrants. The senior subordinated loan had an outstanding balance, cost basis and a fair valued of $8.4 million. The junior revolving note had an outstanding balance, cost, and fair value of $1.0 million.  The membership interest had a cost of $3.5 million and a fair value of $2.7 million.  The warrants had a cost of $0 and a fair value of $0.
 
During the fiscal year ended October 31, 2012, the Valuation Committee increased the fair value of the membership interest by $153,000.
 
At October 31, 2012, the mezzanine loan had an outstanding balance, cost basis and a fair value of approximately $8.4 million.  The junior revolving note had an outstanding balance and fair value of $1.0 million.  The membership interest has a cost of approximately $3.5 million and a fair value of approximately $2.9 million.  The warrants had a cost of $0 and a fair value of $0.
 
Michael Tokarz, Chairman of the Company, and Puneet Sanan and Shivani Khurana, representatives of the Company, serve as directors of Turf.
 
U.S. Gas & Electric, Inc.
 
U.S. Gas, North Miami Beach, Florida, is a licensed Energy Service Company ("ESCO") that markets and distributes natural gas to small commercial and residential retail customers in the state of New York.
 
At October 31, 2011, the Company’s investment in U.S. Gas consisted of a second lien loan with an outstanding balance, cost and fair value of $9.1 million.  The second lien loan bears annual interest at 14% and was to mature on July 26, 2012.  The 32,200 shares of convertible Series I preferred stock had a fair value of $78.5 million and a cost of $500,000, and the convertible Series J preferred stock had a fair value of $2.6 million and a cost of $0.
 
On October 12, 2012, the Company received a dividend from U.S. Gas of approximately $2.4 million.  U.S. Gas’ board approved an initial dividend to its shareholders, with future distributions projected to be paid quarterly. The Company anticipates receiving dividends from U.S. Gas for as long as it maintains its equity investment in U.S. Gas, and its cash flows can support the dividend. Each quarterly dividend must be approved by U.S. Gas's board of directors and be permissible under its gas and electric supply credit agreement.
 
At October 31, 2012, the second lien loan had an outstanding balance, cost basis and a fair value of approximately $9.6 million.  The increases in the outstanding balance, cost and fair value of the loan are due to the amortization of loan origination fees and the capitalization of "payment in kind" interest.  These increases were approved by the Company's Valuation Committee.  The maturity date for the second lien loan was extended to July 25, 2015.  The convertible Series I preferred stock had a fair value of $81.1 million and a cost of $500,000 and the convertible Series J preferred stock had a cost and fair value of $0.  The value of the Series J preferred shares was allocated to the Series I preferred shares as a result of share buybacks, cancellations of certain other shareholders shares and U.S. Gas exceeding performance targets.
 
 
56

 
 
Puneet Sanan, a representative of the Company, and Warren Holtsberg, a director of the Company, serve as Chairman and director, respectively, of U.S. Gas.
 
Velocitius B.V.
 
Velocitius, a Netherlands based holding company, manages wind farms based in Germany through operating subsidiaries.
 
At October 31, 2011, the Company’s investment in Velocitius consisted of an equity investment with a cost of $11.4 million and a fair value of $25.1 million.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the equity investment by approximately $3.4 million.
 
At October 31, 2012, the equity investment in Velocitius had a cost of $11.4 million and a fair value of $21.7 million.
 
Bruce Shewmaker, an officer of the Company, serves as a director of Velocitius.
 
Vestal Manufacturing Enterprises, Inc.
 
Vestal, Sweetwater, Tennessee, is a market leader for steel fabricated products to brick and masonry segments of the construction industry. Vestal manufactures and sells both cast iron and fabricated steel specialty products used in the construction of single-family homes.
 
At October 31, 2011, the Company’s investment in Vestal consisted of a senior subordinated promissory note and 81,000 shares of common stock.  The senior subordinated note had an annual interest of 12%, a maturity date of April 29, 2013 and an outstanding balance, cost, and fair value of $600,000.  The 81,000 shares of common stock had a cost basis of $1.9 million and a fair value of $1.5 million.
 
During the fiscal year ended October 31, 2012, the Valuation Committee increased the fair value of the common stock by approximately $4.2 million.
 
At October 31, 2012, the Company’s investment in Vestal consisted of a senior subordinated promissory note and 81,000 shares of common stock.  The senior subordinated note had an outstanding balance, cost, and fair value of $600,000.  The 81,000 shares of common stock had a cost basis of approximately $1.9 million and a fair value of $5.7 million.
 
Bruce Shewmaker and Scott Schuenke, officers of the Company, serve as directors of Vestal.
 
LIQUIDITY AND CAPITAL RESOURCES
 
Our liquidity and capital resources are derived from our credit facility and cash flows from operations, including investment sales and repayments and income earned.  Our primary use of funds includes investments in portfolio companies and payments of fees and other operating expenses we incur.  We have used, and expect to continue to use, our credit facility, proceeds generated from our portfolio investments and proceeds from public and private offerings of securities to finance pursuit of our investment objective.
 
At October 31, 2012, the Company had investments in portfolio companies totaling $404.2 million. Also, at October 31, 2012, the Company had investments in cash and cash equivalents totaling approximately $42.6 million. Of the $42.6 million in cash and cash equivalents, $6.5 million was restricted cash related to the project guarantee for Security Holdings.  The Company considers all money market and other cash investments purchased with an original maturity of less than three months to be cash equivalents. U.S. government securities and cash equivalents are highly liquid.  Pending investments in portfolio companies pursuant to our principal investment strategy, the Company may make other short-term or temporary investments, including in exchange-traded funds and private investment funds offering significantly more liquidity than traditional portfolio company investments.
 
 
57

 
 
During the fiscal year ended October 31, 2012, the Company made two new investments, committing capital totaling $2.5 million.  The investments were made in Freshii ($1.0 million) and Biovation ($1.5 million).
 
During the fiscal year ended October 31, 2012, the Company made nine follow-on investments in five existing portfolio companies totaling approximately $8.8 million. The Company, through MVC Partners Limited Partnership interest and MVCFS’ General Partnership interest, contributed approximately $8.2 million of its $20.1 million capital commitment to the PE Fund, which as of October 31, 2012, has invested in Plymouth Rock Energy, LLC, Gibdock Limited and Focus Pointe Holdings, Inc.  On February 1, 2012, the Company made an equity investment in SHL Group Limited of approximately $48,000 for an additional 9,568 shares of common stock.  On September 17, 2012, the Company loaned SGDA $360,000, increasing the term loan to approximately $6.5 million at October 31, 2012 and extended the maturity date to August 31, 2014.  On October 3, 2012, the Company increased its common equity interest in Centile by approximately $173,000, which was fair valued at $3.1 million as of October 31, 2012.
 
Current balance sheet resources, which include the additional cash resources from the Credit Facility, are believed to be sufficient to finance current commitments.  Current commitments include:
 
Commitments to/for Portfolio Companies
 
At October 31, 2012, the Company's existing commitments to portfolio companies consisted of the following:
 
Portfolio Company
  Amount Committed
Amount Funded at October 31, 2012
Turf
$1.0 million
$1.0 million
MVC Partners/MVCFS
$20.1 million
$8.2 million
Total
$21.1 million
$9.2 million

Guarantees
 
As of October 31, 2012, the Company had the following commitments to guarantee various loans and mortgages:
 
Guarantee
Amount Committed
Amount Funded at October 31, 2012
MVC Automotive
$5.2 million
Tekers
$194,000
Ohio Medical
$21.1 million
Total
$26.5 million
 
ASC 460, Guarantees, requires the Company to estimate the fair value of the guarantee obligation at its inception and requires the Company to assess whether a probable loss contingency exists in accordance with the requirements of ASC 450, Contingencies.  At October 31, 2012, the Valuation Committee estimated the fair values of the guarantee obligations noted above to be $825,000.
 
These guarantees are further described below, together with the Company's other commitments.
 
On June 30, 2005, the Company pledged its common stock of Ohio Medical to Guggenheim to collateralize a loan made by Guggenheim to Ohio Medical.
 
On July 19, 2007, the Company agreed to guarantee a 1.4 million Euro mortgage for Tekers.  The guarantee had a commitment of approximately 150,000 euros at October 31, 2012, equivalent to approximately $194,000.
 
On January 15, 2008, the Company agreed to guarantee a 6.5 million Euro mortgage for MVC Automotive.  The guarantee had a commitment of approximately 5.9 million euros at October 31, 2011, equivalent to approximately $8.2 million.  On July 31, 2012, the mortgage that was guaranteed was repaid by MVC Automotive, resulting in the release of the guarantee.  As of October 31, 2012, the guarantee was no longer a commitment of the Company.
 
 
58

 
 
On January 16, 2008, the Company agreed to support a 4.0 million Euro mortgage for a Ford dealership owned and operated by MVC Automotive (equivalent to approximately $5.2 million at October 31, 2012) through making financing available to the dealership and agreeing under certain circumstances not to reduce its equity stake in MVC Automotive.  The Company has consistently reported the amount of the guarantee as 4.0 million Euro.  The Company and MVC Automotive continue to view this amount as the full amount of our commitment. Erste Bank, the bank extending the mortgage to MVC Automotive, believes, based on a different methodology, that the balance of the guarantee as of October 31, 2012 is approximately 6.3 million Euro (equivalent to approximately $8.2 million). 
 
On July 31, 2008, the Company extended a $1.0 million loan to Turf in the form of a secured junior revolving note.  The note bears annual interest at 6.0% and expires on January 31, 2014.  On July 31, 2008, Turf borrowed $1.0 million from the secured junior revolving note.  At October 31, 2011 and October 31, 2012, the outstanding balance of the secured junior revolving note was $1.0 million.
 
On March 31, 2010, the Company pledged its Series I and Series J preferred stock of U.S. Gas to Macquarie Energy, LLC ("Macquarie Energy") as collateral for Macquarie Energy's trade supply credit facility to U.S. Gas.
 
On October 29, 2010, through MVC Partners and MVCFS, the Company committed to invest approximately $20.1 million in the PE Fund, for which an indirect wholly-owned subsidiary of the Company serves as GP.  The PE Fund closed on approximately $104 million of capital commitments.  During the fiscal year ended October 31, 2012, MVC Partners was consolidated with the operations of the Company as MVC Partners’ limited partnership interest in the PE Fund is a substantial portion of MVC Partners operations.  As of October 31, 2012, $8.2 million of the Company’s commitment was contributed.
 
On April 26, 2011, the Company agreed to collateralize a 5.0 million Euro letter of credit from JPMorgan Chase Bank, N.A., which is classified as restricted cash on the Company’s consolidated balance sheet.  This letter of credit is being used as collateral for a project guarantee by AB DnB NORD bankas to Security Holdings.
 
On November 30, 2011, as part of Ohio Medical’s refinancing of their debt, the Company agreed to guarantee a series B preferred stock tranche of equity with a 12% coupon for the first 18 months it is outstanding.  After that initial period, the rate increases by 400bps to 16% for the next 6 months and increases by 50 bps (.5%) each 6 month period thereafter.  As of October 31, 2012, the amount guaranteed was approximately $21.1 million and the guarantee obligation was fair valued at $825,000 by the Valuation Committee.
 
Commitments of the Company
 
Effective November 1, 2006, under the terms of the Investment Advisory and Management Agreement with TTG Advisers, which has since been amended and restated (the "Advisory Agreement") and described in Note 9 of the consolidated financial statements, "Management", TTG Advisers is responsible for providing office space to the Company and for the costs associated with providing such office space.  The Company's offices continue to be located on the second floor of 287 Bowman Avenue, Purchase, New York 10577.
 
On April 27, 2006, the Company and MVCFS, as co-borrowers, entered into a four-year, $100 million Credit Facility, consisting of $50.0 million in term debt and $50.0 million in revolving credit, with Guggenheim as administrative agent for the lenders.  On April 13, 2010, the Company renewed the Credit Facility for three years.  The Credit Facility consists of a $50.0 million term loan with an interest rate of LIBOR plus 450 basis points with a 1.25% LIBOR floor.  As of October 31, 2012, there was $50.0 million in term debt outstanding under the Credit Facility and approximately $9,000 of interest payable.  The proceeds from the borrowings made under the Credit Facility are used to fund new and existing portfolio investments and for general corporate purposes.  The Credit Facility will expire on April 27, 2013, at which time the outstanding amount under the Credit Facility will be due and payable.  During the year ended October 31, 2012, the Company requested Guggenheim's consent to waive compliance with a particular covenant of the Credit Facility.  In order to obtain this waiver, the Company agreed to increase the interest rate on the Credit Facility if the Company did not meet a newly established covenant level that was more stringent than required in the Company’s Credit Facility documents.  The covenant level for an event of default remained the same.    As of October 31, 2012, the Company has met all of its original covenant levels and is not in default, but was unable to meet the increased covenant level required by Guggenheim as part of the waiver obtained earlier in the year.  As a result, the interest rate on the Credit Facility has increased to LIBOR plus 525 basis points with a 1.25% LIBOR floor.  The increased rate will be effective until the Company demonstrates that it has passed the higher covenant level.  The Company paid a closing fee, legal and other costs associated with obtaining and renewing the Credit Facility.  These costs are being amortized evenly over the life of the facility.  The prepaid expenses on the consolidated balance sheet include the unamortized portion of these costs.  Borrowings under the Credit Facility are secured, by among other things, cash, cash equivalents, debt investments, accounts receivable, equipment, instruments, general intangibles, the capital stock of MVCFS, and any proceeds from all the aforementioned items, as well as all other property except for equity investments made by the Company.
 
 
59

 
 
At October 31, 2012, the carrying amount of our Credit Facility approximates the fair value, using Level 3 inputs under the fair value hierarchy,  of our Credit Facility, which was $50.0 million. The fair value of our debt obligation is determined in accordance with ASC 820, which defines fair value in terms of the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The fair value of our Credit Facility is estimated based upon market interest rates for our own borrowings or entities with similar credit risk, adjusted for nonperformance risk, if any.  
 
The Company enters into contracts with portfolio companies and other parties that contain a variety of indemnifications. The Company's maximum exposure under these arrangements is unknown. However, the Company has not experienced claims or losses pursuant to these contracts and believes the risk of loss related to indemnifications to be remote.
 
A summary of our contractual payment obligations as of October 31, 2012 is as follows:
 
   
Payments Due by Period
   
Total
 
Less than
1 year
 
1-3 years
 
4-5 years
 
After
5 years
Credit Facility I
 
$50,000,000
 
$50,000,000
 
N/A
 
N/A
 
N/A
                     
Total Debt
 
$50,000,000
 
$50,000,000
 
N/A
 
N/A
 
N/A

SUBSEQUENT EVENTS
 
On November 26, 2012, the Company loaned an additional $8.0 million to JSC Tekers, increasing the secured loan amount to $12.0 million.  The interest rate remains at 8% per annum and the maturity date was extended to December 31, 2014.
 
On December 14, 2012, the Company loaned an additional $500,000 to Biovations, increasing the loan amount to $2.0 million.
 
On December 17, 2012, the Company declared a dividend of $0.135 per share, or a total of approximately $3.2 million.  The dividend is payable on January 7, 2013 to shareholders of record on December 31, 2012.
 
On December 17, 2012, the Company received a dividend from Vestal of approximately $426,000.
 
On December 19, 2012, MVC Automotive made a principal payment of approximately $2.0 million on its bridge loan.
 
SIGNIFICANT ACCOUNTING POLICIES
 
The following is a summary of significant accounting policies followed by the Company in the preparation of its consolidated financial statements:
 
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts and disclosures in the consolidated financial statements.  Actual results could differ from those estimates.
 
 
60

 
 
Recent Accounting Pronouncements
 
On May 12, 2011, the FASB issued Accounting Standards Update No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (“ASU 2011-04”).  ASU 2011-04 amends ASC 820, which requires entities to change the wording used to describe the requirements in GAAP for measuring fair value and for disclosing information about fair value measurements.  ASU 2011-04 clarifies the application of existing fair value measurement and disclosure requirements related to the application of the highest and best use and valuation premise concepts for financial and nonfinancial instruments, measuring the fair value of an instrument classified in equity, and disclosures about fair value measurements.  ASU 2011-04 requires additional disclosures about fair value measurements categorized within Level 3 of the fair value hierarchy, including the valuation processes used by the reporting entity, the sensitivity of the fair value to changes in unobservable inputs, and the interrelationships between those unobservable inputs, if any. All the amendments to ASC 820 made by ASU 2011-04 are effective for interim and annual periods beginning after December 15, 2011.  The adoption of this new guidance has not had a material effect on the financial position or results of operations of the Company and has resulted in additional disclosures.  Please see Note 9 “Portfolio Investments.”
 
Tax Status and Capital Loss Carryforwards
 
As a RIC, the Company is not subject to federal income tax to the extent that it distributes all of its investment company taxable income and net realized capital gains for its taxable year (see Notes 12 and 13. "Notes to Consolidated Financial Statements"). This allows us to attract different kinds of investors than other publicly held corporations. The Company is also exempt from excise tax if it distributes at least (1) 98% of its ordinary income during each calendar year, (2) 98.2% of its capital gains realized in the period from November 1 of the prior year through October 31 of the current year, and (3) all such ordinary income and capital gains for previous years that were not distributed during those years. At October 31, 2011, the Company had $26.3 million in capital loss carryforwards.  During fiscal year 2012, the Company had net realized losses of approximately $18.8 million, net of book/tax difference related to the treatment of partnership income, and as a result, the Company had approximately $45.1 million in capital loss carryforwards as of October 31, 2012.  The Company also has approximately $19.5 million in unrealized losses associated with Legacy Investments.
 
Valuation of Portfolio Securities
 
ASC 820 defines fair value in terms of the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The price used to measure the fair value is not adjusted for transaction costs while the cost basis of our investments may include initial transaction costs. Under ASC 820, the fair value measurement also assumes that the transaction to sell an asset occurs in the principal market for the asset or, in the absence of a principal market, the most advantageous market for the asset. The principal market is the market in which the reporting entity would sell or transfer the asset with the greatest volume and level of activity for the asset to which the reporting entity has access as of the measurement date.  If no market for the asset exists or if the reporting entity does not have access to the principal market, the reporting entity should use a hypothetical market.
 
Pursuant to our Valuation Procedures, the Valuation Committee (which is comprised of three Independent Directors) determines fair values of portfolio company investments on a quarterly basis (or more frequently, if deemed appropriate under the circumstances). Any changes in valuation are recorded in the consolidated statements of operations as "Net change in unrealized appreciation (depreciation) on investments." Currently, our NAV per share is calculated and published on a quarterly basis.  The Company calculates our NAV per share by subtracting all liabilities from the total value of our portfolio securities and other assets and dividing the result by the total number of outstanding shares of our common stock on the date of valuation.  Fair values of foreign investments determined as of quarter end reflect exchange rates, as applicable, in effect on the last business day of the quarter.  Exchange rates fluctuate on a daily basis, sometimes significantly.  Exchange rate fluctuations following the most recent fiscal year end are not reflected in the valuations reported in this Annual Report.  See Item 1A Risk Factor, "Investments in foreign debt or equity may involve significant risks in addition to the risks inherent in U.S. investments."
 
The Company calculates our NAV per share by subtracting all liabilities from the total value of our portfolio securities and other assets and dividing the result by the total number of outstanding shares of our common stock on the date of valuation.
 
 
61

 
 
At October 31, 2012, approximately 88.77% of our total assets represented portfolio investments and escrow receivables recorded at fair value ("Fair Value Investments").
 
Under most circumstances, at the time of acquisition, Fair Value Investments are carried at cost (absent the existence of conditions warranting, in management's and the Valuation Committee's view, a different initial value).  During the period that an investment is held by the Company, its original cost may cease to approximate fair value as the result of market and investment specific factors.  No pre-determined formula can be applied to determine fair value.  Rather, the Valuation Committee analyzes fair value measurements based on the value at which the securities of the portfolio company could be sold in an orderly disposition over a reasonable period of time between willing parties, other than in a forced or liquidation sale.  The liquidity event whereby the Company ultimately exits an investment is generally the sale, the merger, the recapitalization or, in some cases, the initial public offering of the portfolio company.
 
There is no one methodology to determine fair value and, in fact, for any portfolio security, fair value may be expressed as a range of values, from which the Company derives a single estimate of fair value.  To determine the fair value of a portfolio security, the Valuation Committee analyzes the portfolio company's financial results and projections, publicly traded comparable companies when available, comparable private transactions when available, precedent transactions in the market when available, third-party real estate and asset appraisals if appropriate and available, discounted cash flow analysis, if appropriate, as well as other factors.  The Company generally requires, where practicable, portfolio companies to provide annual audited and more regular unaudited financial statements, and/or annual projections for the upcoming fiscal year.
 
The fair value of our portfolio securities is inherently subjective. Because of the inherent uncertainty of fair valuation of portfolio securities and escrow receivables that do not have readily ascertainable market values, our estimate of fair value may significantly differ from the fair value that would have been used had a ready market existed for the securities. Such values also do not reflect brokers' fees or other selling costs, which might become payable on disposition of such investments.
 
Our investments are carried at fair value in accordance with the 1940 Act and Accounting Standards Codification, Fair Value Measurements and Disclosures (“ASC 820”). In accordance with the 1940 Act, unrestricted minority-owned publicly traded securities for which market quotations are readily available are valued at the closing market quote on the valuation date and majority-owned publicly traded securities and other privately held securities are valued as determined in good faith by the Valuation Committee of our Board of Directors. For legally or contractually restricted securities of companies that are publicly traded, the value is based on the closing market quote on the valuation date minus a discount for the restriction.  At October 31, 2012, we did not hold restricted or unrestricted securities of publicly traded companies for which we have a majority-owned interest.
 
ASC 820 provides a framework for measuring the fair value of assets and liabilities and provides guidance regarding a fair value hierarchy which prioritizes information used to measure value.  In determining fair value, the Valuation Committee primarily uses the level 3 inputs referenced in ASC 820.
 
If a security is publicly traded, the fair value is generally equal to market value based on the closing price on the principal exchange on which the security is primarily traded.
 
For equity securities of portfolio companies, the Valuation Committee estimates the fair value based on market and/or income approach with value then attributed to equity or equity like securities using the enterprise value waterfall ("Enterprise Value Waterfall") valuation methodology.  Under the Enterprise Value Waterfall valuation methodology, the Valuation Committee estimates the enterprise fair value of the portfolio company and then waterfalls the enterprise value over the portfolio company's securities in order of their preference relative to one another.  To assess the enterprise value of the portfolio company, the Valuation Committee weighs some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value.  The methodologies for performing assets may be based on, among other things:  valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company, and third-party asset and real estate appraisals.  For non-performing assets, the Valuation Committee may estimate the liquidation or collateral value of the portfolio company's assets.  The Valuation Committee also takes into account historical and anticipated financial results.
 
 
62

 
 
In assessing enterprise value, the Valuation Committee considers the mergers and acquisitions ("M&A") market as the principal market in which the Company would sell its investments in portfolio companies under circumstances where the Company has the ability to control or gain control of the board of directors of the portfolio company ("Control Companies").  This approach is consistent with the principal market that the Company would use for its portfolio companies if the Company has the ability to initiate a sale of the portfolio company as of the measurement date, i.e., if it has the ability to control or gain control of the board of directors of the portfolio company as of the measurement date.  In evaluating if the Company can control or gain control of a portfolio company as of the measurement date, the Company takes into account its equity securities on a fully diluted basis, as well as other factors.
 
For non-Control Companies, consistent with ASC 820, the Valuation Committee considers a hypothetical secondary market as the principal market in which it would sell investments in those companies.
 
For loans and debt securities of non-Control Companies (for which the Valuation Committee has identified the hypothetical secondary market as the principal market), the Valuation Committee determines fair value based on the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield ("Market Yield") valuation methodology.  In applying the Market Yield valuation methodology, the Valuation Committee determines the fair value based on such factors as third party broker quotes and market participant assumptions, including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date.
 
Estimates of average life are generally based on market data of the average life of similar debt securities.  However, if the Valuation Committee has information available to it that the debt security is expected to be repaid in the near term, the Valuation Committee would use an estimated life based on the expected repayment date.
 
The Valuation Committee determines fair value of loan and debt securities of Control Companies based on the estimate of the enterprise value of the portfolio company.  To the extent the enterprise value exceeds the remaining principal amount of the loan and all other debt securities of the company, the fair value of such securities is generally estimated to be their cost.  However, where the enterprise value is less than the remaining principal amount of the loan and all other debt securities, the Valuation Committee may discount the value of such securities to reflect an impairment.
 
For the Company's or its subsidiary's investment in the PE Fund, for which an indirect wholly-owned subsidiary of the Company serves as the general partner (the "GP") of the PE Fund, the Valuation Committee relies on the GP's determination of the Fair Value of the PE Fund which will be generally valued, as a practical expedient, utilizing the net asset valuations provided by the GP, which will be made:  (i) no less frequently than quarterly as of the Company's fiscal quarter end and (ii) with respect to the valuation of PE Fund investments in portfolio companies, will be based on methodologies consistent with those set forth in the valuation procedures.  The determination of the net asset value of the Company’s or its subsidiary’s investment in the PE Fund will follow the methodologies described for valuing interests in private investment funds (“Investment Vehicles”) described below.  Additionally, when both the Company and the PE Fund hold investments in the same portfolio company, the GP's Fair Value determination shall be based on the Valuation Committee's determination of the Fair Value of the Company's portfolio security in that portfolio company.
 
As permitted under GAAP, the Company’s interests in private investment funds are generally valued, as a practical expedient, utilizing the net asset valuations provided by management of the underlying Investment Vehicles, without adjustment, unless TTG Advisers is aware of information indicating that a value reported does not accurately reflect the value of the Investment Vehicle, including any information showing that the valuation has not been calculated in a manner consistent with GAAP.  Net unrealized appreciation (depreciation) of such investments is recorded based on the Company’s proportionate share of the aggregate amount of appreciation (depreciation) recorded by each underlying Investment Vehicle.  The Company’s proportionate investment interest includes its share of interest and dividend income and expense, and realized and unrealized gains and losses on securities held by the underlying Investment Vehicles, net of operating expenses and fees.  Realized gains and losses on withdrawals from Investment Vehicles are generally recognized on a first in, first out basis.
 
 
63

 
 
The Company applies the practical expedient to interests in Investment Vehicles on an investment by investment basis, and consistently with respect to the Company’s entire interest in an investment.  The Company may adjust the valuation obtained from an Investment Vehicle with a premium, discount or reserve if it determines that the net asset value is not representative of fair value.
 
If the Company intends to sell all or a portion of its interest in an Investment Vehicle to a third-party in a privately negotiated transaction, the Company will consider offers from third parties to buy the interest in an Investment Vehicle in valuations which may be discounted for both probability of close and time.
 
When the Company receives nominal cost warrants or free equity securities ("nominal cost equity") with a debt security, the Company typically allocates its cost basis in the investment between debt securities and nominal cost equity at the time of origination.
 
Interest income, adjusted for amortization of premium and accretion of discount on a yield to maturity methodology, is recorded on an accrual basis to the extent that such amounts are expected to be collected.  Origination and/or closing fees associated with investments in portfolio companies are accreted into income over the respective terms of the applicable loans.  Upon the prepayment of a loan or debt security, any prepayment penalties and unamortized loan origination, closing and commitment fees are recorded as income. Prepayment premiums are recorded on loans when received.  Dividend income, if any, is recognized on an accrual basis on the ex-dividend date to the extent that the Company expects to collect such amounts.
 
For loans, debt securities, and preferred securities with contractual payment-in-kind interest or dividends, which represent contractual interest/dividends accrued and added to the loan balance or liquidation preference that generally becomes due at maturity, the Company will not ascribe value to payment-in-kind interest/dividends, if the portfolio company valuation indicates that the payment-in-kind interest is not collectible.  However, the Company may ascribe value to payment-in-kind interest if the health of the portfolio company and the underlying securities are not in question.  All payment-in-kind interest that has been added to the principal balance or capitalized is subject to ratification by the Valuation Committee.
 
Escrows from the sale of a portfolio company are generally valued at an amount which may be expected to be received from the buyer under the escrow's various conditions discounted for both risk and time.
 
ASC 460, Guarantees, requires the Company to estimate the fair value of the guarantee obligation at its inception and requires the Company to assess whether a probable loss contingency exists in accordance with the requirements of ASC 450, Contingencies.  The Valuation Committee typically will look at the pricing of the security in which the guarantee provided support for the security and compare it to the price of a similar or hypothetical security without guarantee support.  The difference in pricing will be discounted for time and risk over the period in which the guarantee is expected to remain outstanding.
 
Investment Classification
 
We classify our investments by level of control.  As defined in the 1940 Act, "Control Investments" are investments in those companies that we are deemed to "Control."  "Affiliate Investments" are investments in those companies that are "Affiliated Companies" of us, as defined in the 1940 Act, other than Control Investments.  "Non-Control/Non-Affiliate Investments" are those that are neither Control Investments nor Affiliate Investments.  Generally, under the 1940 Act, we are deemed to control a company in which we have invested if we own 25% or more of the voting securities of such company or have greater than 50% representation on its board.  We are deemed to be an affiliate of a company in which we have invested if we own 5% or more and less than 25% of the voting securities of such company.
 
Investment Transactions and Related Operating Income
 
Investment transactions and related revenues and expenses are accounted for on the trade date (the date the order to buy or sell is executed).  The cost of securities sold is determined on a first-in, first-out basis, unless otherwise specified.  Dividend income and distributions on investment securities is recorded on the ex-dividend date.  The tax characteristics of such distributions received from our portfolio companies will be determined by whether or not the distribution was made from the investment's current taxable earnings and profits or accumulated taxable earnings and profits from prior years. Interest income, which includes accretion of discount and amortization of premium, if applicable, is recorded on the accrual basis to the extent that such amounts are expected to be collected.  Fee income includes fees for guarantees and services rendered by the Company or its wholly-owned subsidiary to portfolio companies and other third parties such as due diligence, structuring, transaction services, monitoring services, and investment advisory services. Guaranty fees are recognized as income over the related period of the guaranty. Due diligence, structuring, and transaction services fees are generally recognized as income when services are rendered or when the related transactions are completed. Monitoring and investment advisory services fees are generally recognized as income as the services are rendered.  Any fee income determined to be loan origination fees, original issue discount, and market discount are capitalized and then amortized into income using the effective interest method. Upon the prepayment of a loan or debt security, any unamortized loan origination fees are recorded as income and any unamortized original issue discount or market discount is recorded as a realized gain.  For investments with PIK interest and dividends, we base income and dividend accrual on the valuation of the PIK notes or securities received from the borrower.  If the portfolio company indicates a value of the PIK notes or securities that is not sufficient to cover the contractual interest or dividend, we will not accrue interest or dividend income on the notes or securities.
 
 
64

 
 
Cash Equivalents
 
For the purpose of the Consolidated Balance Sheets and Consolidated Statements of Cash Flows, the Company considers all money market and all highly liquid temporary cash investments purchased with an original maturity of less than three months to be cash equivalents.
 
Restricted Cash and Cash Equivalents
 
Cash and cash equivalent accounts that are not available to the Company for day to day use are classified as restricted cash. Restricted cash and cash equivalents are carried at cost which approximates fair value.
 
Restricted Securities
 
The Company will invest in privately-placed restricted securities.  These securities may be resold in transactions exempt from registration or to the public if the securities are registered.  Disposal of these securities may involve time-consuming negotiations and expense, and a prompt sale at an acceptable price may be difficult.
 
Distributions to Shareholders
 
Distributions to shareholders are recorded on the ex-dividend date.
 
Income Taxes
 
It is the policy of the Company to meet the requirements for qualification as a RIC under Subchapter M of the Code.  As a RIC, the Company is not subject to income tax to the extent that it distributes all of its investment company taxable income and net realized capital gains for its taxable year.  The Company is also exempt from excise tax if it distributes at least 98% of its income and 98.2% of its capital gains during each calendar year.
 
Our consolidated operating subsidiary, MVCFS, is subject to federal and state income tax.  We use the liability method in accounting for income taxes.  Deferred tax assets and liabilities are recorded for temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, using statutory tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided against deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized.
 
ASC 740, Income Taxes, provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions deemed to meet a "more-likely-than-not" threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statement of operations. During the fiscal year ended October 31, 2012, the Company did not incur any interest or penalties.  Although we file federal and state tax returns, our major tax jurisdiction is federal for the Company and MVCFS.  The fiscal years 2009, 2010, 2011 and 2012 for the Company and MVCFS remain subject to examination by the IRS.
 
 
65

 
 
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
 
The Company has procedures in place for the review, approval and monitoring of transactions involving the Company and certain persons related to the Company. For example, the Company has a Code of Ethics that generally prohibits, among others, any officer or director of the Company from engaging in any transaction where there is a conflict between such individual’s personal interest and the interests of the Company. As a business development company, the 1940 Act also imposes regulatory restrictions on the Company’s ability to engage in certain related party transactions. However, the Company is permitted to co-invest in certain portfolio companies with its affiliates to the extent consistent with applicable law or regulation and, if necessary, subject to specified conditions set forth in an exemptive order obtained from the SEC. Since the Company’s current management team joined the Company in 2003, no transactions have been effected pursuant to the exemptive order. As a matter of policy, our Board has required that any related-party transaction (as defined in Item 404 of Regulation S-K) must be subject to the advance consideration and approval of the Independent Directors, in accordance with applicable procedures set forth in Section 57(f) of the 1940 Act.
 
The principal equity owner of the Adviser is Mr. Tokarz, our Chairman. Our senior officers and Mr. Holtsberg have other financial interests in the Adviser ( i.e. based on the Adviser’s performance). In addition, our officers and the officers and employees of the Adviser may serve as officers, directors or principals of entities that operate in the same or related line of business as we do or of investment funds managed by the Adviser or our affiliates. These related businesses currently include a private equity fund (“PE Fund”), the establishment of which was authorized by our Board. As previously disclosed in our 10-K Reports for the last three fiscal years, an indirect wholly-owned subsidiary of the Company serves as the general partner and the Adviser serves as the portfolio manager of the PE Fund, and both entities receives a portion of the carried interest and management fees generated from the PE Fund. The Adviser intends to allocate investment opportunities in a fair and equitable manner.  Our Board has approved a specific policy regarding the allocation of investment opportunities, which is set forth in this prospectus. For a further discussion of this allocation policy, please see "MVC Capital – Our Investment Strategy – Allocation of Investment Opportunities" below.
 
SENIOR SECURITIES
 
Information about our senior securities is shown in the following table as of each fiscal year ended October 31 since the Company commenced operations, unless otherwise noted.  The report of Ernst & Young LLP, the Company's current independent registered public accounting firm, on the senior securities table as of October 31, 2012, is attached as an exhibit to the Registration Statement of which this prospectus is a part.  The "—" indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.

Class and Year
Total Amount
Outstanding Exclusive of Treasury Securities(1)
Asset Coverage
 per Unit(2)
Involuntary Liquidating Preference per Unit(3)
Average Market
Value per Unit(4)
Lines of Credit
       
2000
$           —
$         —
$      —
N/A
2001
$           —
$         —
$      —
N/A
2002
$           —
$         —
$      —
N/A
2003
$           —
$         —
$      —
N/A
2004
$10,025,000
$12,527.91
$      —
N/A
2005
$           —
$         —
$      —
N/A
2006
$100,000,000
$3,369.93
$      —
N/A
2007
$80,000,000
$5,613.71
$      —
N/A
2008
$69,000,000
$7,114.07
$      —
N/A
2009
$62,300,000
$7,813.09
$      —
N/A
2010
$50,000,000
$9,499.89
$      —
N/A
2011
$50,000,000
$9,390.19
$      —
N/A
2012
$50,000,000
$8,720.32
$      —
N/A
____________
(1)
Total amount of each class of senior securities outstanding at the end of the period presented.
 
 
66

 
 
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by senior securities representing indebtedness. This asset coverage ratio is multiplied by $1,000 to determine the Asset Coverage Per Unit.
 
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
 
(4)
Not applicable, as senior securities are not registered for public trading.
 
ABOUT MVC CAPITAL
 
Overview
 
MVC Capital is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act. MVC Capital provides debt and equity investment capital to fund growth, acquisitions and recapitalizations of small and middle-market companies in a variety of industries primarily located in the United States.  Our investments can take the form of common and preferred stock and warrants or rights to acquire equity interests, senior and subordinated loans, or convertible securities.  Our common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "MVC."
 
Our Corporate History
 
From 2000 through 2003, the Company experienced significant valuation declines from investments made by the original management team.  During fiscal 2002, the Company's largest shareholder at the time launched a proxy contest against the former management.  In late February 2003, a shareholder meeting was held which replaced the entire Board of Directors who then removed the former management of the Company.
 
In September 2003, the Company's shareholders voted to implement the Board of Director's long-term plan  to adopt and amend the investment objective and strategy of the Company,  seeking to maximize total return from more traditional mezzanine investments, senior and subordinated loans and other private equity investments and to elect a new Chairman and Portfolio Manager, Michael Tokarz.  Also as part of the long-term plan of the Board, the Company decided to conduct a tender offer for 25% of the Company's outstanding shares at a price of 95% of the net asset value of the Company.
 
While the Company has been in operation since 2000, fiscal 2004 marked a new beginning for the Company as this period reflects when Mr. Tokarz and his management team assumed portfolio management responsibilities for the Company.  As part of this change, Mr. Tokarz and his team determined to manage the existing investments made by the prior management which we refer to as our Legacy Investments.  After only three quarters of operations under the new management team, the Company posted a profitable third quarter for fiscal year 2004, reversing a trend of 12 consecutive quarters of net investment losses and earned a profit for the entire fiscal year.
 
As described above, the current management team determined to manage the Legacy Investments, which were comprised of all the remaining portfolio investments made by the original management team.  At the time that the current management team took over the portfolio responsibilities of the Company, the fair market value of the Legacy Investments was $24.1 million.  Through active management of these assets, current management was able to realize $58.6 million of cash from the Legacy Investments, providing more than $34 million of value to the  Company’s shareholders.  As of October 31, 2012, the Legacy Investments represent 2.36% of the Company's assets.
 
During fiscal 2006, the Company found itself being presented with a number of opportunities to manage and invest in various private funds and offshore enterprises.  Under the internal management structure, due to regulatory and tax constraints on the Company, due to its status as a business development company and regulated investment company, the Company was restricted in its ability to participate in many of these opportunities.  During fiscal 2006, the Board developed a structure that would allow the Company's stockholders to benefit from a broader range of investment and management opportunities and, in this connection, determined to externalize the Company's management.  The Board proposed the externalization to shareholders for a vote, which was overwhelmingly approved in September 2006.  As a result, beginning on November 1, 2006, TTG Advisers began serving as the Company's external investment adviser.  (All of the employees of the Company immediately prior to that date became employees of TTG Advisers.)
 
 
67

 
 
Our Management
 
The Company is managed by TTG Advisers, the Company's investment adviser, which is headed by Michael Tokarz, who has over 35 years of lending and investment experience. TTG Advisers has a dedicated originations and transaction development investment team with significant experience in private equity, leveraged finance, investment banking, distressed debt transactions and business operations. The members of the investment team have invested in and managed businesses during both recessionary and expansionary periods, through interest rate cycles and a variety of financial market conditions. TTG Advisers has 12 full-time investment professionals and two part-time investment professionals. TTG Advisers also uses the services of other investment professionals with whom it has developed long-term relationships, on an as-needed basis. In addition, TTG Advisers employs seven other full-time professionals and two part-time professionals who manage the operations of the Company and provide investment support functions both directly and indirectly to our portfolio companies. As TTG Advisers grows, it expects to hire, train, supervise and manage new employees at various levels, many of whom would be expected to provide services to the Company.
 
When the current management team began managing the Company in fiscal 2004, total assets after the tender offer were $108.3 million.  Since then and through October 31, 2012, the Company generated over $230 million of bottom line performance (net change in net assets resulting from operations).  The current management team has also earned approximately $186.8 million in realized and unrealized gains (net of realized and unrealized losses) thus far on the portfolio (through October 31, 2012) and has repurchased approximately $37.0 million of stock below NAV, including the shares purchased during the 2004 tender offer.
 
Beginning in fiscal 2004, after nearly three years of not paying a dividend under the previous management team, the Company began paying a $0.12 per share dividend, with an average annual distribution rate of $0.42 per share since that time. From fiscal 2004 through fiscal 2012, the Company paid over $85 million in dividends, of which $79.5 million was paid from ordinary income, $2.2 million was paid from capital gains and $3.9 million represented a return of capital on a tax basis.  During fiscal 2012, the Company paid $0.495 per share in dividends.  Recently, the Company declared a 13.5 cent per share dividend for each of the fourth fiscal quarter of 2012 and the first fiscal quarter of 2013.  The most recent distribution represents the thirty-first consecutive quarterly dividend paid by the Company since implementing a dividend policy in July 2005.
 
Our Portfolio
 
We continue to perform due diligence and seek new investments that are consistent with our objective of maximizing total return from capital appreciation and/or income. We believe that we have extensive relationships with private equity firms, investment banks, business brokers, commercial banks, accounting firms, law firms, hedge funds, other investment firms, industry professionals and management teams of several companies, which can continue to provide us with investment opportunities.
 
We are currently working on an active pipeline of potential new investment opportunities with a view to move the composition of our portfolio to a more yielding portfolio, over time.  As of October 31, 2012, our portfolio is currently comprised of approximately 78% equity and 22% debt investments.  Our goal is that, over time, yielding investments (i.e., investments that produce regular income or cash distributions) will comprise the majority of our portfolio.  During fiscal 2012, two of the Company's largest investments (based upon fair market value), U.S. Gas & Electric, Inc. and Summit Research Labs, Inc. paid dividends to the Company, totaling approximately $14.4 million. Although the majority of the current portfolio is comprised of equity investments, the Company expects to continue seeking to earn income distributions from certain portfolio companies, thereby enhancing our opportunity to generate yield for our shareholders.
 
 
68

 
 
We expect that our loan and equity investments will generally range between $3 million and $25 million each, although we may occasionally invest smaller or greater amounts of capital depending upon the particular investment. While the Company does not adhere to a specific equity and debt asset allocation mix, no more than 25% of the value of our total assets may be invested in the securities of one issuer (other than U.S. government securities), or of two or more issuers that are controlled by us and are engaged in the same or similar or related trades or businesses, determined as of the close of each quarter. Our portfolio company investments are typically illiquid and are made through privately negotiated transactions.  We generally target companies with annual revenues of between $10.0 million and $150.0 million and annual EBITDA (earnings before net interest expense, income tax expense, depreciation and amortization) of between $3.0 million and $25.0 million.  We generally seek to invest in companies with a history of strong, predictable, positive EBITDA.
 
Due to our asset growth and composition, compliance with the RIC (as defined below) requirements currently restricts our ability to make to make additional investments that represent more than 5% of our total assets or more than 10% of the outstanding voting securities of the issuer (“Non-Diversified Investments”).  Among the key factors resulting in this current restriction is that, at the time of original investment, certain portfolio investments were “Diversified” because they represented (on a cost basis) significantly less than 5% of the Company’s total assets.  However, since then, the fair values of certain of these investments (e.g., U.S. Gas) have grown significantly thereby causing the investment to be reclassified as “Non-Diversified” as it surpassed the 5% threshold.  Accordingly, to maintain adherence to the diversification requirements, the Company currently is restricted from making additional Non-Diversified Investments.  This restriction causes us to forgo certain investment opportunities that we may otherwise deem attractive (including in existing portfolio companies that are deemed “Non-Diversified”).  See the discussion on the Company's diversification compliance in "Federal Income Tax Matters" on page 104 and the "Risk Factors" on page 15 for more information (including the risk that complying with this limitation can cause us to forego otherwise attractive opportunities).
 
As of October 31, 2012, the Company's net assets were approximately $386 million compared with net assets of approximately $137 million at October 31, 2003 (immediately prior to Mr. Tokarz assuming portfolio management responsibilities for the Company), an approximate $144.9 million or 106% cumulative increase (this increase does not include $104.1 million in net capital contributions since the beginning of fiscal 2004).  Since Mr. Tokarz and his team assumed portfolio management control of the Company through October 31, 2012, the Company's market value per share increased from $8.10 to $12.36, a return of 52.6%.  Over the same period, the net asset value per share increased from $8.48 as of October 31, 2003 to $16.14 as of October 31, 2012 (which includes the effects of the capital contributions mentioned above).  At the same time, the Company's common stock price discount to NAV was (4.5)% as of October 31, 2003 and (23.4)% as of October 31, 2012, with an average annual market discount rate of (14.1)% based on the common stock price and NAV per share on the last day of each fiscal year from 2004 to 2012.  The Company's average annual yield was 2.8% based on net assets per share as of the last day of each fiscal year from 2004 to 2012 and 3.4% based on common stock price on the last day of each fiscal year from 2004 to 2012.
 
Fiscal year 2012 represented a year where we increased our liquidity, continued to allocate capital at a deliberate pace into new opportunities while supporting our existing portfolio companies.  The Company made two new investments in Freshii USA, Inc. ("Freshii") and Biovation Holdings, Inc. ("Biovations") and nine follow-on investments in the following five existing portfolio companies: MVC Partners, LLC ("MVC Partners") Limited Partnership interest, MVCFS' General Partnership interest, Centile Holdings B.V. ("Centile"), SGDA Sanierungsgesellschaft fur Deponien und Altasten GmbH ("SGDA") and SHL Group Limited.  The total capital committed in fiscal year 2012 was $11.3 million compared to $43.2 million committed in fiscal year 2011 and $8.3 million committed in fiscal year 2010.
 
MVC Private Equity Fund, L.P.. In seeking to achieve our investment objective, we established subsidiaries to sponsor, and provide services to, a private equity fund, MVC Private Equity Fund, L.P. (the “PE Fund”). Specifically, on October 29, 2010, the Company committed to invest approximately $20.1 million in the PE Fund.  MVC GP II, LLC, an indirect wholly-owned subsidiary of the Company, serves as the general partner of the PE Fund (the “GP”).  Substantially all of the Company's commitment was made by our wholly-owned subsidiary, MVC Partners, as a limited partner investor in the Fund.  Additionally, pursuant to the direction of the Company and the GP, MVC Partners, as the anchor investor and sponsor of the PE Fund, was designated as the “Carried Interest Partner,” entitling it to up to 30% of the carried interest generated by the PE Fund.  The GP’s general partnership interest capital commitment is nominal – approximately $500,000 of the total $20.1 million capital commitment attributable to the Company.  The Company’s capital commitment (i.e., its investment in the Fund) was made mostly through MVC Partners’ limited partnership interest for tax efficiency reasons, including that, for tax purposes, MVC Partners is a partnership (i.e., a look through vehicle), which can help limit the Company’s taxable income associated with its investment in the PE Fund.  The PE Fund has closed on approximately $104 million of capital commitments.  As of October 31, 2012, the Company has contributed to the PE Fund $8.0 million of its $19.6 million limited partner capital commitment, and the GP has contributed $200,000 of its general partner capital commitment.  As of October 31, 2012, the PE Fund has invested in Plymouth Rock Energy, LLC, Gibdock Limited and Focus Pointe Holdings, Inc.  We may continue to establish additional subsidiaries for similar purposes and/or sponsor additional private equity or other investment funds in seeking to achieve our investment objective.
 
 
69

 
 
Our portfolio company investments currently consist of common and preferred stock, other forms of equity interest and warrants or rights to acquire equity interests, senior and subordinated loans, and convertible securities in addition to our interest in the PE Fund. At October 31, 2012, the value of all investments in portfolio companies was approximately $404.2 million and our gross assets were approximately $456.4 million.
 
We expect that our investments in senior loans, subordinated debt, mezzanine debt and other yielding instruments will generally have stated terms of three to ten years. However, there is no limit on the maturity or duration of any security in our portfolio. Our debt investments are not, and typically will not be, rated by any rating agency, but we believe that if such investments were rated, they would be below investment grade (rated lower than "Baa3" by Moody's or lower than "BBB-" by Standard & Poor's). We may invest without limit in debt of any rating and debt that has not been rated by any nationally recognized statistical rating organization.
 
Our Board of Directors (the "Board") has the authority to change any of the strategies described in this prospectus without seeking the approval of our shareholders. However, the 1940 Act prohibits us from altering or changing our investment objective, strategies or policies such that we cease to be a business development company and prohibits us from voluntarily withdrawing our election to be regulated as a business development company, without the approval of the holders of a "majority of the outstanding voting securities," as defined in the 1940 Act, of the Company.
 
Corporate History and Offices
 
The Company was organized on December 2, 1999. Prior to July 2004, our name was meVC Draper Fisher Jurvetson Fund I, Inc. On March 31, 2000, the Company raised $330.0 million in an initial public offering whereupon it commenced operations as a closed-end investment company. On December 4, 2002, the Company announced it had commenced doing business under the name MVC Capital. We are a Delaware corporation and a non-diversified closed-end management investment company that has elected to be regulated as a business development company under the 1940 Act. On July 16, 2004, the Company formed MVCFS.
 
All but two of the independent members of the current Board were first elected at the February 28, 2003 Annual Meeting of the shareholders, replacing the previous Board in its entirety. The new Board then worked on developing a new long-term strategy for the Company. Then, in September 2003, upon the recommendation of the Board, shareholders voted to adopt our new investment objective. With the recommendation of the Board, shareholders also voted to appoint Mr. Tokarz as Chairman and Portfolio Manager to lead the implementation of our new objective and strategy and to stabilize the existing portfolio. Mr. Tokarz and his team managed the Company under an internal structure through October 31, 2006. On September 7, 2006, the shareholders of the Company approved the Advisory Agreement (with over 92% of the votes cast on the agreement voting in its favor) that provided for the Company to be externally managed by TTG Advisers. The agreement took effect on November 1, 2006. TTG Advisers is a registered investment adviser that is controlled by Mr. Tokarz. All of the individuals (including the Company's investment professionals) who had been previously employed by the Company as of the fiscal year ended October 31, 2006 became employed by TTG Advisers.
 
Our principal executive office is located at 287 Bowman Avenue, Purchase, New York 10577 and our telephone number is (914) 701-0310. Our website address is www.mvccapital.com.
 
 
70

 
 
Our Investment Strategy
 
On November 6, 2003, Mr. Tokarz assumed his current positions as Chairman and Portfolio Manager. We seek to implement our investment objective (i.e., to maximize total return from capital appreciation and/or income) through making a broad range of private investments in a variety of industries. The investments can include common and preferred stock, other forms of equity interests and warrants or rights to acquire equity interests, senior and subordinated loans, or convertible securities. Since assuming responsibilities in 2003, as of October 31, 2012, the Company made 52 new investments and 64 follow-on investments, committing a total of $638.3 million of capital to these investments.
 
We are concentrating our investment efforts on small and middle-market companies that, in our view, provide opportunities to maximize total return from capital appreciation and/or income. Under our investment approach, we have the authority to invest, without limit, in any one portfolio company, subject to any diversification limits that may be required in order for us to continue to qualify as a RIC under Subchapter M of the Code.  See the discussion above regarding the Company's current diversification restrictions.
 
We participate in the private equity business generally by providing negotiated equity and/or long-term debt investment capital. Our financing is generally used to fund growth, buyouts, acquisitions, recapitalizations, note purchases, and/or bridge financings. We are typically the lead investor in such transactions but may also provide equity and debt financing to companies led by private equity firms. We generally invest in private companies, though, from time to time, we may invest in small public companies that may lack adequate access to public capital.
 
At October 31, 2012, October 31, 2011, October 31, 2010 and October 31, 2009, the fair value of the invested portion (excluding cash and short-term securities) as a percentage of our net assets consisted of the following:

 
Fair Value as a Percentage of Our Net Assets
Type of Investment
As of
October 31, 2012
As of
October 31, 2011
As of
October 31, 2010
As of
October 31, 2009
Senior/Subordinated Loans and credit facility
23.18%
20.40%
26.17%
36.16%
Common Stock
18.05%
22.41%
18.56%
20.33%
Warrants
0.01%
0.00%
0.00%
0.90%
Preferred Stock
35.77%
34.89%
35.06%
38.86%
Other Equity Investments
27.90%
30.09%
22.30%
22.21%
Guarantees
(0.21)%
-
-
-
Escrow Receivables
0.26%
0.27%
0.49%
-

Substantially all amounts not invested in securities of portfolio companies are invested in short-term, liquid money market investments or held in cash in an interest bearing account. As of October 31, 2012 these investments were valued at approximately $42.6 million or 11.05% of net assets.
 
The current portfolio has investments in a variety of industries, including energy, medical devices, automotive dealerships, consumer products, specialty chemicals, food and food service, value-added distribution, industrial manufacturing, financial services, and information technology in a variety of geographical areas, including the United States, Europe and Asia.
 
Market. We have developed and maintain relationships with intermediaries, including investment banks, industry executives, financial services companies and private mezzanine and equity sponsors, through which we source investment opportunities. Through these relationships, we have been able to strengthen our position as an investor. For the transactions in which we may provide debt capital, an equity sponsor can provide a source of additional equity capital if a portfolio company requires additional financing. Private equity sponsors also assist us in confirming due diligence findings when assessing a new investment opportunity, and they may provide assistance and leadership to the portfolio company's management throughout our investment period.
 
Investment Criteria. Prospective investments are evaluated by TTG Advisers' investment team based upon criteria that may be modified from time to time. The criteria currently being used by management in determining whether to make an investment in a prospective portfolio company include, but are not limited to, management's view of:
 
 
71

 
 
 
·
Opportunity to revitalize and redirect a company's resources and strategy;
 
 
·
Businesses with secure market niches and predictable profit margins;
 
 
·
The presence or availability of highly qualified management teams;
 
 
·
The line of products or services offered and their market potential;
 
 
·
The presence of a sustainable competitive advantage;
 
 
·
Favorable industry and competitive dynamics; and
 
 
·
Stable free cash flow of the business.
 
Due diligence includes a thorough review and analysis of the business plan and operations of a potential portfolio company. We generally perform financial and operational due diligence, study the industry and competitive landscape, and meet with current and former employees, customers, suppliers and/or competitors. In addition, as applicable, we engage attorneys, independent accountants and other consultants to assist with legal, environmental, tax, accounting and marketing due diligence.
 
Investment Sourcing. Mr. Tokarz and the other investment professionals have established an extensive network of investment referral relationships. Our network of relationships with investors, lenders and intermediaries includes:
 
 
·
Private mezzanine and equity investors;
 
 
·
Investment banks;
 
 
·
Industry executives;
 
 
·
Business brokers;
 
 
·
Merger and acquisition advisors;
 
 
·
Financial services companies; and
 
 
·
Banks, law firms and accountants.
 
Allocation of Investment Opportunities. In allocating investment opportunities, TTG Advisers adheres to the following policy, which was approved by the Board: TTG Advisers will give the Company priority with respect to all investment opportunities in (i) mezzanine and debt securities and (ii) equity or other "non-debt" investments that are (a) expected to be equal to or less than the lesser of 10% of the Company's net assets or $25.0 million, and (b) issued by U.S. companies with less than $150.0 million in revenues during the prior twelve months.  However, as a result of the PE Fund's close, the PE Fund will now receive only a priority allocation of all equity investments that would otherwise be Non-Diversified Investments for the Company, which will terminate on the later of:  (i) the deployment of 80% of the committed capital of the PE Fund or (ii) two years from the first closing date of the PE Fund.
 
Investment Structure. Portfolio company investments typically will be negotiated directly with the prospective portfolio company or its affiliates. The investment professionals will structure the terms of a proposed investment, including the purchase price, the type of security to be purchased or financing to be provided and the future involvement of the Company and affiliates in the portfolio company's business (including potential representation on its board of directors). TTG Advisers will seek to structure the terms of the investment as to provide for the capital needs of the portfolio company and at the same time seek to maximize the Company's total return.
 
 
72

 
 
Once we have determined that a prospective portfolio company is suitable for investment, we work with the management and, in certain cases, other capital providers, such as senior, junior and/or equity capital providers, to structure an investment. We negotiate on how our investment is expected to relate relative to the other capital in the portfolio company's capital structure.
 
We make preferred and common equity investments in companies as a part of our investing activities, particularly when we see an opportunity to profit from the growth of a company and the potential to enhance our returns. At times, we may invest in companies that are undergoing new strategic initiatives or a restructuring but have several of the above attributes and a management team that we believe has the potential to successfully execute their plans. Preferred equity investments may be structured with a dividend yield, which may provide us with a current return, if earned and received by the Company.
 
Our senior, subordinated and mezzanine debt investments are tailored to the facts and circumstances of the deal. The specific structure is negotiated over a period of several weeks and is designed to seek to protect our rights and manage our risk in the transaction. We may structure the debt instrument to require restrictive affirmative and negative covenants, default penalties, lien protection, equity calls, take control provisions and board observation. Our debt investments are not, and typically will not be, rated by any rating agency, but we believe that if such investments were rated, they would be below investment grade quality (rated lower than "Baa3" by Moody's or lower than "BBB-" by Standard & Poor's, commonly referred to as "junk bonds").
 
Our mezzanine debt investments are typically structured as subordinated loans (with or without warrants) that carry a fixed rate of interest. The loans may have interest-only payments in the early years and payments of both principal and interest in the later years, with maturities of three to ten years, although debt maturities and principal amortization schedules vary.
 
Our mezzanine debt investments may include equity features, such as warrants or options to buy a minority interest in a portfolio company. Any warrants or other rights we receive with our debt securities generally require only a nominal cost to exercise, and thus, as the portfolio company appreciates in value, we may achieve additional investment return from this equity interest. We may structure the warrants to provide minority rights provisions and event-driven puts. We may seek to achieve additional investment return from the appreciation and sale of our warrants.
 
Under certain circumstances, we may acquire more than 50% of the common stock of a company in a control buyout transaction, including in foreign holding companies. In addition to our common equity investment, we may also provide additional capital to the controlled portfolio company in the form of senior loans, subordinated debt or preferred stock.
 
We fund new investments using cash, the reinvestment of accrued interest and dividends in debt and equity securities, or the current reinvestment of interest and dividend income through the receipt of a debt or equity security (payment-in-kind income). From time to time, we may also opt to reinvest accrued interest receivable in a new debt or equity security, in lieu of receiving such interest in cash and funding a subsequent investment. We may also acquire investments through the issuance of common or preferred stock, debt, or warrants representing rights to purchase shares of our common or preferred stock. The issuance of our stock as consideration may provide us with the benefit of raising equity without having to access the public capital markets in an underwritten offering, including the added benefit of the elimination of any commissions payable to underwriters.
 
Providing Management Assistance. As a business development company, we are required to make significant managerial assistance available to the companies in our investment portfolio. In addition to the interest and dividends received from our investments, we often generate additional fee income for the structuring, diligence, transaction, administration and management services and financial guarantees we provide to our portfolio companies through the Company or our wholly-owned subsidiary, MVCFS. In some cases, officers, directors and employees of the Company or TTG Advisers may serve as members of the board of directors of portfolio companies or fill officer roles within portfolio companies. The Company may provide guidance and management assistance to portfolio companies with respect to such matters as budgets, profit goals, business and financing strategies, management additions or replacements and plans for liquidity events for portfolio company investors such as a merger or initial public offering. MVCFS may also generate additional fee income for providing administrative and other management services to other entities, including private equity firms or other business development companies.
 
 
73

 
 
Portfolio Company Monitoring. We monitor our portfolio companies closely to determine whether or not they continue to be attractive candidates for further investment. Specifically, we monitor their ongoing performance and operations and provide guidance and assistance where appropriate. We would decline additional investments in portfolio companies that, in TTG Advisers' view, do not continue to show promise. However, we may make follow on investments in portfolio companies that we believe may perform well in the future.
 
TTG Advisers follows established procedures for monitoring the Company's equity and loan investments. The investment professionals have developed a multi-dimensional flexible rating system for all of the Company's portfolio investments. The rating grids are updated regularly and reviewed by the Portfolio Manager, together with the investment team. Additionally, the Valuation Committee meets at least quarterly, to review a written valuation memorandum for each portfolio company and to discuss business updates. Furthermore, the Company's Chief Compliance Officer administers the Company's compliance policies and procedures, specifically as they relate to the Company's investments in portfolio companies.
 
We exit our investments generally when a liquidity event takes place, such as the sale, recapitalization or initial public offering of a portfolio company. Our equity holdings, including shares underlying warrants, after the exercise of such warrants, typically include registration rights which would allow us to sell the securities if the portfolio company completes a public offering.
 
Investment Approval Procedures. Generally, prior to approving any new investment, we follow the process outlined below. We usually conduct one to four months of due diligence and structuring before an investment is considered for approval. However, depending on the type of investment being contemplated, this process may be longer or shorter.
 
The typical key steps in our investment approval process are:
 
 
·
Initial investment screening by deal person or investment team;
 
 
·
Investment professionals present an investment proposal containing key terms and understandings (verbal and written) to the entire investment team;
 
 
·
Our Chief Compliance Officer reviews the proposed investment for compliance with the 1940 Act, the Code and all other relevant rules and regulations;
 
 
·
Investment professionals are provided with authorization to commence due diligence;
 
 
·
Any investment professional can call a meeting, as deemed necessary, to: (i) review the due diligence reports; (ii) review the investment structure and terms; or (iii) to obtain any other information deemed relevant;
 
 
·
Once all due diligence is completed, the proposed investment is rated using a rating system which tests several factors including, but not limited to, cash flow, EBITDA growth, management and business stability. We use this rating system as the base line for tracking the investment in the future;
 
 
·
Our Chief Compliance Officer confirms that the proposed investment will not cause us to violate the 1940 Act, the Code or any other applicable rule or regulation;
 
 
·
Mr. Tokarz approves the transaction; and
 
 
·
The investment is funded.
 
The Investment Team
 
Mr. Tokarz is responsible for the day-to-day management of the Company's portfolio. Mr. Tokarz draws upon the experience of the 12 full-time investment professionals and two part-time investment professionals of TTG Advisers. TTG Advisers also uses the services of other investment professionals, with whom it has developed long-term relationships, on an as-needed basis. TTG Advisers looks to benefit from the combined resources and investment experience of all of its investment professionals. In addition, TTG Advisers employs seven other full-time professionals and two part-time professionals who manage the operations of the Company and provide investment support functions both directly and indirectly to our portfolio companies. As the Company grows, TTG Advisers expects to hire, train, supervise and manage new employees at various levels, many of which would be expected to provide services to the Company. The following information contains biographical information for key personnel of TTG Advisers (including their titles with TTG Advisers).
 
 
74

 
 
Senior Management Team
 
Michael T. Tokarz, Managing Principal & Co-Head of Portfolio
 
Mr. Tokarz is a senior investment professional with over 30 years of lending and investment experience. Prior to assuming his position as Chairman and Portfolio Head of MVC Capital (NYSE:MVC), and prior to founding The Tokarz Group (in 2002), a private merchant bank of which he is Chairman, Mr. Tokarz was a General Partner with Kohlberg Kravis Roberts & Co. ("KKR"), one of the world's most experienced private equity firms. During his 18-year tenure at KKR, he participated in diverse leveraged buyouts, financings, restructurings and dispositions. Mr. Tokarz currently serves on corporate boards including Walter Energy, Inc., Mueller Water Products, Inc., Walter Investment Management Corp., IDEX Corporation and CNO Financial Group. In addition, Mr. Tokarz is on the Board of Managers of Illinois Ventures, a University of Illinois-focused venture capital seed fund and high technology incubator, and is Chairman of a related private equity follow-on investment fund. Mr. Tokarz also serves as the Chairman Emeritus of the University of Illinois Foundation and its Investment and Executive Committees. Prior to his tenure at KKR, Mr. Tokarz was a commercial banker at Continental Illinois where he was renowned for innovation and buyout financings. Mr. Tokarz rose to run the East Coast operation of Continental Illinois from New York. He was active on the Endowment Committee and Board of Directors of the National Wildlife Federation. He received his undergraduate degree with High Distinction in Economics, an MBA in Finance from the University of Illinois and is a Certified Public Accountant. He was selected as one of the "The Best Corporate Directors in America" by Outstanding Directors Exchange in 2007.
 
Warren E. Holtsberg, Managing Principal & Co-Head of Portfolio
 
Mr. Holtsberg is Co-Head of Portfolio Management of the Fund and is a member of the Board of Directors of MVC Capital (NYSE:MVC). Mr. Holtsberg, who joined TTG Advisers in 2007, is a senior investment professional with almost 20 years of lending and investment experience. In his role at TTG Advisers, he sources and executes new investments and helps manage the Fund’s global portfolio of private equity, venture, and small- and mid-cap debt and equity investments across a broad range of industries including technology, consumer/retail, energy and finance. He also heads the Chicago Office of TTG Advisers. Previously, Mr. Holtsberg founded Motorola Ventures, the venture capital and private equity investment arm for Motorola, Inc. (NYSE:MOT) where he led the worldwide fund for eight years. Mr. Holtsberg was also a member of the Motorola Corporate Credit Committee. Before Motorola, Mr. Holtsberg spent two decades with the U.S. Government where he held a number of senior executive positions in the Aviation, Defense and Intelligence communities. Mr. Holtsberg serves on the Advisory Board of Arcapita Ventures, the private equity and venture capital arm of Arcapita Bank. Mr. Holtsberg is also a member of the Board of Directors of the Illinois Venture Capital Association, the Chicagoland Entrepreneurship Center, the Big Shoulders Fund for the Archdiocese of Chicago’s inner-city school fund, and Illinois Ventures, a University of Illinois focused venture capital seed fund and high technology incubator, and he is a Director of a related private equity follow-on investment fund. Mr. Holtsberg is a graduate of the University of Illinois and the Kellogg Management Institute at Northwestern University J.L. Kellogg Graduate School of Management.
 
Bruce W. Shewmaker, Senior Managing Director
 
Mr. Shewmaker is a senior investment professional with over 30 years of private equity and investment banking experience. Prior to becoming a Managing Director of MVC in November 2003, Mr. Shewmaker served as a member of the Board of MVC from March 2003 and served out his one year term. Mr. Shewmaker was a Co-founder of Merrill Lynch Venture Capital, Inc. where he initiated several private equity investment partnerships, including three business development companies. During his ten year career at Merrill Lynch, he participated in sourcing, negotiating and monitoring over 40 private equity transactions including leveraged buyouts and venture capital investments, of which seven companies completed initial public offerings. More recently, Mr. Shewmaker served as President and CEO of The US Russia Investment Fund, with committed capital of $440 million, where he managed a staff of 60 people, including eight private equity professionals, in seven offices across the Russian Federation. As a Managing Director of E*OFFERING Corp., he helped this investment banking firm participate in underwriting more than 50 initial public offerings of domestic companies and was responsible for organizing a global investment banking network. While Mr. Shewmaker has spent the majority of his career with registered investment companies or investment management divisions of NYSE listed firms (divisions of The Chase Manhattan Bank and Time Inc.), in the late 1990’s Mr. Shewmaker Co-founded Crossbow Ventures, a regionally focused private equity partnership located in Florida. He earned his undergraduate degree in Finance from The Ohio State University and has passed the Series 7 and 63 NASD qualifying examinations.
 
 
75

 
 
Investment Team
 
Shivani Khurana, Managing Director
 
Ms. Khurana is a senior investment professional with over 11 years' experience in private equity, leveraged finance, investment banking and investment management. Ms. Khurana joined MVC in March 2004 and has played a key role in MVC’s growth and sourcing, execution and monitoring of several of MVC’s equity and debt investments across a variety of industries. She also serves as a Managing Director of MVC Financial Services, Inc. Before joining MVC, Ms. Khurana worked at Cadigan Investment Partners, a middle-market leveraged buyout firm where she was involved in originating, structuring, financing and negotiating leveraged and management buyout and recapitalization transactions. Previously, Ms. Khurana worked in the leveraged finance group of Wachovia Securities where she specialized in restructuring advisory, distressed debt investing and turnaround financing; and the investment banking group of Merrill Lynch. Ms. Khurana’s prior experience includes independently managing $20 million in diversified U.S. and European equities at Al-Ahlia Investment Company. Ms. Khurana received a Bachelor of Commerce with accounting honors from Panjab University, India; an MBA in Finance from University of Sheffield, UK; and an M.S. in Finance from University of Rochester, New York.
 
James D. Lynch, Managing Director
 
Mr. Lynch is a senior investment professional with over 13 years of consulting, operations and private equity experience. Mr. Lynch is a Managing Director of TTG Advisers with responsibilities for deal sourcing, execution and monitoring of portfolio investments. Prior to joining TTG Advisers in 2007, Mr. Lynch was a Managing Director at FTI Consulting (NYSE:FCN) and a Leader of the Intellectual Property Transactions practice. Previously, Mr. Lynch worked at Deloitte & Touche Financial Advisory Services as a Practice Leader of Deloitte's Intellectual Asset Management service line and the Venture Strategy Group. At both Deloitte and FTI, he managed global teams that performed innovation and corporate finance engagements for Fortune 500 corporations, financial institutions, entrepreneurial ventures and public sector institutions. The client engagements included corporate finance, M&A and intellectual property transactions, strategic innovation and operational consulting, technology commercialization and the creation of new business enterprises. Before Deloitte, Mr. Lynch worked in business competitive intelligence and internal audit for Owens Corning Corporation (NYSE:OC). Mr. Lynch is a member of the Board of Advisors of DRI Capital and Illinois Business Consulting. He holds a Bachelor of Science (Accounting) from Purdue University and an MBA from the University of Illinois.
 
James J. O'Connor, Managing Director, Chicago
 
Mr. O'Connor is a senior investment professional with over a decade of private equity and venture capital experience. Prior to joining TTG Advisers, Mr. O'Connor held senior management positions within Motorola, Inc. (NYSE:MOT). Mr. O’Connor was Co-Founder and Managing Director of Motorola Ventures, the venture capital and private equity investment arm for Motorola, where he led numerous global transactions. In 2006, Mr. O’Connor was named to the American Ventures Magazine (AVM) "40 UNDER 40" list. In his most recent role, Mr. O’Connor also led Motorola’s Innovation Program where he built several high growth businesses for the corporation, including the initial successful launch of the development team for the Google – Motorola “Droid” product. Before Motorola, he worked for A.T. Kearney as a management consultant and the U.S. Treasury Department in the areas of Domestic and International Finance as a White House Fellow. Additionally, he held roles at Ariel Capital Management, Sidley & Austin, the U.S. House Ways & Means Committee and the City of Chicago Finance Committee. Mr. O’Connor is Co-Chair of the Chicago Entrepreneurial Center (CEC) and a Board member of the Chicagoland Chamber of Commerce, the Chicago Urban League, Kohl Children’s Museum, Children’s Home + Aid, the Big Shoulders Fund for the Archdiocese of Chicago's inner-city school fund and serves as a Trustee on the Board of the Field Museum of National History. He is a Henry Crown Leadership Fellow of the Aspen Institute. He holds a BA (Government) and JD from Georgetown University and an MBA from the Northwestern University J.L. Kellogg Graduate School of Management.
 
 
76

 
 
Puneet Sanan, Managing Director
 
Mr. Sanan is a senior investment professional with over 15 years' experience in private equity, leveraged/corporate finance and investment banking. Mr. Sanan joined MVC in March 2004 and has played a key role in MVC’s growth, debt and equity capital raise, and sourcing, execution and monitoring of investments. He also serves as a Managing Director of MVC Financial Services, Inc. Before joining MVC, Mr. Sanan worked at Cadigan Investment Partners, a leveraged buyout firm, and was involved in originating, developing, analyzing, structuring, financing and negotiating leveraged and management buyouts, recapitalizations and growth capital financing for middle-market companies. Previously, Mr. Sanan was a Vice President and managed the Investment Banking Division of Fano Securities, where he received international recognition for financial advisory work in alternative energy technology. Prior to joining Fano, Mr. Sanan was an Associate Director at UBS Warburg’s Leveraged Finance/Financial Sponsors group where he advised leading private equity firms on leveraged buyouts, mergers and acquisitions and private equity investments. Mr. Sanan has held various corporate finance and industry positions at PaineWebber, Legg Mason, Royal Dutch/Shell Group and Gist Brocades (now DSM N.V.). In 2003 and 2004, Mr. Sanan was named to the International Who’s Who of Professionals. Mr. Sanan received a Bachelor of Engineering (Honors) in Chemical Engineering from Panjab University, India; and an MBA in Finance from The University of Texas at Austin; and has passed the Series 7 and 63 NASD qualifying examinations.
 
Peter F. Seidenberg, Chief Financial Officer
 
Mr. Seidenberg is the Chief Financial Officer of MVC and a senior investment professional with over 15 years' experience in private equity and venture capital investing, corporate finance, operations and general management. Mr. Seidenberg joined MVC in April of 2005 and has played a key role in MVC’s growth, debt and equity capital raises, execution and monitoring of investments. He previously served as a Principal and Chief Financial Officer of Nebraska Heavy Industries and worked on engagements including serving as CFO of Commerce One, Inc. (NASDAQ:CMRC). Prior to his tenure at NHI, Mr. Seidenberg served as the Director of Finance and Business Development and as Corporate Controller for Plumtree Software, Inc. (NASDAQ:PLUM) where he was responsible for driving strategic initiatives and managing the finance and accounting staff. Before joining Plumtree, Mr. Seidenberg worked at AlliedSignal. While at AlliedSignal, Mr. Seidenberg held a variety of roles including Controller and Manager of Financial Operations. Mr. Seidenberg has served in a variety of roles including General Manager at several small manufacturing companies. Mr. Seidenberg received his bachelor degree and MBA from Cornell University.
 
Christopher P. Sullivan, Managing Director, Boston
 
Mr. Sullivan is a senior investment professional with over 10 years of experience in private equity, investment banking and equity capital markets. Mr. Sullivan is a Managing Director of TTG Advisers with responsibilities for deal sourcing, execution and monitoring of portfolio investments. Since joining MVC in 2004, Mr. Sullivan has led nine investments in the current portfolio.  Prior to joining MVC, Mr. Sullivan worked as an Associate at Credit Suisse First Boston in Equity Capital Markets, where he worked with numerous issuers and financial sponsors to execute initial public offerings and follow-on stock offerings. Prior to his employment at Credit Suisse First Boston, Mr. Sullivan worked as an Analyst in Equity Capital Markets at CIBC World Markets. Mr. Sullivan holds a BA in History from Dartmouth College and an MBA, with a concentration in Finance, from the Carroll School of Management at Boston College.
 
Portfolio Investment Operations
 
Kathleen A. Buenik, Office Administrator - Chicago / LP Investor Relations
 
Ms. Buenik joined TTG Advisers in August of 2007 as Office Administrator for the Chicago office, as well as Manager Investor Relations. In her role, Ms. Buenik supports the Co-Head of Portfolio Management, manages the office's daily operations and administration of the Limited Partner database. Prior to joining TTG Advisers, Ms. Buenik was employed for 15 years as the Office Administrator for Goldstick & Associates, Ltd., a law firm and securities broker/dealer in Chicago. Ms. Buenik was previously employed by Oppenheimer & Co. and Bear Stearns as a Series 7 Registered Sales Assistant. Ms. Buenik holds a Bachelor of Science degree in Business Administration from Elmhurst College.
 
 
77

 
 
Chris Ferguson, Associate
 
Mr. Ferguson joined TTG Advisers in April of 2012 and is responsible for sourcing, executing and monitoring investments. Prior to joining TTG Advisers Mr. Ferguson has worked in Private Equity at CCMP Capital, and as a member of a corporate cash management team at Credit Suisse. Mr. Ferguson holds a BA (Government) from Franklin and Marshall College in Lancaster Pennsylvania, and a MBA with a dual concentration in Finance and Management from Seton Hall University's Stillman School of Business.
 
Martha Kausch, Office Administrator - NY / Special Projects Coordinator
 
Ms. Kausch joined TTG Advisers in September 2005 and is responsible for all information technology, supporting portfolio company initiatives, including opening and managing several high-profile and high-trafficked airport locations for Harmony Pharmacy & Health Centers, Inc., as well as working on the development of new locations, vendor relations and product/service offerings. In addition, Ms. Kausch is responsible for managing the Quarterly Valuation Process of the Board of Directors. Prior to joining TTG Advisers, Ms. Kausch worked at Xerox Corporation for fifteen years. During her tenure, she held various positions including managing a digital manufacturing line with 50 direct reports, in addition to roles in distribution, supply chain, quality control and within the headquarters administrative organization.
 
John P. Kelly, Vice President
 
Mr. Kelly is an investment professional with over six years of experience in private equity, leveraged finance and investment banking.  Mr. Kelly is a Vice President of TTG Advisers with responsibilities for deal sourcing, executing and monitoring of investments. Prior to joining TTG Advisers in 2008, Mr. Kelly worked in the investment banking group of Bear, Stearns & Co., where he executed leverage buyouts, mergers and acquisitions and equity and debt offerings. Mr. Kelly holds a Bachelors of Business Administration in Finance from the University of Notre Dame and an MBA from the University of Chicago’s Booth School of Business.
 
Jennifer Kosiba
 
Ms. Kosiba first joined TTG Advisers in June 2006. After spending a year at Harmony Pharmacy & Health Center, Inc. to help launch the start-up, Ms. Kosiba returned to TTG Advisers on a full time basis through the externalization to The Tokarz Group Advisers. Ms. Kosiba is responsible for supporting the Investor Relations functions and daily operations of the Fund. Prior to joining TTG Advisers on a full time basis, Ms. Kosiba was a full-time student spending her summers working with TTG Advisers or its portfolio companies. Ms. Kosiba earned a Bachelors of Science in Finance from the University of Illinois at Urbana-Champaign, where she graduated with honors.
 
Patrick Mullins, Assistant Controller
 
Mr. Mullins is the Assistant Controller of TTG Advisers. His responsibilities include assisting the Controller in overseeing the financial operations of MVC Capital and its wholly owned subsidiary MVC Financial Services, Inc. Mr. Mullins has over nine years of experience in public and private accounting. Previously, Mr. Mullins worked at the Designtex Group a textile distribution company where he was the Accounting Manager and was involved with audits and reviews of small and mid-size companies at Huth Thompson LLP. He received his Bachelors of Arts in Accounting from Moravian College in Bethlehem PA.
 
Maura E. O'Brien, Executive Assistant - Chicago
 
Ms. O'Brien joined TTG Advisers in September of 2008 as Executive Assistant in Chicago. Ms. O'Brien was previously an Assistant Vice President at Diners Club International, an Office Manager at a boutique executive search firm in Chicago, and a Personal Assistant for the Clara Williams Company. She is on the Chicago Sister Cities International - Galway Board, a Ronald McDonald House Volunteer, a St. Patrick's Day Parade Judge, and was a Member of the Young Irish Fellowship Executive Board and a Mentor with Big Shoulders. Ms. O'Brien attended Spring Hill College in Mobile, AL, where she received her Bachelor of Science degree in Marketing.
 
 
78

 
 
Renata Quin, Executive Assistant - New York
 
Ms. Quin joined TTG Advisers in August 2005 and is responsible for all aspects of administrative and operational support including managing the quarterly board book process. Prior to joining TTG Advisers, Ms. Quin worked at the office of the Westchester District Attorney directly supporting the District Attorney for two years. Prior to that Ms. Quin worked for the Space and Naval Warfare Systems Command for the military in San Diego, CA. Prior to her tenure with the military, Ms. Quin worked directly for the Chief Operating Officer of Island Destinations, a large luxury travel agency based in New York. Ms. Quin received her Bachelor degree in Business Administration from Berkeley College where she majored in International Business.
 
Jaclyn Shapiro-Rothchild, Vice President and Secretary
 
Ms. Shapiro-Rothchild serves as Vice President and Secretary of MVC Capital and TTG Advisers. She is responsible for board and shareholder matters, portfolio development and fund administration, monitoring the Fund’s legacy portfolio, and directing the Fund and TTG Advisers’ operations. Prior to joining MVC Capital and TTG Advisers, Ms. Shapiro-Rothchild was an Associate and Business Manager with Draper Fisher Jurvetson meVC Management Co. LLC, the former sub-advisor of the Fund. Before joining the Fund’s former sub-advisor, Ms. Shapiro-Rothchild was an Associate at The Bank Companies (acquired by Newmark & Co. Real Estate), where she was responsible for analyzing the various real estate trends in the Washington, D.C. greater metropolitan area. Previously, Ms. Shapiro-Rothchild worked as a Research Analyst to a Senior Portfolio Manager at Gruntal & Co. and began her business career as a Marketing Consultant at Archstone-Smith, formerly known as Charles E. Smith & Co. Ms. Shapiro-Rothchild received her Bachelors of Business Administration degree in Entrepreneurship and Small Business Management from George Washington University in Washington, DC.
 
Scott Schuenke, CPA, Corporate Controller and Chief Compliance Officer
 
Mr. Schuenke originally joined MVC Capital in June 2004 as its Corporate Controller and later in the year became MVC Capital’s Chief Compliance Officer. Currently, Mr. Schuenke is employed by TTG Advisers where he is the Corporate Controller and Chief Compliance Officer. He retains his Chief Compliance Officer position with the Fund and is responsible for overseeing the financial operations of TTG Advisers, MVC Capital and its wholly-owned subsidiaries. Mr. Schuenke also provides financial expertise and monitoring to various portfolio companies and assists investment professionals in deal sourcing, due diligence, modeling and closing activities. As Chief Compliance Officer, Mr. Schuenke is responsible for overseeing the MVC Capital and TTG Advisers’ compliance programs. Before joining MVC Capital, Mr. Schuenke was a compliance officer with US Bancorp Fund Services, LLC, where he was responsible for financial reporting and compliance oversight of more than 15 open- and closed-end registered investment companies. Previously, Mr. Schuenke worked in the audit and assurance services area with PricewaterhouseCoopers, LLP (“PWC”). While with PWC, he performed audit and review services for financial services clients including several large mutual fund complexes. Mr. Schuenke received his Bachelor of Business Administration from the University of Wisconsin, Milwaukee. He also holds a Masters of Professional Accountancy from the University of Wisconsin, Whitewater. Mr. Schuenke is a Certified Public Accountant licensed in the State of Wisconsin.
 
Kevin Scoby, Associate
 
Mr. Scoby joined TTG Advisers full time in January of 2012 and is responsible for sourcing, executing and monitoring investments. Prior to joining TTG Advisers on a full time basis, Mr. Scoby had interned at Connaught Real Estate Finance. Mr. Scoby earned a Bachelor's of Science in Economics with a concentration in Finance from The Wharton School of the University of Pennsylvania.
 
Kashyap Shah, Associate
 
Kashyap Shah joined TTG Advisers in June 2010 and has been involved in sourcing, evaluating and executing investment opportunities. Before joining TTG Advisers, Mr. Shah held several roles at Edelweiss Capital Limited in Mumbai, where he was most recently the COO of its investment banking group. In that capacity, Mr. Shah was responsible for high priority strategic initiatives including the setting-up of the financial sponsors and country coverage groups and establishing strategic alliances. Prior to this role, Mr. Shah was a Senior Manager responsible for managing investment banking transactions across product and sector groups. His experience spans across M&A, private placements, structured finance and ECM transactions. Prior to Edelweiss Capital, Mr. Shah worked with KPMG in its Mumbai office. Mr. Shah received a Bachelor of Commerce from Mumbai University, India where he was on the Dean's list and is a Chartered Accountant from The Institute of Chartered Accountants of India. Mr. Shah holds an MBA degree with concentrations in Finance, Strategic Management and Entrepreneurship from The University of Chicago Booth School of Business.
 
 
79

 
 
Other Accounts Managed
 
Mr. Tokarz, our Portfolio Manager, is also responsible for the day-to-day management of the PE Fund, a pooled investment vehicle for which TTG Advisers is entitled to receive a performance-based fee.  As of  October 31, 2012, the PE Fund has approximately $104 million in committed assets.  For a further discussion of the Board approved allocation of investment opportunities policy, please see "MVC Capital – Our Investment Strategy – Allocation of Investment Opportunities."
 
Compensation of the Portfolio Manager
 
Mr. Tokarz does not receive compensation from TTG Advisers in the form of salary, bonus, deferred compensation or pension and retirement plans. However, as the sole controlling equity owner of TTG Advisers, he has a significant equity interest in the profits generated by TTG Advisers from its management of the Company.
 
Company Ownership
 
Mr. Tokarz owns, as of October 31, 2012, over $1,000,000 worth of our common shares.  Mr. Tokarz purchased each share on his own behalf.  The Company did not grant any shares to him or any other member of the team.
 
Portfolio Diversity
 
Our portfolio is not currently concentrated and we currently do not have a policy with respect to "concentrating" (i.e., investing 25% or more of our total assets) in any industry or group of industries and currently our portfolio is not concentrated. We may or may not concentrate in any industry or group of industries in the future.
 
PORTFOLIO COMPANIES
 
The following is a listing of our portfolio companies in which we had an investment at October 31, 2012. The portfolio companies are presented in three categories — companies more than 25% owned which represent portfolio companies where we directly or indirectly own more than 25% of the outstanding voting securities of such portfolio company and, therefore, are deemed controlled by us under the 1940 Act; companies owned 5% to 25% which represent portfolio companies where we directly or indirectly own 5% to 25% of the outstanding voting securities of such portfolio company and, therefore, are deemed to be an affiliated person under the 1940 Act; and companies less than 5% owned which represent portfolio companies where we directly or indirectly own less than 5% of the outstanding voting securities of such portfolio company.   
 
We make available significant managerial assistance to our portfolio companies. We generally receive rights to observe the meetings of our portfolio companies' board of directors, and may have one or more voting seats on their boards.
 
For further information relating to the amount and nature of our investments in portfolio companies, see our Consolidated Schedule of Investments for October 31, 2012, on pages F-2 to F-3.
 
 
80

 
 
Company Name and Address
 
Nature of its Principal Business
 
Titles of Securities Held
 
Percent of
Class Held
             
Non-control/Non-affiliated investments - 12.69%
       
             
Actelis Networks, Inc.
 
Telecommunications
 
Preferred Stock
 
10.81%
6150 Stevenson Blvd.
           
Fremont, CA 94538
           
Biovation Holdings, Inc.
 
Manufacturer of Laminate Material & Composites
 
Bridge Loan, 02/28/2014
 
N/A
110 Deer Place
           
Mankato, MN 56001
           
BPC II, LLC
 
Apparel
 
Limited Liability Company Interest
 
9.40%
116 E Live Oak Ave. #167
           
Arcadia, CA 91006
           
DPHI, Inc.
 
Technology Investments
 
Preferred Stock
 
48.90%
1900 Pike Road
           
Suite F
           
Longmont, CO 80501
           
FOLIOfn, Inc.
 
Technology Investments
 
Preferred Stock
 
49.36%
8180 Greensboro Drive
           
8th Floor
           
McLean, VA 22102
           
Freshii USA, Inc.
 
Food Services
 
Senior Secured Loan
 
N/A
1 North Franklin
     
Warrants
 
1.00%
Suite 3310
           
Chicago, IL 60606
           
Lockorder Limited
 
Technology Investments
 
Common Stock
 
10.45%
4 Anglo Office Park, Lincoln Road, High Wycombe
           
Bucks HP 123RH
           
MainStream Data, Inc.
 
Technology Investments
 
Common Stock
 
0.46%
375 Chipeta Way
           
Suite B
           
Salt Lake City, UT 84108-1261
           
NPWT Corporation
 
Medical Device Manufacturer
 
Common Stock
 
56.20%
1111 Lakeside Drive
     
Preferred Stock
 
100.00%
Gurnee, IL 60031
           
Prepaid Legal Services, Inc.
 
Consumer Services
 
Term Loan A
 
N/A
One Pre-Paid Way
     
Term Loan B
 
N/A
Ada, Oklahoma 74820
           
 
 
81

 
 
SGDA Sanierungsgesellschaft 
fur Deponien und Altlasten GmbH
 
Soil Remediation
 
Term Loan, 08/31/2012
 
N/A
Bahnhofstrasse 66
           
98544 Zella - Mehlis
           
Germany
           
Teleguam Holdings, LLC
 
Telecommunications
 
Second Lien Loan, 06/09/2017
 
N/A
624 North Marine Corps Drive
           
Tamuning, Guam 96913
           
Affiliate investments - 45.80%
       
Centile Holdings B.V.
 
Software
 
 Common Equity Interest
 
98.00%
411 Strawinskylaan
           
World Trade Center Tower A
           
1077 XX
           
Amsterdam, Netherlands
           
Custom Alloy Corporation
 
Manufacturer of Pipe Fittings
 
Unsecured Subordinated Loan
 
N/A
3 Washington Avenue
     
Convertible A Preferred Stock
 
100.00%
High Bridge, NJ 08829
     
Convertible B Preferred Stock
 
100.00%
Harmony Health & Beauty, Inc.
 
Health & Beauty - Retail
 
Common Stock
 
99.90%
287 Bowman Avenue, 2nd Floor
           
Purchase, NY 10577
           
JSC Tekers Holdings
 
Real Estate Management
 
Common Stock
 
9.00%
15-3 Jauniela Street
     
Secured Loan
 
N/A
Riga, LV-1050
           
Latvia
           
Marine Exhibition Corporation
 
Theme Park
 
Senior Subordinated Loan
 
N/A
4400 Rickenbacker Causeway
     
Convertible Preferred Stock
 
100.00%
Key Biscayne, FL 33149
           
Octagon Credit Investors, LLC
 
Financial Services
 
Limited Liability Company Interest
 
6.74%
245 Park Avenue
           
16th Floor
           
New York, NY 10167
           
RuMe Inc.
 
Consumer Products
 
Common Stock
 
8.44%
7022 South Revere Parkway
     
Series B-1 Preferred Stock
 
100.00%
Suite 240
           
Centennial, CO 80112
           
 
 
82

 
 
Security Holdings B.V.
 
Electrical Engineering
 
Common Equity Interest
 
98.00%
411 Strawinskylaan
           
World Trade Center Tower A
           
1077 XX
           
Amsterdam, Netherlands
           
SGDA Europe B.V.
 
Soil Remediation
 
Common Equity Interest
 
99.90%
411 Strawinskylaan
           
World Trade Center Tower A
           
1077 XX
           
Amsterdam, Netherlands
           
U.S. Gas & Electric, Inc.
 
Energy Services
 
Second Lien Loan
 
N/A
290 N.W. 165th Street
     
Convertible Series I Preferred Stock
 
100.00%
PH5 (4th floor)
     
Convertible Series J Preferred Stock
 
100.00%
North Miami Beach, FL 33169
           
Control Investments - 49.82%
       
MVC Automotive Group B.V.
 
Automotive Dealerships
 
Common Equity Interest
 
100.00%
123 Fred Roeskestraat
     
Bridge Loan
 
N/A
Amsterdam, 1076 EE
           
The Netherlands
           
MVC Private Equity Fund LP
 
Private Equity
 
General Partnership Interest
 
100.00%
71 South Wacker Drive
      Limited Partnership Interest   19.03%
Suite 2760
           
Chicago, IL 60606
           
Ohio Medical Corporation
 
Medical Device Manufacturer
 
Common Stock
 
56.20%
1111 Lakeside Drive
     
Series A Convertible Preferred Stock
 
74.62%
Gurnee, IL 60031
     
Guarantee - Series B Preferred
 
N/A
SIA Tekers Invest
 
Port Facilities
 
Common Stock
 
100.00%
15 Atlantijas Street
           
Riga, LV-1015
           
Latvia
           
Summit Research Labs, Inc.
 
Specialty Chemicals
 
Second Lien Loan
 
N/A
15 Big Pond Road
     
Common Stock
 
80.00%
Huguenot, NY 12746
           
Turf Products, LLC
 
Distributor - Landscaping and
 
Senior Subordinated Loan
 
N/A
157 Moody Road
 
Irrigation Equipment
 
Junior Revolving Note
 
N/A
PO Box 1200
     
Limited Liability Company Interest
 
45.00%
Enfield, CT 06083
     
Warrants
 
15.00%
 
 
83

 
 
Velocitius B.V.
 
Renewable Energy
 
Common Equity Interest
 
100.00%
Telestone 8 - Teleport
           
Naritaweg 165
           
Amsterdam, 1007 JE
           
Netherlands
           
Vestal Manufacturing Enterprises, Inc.
 
Iron Foundries
 
Senior Subordinated Loan
 
N/A
176 Industrial Park Road
     
Common Stock
 
85.26%
Sweetwater, TN 37874             
 
 
84

 
 
For companies held by the Company at October 31, 2012, please reference pages 45 to 57 for a brief description of each portfolio company's business. In addition, we have provided below a more detailed description for each portfolio company which represented more than 5% of our assets as of October 31, 2012.
 
Custom Alloy Corporation
 
Custom Alloy, High Bridge, New Jersey, manufactures time sensitive and mission critical butt-weld pipe fittings for the natural gas pipeline, power generation, oil/gas refining and extraction, and nuclear generation markets.
 
At October 31, 2011, the Company’s investment in Custom Alloy consisted of nine shares of convertible series A preferred stock at a cost and fair value of $44,000 and 1,991 shares of convertible series B preferred stock at a cost and fair value of approximately $10.0 million. The unsecured subordinated loan, which bears annual interest at 14% and was to mature on September 18, 2012, had a cost of $14.5 million and a fair value of $14.6 million.
 
At October 31, 2012, the Company’s investment in Custom Alloy consisted of nine shares of convertible series A preferred stock at a cost and fair value of $44,000 and the 1,991 shares of convertible series B preferred stock had a cost and fair value of approximately $10.0 million. The unsecured subordinated loan had a cost basis, outstanding balance and fair value of approximately $15.6 million. The Company extended the maturity date of the loan to June 18, 2013. The increase in the cost basis and fair value of the loan is due to the amortization of loan origination fees and the capitalization of “payment in kind” interest. These increases were approved by the Company’s Valuation Committee.
 
MVC Automotive Group B.V.
 
MVC Automotive, an Amsterdam-based holding company, owns and operates ten Ford, Jaguar, Land Rover, Mazda, and Volvo dealerships located in Austria, Belgium, and the Czech Republic.
 
At October 31, 2011, the Company’s investment in MVC Automotive consisted of an equity interest with a cost of approximately $34.7 million and a fair value of approximately $42.5 million. The bridge loan, which bears annual interest at 10% and matures on December 31, 2012, had a cost and fair value of approximately $3.6 million. The guarantees for MVC Automotive were equivalent to approximately $13.7 million at October 31, 2011.
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the equity interest by approximately $8.9 million.
 
At October 31, 2012, the Company’s investment in MVC Automotive consisted of an equity interest with a cost of approximately $34.7 million and a fair value of approximately $33.5 million. The bridge loan had a cost and fair value of approximately $3.6 million. The mortgage guarantee for MVC Automotive was equivalent to approximately $5.2 million at October 31, 2012. This guarantee was taken into account in the valuation of MVC Automotive.
 
Ohio Medical Corporation
 
Ohio Medical, Gurnee, Illinois, is a manufacturer and supplier of suction and oxygen therapy products, medical gas equipment, and input devices.
 
At October 31, 2011, the Company’s investment in Ohio Medical consisted of 5,620 shares of common stock with a cost basis and fair value of approximately $15.8 million and $0, respectively, and 18,102 shares of convertible preferred stock with a cost basis of $30.0 million and a fair value of $39.5 million.
 
On November 30, 2011, as part of Ohio Medical’s refinancing of their debt, the Company agreed to guarantee a series B preferred stock tranche of equity, with a 12% coupon for the first 18 months it is outstanding. After that initial period, the rate increases by 400bps to 16% for the next 6 months and increases by 50 bps (.5%) each 6 month period thereafter. The amount guaranteed was approximately $19.0 million and initially fair valued at $700,000 by the Valuation Committee.
 
 
85

 
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the preferred stock by $8.4 million and increased the guarantee obligation by $125,000.
 
At October 31, 2012, the Company’s investment in Ohio Medical consisted of 5,620 shares of common stock with a cost basis of approximately $15.8 million and a fair value of $0 and 21,176 shares of convertible preferred stock with a cost basis of $30.0 million and a fair value of $31.1 million. The guarantee obligation had a fair value of negative $825,000.
 
Security Holdings, B.V.
 
Security Holdings is an Amsterdam-based holding company that owns FIMA, a Lithuanian security and engineering solutions company.
 
On April 26, 2011, the Company agreed to collateralize a 5.0 million Euro letter of credit from JPMorgan Chase Bank, N.A., which is classified as restricted cash on the Company’s consolidated balance sheet. This letter of credit is being used as collateral for a project guarantee by AB DnB NORD bankas to Security Holdings.
 
At October 31, 2011, the Company’s common equity interest in Security Holdings had a cost basis of approximately $40.2 million and a fair value of $33.2 million.
 
On August 29, 2012, TTG Advisers extended a short-term, below market interest rate loan to FIMA. Our Board of Directors, including all of the Independent Directors, approved the loan (Mr. Tokarz recused himself from making a determination or recommendation on this matter).
 
During the fiscal year ended October 31, 2012, the Valuation Committee decreased the fair value of the common equity interest by $9.2 million.
 
At October 31, 2012, the Company’s common equity interest in Security Holdings had a cost basis of approximately $40.2 million and a fair value of approximately $24.0 million.

Summit Research Labs, Inc.
 
Summit, Huguenot, New York, is a specialty chemical company that manufactures antiperspirant actives.
 
At October 31, 2011, the Company’s investment in Summit consisted of a second lien loan and 1,115 shares of common stock. The second lien loan bears annual interest at 14% and matures on August 31, 2013. The second lien loan had an outstanding balance of $11.1 million with a cost of $11.0 million. The second lien loan was fair valued at $11.1 million. The common stock had been fair valued at $74.5 million with a cost basis of $16.0 million.
 
On March 7, 2012, the Board of Directors of Summit approved a recapitalization and declared a $15.0 million dividend, of which $12.0 million was paid to the Company, resulting in a $12.0 million reduction in the fair value of the common stock.
 
At October 31, 2012, the Company’s second lien loan had an outstanding balance of approximately $11.9 million with a cost of approximately $11.8 million. The second lien loan was fair valued at approximately $11.9 million. The maturity date for the second lien loan was extended to September 30, 2017. The 1,115 shares of common stock were fair valued at $62.5 million and had a cost basis of $16.0 million. The increase in cost and fair value of the loan is due to the amortization of loan origination fees and the capitalization of “payment in kind” interest. These increases were approved by the Company’s Valuation Committee.
 
U.S. Gas & Electric, Inc.
 
U.S. Gas, North Miami Beach, Florida, is a licensed Energy Service Company (“ESCO”) that markets and distributes natural gas to small commercial and residential retail customers in the state of New York.
 
At October 31, 2011, the Company’s investment in U.S. Gas consisted of a second lien loan with an outstanding balance, cost and fair value of $9.1 million. The second lien loan bears annual interest at 14% and was to mature on July 26, 2012. The 32,200 shares of convertible Series I preferred stock had a fair value of $78.5 million and a cost of $500,000, and the convertible Series J preferred stock had a fair value of $2.6 million and a cost of $0.
 
 
86

 
 
On October 12, 2012, the Company received a dividend from U.S. Gas of approximately $2.4 million. U.S. Gas’ board approved an initial dividend to its shareholders, with future distributions projected to be paid quarterly. The Company anticipates receiving dividends from U.S. Gas for as long as it maintains its equity investment in U.S. Gas, and its cash flows can support the dividend. Each quarterly dividend must be approved by U.S. Gas’s board of directors and be permissible under its gas and electric supply credit agreement.
 
At October 31, 2012, the second lien loan had an outstanding balance, cost basis and a fair value of approximately $9.6 million. The increases in the outstanding balance, cost and fair value of the loan are due to the amortization of loan origination fees and the capitalization of “payment in kind” interest. These increases were approved by the Company’s Valuation Committee. The maturity date for the second lien loan was extended to July 25, 2015. The convertible Series I preferred stock had a fair value of $81.1 million and a cost of $500,000 and the convertible Series J preferred stock had a cost and fair value of $0. The value of the Series J preferred shares was allocated to the Series I preferred shares as a result of share buybacks, cancellations of certain other shareholders shares and U.S. Gas exceeding performance targets.

DETERMINATION OF COMPANY'S NET ASSET VALUE
 
Pursuant to the requirements of the 1940 Act, the Company values its portfolio securities at their current market values or, if market quotations are not readily available, at their estimates of fair value. Because the Company's portfolio company investments generally do not have readily ascertainable market values, the Company records these investments at fair value in accordance with our Valuation Procedures adopted by our Board.  As permitted by the SEC, the Board has delegated the responsibility of making fair value determinations to the Valuation Committee, subject to the Board's supervision and pursuant to the Valuation Procedures.  The Company's Board may also elect in the future to hire independent consultants to review the Valuation Procedures or to conduct an independent valuation of one or more of its portfolio investments.
 
Pursuant to our Valuation Procedures, the Valuation Committee determines fair valuations of portfolio company investments on a quarterly basis (or more frequently, if deemed appropriate under the circumstances). Any changes in valuation are recorded in the consolidated statements of operations as "Net change in unrealized appreciation (depreciation) on investments." Currently, the Company's net asset value per share is calculated and published on a monthly basis. The fair values determined as of the most recent quarter end are reflected in that quarter's net asset value per share and in the next two month's calculation of net asset value per share. (If the Valuation Committee determines to fair value an investment more frequently than quarterly, the most recently determined fair value would be reflected in the published net asset value per share.) In addition, in connection with each offering of shares of our common stock, the Board or a committee thereof is required to make the determination that we are not selling shares of our common stock at a price below our then current net asset value at the time at which the sale is made.  Importantly, this determination does not require that we calculate net asset value in connection with each offering of shares of our common stock, but instead it involves the determination by the Board or a committee thereof that we are not selling shares of our common stock at a price below the then current net asset value at the time at which the sale is made.
 
The Company calculates its net asset value per share by subtracting all liabilities from the total value of its portfolio securities and other assets and dividing the result by the total number of outstanding shares of its common stock on the date of valuation.
 
At October 31, 2012, approximately 88.77% of the Company's total assets represented portfolio investments and escrow receivables recorded at fair value ("Fair Value Investments").
 
Under most circumstances, at the time of acquisition, Fair Value Investments are carried at cost (absent the existence of conditions warranting, in management's and the Valuation Committee's view, a different initial value). During the period that an investment is held by the Company, its original cost may cease to approximate fair value as the result of market and investment specific factors. No pre-determined formula can be applied to determine fair values. Rather, the Valuation Committee analyzes fair value measurements based on the estimated value at which the securities of the portfolio company could be sold in an orderly disposition over a reasonable period of time between willing parties (other than in a forced or liquidation sale). The liquidity event whereby the Company ultimately exits an investment is generally the sale, the merger, the recapitalization or, in some cases, the initial public offering of the portfolio company.
 
 
87

 
 
Valuation Methodology
 
Pursuant to the requirements of the 1940 Act and in accordance with ASC 820, we value our portfolio securities at their current market values or, if market quotations are not readily available, at their estimates of fair values.
 
Pursuant to our Valuation Procedures, the Valuation Committee (which is comprised of three Independent Directors) determines fair values of portfolio company investments on a quarterly basis (or more frequently, if deemed appropriate under the circumstances). Any changes in valuation are recorded in the consolidated statements of operations as “Net change in unrealized appreciation (depreciation) on investments.” Currently, our NAV per share is calculated and published on a quarterly basis. The Company calculates our NAV per share by subtracting all liabilities from the total value of our portfolio securities and other assets and dividing the result by the total number of outstanding shares of our common stock on the date of valuation. Fair values of foreign investments determined as of quarter end reflect exchange rates, as applicable, in effect on the last business day of the quarter. Exchange rates fluctuate on a daily basis, sometimes significantly. Exchange rate fluctuations following the most recent quarter end are not reflected in the valuations reported in the Company's quarterly reports.
 
Under most circumstances, at the time of acquisition, Fair Value Investments are carried at cost (absent the existence of conditions warranting, in management’s and the Valuation Committee’s view, a different initial value). During the period that an investment is held by the Company, its original cost may cease to approximate fair value as the result of market and investment specific factors. No pre-determined formula can be applied to determine fair value. Rather, the Valuation Committee analyzes fair value measurements based on the value at which the securities of the portfolio company could be sold in an orderly disposition over a reasonable period of time between willing parties, other than in a forced or liquidation sale. The liquidity event whereby the Company ultimately exits an investment is generally the sale, the merger, the recapitalization or, in some cases, the initial public offering of the portfolio company.
 
There is no one methodology to determine fair value and, in fact, for any portfolio security, fair value may be expressed as a range of values, from which the Company derives a single estimate of fair value. To determine the fair value of a portfolio security, the Valuation Committee analyzes the portfolio company’s financial results and projections, publicly traded comparable companies when available, comparable private transactions when available, precedent transactions in the market when available, third-party real estate and asset appraisals if appropriate and available, discounted cash flow analysis, if appropriate, as well as other factors. The Company generally requires, where practicable, portfolio companies to provide annual audited and more regular unaudited financial statements, and/or annual projections for the upcoming fiscal year.
 
The fair value of our portfolio securities is inherently subjective. Because of the inherent uncertainty of fair valuation of portfolio securities and escrow receivables that do not have readily ascertainable market values, our estimate of fair value may significantly differ from the fair value that would have been used had a ready market existed for the securities. Such values also do not reflect brokers’ fees or other selling costs, which might become payable on disposition of such investments.
 
If a security is publicly traded, the fair value is generally equal to market value based on the closing price on the principal exchange on which the security is primarily traded unless restricted and a restricted discount is applied.
 
For equity securities of portfolio companies, the Valuation Committee estimates the fair value based on market and/or income approach with value then attributed to equity or equity like securities using the enterprise value waterfall (“Enterprise Value Waterfall”) valuation methodology. Under the Enterprise Value Waterfall valuation methodology, the Valuation Committee estimates the enterprise fair value of the portfolio company and then waterfalls the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To assess the enterprise value of the portfolio company, the Valuation Committee weighs some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing assets may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company, and third-party asset and real estate appraisals. For non-performing assets, the Valuation Committee may estimate the liquidation or collateral value of the portfolio company’s assets. The Valuation Committee also takes into account historical and anticipated financial results.
 
 
88

 
 
In assessing enterprise value, the Valuation Committee considers the mergers and acquisitions (“M&A”) market as the principal market in which the Company would sell its investments in portfolio companies under circumstances where the Company has the ability to control or gain control of the board of directors of the portfolio company (“Control Companies”). This approach is consistent with the principal market that the Company would use for its portfolio companies if the Company has the ability to initiate a sale of the portfolio company as of the measurement date, i.e., if it has the ability to control or gain control of the board of directors of the portfolio company as of the measurement date. In evaluating if the Company can control or gain control of a portfolio company as of the measurement date, the Company takes into account its equity securities on a fully diluted basis, as well as other factors.
 
For non-Control Companies, consistent with ASC 820, the Valuation Committee considers a hypothetical secondary market as the principal market in which it would sell investments in those companies.
 
For loans and debt securities of non-Control Companies (for which the Valuation Committee has identified the hypothetical secondary market as the principal market), the Valuation Committee determines fair value based on the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield (“Market Yield”) valuation methodology. In applying the Market Yield valuation methodology, the Valuation Committee determines the fair value based on such factors as third party broker quotes and market participant assumptions, including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date.
 
Estimates of average life are generally based on market data of the average life of similar debt securities. However, if the Valuation Committee has information available to it that the debt security is expected to be repaid in the near term, the Valuation Committee would use an estimated life based on the expected repayment date.
 
The Valuation Committee determines fair value of loan and debt securities of Control Companies based on the estimate of the enterprise value of the portfolio company. To the extent the enterprise value exceeds the remaining principal amount of the loan and all other debt securities of the company, the fair value of such securities is generally estimated to be their cost. However, where the enterprise value is less than the remaining principal amount of the loan and all other debt securities, the Valuation Committee may discount the value of such securities to reflect an impairment.
 
For the Company’s subsidiary’s investment in the PE Fund, for which an indirect wholly-owned subsidiary of the Company serves as the general partner (the “GP”) of the PE Fund, the Valuation Committee relies on the GP’s determination of the Fair Value of the PE Fund which will be generally valued, as a practical expedient, utilizing the net asset valuations provided by the GP (who will in turn rely on the recommendation of TTG Advisers), which will be made: (i) no less frequently than quarterly as of the Company’s fiscal quarter end and (ii) with respect to the valuation of PE Fund investments in portfolio companies, will be based on methodologies consistent with those set forth in the valuation procedures. The determination of the net asset value of the Company’s subsidiary’s investment in the PE Fund will follow the methodologies described for valuing interests in private investment funds (“Investment Vehicles”) described below. Additionally, when both the Company and the PE Fund hold investments in the same portfolio company, the GP’s Fair Value determination shall be based on the Valuation Committee’s determination of the Fair Value of the Company’s portfolio security in that portfolio company.
 
As permitted under GAAP, the Company’s interests in private investment funds are generally valued, as a practical expedient, utilizing the net asset valuations provided by management of the underlying Investment Vehicles, without adjustment, unless The Tokarz Group Advisers LLC (“TTG Advisers”) is aware of information indicating that a value reported does not accurately reflect the value of the Investment Vehicle, including any information showing that the valuation has not been calculated in a manner consistent with GAAP. Net unrealized appreciation (depreciation) of such investments is recorded based on the Company’s proportionate share of the aggregate amount of appreciation (depreciation) recorded by each underlying Investment Vehicle. The Company’s proportionate investment interest includes its share of interest and dividend income and expense, and realized and unrealized gains and losses on securities held by the underlying Investment Vehicles, net of operating expenses and fees. Realized gains and losses on distributions from Investment Vehicles are generally recognized on a first in, first out basis.
 
 
89

 
 
The Company applies the practical expedient to interests in Investment Vehicles on an investment by investment basis, and consistently with respect to the Company’s entire interest in an investment. The Company may adjust the valuation obtained from an Investment Vehicle with a premium, discount or reserve if it determines that the net asset value is not representative of fair value.
 
If the Company intends to sell all or a portion of its interest in an Investment Vehicle to a third-party in a privately negotiated transaction near the valuation date, the Company will consider offers from third parties to buy the interest in an Investment Vehicle in valuations which may be discounted for both probability of close and time.
 
When the Company receives nominal cost warrants or free equity securities (“nominal cost equity”) with a debt security, the Company typically allocates its cost basis in the investment between debt securities and nominal cost equity at the time of origination.
 
Interest income, adjusted for amortization of premium and accretion of discount on a yield to maturity methodology, is recorded on an accrual basis to the extent that such amounts are expected to be collected. Origination and/or closing fees associated with investments in portfolio companies are accreted into income over the respective terms of the applicable loans. Upon the prepayment of a loan or debt security, any prepayment penalties and unamortized loan origination, closing and commitment fees are recorded as income. Prepayment premiums are recorded on loans when received. Dividend income, if any, is recognized on an accrual basis on the ex-dividend date to the extent that the Company expects to collect such amounts.
 
For loans, debt securities, and preferred securities with contractual payment-in-kind interest or dividends, which represent contractual interest/dividends accrued and added to the loan balance or liquidation preference that generally becomes due at maturity, the Company will not ascribe value to payment-in-kind interest/dividends, if the portfolio company valuation indicates that the payment-in-kind interest is not collectible. However, the Company may ascribe value to payment-in-kind interest if the health of the portfolio company and the underlying securities are not in question. All payment-in-kind interest that has been added to the principal balance or capitalized is subject to ratification by the Valuation Committee.
 
Escrows from the sale of a portfolio company are generally valued at an amount which may be expected to be received from the buyer under the escrow’s various conditions discounted for both risk and time.
 
ASC 460, Guarantees, requires the Company to estimate the fair value of the guarantee obligation at its inception and requires the Company to assess whether a probable loss contingency exists in accordance with the requirements of ASC 450, Contingencies. The Valuation Committee typically will look at the pricing of the security in which the guarantee provided support for the security and compare it to the price of a similar or hypothetical security without guarantee support. The difference in pricing will be discounted for time and risk over the period in which the guarantee is expected to remain outstanding.
 
MANAGEMENT
 
The overall responsibility for oversight of the Company rests with the Company's Board. The day-to-day operations of the Company are delegated to TTG Advisers, subject to the supervision of our Board.
 
The Board currently has seven members. The Board maintains an Audit Committee, a Valuation Committee, a Compensation Committee, and a Nominating/Corporate Governance/Strategy Committee, and may establish additional committees in the future.
 
 
90

 
 
The Company is externally managed by TTG Advisers pursuant to the Advisory Agreement. The investment professionals of TTG Advisers collectively have extensive experience in managing investments in private businesses in a variety of industries, and are familiar with the Company's approach of lending and investing. Because the Company is externally managed, it pays a base management fee and an incentive fee. The Advisory Agreement and fees paid by the Company to TTG Advisers pursuant to the Advisory Agreement are described under "Advisory Agreement" below.
 
Information regarding the directors and the executive officers of the Company, including brief biographical information, is set forth below:
 
(1)
Name, Address 
and Age
(2)
Position(s)
Held with
the Company
(3)
Term of Office/
Length of Time
Served
(4)
Principal
Occupation(s)
During Past 5 Years
(5)
Number of
Portfolios in
Fund Complex
Overseen by
Director
(6)
Other
Directorships
Held by Director
During
Past 5 Years
Independent Directors
       
Emilio Dominianni
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 81
Director
 
 
1 year/9 years,
10 months
Mr. Dominianni is a retired Partner of, and was Special Counsel to, Coudert Brothers LLP, a law firm. He is currently a director of Stamm International Corporation, Powrmatic Inc., and Powrmatic of Canada Ltd., manufacturers and distributors of heating, ventilating, and air conditioning equipment.
None(1)
See column 4
Phillip F. Goldstein
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 67
Director
1 year/3 months
Mr. Goldstein is a portfolio manager of Bulldog Investors. Through Brooklyn Capital Management LLC, he serves as the investment advisor to the Special Opportunities Fund, Inc. (NYSE: SPE), a registered closed-end fund.  Mr. Goldstein is currently a director of the Mexico Equity & Income Fund, Inc. (NYSE: MXE), ASA Ltd. (NYSE: ASA), Special Opportunities Fund, Inc. (NYSE: SPE), Brantley Capital Corporation and Imperial Holdings, Inc. (NYSE: IFT). Mr. Goldstein was previously a director of Korea Equity Fund, Inc.
None(1)
See column 4
Gerald Hellerman
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 75
Director
1 year/9 years,
10 months
Mr. Hellerman owns and has served as Managing Director of Hellerman Associates, a financial and corporate consulting firm, since the firm’s inception in 1993. Mr. Hellerman currently serves as a director, chief financial officer and chief compliance officer for The Mexico Equity and Income Fund, Inc., as director, chief financial officer and chief compliance officer for Special Opportunities Fund, Inc., and as a director of Brantley Capital Corporation and Imperial Holdings, Inc. Mr. Hellerman was previously a director of AirNet Systems, Inc., a director of the Old Mutual registered hedge fund complex and a director of TM Entertainment and Media, Inc.
None(1)
See column 4
Robert Knapp
Ironsides Partners LLC
100 Summer Street
27th Floor
Boston, MA 02108
Age: 46
Director
1 year/9 years,
10 months
Mr. Knapp is the Founder and Managing Director of Ironsides Partners, LLC and Ironsides Partners Opportunity Fund (fund complex) and specializes in closed end funds, emerging markets, distressed debt, and corporate restructurings. He is also a director of the Africa Opportunity Fund (fund complex), Africa Opportunity Cayman Limited, Africa Opportunity Partners, Pacific Alliance Asia Opportunity Fund (fund complex) and Veracity Worldwide LLC. Mr. Knapp serves as an independent, non-executive director of Pacific Alliance Group Asset Management Ltd. and is a member of the Board of Managers of Waterloo Oil & Gas LLC. In addition to his directorships named above, Mr. Knapp is a Trustee of Princeton-in-Asia Sea Education Association. Mr. Knapp was previously a director of Pacific Alliance Investment Management Ltd. and the Vietnam Opportunity Fund. Mr. Knapp was previously a managing director with Millennium Partners.
None(1)
See column 4
William Taylor
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 70
Director
1 year/6 years,
10 months
Mr. Taylor is a Certified Public Accountant and is currently a director of Northern Illinois University Foundation and President and a director of The William & Dian Taylor Foundation. Mr. Taylor was previously a trustee of Writers Theatre. From 1976 through May 2005, Mr. Taylor was a Partner at Deloitte & Touche. From 1997 to 2001, Mr. Taylor was a director of Deloitte & Touche USA and from 1999 to 2003 Mr. Taylor was a director of Deloitte Touche Tohmatsu.
None(1)
See column 4
 
 
91

 
 
(1)
Name, Address 
and Age
(2)
Position(s)
Held with
the Company
(3)
Term of Office/
Length of Time
Served
(4)
Principal
Occupation(s)
During Past 5 Years
(5)
Number of
Portfolios in
Fund Complex
Overseen by
Director
(6)
Other
Directorships
Held by Director
During
Past 5 Years
Officer and Interested Directors
     
Warren Holtsberg(2)
287 Bowman Avenue
2nd Floor Purchase,
NY 10577
Age: 62
Director
1 year/5 years,
9 months
Mr. Holtsberg currently serves as Co-Head of Portfolio Management of The Tokarz Group Advisers LLC (the “Adviser”), the investment adviser to the Fund. Mr. Holtsberg founded Motorola Ventures, the venture capital and equity investment arm for Motorola, Inc. where he led the worldwide fund for eight years. He was also Corporate Vice President and Director of Equity Investments at Motorola. Mr. Holtsberg currently serves as a member of the Board of Directors of the Illinois Venture Capital Association, Sportvision, the Big Shoulders Fund and the Chicagoland Entrepreneurship Center and Illinois Ventures, the venture investment arm for the University of Illinois. Mr. Holtsberg serves on the advisory board of the Arcapita Fund. Mr. Holtsberg serves as a director for U.S. Gas & Electric, Inc. and MVC Partners LLC, portfolio companies of the Fund.
None(1)
See column 4
Michael Tokarz(3)
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 63
Director
1 year/9 years,
2 months
Mr. Tokarz currently serves as Chairman and Portfolio Manager of the Fund and as Manager of the Adviser. Mr. Tokarz also is Managing Member of The Tokarz Group, a private merchant bank, since 2002. Prior to this, Mr. Tokarz was a senior General Partner and Administrative Partner at Kohlberg Kravis Roberts & Co., a private equity firm specializing in management buyouts. He also currently serves on the corporate boards of CNO Financial Group, Inc., Walter Energy, Inc. (Chairman of the board), Walter Investment Management Corp., Mueller Water Products, Inc., and IDEX Corporation. He is Chairman Emeritus and is a member of the Board of the University of Illinois Foundation, and serves on its executive committee, investment policy committee and finance committee. He is also a member of the Board of Managers for Illinois Ventures, LLC, and its related, Illinois Emerging Technology Fund LLC. Mr. Tokarz serves as a director for the following portfolio companies of the Fund: Custom Alloy Corporation, Harmony Health and Beauty, Inc., MVC Automotive Group B.V., MVC Partners LLC, Ohio Medical Corporation, Summit Research Labs, Inc. and Turf Products, LLC.  He was previously on the board of Lomonosov, Althleta, Inc. and Apertio Ltd. In addition, he was on the boards of Timberland Machines & Irrigation, Inc., Dakota Growers Pasta Company, Harmony Pharmacy & Health Centers, Inc., and Huamei Capital Company, formerly portfolio companies of the Fund.
None(1)
See column 4
 
 
92

 
 
(1)
Name, Address 
and Age
(2)
Position(s)
Held with
the Company
(3)
Term of Office/
Length of Time
Served
(4)
Principal
Occupation(s)
During Past 5 Years
(5)
Number of
Portfolios in
Fund Complex
Overseen by
Director
(6)
Other
Directorships
Held by Director
During
Past 5 Years
Executive Officers
         
Bruce Shewmaker
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 66
Managing Director
Indefinite
term/8 years,
3 months
Mr. Shewmaker currently serves as Managing Director of the Adviser and the Fund. Mr. Shewmaker worked directly for the Fund from November 2003 through October 2006. Previously, Mr. Shewmaker served as an Independent Director of the Fund in 2003. From 2001 to 2007, Mr. Shewmaker was a director of Infrared Imaging Systems, Inc., a medical devices company. Mr. Shewmaker currently serves on the board of Harris & Harris Group, Inc. and as an independent director of Garrison Capital Inc. Mr. Shewmaker served as a director for the following portfolio companies of the Fund: Baltic Motors Corporation, Phoenix Coal Corporation and Vendio Services, Inc. He currently serves on the Boards of Foliofn, Inc., MVC Partners LLC, Velocitius B.V. and Vestal Manufacturing Enterprises, Inc.
N/A
N/A
Peter Seidenberg
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 43
Chief Financial Officer
Indefinite
term/6 years,
4 months
Mr. Seidenberg currently serves as Chief Financial Officer of the Adviser, in addition to his service as Chief Financial Officer of the Fund. Mr. Seidenberg joined the Fund in April 2005 after having previously served as a principal of Nebraska Heavy Industries, where he worked on engagements, including serving as the chief financial officer of Commerce One, Inc. Mr. Seidenberg, on behalf of the Fund, sits on the board of Biovation Holdings, Inc., Ohio Medical Corp and serves as its corporate secretary. Mr. Seidenberg also serves on the Board of MVC Partners LLC. He was formerly a director of Vitality Foodservice, Inc. and a director of LHD Europe Holdings, Inc. (the European holdings of Vitality Foodservice, Inc.), both formerly portfolio companies of the Fund. Mr. Seidenberg also serves on the Advisory Counsel of Entrepreneurship@Cornell.
N/A
N/A
Scott Schuenke
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 33
Chief Compliance Officer
Indefinite
term/7 years,
4 months
Mr. Schuenke currently serves as the Controller and Chief Compliance Officer of the Adviser, in addition to his service as Chief Compliance Officer of the Fund. Prior to joining the Fund in June 2004, Mr. Schuenke served as a compliance officer with U.S. Bancorp Fund Services, LLC, from 2002 until he joined the Fund in 2004. Mr. Schuenke also served as the secretary of The Mexico Equity & Income Fund, Inc. and assistant secretary of Tortoise Energy Infrastructure Corporation during his tenure at U.S. Bancorp Fund Services, LLC. He serves on the Board of Vestal Manufacturing Enterprises, Inc. and NPWT Corporation, portfolio companies of the Fund. Mr. Schuenke is a Certified Public Accountant.
N/A
N/A
Jaclyn Rothchild
287 Bowman Avenue
2nd Floor
Purchase, NY 10577
Age: 34
Vice President/
Secretary
Indefinite
term/7 years,
2 months;
Indefinite
term/8 years
Ms. Rothchild currently serves as Vice President and Secretary of the Adviser, in addition to her service as Vice President and Secretary of the Fund. Prior to joining the Fund in June 2002, she was an Associate and Business Manager with Draper Fisher Jurvetson meVC Management Co. LLC, the former investment sub-adviser to the Fund, and an Associate at The Bank Companies (acquired by Newmark & Co. Real Estate), a commercial real estate company. Ms. Rothchild serves as Chief Operating Officer of Eleventh Street Partners, Inc. and is a member of the Advisory Board of Forward Health. Ms. Shapiro-Rothchild serves on the Board of MVC Partners LLC, a portfolio company of the Fund.
N/A
N/A
____________
(1)
Other than the Fund.
(2)
Mr. Holtsberg is an “interested person,” as defined in the 1940 Act, of the Fund (an “Interested Director”) because of his employment with the Adviser.
(3)
Mr. Tokarz is an Interested Director because he serves as an officer of the Fund.
 
 
93

 
 
Board Meetings and Committees
 
The Board currently has an Audit Committee, a Valuation Committee, a Nominating/Corporate Governance/Strategy Committee and a Compensation Committee.
 
The current members of the Audit Committee are Messrs. Dominianni, Hellerman and Taylor, each of whom is an independent audit committee member, as defined in Sections 303.01(B)(2)(a) and (3) of the NYSE's listing standards, and an Independent Director. Mr. Hellerman is the Chairman of the Audit Committee. The Audit Committee's primary purposes are:
 
 
·
oversight responsibility with respect to: (a) the adequacy of the Company's accounting and financial reporting processes, policies and practices; (b) the integrity of the Company's financial statements and the independent audit thereof; (c) the adequacy of the Company's overall system of internal controls and risk management processes (to the extent not separately evaluated and monitored by the full Board), as appropriate, the internal controls of certain service providers; (d) the Company's compliance with certain legal and regulatory requirements; (e) determining the qualification and independence of the Company's independent auditors; and (f) the Company's internal audit function, if any; and
 
 
·
oversight of the preparation of any report required to be prepared by the Audit Committee pursuant to the rules of the SEC for inclusion in the Company's annual proxy statement with respect to the election of directors.
 
The most recent fiscal year of the Company ended on October 31, 2012. During that fiscal year, the Audit Committee held five (5) meetings. The Board has adopted a written charter for the Audit Committee, a copy of which is currently available on the Company's website at http://www.mvccapital.com.
 
During the fiscal year ended October 31, 2012, the Board held twelve (12) meetings. During the last fiscal year, each of the Directors then serving attended 100% of the aggregate number of meetings of the Board. Each of the Directors then serving attended 100% of the aggregate number of meetings of any committee of the Board on which such Director served. Currently, a majority of the Directors are not “interested persons”, as defined in the Investment Company Act of 1940 (the “1940 Act”), of the Fund (the “Independent Directors”). Mr. Knapp has been appointed by the Independent Directors to serve as the “Lead” Independent Director and, in that role, serves as the Presiding Director over executive sessions of non-management directors. Mr. Tokarz, the Portfolio Manager and principal executive officer of the Fund and the Adviser, serves as Chairman of the Board. Although he is an Interested Director ( i.e. , not independent), the Board believes that by having the principal executive serve as Chairman, it can more effectively conduct the regular business of the Fund and that through its regularly-scheduled executive sessions, the Independent Directors have adequate opportunity to serve as an independent, effective check on management and protect stockholders’ interests. Furthermore, as described below, the Board has three committees performing critical functions for the Fund’s governance and operations: the Audit, Valuation and Nominating/Corporate Governance/Strategy Committees and all three are comprised exclusively of Independent Directors.
 
The Valuation Committee, the principal purpose of which is to determine the fair values of securities in the Company's portfolio for which market quotations are not readily available, is currently comprised of Messrs. Dominianni, Hellerman and Knapp. Mr. Knapp is the Chairman of the Valuation Committee. The Valuation Committee held four (4) meetings during the fiscal year ended October 31, 2012.
 
The Nominating/Corporate Governance/Strategy Committee (the "Nominating Committee"), the principal purposes of which are to consider and nominate persons to serve as Independent Directors and oversee the composition and governance of the Board and its committees and to provide strategic direction with respect to the Company, is currently comprised of Messrs. Dominianni, Goldstein, Hellerman, Knapp and Taylor, each of whom is an Independent Director.  Mr. Dominianni is the Chairman of the Nominating Committee.  The Nominating Committee was established in January 2004.  The Board has adopted a written charter for the Nominating Committee, a copy of which is available on the Company's website at http://www.mvccapital.com. The Nominating Committee held two (2) meetings during the fiscal year ended October 31, 2012.  Mr. Goldstein joined the Nominating Committee in October of 2012.
 
 
94

 
 
The Nominating Committee considers director candidates nominated by shareholders in accordance with procedures set forth in the Company's By-Laws. The Company's By-Laws provide that nominations may be made by any shareholder of record of the Company entitled to vote for the election of directors at a meeting, provided that such nominations are made pursuant to timely notice in writing to the Secretary. The Nominating Committee then determines the eligibility of any nominated candidate based on criteria described below. To be timely, a shareholder's notice must be received at the principal executive offices of the Company not less than 60 days nor more than 90 days prior to the scheduled date of a meeting. A shareholder's notice to the Secretary shall set forth: (a) as to each shareholder-proposed nominee, (i) the name, age, business address and residence address of the nominee, (ii) the principal occupation or employment of the nominee, (iii) the class, series and number of shares of capital stock of the Company that are owned beneficially by the nominee, (iv) a statement as to the nominee's citizenship, and (v) any other information relating to the person that is required to be disclosed in solicitations for proxies for election of directors pursuant to Section 14 of the Securities Exchange Act of 1934, as amended (the "1934 Act"), and the rules and regulations promulgated thereunder; and (b) as to the shareholder giving the notice, (i) the name and record address of the shareholder and (ii) the class, series and number of shares of capital stock of the corporation that are owned beneficially by the shareholder. The Company or the Nominating Committee may require a shareholder who proposes a nominee to furnish any such other information as may reasonably be required by the Company to determine the eligibility of the proposed nominee to serve as director of the Company. In addition, the Nominating Committee considers potential director candidates with input from various sources, which may include:  current Directors, members of the management team, or an outside search firm.  The Nominating Committee seeks to identify candidates that possess, in its view, strong character, judgment, business experience and acumen.  As a minimum requirement, any eligible candidate who is not proposed to serve as an Interested Director (i.e., a candidate who is not employed or proposed to be employed by the Company or TTG Advisers) must not be an "interested person" (as defined by the 1940 Act) of the Company.  The Nominating Committee also considers, among other factors, certain other relationships (beyond those delineated in the 1940 Act) that might impair the independence of a proposed Director.   Although the Board does not have a formal diversity policy, it endeavors to comprise itself of members with a variety of professional backgrounds.
 
In determining to select each of the Directors, the Nominating Committee and the Board considered a variety of factors, including each of the Directors' performance as current Directors and their professional background and experience.  In particular, the Nominating Committee and the Board noted that during the tenures of Messrs. Dominianni, Hellerman, Knapp and Tokarz, which began in 2003, the Company has witnessed a significant turnaround in performance.  In considering Mr. Goldstein's recent appointment, the Nominating Committee took into account, among other things, Mr. Goldstein's unique career professional focus on creating shareholder value from closed-end funds and BDCs.  The Board also noted the Directors' collective knowledge and experience in financial services, legal and financial analysis, corporate finance, portfolio management and accounting, all of which strengthen the Board's collective qualifications.  The Nominating Committee members considered that Messrs. Tokarz and Holtsberg are not Independent Directors but recognized that they represent TTG Advisers, and, as such, help foster the Board's direct access to information regarding TTG Advisers, which is the Company's most significant service provider.
 
The Compensation Committee, the principal purpose of which is to oversee the compensation of the Independent Directors, is currently comprised of Messrs. Hellerman and Knapp. Mr. Hellerman is the Chairman of the Compensation Committee.  The Compensation Committee was established in March 2003. The Compensation Committee held one (1) meeting during the fiscal year ended October 31, 2012.  The Board has adopted a written charter for the Compensation Committee, a copy of which is available on the Company's website at http://www.mvccapital.com.
 
COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS
 
Director and Executive Officer Compensation
 
The Company's officers do not receive any direct compensation from the Company.  The Company does not currently have any employees and does not expect to have any employees.  Services necessary for its business are provided by individuals who are employees of TTG Advisers, and the Company's administrator, U.S. Bancorp Fund Services, LLC (the "Administrator"), pursuant to the terms of the Company's Advisory Agreement and administration agreement. Each of the Company's executive officers is an employee of TTG Advisers. The Company's day-to-day investment operations are managed by TTG Advisers.
 
 
95

 
 
The following table sets forth compensation paid by the Company in all capacities during the fiscal year ended October 31, 2012 to all of our Directors. Our Directors have been divided into two groups — Interested Directors and Independent Directors. The Interested Directors are "interested persons," as defined in the 1940 Act, of the Company.  No compensation is paid to the Interested Directors.  (The Company is not part of any Fund Complex.)   No information has been provided with respect to executive officers of the Company because the Company's executive officers do not receive any direct compensation from the Company.
 
Name of Person, Position
Fees Earned or
Paid in Cash
Stock Awards
All Other
Compensation (1)
Total
Interested Directors
       
Warren Holtsberg, Director
None
None
None
None
Michael Tokarz, Chairman and Portfolio Manager
None
None
None
None
         
Independent Directors
       
Emilio Dominianni, Director
$70,000
None
None
$70,000
Phillip Goldstein, Director(2)
$17,500
None
None
$17,500
Gerald Hellerman, Director
$80,000
None
None
$80,000
Robert Knapp, Director
$80,000
None
None
$80,000
William Taylor, Director
$70,000
None
None
$70,000
____________
(1) Directors do not receive any pension or retirement benefits from the Company.
 
(2) Mr. Goldstein was appointed to the Board in September 2012.

The fees payable to Independent Directors and the fees payable to the Chairman of the Audit Committee, Valuation Committee, and Nominating Committee are as follows:  Each Independent Director is paid an annual retainer of $70,000 ($80,000 for each of the Chairman of the Audit Committee and the Chairman of the Valuation Committee) for up to five in-person Board meetings and committee meetings per year. In the event that more than five in-person Board meetings and committee meetings occur, each Director will be paid an additional $1,000 for an in-person meeting. Each Independent Director is also reimbursed by the Company for reasonable out-of-pocket expenses. The Directors do not receive any pension or retirement benefits from the Company.
 
Director Equity Ownership
 
The following table sets forth, as of the date of this prospectus, with respect to each Director, certain information regarding the dollar range of equity securities beneficially owned in the Company. The Company does not belong to a family of investment companies.
 
(1)
Name of Director
(2)
Dollar Range of
Equity Securities
in the Company
(3)
Aggregate Dollar Range of Equity Securities of All Funds Overseen or to be Overseen by Director in Family of Investment Companies
Independent Directors
   
Emilio Dominianni
Over $100,000
Over $100,000
Phillip Goldstein
Over $100,000
Over $100,000
Gerald Hellerman
Over $100,000
Over $100,000
Robert Knapp
Over $100,000
Over $100,000
William Taylor
Over $100,000
Over $100,000
Interested Directors
   
 
 
96

 
 
Warren Holtsberg (1)
$50,000-$100,000
$50,000-$100,000
Michael Tokarz (2)
Over $100,000
Over $100,000
____________
(1)
Mr. Holtsberg is an Interested Director of the Company because of his employment with TTG Advisers.
(2)
Mr. Tokarz is an Interested Director of the Company because he serves as an officer of the Company and controls TTG Advisers.
 
ADVISORY AGREEMENT
 
Under the terms of the Advisory Agreement, TTG Advisers determines the composition of our portfolio, the nature and timing of the changes to our portfolio and the manner of implementing such changes, identifies, evaluates and negotiates the structure of the investments we make (including performing due diligence on our prospective portfolio companies), closes and monitors the investments we make, determines the securities and other assets that we purchase, retain or sell and oversees the administration, recordkeeping and compliance functions of the Company and/or third parties performing such functions for the Company. TTG Advisers' services under the Advisory Agreement are not exclusive, and it may furnish similar services to other entities.
 
Pursuant to the Advisory Agreement, the Company pays TTG Advisers a fee for investment advisory and management services consisting of two components—a base management fee and an incentive fee.
 
The base management fee is calculated at an annual rate of 2% of our total assets (excluding: (i) cash, (ii) the value of any investment in a third-party vehicle covered by a separate agreement, and (iii) the value of any investment by the Company not made in a portfolio company ("Non-Eligible Assets"); but including assets purchased with borrowed funds that are not Non-Eligible Assets) (the "Base Management Fee"). The Base Management Fee is payable quarterly in arrears. The Base Management Fee is calculated based on the value of our total assets (excluding Non-Eligible Assets, but including assets purchased with borrowed funds that are not Non-Eligible Assets) at the end of the most recently completed fiscal quarter. Base Management Fees for any partial month or quarter will be appropriately prorated.  Because the Base Management Fee payable is based on total assets, TTG Advisers may have an incentive to increase portfolio leverage in order to earn higher Base Management Fees.
 
The incentive fee is comprised of the following two parts:
 
The income portion of the incentive fee is calculated and payable quarterly in arrears based on our pre-incentive fee net operating income. Pre-incentive fee net operating income means interest income, dividend income and any other income (including any other fees paid to the Company and MVCFS, such as directors', commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the fiscal quarter, minus the Company's and MVCFS' operating expenses for the quarter (including the Base Management Fee and any interest expense and dividends paid on any outstanding preferred stock, but excluding the incentive fee (whether paid or accrued)). Pre-incentive fee net operating income includes, in the case of investments with a deferred interest feature (such as market discount, debt instruments with payment-in-kind interest, preferred stock with payment-in-kind dividends and zero coupon securities), accrued income that we have not yet received in cash. TTG Advisers is not under any obligation to reimburse us for any part of the incentive fee it received that was based on accrued income that we never receive as a result of a default by an entity on the obligation that resulted in the accrual of such income.
 
Pre-incentive fee net operating income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Because of the structure of the incentive fee, it is possible that we may pay an incentive fee in a quarter where we incur a loss. For example, if we receive pre-incentive fee net operating income in excess of the hurdle amounts (explained below) for a quarter, we will pay the applicable incentive fee even if we have incurred a loss in that quarter due to realized and unrealized capital losses.
 
In calculating the income portion of the incentive fee (the "Income Incentive Fee") pre-incentive fee net operating income, at the end of the immediately preceding fiscal quarter, will be compared to two "hurdle amounts": 1.75% of the Company's net assets (defined as total assets less total liabilities) ("Lower Hurdle Amount") and 2.1875% of the Company's net assets ("Higher Hurdle Amount").  The Company would pay the TTG Advisers the Income Incentive Fee with respect to the Company's pre-incentive fee net operating income in each fiscal quarter as follows:
 
 
97

 
 
 
·
no Income Incentive Fee in any fiscal quarter in which our pre-incentive fee net operating income does not exceed the Lower Hurdle Amount;
 
 
·
100% of our pre-incentive fee net operating income with respect to that portion of such pre-incentive fee net operating income, if any, that exceeds the Lower Hurdle Amount but is less than the Higher Hurdle Amount in any fiscal quarter; and
 
 
·
20% of the amount of our pre-incentive fee net operating income, if any, that exceeds the Higher Hurdle Amount in any fiscal quarter.
 
The second part of the incentive fee (the "Capital Gains Fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Advisory Agreement, as of the termination date), commencing with the fiscal year ended on October 31, 2009, and equals 20% of: (i) the Company's cumulative aggregate net realized capital gains, during such fiscal year, on the Company's investments made after November 1, 2003 (the "Company's New Portfolio") (exclusive of any realized gains on an investment in a third-party vehicle covered by a separate agreement or that are subject to an SPV Incentive Allocation, as defined below); minus (ii) the cumulative aggregate unrealized capital depreciation of the Company's New Portfolio calculated from November 1, 2003.  If the Capital Gains Fee is positive at the end of such year, then the aggregate amount of Capital Gains Fees paid in all prior years shall be subtracted from the Capital Gains Fee for such year.  For purposes of this calculation, neither the Company's contribution of an investment to a wholly-owned subsidiary nor the Company's distribution of an investment to the Company's stockholders shall be deemed to be a realization event.
 
In addition, the Company has authorized TTG Advisers to create or arrange for the creation of one or more special purpose vehicles for which it may serve as the general partner or managing member for purposes of making investments on behalf of the Company (each, an "SPV"). It is proposed that TTG Advisers, in its role as the general partner or managing member of an SPV, receive an incentive allocation equal to 20% of the net profits of the SPV (the "SPV Incentive Allocation"). In no event would any SPV Incentive Allocation received by TTG Advisers cause the total compensation received by TTG Advisers under the Advisory Agreement to exceed the limits imposed by the Investment Advisers Act of 1940, as amended.
 
Notwithstanding the foregoing, in no event shall the sum of the Capital Gains Fee and the SPV Incentive Allocation, if any, for any fiscal year exceed:  (i)20% of (a) the Company's cumulative aggregate realized capital gains on the Company's investments (the "Company's Total Portfolio") (including any realized gains attributable to an SPV Incentive Allocation), minus (b) the sum of the Company's cumulative aggregate realized capital losses on, and aggregate unrealized capital depreciation of, the Company's Total Portfolio; minus (ii) the aggregate amount of Capital Gains Fees paid and the value of SPV Incentive Allocations made in all prior years (the "Cap"). For purposes of calculating the Cap: (i) the initial value of any investment held by the Company on November 1, 2003 shall equal the fair value of such investment on November 1, 2003; and (ii) the initial value of any investment made by the Company after November 1, 2003 shall equal the accreted or amortized cost basis of such investment. Furthermore, in the event that the Capital Gains Fee for any fiscal year exceeds the Cap ("Uncollected Capital Gains Fees"), all or a portion of such amount shall be accrued and payable to TTG Advisers following any subsequent fiscal year in which the Advisory Agreement is in effect, but only to the extent the Capital Gains Fee, plus the amount of Uncollected Capital Gains Fees, each calculated as of the end of such subsequent fiscal year, do not exceed the Cap. Any remaining Uncollected Capital Gains Fees shall be paid following subsequent fiscal years in accordance with the same process, provided the Advisory Agreement is in effect during such fiscal year.
 
In addition, for the 2012 fiscal year, the Adviser voluntarily agreed to waive $150,000 of expenses that the Company is obligated to reimburse the Adviser under the Advisory Agreement (the “Voluntary Waiver”). For the fiscal year through October 31, 2012, the Adviser waived $150,000 in expenses under the Voluntary Waiver.  In addition, the Adviser waived $2.3 million in income incentive fees primarily associated with the $12 million dividend received from Summit Research Labs, Inc. in March 2012.  The Adviser also voluntarily waived a portion of the management fee associated with assets of the Company invested in the Octagon High Income Fund in the amount of approximately $59,000 for the fiscal year ended October 31, 2012.
 
 
98

 
 
Examples of Incentive Fee Calculations
 
Example 1: Income Related Portion of Incentive Fee(1):
 
Assumptions
 
 
·
Hurdle rate(2) = 1.75%
 
 
·
Management fee(3) = 2.00%
 
 
·
Other expenses (legal, accounting, custodian, transfer agent, etc.)(4) = maximum value of 3.5% of the Company's average net asset value including management fee
 
Alternative 1
 
Additional Assumptions
 
 
·
Operating income (including interest, dividends, fees, etc.) = 4.00%
 
 
·
Pre-incentive fee net operating income
 
(operating income - (management fee + other expenses)) = .075%
 
Pre-incentive fee net operating income does not exceed hurdle rate, therefore there is no incentive fee.
 
Alternative 2
 
Additional Assumptions
 
 
·
Operating income (including interest, dividends, fees, etc.) = 5.25%
 
 
·
Pre-incentive fee net operating income
 
(operating income - (management fee + other expenses)) = 2.00%
 
Pre-incentive fee net operating income exceeds hurdle rate, therefore there is an incentive fee.
 
Incentive Fee
 
=      100% × "Catch-Up" + the greater of 0% AND (20% × (pre-incentive fee net operating income - 2.1875%)
 
=      (100% × (2.00% - 1.75%)) + 0%
 
=      0.25%
 
Alternative 3
 
Additional Assumptions
 
 
·
Operating income (including interest, dividends, fees, etc.) = 6.00%
 
 
·
Pre-incentive fee net operating income
 
(operating income - (management fee + other expenses)) = 2.75%
 
Pre-incentive fee net operating income exceeds hurdle rate, therefore there is an incentive fee.
 
 
99

 

Incentive Fee
   
     
 
=
100% × "Catch-Up" + the greater of 0% AND (20% × (pre-incentive fee net operating income -2.1875%)
     
 
=
(100% × (2.1875% - 1.75%)) + (20% × (2.75% - 2.1875%))
     
 
=
0.4375% + (20% × 0.5625%)
     
 
=
0.4375% + 0.1125%
     
 
=
0.55%
____________
(1)
The hypothetical amount of pre-incentive fee net operating income shown is based on a percentage of total net assets.
 
(2)
Represents 1.75% annualized hurdle rate.
 
(3)
Represents 2.00% annualized management fee.
 
(4)
Excludes offering expenses.
 
Example 2: Capital Gains Portion of Incentive Fee
 
Assumptions
 
Year 1:
 
$20 million investment made in Company A ("Investment A"), $30 million investment made in Company B ("Investment B") and $10 million investment in Company C ("Investment C").
 
Year 2:
 
Investment A is sold for $50 million, fair market value ("FMV") of Investment B is $32 million and FMV of Investment C is $5 million.
 
Year 3:
 
FMV of Investment B is $32 million and FMV of Investment C is $0.
 
Year 4:
 
Investment B is sold for $50 million and FMV of Investment C is $0.
 
 
Calculation of Capital Gains Fee (20% of: cumulative aggregate net realized capital gains on the Fund's investments made after November 1, 2003 (the "Fund's New Portfolio") minus the cumulative aggregate unrealized capital depreciation on the Fund's New Portfolio calculated from November 1, 2003)  If the Capital Gains Fee is positive at the end of a year, then the aggregate amount of the Capital Gains Fee paid in all prior years shall be subtracted from the Capital Gains Fee.
Year 1
20% of: ($0 cumulative aggregate realized capital gains on the Fund's New Portfolio minus $0 cumulative aggregate realized losses on the Fund's New Portfolio) minus ($0 cumulative aggregate unrealized capital depreciation on the Fund's New Portfolio) = $0
Year 2
20% of: ($30 million cumulative aggregate realized capital gains on the Fund's New Portfolio minus $0 cumulative aggregate realized losses on the Fund's New Portfolio) minus ($5 million cumulative aggregate unrealized capital depreciation on the Fund's New Portfolio) = $5 million
 
 
100

 
 
Year 3
(i) 20% of: ($30 million cumulative aggregate realized capital gains on the Fund's New Portfolio minus $0 cumulative aggregate realized losses on the Fund's New Portfolio) minus ($10 million cumulative aggregate unrealized capital depreciation on the Fund's New Portfolio) less (ii) $5 million capital gains fee received in Year 2 = $0
Year 4
(i) 20% of: ($50 million cumulative aggregate realized capital gains on the Fund's New Portfolio minus $0 cumulative aggregate realized losses on the Fund's New Portfolio) minus ($10 million cumulative aggregate unrealized capital depreciation on the Fund's New Portfolio) less (ii) $5 million capital gains fee received in Year 2 = $3 million
 
Payment of our expenses
 
Pursuant to the Advisory Agreement, all investment professionals of TTG Advisers and its staff, when and to the extent engaged in providing services required to be provided by TTG Advisers under the Advisory Agreement, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by TTG Advisers and not by the Company, except that costs or expenses relating to the following items are borne by the Company: (i) the cost and expenses of any independent valuation firm; (ii) expenses incurred by TTG Advisers payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs for the Company and in monitoring the Company's investments and performing due diligence on its prospective portfolio companies, provided, however, the retention by TTG Advisers of any third party to perform such services shall require the advance approval of the Board (which approval shall not be unreasonably withheld) if the fees for such services are expected to exceed $30,000; once the third party is approved, any expenditure to such third party will not require additional approval from the Board; (iii) interest payable on debt and other direct borrowing costs, if any, incurred to finance the Company's investments or to maintain its tax status; (iv) offerings of the Company's common stock and other securities; (v) investment advisory and management fees; (vi) fees and payments due under any administration agreement between the Company and its administrator; (vii) transfer agent and custodial fees; (viii) federal and state registration fees; (ix) all costs of registration and listing the Company's shares on any securities exchange; (x) federal, state and local taxes; (xi) Independent Directors' fees and expenses; (xii) costs of preparing and filing reports or other documents required by governmental bodies (including the SEC); (xiii) costs of any reports, proxy statements or other notices to stockholders, including printing and mailing costs; (xiv) the cost of the Company's fidelity bond, directors and officers/errors and omissions liability insurance, and any other insurance premiums; (xv) direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, independent auditors and outside legal costs; (xvi) the costs and expenses associated with the establishment of an SPV; (xvii) the allocable portion of the cost (excluding office space) of the Company's Chief Financial Officer, Chief Compliance Officer and Secretary in an amount not to exceed $200,000, per year, in the aggregate; (xviii) subject to a cap of $150,000 in any fiscal year of the Company, fifty percent of the unreimbursed travel and other related (e.g., meals) out-of-pocket expenses (subject to item (ii) above) incurred by TTG Advisers in sourcing investments for the Company; provided that, if the investment is sourced for multiple clients of TTG Advisers, then the Company shall only reimburse fifty percent of its allocable pro rata portion of such expenses; and (xix) all other expenses incurred by the Company in connection with administering the Company's business (including travel and other out-of-pocket expenses (subject to item (ii) above) incurred in providing significant managerial assistance to a portfolio company). Notwithstanding the foregoing, absent the consent of the Board, any fees or income earned, on the Company's behalf, by any officer, director, employee or agent of TTG Advisers in connection with the monitoring or closing of an investment or disposition by the Company or for providing managerial assistance to a portfolio company (which includes, for example, service on the board of directors of a portfolio company but does not include TTG Advisers' furnishing of portfolio management or other management services to a third-party vehicle) shall inure to the Company.
 
The Expense Cap
 
In addition, for fiscal year 2013, TTG Advisers has voluntarily agreed to extend the expense cap (which was in effect during the 2009 through 2012 fiscal years) to absorb or reimburse operating expenses of the Company (promptly following the completion of such year), to the extent necessary to limit the Company's Expense Ratio for such year to 3.5% (the "Expense Cap.  For purposes of this paragraph, the Company's "Expense Ratio" is calculated as of October 31 of any such year in which an expense cap applies and mean: (i) the consolidated expenses of the Company (which expenses include any amounts payable to TTG Advisers under the Base Management Fee, but exclude the amount of any interest, taxes, incentive compensation, amount of any payments made by the general partner ("GP") of the PE Fund to TTG Advisers pursuant to the Portfolio Management Agreement between the GP and TTG Advisers, and extraordinary expenses (including, but not limited to, any legal claims and liabilities and litigation costs and any indemnification related thereto, and the costs of any spin-off or other similar type transaction contemplated by the Advisory Agreement)), as a percentage of (ii) the average net assets of the Company (i.e., average consolidated assets less average consolidated liabilities) during such fiscal year as set forth in the Company's financial statements contained in the Company's annual report on Form 10-K.
 
 
101

 
 
In addition, for the 2010 through 2013 fiscal years, TTG Advisers voluntarily agreed to waive $150,000 of expenses that the Company is obligated to reimburse to TTG Advisers under the Advisory Agreement.  TTG Advisers has also voluntarily agreed that any assets of the Company that were invested in exchange-traded funds and the Octagon High Income Fund would not be taken into account in the calculation of the base management fee due to TTG Advisers under the Advisory Agreement.
 
Indemnification
 
The Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of its duties or by reason of the reckless disregard of its duties and obligations, TTG Advisers, its members and their respective officers, managers, partners, agents, employees, controlling persons, members and any other person or entity affiliated with it (collectively, the "Indemnified Parties") are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of TTG Advisers' services under the Advisory Agreement or otherwise as an investment adviser of the Company. In addition, TTG Advisers has agreed to indemnify the Company for losses or damages arising out of the willful misfeasance, bad faith or gross negligence in the performance of an Indemnified Party's duties or by reason of the reckless disregard of its duties and obligations under the Advisory Agreement.
 
The Opportunities to Manage Other Entities
 
We may also seek to achieve our investment objective by establishing a subsidiary or subsidiaries that would serve as general partner to a private equity or other investment fund(s). In fact, during fiscal year 2006, we established MVC Partners for this purpose. Furthermore, the Board of Directors authorized the establishment of a private equity fund (the “PE Fund”), for which an indirect wholly-owned subsidiary of the Company serves as the general partner (the “GP”). On October 29, 2010, through MVC Partners and MVCFS, the Company committed to invest approximately $20.1 million in the PE Fund. The PE Fund closed on approximately $104 million of capital commitments. The Company’s Board of Directors authorized the establishment of, and investment in, the PE Fund for a variety of reasons, including the Company’s ability to make Non-Diversified Investments through the PE Fund. As previously disclosed, the Company is currently restricted from making Non-Diversified Investments. For services provided to the PE Fund, the GP and MVC Partners are together entitled to receive 25% of all management fees paid by the PE Fund and up to 30% of the carried interest generated by the PE Fund. Further, at the direction of the Board of Directors, the GP retained TTG Advisers to serve as the portfolio manager of the PE Fund. In exchange for providing those services, and pursuant to the Board of Directors’ authorization and direction, TTG Advisers is entitled to receive the balance of the fees and any carried interest generated by the PE Fund. Given this separate arrangement with the GP and the PE Fund, under the terms of the Company’s Advisory Agreement with TTG Advisers, TTG Advisers is not entitled to receive from the Company a management fee or an incentive fee on assets of the Company that are invested in the PE Fund.
 
As a result of the closings of the PE Fund, consistent with the Board-approved policy concerning the allocation of investment opportunities, the PE Fund will receive a priority allocation of all private equity investments that would otherwise be Non-Diversified Investments for the Company during the PE Fund’s investment period. In allocating investment opportunities, TTG Advisers adheres to the following policy, which was approved by the Board of Directors: TTG Advisers will give the Company priority with respect to all investment opportunities in (i) mezzanine and debt securities and (ii) equity or other “non-debt” investments that are (a) expected to be equal to or less than the lesser of 10% of the Company’s net assets or $25.0 million, and (b) issued by U.S. companies with less than $150.0 million in revenues during the prior twelve months. However, as a result of the PE Fund’s close, the PE Fund will now receive a priority allocation of all equity investments that would otherwise be Non-Diversified Investments for the Company, which will terminate on the later of: (i) the deployment of 80% of the committed capital of the PE Fund or (ii) two years from the first closing date of the PE Fund.
 
 
102

 
 
Additionally, in pursuit of our objective we may acquire a portfolio of existing private equity or debt investments held by financial institutions or other investment funds should such opportunities arise.
 
Principal Executive Officers
 
The following individuals are the principal executive officers of TTG Advisers. The principal business address of each such person is c/o The Tokarz Group Advisers LLC, at 287 Bowman Avenue, 2nd Floor, Purchase, NY 10577. The principal occupations of the following individuals are set forth under "Management" above.
 
Name
Position
Michael Tokarz
Manager
Warren Holtsberg
Co-Head of Portfolio Management
Bruce Shewmaker
Managing Director
Peter Seidenberg
Chief Financial Officer
Scott Schuenke
Controller and Chief Compliance Officer
Jaclyn Shapiro-Rothchild
Vice President and Secretary

Duration and Termination of Agreement
 
The Advisory Agreement was last renewed by the Independent Directors on October 23, 2012. The continuance  of the Advisory Agreement must be specifically approved at least annually by: (i) the vote of the Board, or by the vote of stockholders holding a majority of the outstanding voting securities of the Company; and (ii) the vote of a majority of the Company's directors who are not parties to the Advisory Agreement and are not "interested persons" (as such term is defined in Section 2(a)(19) of the 1940 Act) of either the Company or TTG Advisers, in accordance with the requirements of the 1940 Act.  The Advisory Agreement may be terminated at any time, without the payment of any penalty, upon 60 days' written notice, by: (i) TTG Advisers in the event (a) a majority of the current Independent Directors cease to serve as Directors of the Company or (b) the Company undergoes a change in "control" (as such term is defined by Section 2(a)(9) of the 1940 Act) not caused by TTG Advisers; (ii) TTG Advisers, following the initial two year term of the Advisory Agreement; (iii) by the vote of the stockholders holding a "majority of the outstanding voting securities" of the Company (as such term is defined by Section 2(a)(42) of the 1940 Act); or (iv) by the action of the Company's Directors. Furthermore, the Advisory Agreement shall automatically terminate in the event of its "assignment" (as such term is defined for purposes of Section 15(a)(4) of the 1940 Act).
 
Mr. Tokarz's Commitment to the Company
 
TTG Advisers has entered into an agreement with Mr. Tokarz pursuant to which Mr. Tokarz agreed to serve as the portfolio manager primarily responsible for the day-to-day management of the Company's portfolio. In addition, the Company and TTG Advisers have acknowledged that Mr. Tokarz is the current Portfolio Manager of the Company and TTG Advisers has covenanted that throughout the term of the Advisory Agreement it will not undertake any action that would cause Mr. Tokarz to cease to serve as the Company's primary Portfolio Manager, including, without limitation, transferring any controlling interest in TTG Advisers to another entity or person.
 
CONTROL PERSONS AND PRINCIPAL HOLDERS OF SECURITIES
 
As of January 15, 2013, there were no persons that owned 25% or more of our outstanding voting securities, and no person would be deemed to control us, as such term is defined in the 1940 Act.
 
The following table sets forth, as of January 15, 2013, information with respect to the beneficial ownership of our common stock by the shareholders who own more than 5% of our outstanding shares of common stock and our current Directors and executive officers. Unless otherwise indicated, we believe that each beneficial owner set forth in the table has sole voting and investment power. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Ownership information for those persons who beneficially own 5% or more of our shares of common stock is based upon publicly available filings with the SEC.
 
 
103

 
 
 
Shareholder Name and Address
 
Amount of
Shares Owned
 
Percentage of
Company Held
Western Investment, LLC
7050 S. Union Park Center
Suite 590
Midvale, UT 84047
 
1,580,367(1)
 
6.61%
Wynnefield Capital Management, L.L.C.
450 Seventh Avenue
Suite 509
New York, NY 10123
 
1,625,258(2)
 
6.80%
C.S. McKee L.P.
One Gateway Ctr
Pittsburgh, PA 15222
 
1,206,137(3)
 
5.04%

(1)
Based on information contained in Form 13F filed with the SEC on November 14, 2012.

(2)
Based on information contained in Form 13F filed with the SEC on November 14, 2012.

(3)
Based on information contained in Form 13F filed with the SEC on November 15, 2012.
 
FEDERAL INCOME TAX MATTERS
 
This summary of certain aspects of the federal income tax treatment of the Company and its shareholders is based upon the Code, judicial decisions, Treasury Regulations and rulings in existence on the date hereof, all of which are subject to change. This summary does not discuss the impact of various proposals to amend the Code which could change certain of the tax consequences of an investment in shares of our common stock.
 
You should consult your own tax adviser with respect to the tax considerations applicable to the holding of shares of our common stock. This discussion does not address all aspects of federal income taxation relevant to holders of our common stock in light of their personal circumstances, or to certain types of holders subject to special treatment under federal income tax laws, including foreign taxpayers. This discussion does not address any aspects of foreign, state or local tax laws. The Company is actively managed and its investment strategies may be employed without regard to the tax consequences of the Company's transactions on the Company's shareholders.
 
We have elected to be treated, and intend to qualify annually, for treatment as a RIC under Subchapter M of the Code and for the favorable tax treatment accorded RICs.  In order to permit us to deduct from our taxable income dividends we distribute to our shareholders, in addition to meeting other requirements, we must distribute for each taxable year at least 90% of (i) our investment company taxable income (consisting generally of net investment income from interest and dividends and net realized short term capital gains) and (ii) our net tax-exempt interest, if any. We must also meet several additional requirements, including:
 
 
·
At least 90% of our gross income for each taxable year must be from dividends, interest, payments with respect to securities loans, gains from sales or other dispositions of stock, securities or foreign currencies, other income derived with respect to our business of investing in such stock, securities or currencies, or net income derived from an interest in a "qualified publicly traded partnership" (generally, a publicly traded partnership other than one where at least 90% of its gross income is gross income that would otherwise be qualifying gross income for a RIC),
 
 
·
As diversification requirements, as of the close of each quarter of our taxable year:
 
 
·
at least 50% of the value of our assets must consist of cash, cash items, U.S. government securities, the securities of other RICs and other securities to the extent that (1) we do not hold more than 10% of the outstanding voting securities of an issuer of such other securities and (2) such other securities of any one issuer do not represent more than 5% of our total assets, and
 
 
104

 
 
 
·
no more than 25% of the value of our total assets may be invested in the securities of one issuer (other than U.S. government securities or the securities of other RICs), of two or more issuers that are controlled by us and are engaged in the same or similar or related trades or businesses, or of one or more qualified publicly traded partnerships.
 
If we were unable to qualify for treatment as a RIC, we would be subject to tax on our ordinary income and realized capital gains (including gains realized on the distribution of appreciated property) at regular corporate rates. We would not be able to deduct distributions to shareholders, nor would they be required to be made. Distributions would be taxable to our shareholders as ordinary dividend income to the extent of our current and accumulated earnings and profits. Subject to certain limitations under the Code, corporate distributees would be eligible for the dividends received deduction and individual distributees would qualify for the reduced tax rates applicable to "qualified dividends" under the Code. Distributions in excess of current and accumulated earnings and profits would be treated first as a return of capital to the extent of the shareholder's tax basis, and any remaining distributions would be treated as a gain realized from the sale or exchange of property. If the Company fails to meet the requirements of Subchapter M for more than two consecutive taxable years and then seeks to requalify under Subchapter M, it may be required to recognize gain to the extent of any unrealized appreciation on its assets. In that case, any gain recognized by the Company likely would be distributed to shareholders as a taxable distribution.
 
Based on the Regulated Investment Company Modernization Act of 2010 (the "Modernization Act"), there is a remedy for a failure of the Subchapter M asset diversification test, if the failure was due to reasonable cause and not willful neglect, subject to certain divestiture and procedural requirements and the payment of a tax.  The Modernization Act also sets forth a de minimis exception to a potential failure of the Subchapter M asset diversification test that would require corrective action but no tax.  In addition, the Modernization Act allows for the remedy of a failure of the source-of-income requirement, if the failure was due to reasonable cause and not willful neglect, subject to certain procedural requirements and the payment of a tax.
 
Certain portfolio companies have appreciated to levels where the Company appears to exceed the thresholds in Section 851(b)(3) of the Code.  However, in accordance with Section 851, because the thresholds were exceeded due to market appreciation of the assets, and not due either wholly or in part to an acquisition, the Company relies on the market value exception described in Section 851(d)(1) of the Code to maintain its Subchapter M status.  As disclosed in the "Risk Factors" section of the prospectus, the Company is restricted from making any additional non-diversified investments until it is under the thresholds set forth in Section 851(b)(3).  
 
If we qualify as a RIC and distribute to shareholders each year in a timely manner the sum of (i) at least 90% of our "investment company taxable income" as defined in the Code and (ii) at least 90% of our net tax-exempt interest, if any, we will not be subject to federal income tax on the portion of our taxable income and gains we distribute to shareholders. In addition, if we distribute in a timely manner the sum of (i) 98% of our ordinary income for each calendar year, (ii) 98.2% of our capital gain net income for the one-year period ending October 31 in that calendar year and (iii) any untaxed income or gains not distributed in prior years, we will not be subject to the 4% nondeductible federal excise tax on certain undistributed income of RICs. We will be subject to regular corporate income tax (currently at rates up to 35%) on any undistributed net investment income and any undistributed net capital gain. We will also be subject to alternative minimum tax, but any tax preference items would be apportioned between us and our shareholders in the same proportion that dividends (other than capital gain dividends) paid to each shareholder bear to our taxable income determined without regard to the dividends paid deduction.
 
The Company's net realized capital gains from securities transactions will be distributed only after reducing such gains by the amount of any available capital loss carry forwards. On October 31, 2012, the Company had a net capital loss carry forward of $45,108,864 of which $26,318,783 will expire in the year 2019 and $18,790,081 has no expiration. To the extent future capital gains are offset by capital loss carry forwards, such gains need not be distributed.
 
If we acquire debt obligations that were originally issued at a discount, or that bear interest at rates that are not fixed (or are not certain "qualified variable rates") or that is not payable, or payable at regular intervals over the life of the obligation, we will be required to include in taxable income each year a portion of the "original issue discount" that accrues over the life of the obligation, regardless of whether the income is received by us, and may be required to make distributions in order to continue to qualify for favorable RIC tax treatment or to avoid the 4% federal excise tax on certain undistributed income. In this event, we may be required to sell temporary investments or other assets to meet the distribution requirements.
 
 
105

 
 
The Company may invest a portion of its assets in a wholly-owned subsidiary (the "Subsidiary"), which may be classified as a corporation for U.S. federal tax purposes.  Foreign corporations will generally not be subject to U.S. federal income tax unless it is deemed to be engaged in a United States trade or business.  Even if not engaged in a United States trade or business, foreign corporations will generally be subject to a withholding tax at a rate of 30% on United States source income that is not effectively connected with a United States trade or business.
 
If the Subsidiary is treated as a controlled foreign corporation, and the Company is treated as a "U.S. Shareholder" of the Subsidiary, the Company will be required to include in its gross income all of the Subsidiary's "subpart F income."  "Subpart F income" is generally treated as ordinary income.  If a net loss is realized by such Subsidiary, such loss generally is not available to offset the income of the Company.  The recognition by the Company of the Subsidiary's "subpart F income" will increase the Company's tax basis in the Subsidiary.  Distributions by such Subsidiary to the Company will not be taxable to the extent of its previously undistributed "subpart F income," and will reduce the Company's tax basis in the Subsidiary.
 
As a regulated investment company, the Company must derive at least 90% of its gross income for each taxable year from sources treated as “qualifying income” under Subchapter M of the Code. Commodity-linked investments generate income that is not “qualifying income” for purposes of meeting this 90% test. Although the Internal Revenue Service (the “IRS”) previously has issued a number of private letter rulings (“PLRs”) that indicate that certain income from a fund’s investment in a controlled foreign corporation will constitute “qualifying income” for purposes of Subchapter M of the Code, the IRS has suspended issuance of further PLRs pending a review of its position on the matter.  If the IRS were to change its position with respect to the conclusions reached in the PLRs (which change in position may be applied retroactively to the Company), the income from the Company’s investment in the Subsidiary might not be “qualifying income” and the Company might not qualify as a regulated investment company for one or more years, which would adversely affect the value of the Company and the favorable tax treatment of the Company.
 
For any period during which we qualify for treatment as a RIC for federal income tax purposes, distributions to shareholders attributable to our ordinary income (including dividends, interest and original issue discount) and net realized short term capital gains generally will be taxable as ordinary income to shareholders to the extent of our current or accumulated earnings and profits, except to the extent the we receive "qualified dividends" and designate such amounts for individual shareholders as "qualified dividends".  The lower tax rate for "qualified dividends" will apply only if the individual shareholder holds shares in the Company, and the Company holds shares in the dividend-paying corporation, at least 61 days during a prescribed period. The prescribed period is the 121-day period beginning 60 days before the date on which the shareholder or the Company, as the case may be, becomes entitled to receive the dividend. In determining the holding period for this purpose, any period during which the recipient's risk of loss is offset by means of options, short sales or similar transactions is not counted. Additionally, an individual shareholder would not benefit to the extent it is obligated (e.g., pursuant to a short sale) to make related payments with respect to positions in substantially similar or related property.
 
Corporate shareholders are generally eligible for the 70% dividends-received deduction with respect to ordinary income (but not capital gain) dividends to the extent such amount designated by us does not exceed the dividends received by us from domestic corporations. A corporate shareholder's dividends-received deduction will be disallowed unless it holds shares in the Company, and the Company holds shares in the dividend-paying corporation, at least 46 days during the 91-day period beginning 45 days before the date on which the shareholder or the Company, as the case may be, becomes entitled to receive the dividend. In determining the holding period for this purpose, any period during which the recipient's risk of loss is offset by means of options, short sales or similar transactions is not counted. Additionally, a corporate shareholder would not benefit to the extent it is obligated (e.g., pursuant to a short sale) to make related payments with respect to positions in substantially similar or related property. Furthermore, the dividends-received deduction will be disallowed to the extent a corporate shareholder's investment in shares of the Company, or the Company's investment in the shares of the dividend-paying corporation, is financed with indebtedness.
 
 
106

 
 
Distributions in excess of our earnings and profits will first be treated as a return of capital which reduces the shareholder's adjusted basis in his or her shares of common stock and then as gain from the sale of shares of our common stock. Distributions of our net realized long-term capital gains (designated by us as capital gain dividends) will be taxable to shareholders as long-term capital gains regardless of the shareholder's holding period in his or her common stock.
 
Any dividend declared by us in October, November or December of any calendar year, payable to shareholders of record on a specified date in such a month and actually paid during January of the following year, will be treated as if it were paid by us and received by the shareholders on December 31 of the year in which it was declared. In addition, we may elect to relate a dividend back to the prior taxable year if we (i) declare such dividend prior to the due date (including extensions) for filing our return for that taxable year, (ii) make the election in that return, and (iii) distribute the amount in the 12-month period following the close of the taxable year but not later than the first regular dividend payment following the declaration. Any such election will not alter the general rule that a shareholder will be treated as receiving a dividend in the taxable year in which the distribution is made (subject to the October, November, December rule described above).
 
To the extent that we retain any capital gains, we may designate them as "deemed distributions" and pay a tax thereon for the benefit of our shareholders. In that event, the shareholders must report their share of retained realized long-term capital gains on their individual tax returns as if the share had been received, and may report a credit on such returns for the tax paid thereon by us. The amount of the deemed distribution net of such tax is then added to the shareholder's cost basis for his or her common stock. Since we expect to pay tax on capital gains at regular corporate tax rates and the maximum rate payable by individuals on such gains is currently 20% (plus the 3.8% Medicare tax discussed below), the amount of credit that individual shareholders may report is expected to exceed the amount of tax that they would be required to pay on the deemed distributions. Shareholders who are not subject to federal income tax or are unable to utilize fully the tax credit attributable to the deemed distribution should be able to file a return on the appropriate form and claim a refund for the excess credit.
 
For taxable years beginning on or after January 1, 2013, individuals, estates and trusts will be subject to a Medicare tax of 3.8% on "net investment income" (or undistributed "net investment income", in the case of estates and trusts) for each such taxable year, with such tax applying to the lesser of such income or the excess of such person's adjusted gross income (with certain adjustments) over a specified amount ($250,000 for married individuals filing jointly $125,000 for married individuals filing separately, $200,000 for other individuals and the dollar amount at which the highest income tax bracket for estates and trusts begins.)  Net investment income includes net income from interest, dividends, annuities, royalties and rents and net gain attributable to the disposition of investment property.  It is anticipated that net income and gain attributable to an investment in the Company will be included in an Investor's "net investment income" subject to this Medicare tax.
 
Section 1202 of the Code permits the exclusion, for federal income tax purposes, of 50% of any gain (subject to certain limitations) realized by noncorporate taxpayers upon the sale or exchange of "qualified small business stock" held for more than five years. A greater exclusion is permitted for gain realized on the sale or exchange of “qualified small business stock” acquired after February 17, 2009, and before January 1, 2014, that otherwise qualifies for the exclusion.  Generally, qualified small business stock is stock of a small business corporation acquired directly from the issuing corporation, which must (i) at the time of issuance and immediately thereafter have assets of not more than $50 million and (ii) throughout substantially all of the holder's holding period for the stock be actively engaged in the conduct of a trade or business not excluded by law. If we acquire qualified small business stock, hold such stock for more than five years and dispose of such stock at a profit, a noncorporate shareholder who held shares of our common stock at the time we purchased the qualified small business stock and at all times thereafter until we disposed of the stock would be entitled to exclude from such shareholder's taxable income 50% of such shareholder's share of such gain (or such greater percentage as applies to qualified small business stock acquired during the period described above). The amount that may be excluded cannot exceed the amount that would have been excluded if determined by reference to such shareholder’s interest on the date we acquired the qualified small business stock. Seven percent (7%) of any amount so excluded would currently be treated as a preference item for alternative minimum tax purposes. Comparable rules apply under the qualified small business stock "rollover" provisions of section 1045 of the Code, under which gain otherwise reportable by individuals with respect to sales by us of qualified small business stock held for more than six months can be deferred if we reinvest the sales proceeds within 60 days in other qualified small business stock.
 
 
107

 
 
A shareholder may recognize taxable gain or loss if the shareholder sells or exchanges such shareholder's shares of common stock. Any gain arising from the sale or exchange of common stock generally will be treated as capital gain or loss if the common stock is held as a capital asset, and will be treated as long-term capital gain or loss if the shareholder has held his or her shares of common stock for more than one year. However, any capital loss arising from a sale or exchange of shares of common stock held for six months or less will be treated as a long-term capital loss to the extent of the amount of long-term capital gain distributions received (or deemed to be received) with respect to such shares of common stock.
 
Pursuant to Treasury Regulations directed at tax shelter activity, taxpayers are required to disclose to the Internal Revenue Service (the "IRS") certain information on Form 8886 if they participate in a "reportable transaction". A transaction may be a "reportable transaction" based upon any of several indicia with respect to a shareholder, including the existence of significant book-tax differences or the recognition of a loss in excess of certain thresholds.  A significant penalty is imposed on taxpayers who participate in a "reportable transaction" and fail to make the required disclosure. Investors should consult their own tax advisors concerning any possible federal, state or local disclosure obligations with respect to their investment in shares of the Company.
 
We may be required to withhold U.S. federal income tax at the rate of 28% on all taxable distributions payable to non-corporate shareholders who fail to provide us with their correct taxpayer identification number or a certificate that the shareholder is exempt from backup withholding, or if the IRS notifies us that the shareholder is subject to backup withholding. Any amounts withheld may be credited against a shareholder's U.S. federal income tax liability.
 
There is generally no withholding tax to a shareholder who is not a U.S. person within the meaning of the Code ("Non-U.S. Person") (i) on the portion of the Company's distributions that consist of long-term capital gains realized by the Company, and (ii) the remaining distributions to Non-U.S. Persons are generally subject to a 30% withholding tax, unless reduced or eliminated by treaty. This 30% withholding would not apply to amounts properly designated by us as an “interest-related dividend” or a “short-term capital gain dividend” paid with respect to taxable years beginning before 2014.  The aggregate amount treated as an interest-related dividend for a year is limited to our qualified net interest income for the year, which is the excess of our qualified interest income (generally, our U.S.-source interest income) over the deductions properly allocable to such income.  The aggregate amount treated as a “short-term capital gain dividend” is generally limited to the excess of our net short-term capital gain over our net long-term capital loss. Other rules may apply to Non-U.S. Persons whose income from the Company is effectively connected with the conduct of a U.S. trade or business by such Non-U.S. Person.  If the income from the Company is "effectively connected" with a U.S. trade or business carried on by a Non-U.S. Shareholder, then distributions of investment company taxable income, any capital gains distributions, any amounts retained by the Company that are designated as undistributed capital gains and any gains realized upon the sale or exchange of shares will generally be subject to U.S. federal income tax at the graduated rates applicable to U.S. citizens, residents or domestic corporations.  A corporate Non-U.S. Shareholder may also be subject to the branch profits tax imposed by the Code.
 
If we distribute our net capital gains in the form of deemed rather than actual distributions, a Non-U.S. Person will be entitled to a U.S. federal income tax credit or tax refund equal to the shareholder's allocable share of the corporate-level tax we pay on the capital gains deemed to have been distributed; however, in order to obtain the refund, the Non-U.S. Person must obtain a U.S. taxpayer identification number and file a U.S. federal income tax return even if the Non-U.S. Person would not otherwise be required to obtain a U.S. taxpayer identification number or file a U.S. federal income tax return.
 
In the case of a Non-U.S. Shareholder, the Company may be required to withhold U.S. federal income tax from distributions that are otherwise exempt from withholding tax (or taxable at a reduced treaty rate) unless the Non-U.S. Shareholder certifies his foreign status under penalties of perjury or otherwise establishes an exemption.
 
Recent legislation generally imposes withholding at a rate of 30% on payments to certain foreign entities (including financial intermediaries) of dividends on and the gross proceeds of dispositions of U.S. common stock, unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied. Shareholders should consult their tax advisors regarding the possible implications of these rules on their investment in the Company.
 
A tax-exempt U.S. person investing in the Company will not realize unrelated business taxable income with respect to an unleveraged investment in shares. Tax-exempt U.S. persons are urged to consult their own tax advisors concerning the U.S. tax consequences of an investment in the Company.
 
 
108

 
 
From time to time, the Company may be considered under the Code to be a nonpublicly offered regulated investment company. Under Temporary Regulations, certain expenses of nonpublicly offered regulated investment companies, including advisory fees, may not be deductible by certain shareholders, generally including individuals and entities that compute their taxable income in the same manner as an individual (thus, for example, a qualified pension plan is not subject to this rule). Such a shareholder's pro rata portion of the affected expenses, including the management fee and incentive fee payable to the manager, will be treated as an additional dividend to the shareholder and will be deductible by such shareholder, subject to the 2% "floor" on miscellaneous itemized deductions and other limitations on itemized deductions set forth in the Code. A "nonpublicly offered regulated investment company" is a RIC whose shares are neither (i) continuously offered pursuant to a public offering, (ii) regularly traded on an established securities market nor (iii) held by at least 500 persons at all times during the taxable year.
 
Unless an exception applies, we will mail to each shareholder, as promptly as possible after the end of each fiscal year, a notice detailing, on a per distribution basis, the amounts includible in such shareholder's taxable income for such year as net investment income, as net realized capital gains (if applicable) and as "deemed" distributions of capital gains, including taxes paid by us with respect thereto. In addition, absent an exemption, the federal tax status of each year's distributions will be reported to the IRS. Distributions may also be subject to additional state, local and foreign taxes depending on each shareholder's particular situation. Shareholders should consult their own tax advisers with respect to the particular tax consequences to them of an investment in us.
 
Under our Plan, all cash distributions to shareholders will be automatically reinvested in additional whole and fractional shares of our common stock unless you elect to receive cash. For federal income tax purposes, however, you will be deemed to have constructively received cash and such amounts should be included in your income to the extent such constructive distribution otherwise represents a taxable dividend for the year in which such distribution is credited to your account. The amount of the distribution is the value of the shares of common stock acquired through the dividend reinvestment plan.
 
CERTAIN GOVERNMENT REGULATIONS
 
We operate in a highly regulated environment. The following discussion generally summarizes certain government regulations.
 
Business Development Company. A business development company is defined and subject to the regulations of the 1940 Act. A business development company must be organized in the United States for the purpose of investing in or lending to primarily private companies and making managerial assistance available to them. A business development company may use capital provided by public shareholders and from other sources to invest in long-term, private investments in businesses.
 
As a business development company, we may not acquire any asset other than "qualifying assets" unless, at the time we make the acquisition, the value of our qualifying assets represents at least 70% of the value of our total assets. The principal categories of qualifying assets relevant to our business are:
 
(1)        Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions):
 
(a) is an eligible portfolio company, or from any person who is, or has been during the preceding 13 months, an affiliated person of an eligible portfolio company, or from any other person, subject to such rules as may be prescribed by the SEC. An eligible portfolio company is defined in the 1940 Act as any issuer which:
 
(i) is organized under the laws of, and has its principal place of business in, the United States;
 
(ii) is not an investment company (other than a small business investment company wholly owned by the business development company) or a company that would be an investment company but for certain exclusions under the 1940 Act; and
 
(iii) satisfies one of the following:
 
 
109

 
 
 
·
does not have any class of securities with respect to which a broker or dealer may extend margin credit;
 
 
·
is controlled by a business development company or a group of companies including a business development company and the business development company has an affiliated person who is a director of the eligible portfolio company; or
 
 
·
is a small and solvent company having total assets of not more than $4.0 million and capital and surplus of not less than $2.0 million.
 
(b) is a company that meets the requirements of (a)(i) and (ii) above, but is not an eligible portfolio company because it has issued a class of securities on a national securities exchange, if:
 
                      (i) at the time of the purchase, we own at least 50% of the (x) greatest number of equity securities of such issuer and securities convertible into or exchangeable for such securities; and (y) the greatest amount of debt securities of such issuer, held by us at any point in time during the period when such issuer was an eligible portfolio company; and
 
                      (ii) we are one of the 20 largest holders of record of such issuer's outstanding voting securities; or
 
(c) is a company that meets the requirements of (a)(i) and (ii) above, but is not an eligible portfolio company because it has issued a class of securities on a national securities exchange, if the aggregate market value of such company's outstanding voting and non-voting common equity is less than $250.0 million.
 
(2)         Securities of any eligible portfolio company which we control.
 
(3)         Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements.
 
(4)         Securities of an eligible portfolio company purchased from any person in a private transaction if there is no ready market for such securities and we already own 60% of the outstanding equity of the eligible portfolio company.
 
(5)         Securities received in exchange for or distributed on or with respect to securities described in (1) through (4) above, or pursuant to the exercise of warrants or rights relating to such securities.
 
(6)         Cash, cash equivalents, U.S. Government securities or high-quality debt maturing in one year or less from the time of investment.
 
To include certain securities described above as qualifying assets for the purpose of the 70% test, a business development company must make available to the issuer of those securities significant managerial assistance such as providing significant guidance and counsel concerning the management, operations, or business objectives and policies of a portfolio company, or making loans to a portfolio company. We offer to provide managerial assistance to each of our portfolio companies.
 
As a business development company, we are entitled to issue senior securities in the form of stock or senior securities representing indebtedness, including debt securities and preferred stock, as long as each class of senior security has an asset coverage ratio of at least 200% immediately after each such issuance. See "Risk Factors." We may also be prohibited under the 1940 Act from knowingly participating in certain transactions with our affiliates without the prior approval of our Independent Directors and, in some cases, prior approval by the SEC. On July 11, 2000, the SEC granted us an exemptive order permitting us to make co-investments with certain of our affiliates in portfolio companies, subject to certain conditions. Under the exemptive order, the Company is permitted to co-invest in certain portfolio companies with its affiliates, subject to specified conditions. Under the terms of the exemptive order, portfolio companies purchased by the Company and its affiliates are required to be approved by the Independent Directors and are required to satisfy certain other conditions established by the SEC.
 
 
110

 
 
As with other companies subject to the regulations of the 1940 Act, a business development company must adhere to certain other substantive ongoing regulatory requirements. A majority of our directors must be persons who are not "interested persons," as that term is defined in the 1940 Act. Additionally, we are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect the business development company. Furthermore, as a business development company, we are prohibited from protecting any director or officer against any liability to the company or our shareholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person's office.
 
We and TTG Advisers maintain a code of ethics that establishes procedures for personal investment and restricts certain transactions by our personnel. The code of ethics generally does not permit investment by our employees in securities that may be purchased or held by us. You may read and copy the code of ethics at the SEC's Public Reference Room in Washington, D.C. You may obtain information on operations of the Public Reference Room by calling the SEC at (202) 942-8090. In addition, the code of ethics is available on the EDGAR Database on the SEC Internet site at http://www.sec.gov. You may obtain copies of the code of ethics, after paying a duplicating fee, by electronic request at the following email address: publicinfo@sec.gov, or by writing to the SEC's Public Reference Section, 100 F Street, NE, Washington, D.C. 20549. The code of ethics is also posted on our website at http://www.mvccapital.com.
 
We may not change the nature of our business so as to cease to be, or withdraw our election as, a business development company unless authorized by vote of a "majority of the outstanding voting securities," as defined in the 1940 Act, of our shares. A majority of the outstanding voting securities of a company is defined by the 1940 Act as the lesser of: (i) 67% or more of such company's shares present at a meeting if more than 50% of the outstanding shares of such company are present and represented by proxy, or (ii) more than 50% of the outstanding shares of such company.
 
We are periodically examined by the SEC for compliance with the 1940 Act.
 
DIVIDEND REINVESTMENT PLAN
 
All of our shareholders who hold shares of common stock in their own name will automatically be enrolled in our dividend reinvestment plan (the "Plan"). All such shareholders will have any cash dividends and distributions automatically reinvested by Computershare Ltd. (the "Plan Agent"), in additional shares of our common stock. Any shareholder may, of course, elect to receive his or her dividends and distributions in cash. Currently, the Company has a policy of seeking to pay quarterly dividends to shareholders. For any of our shares that are held by banks, brokers or other entities that hold our shares as nominees for individual shareholders, the Plan Agent will administer the Plan on the basis of the number of shares certified by any nominee as being registered for shareholders that have not elected to receive dividends and distributions in cash. To receive your dividends and distributions in cash, you must notify the Plan Agent.
 
The Plan Agent serves as agent for the shareholders in administering the Plan. When we declare a dividend or distribution payable in cash or in additional shares of our common stock, those shareholders participating in the Plan will receive their dividend or distribution in additional shares of our common stock. Such shares will be either newly issued by us or purchased in the open market by the Plan Agent. If the market value of a share of our common stock on the payment date for such dividend or distribution equals or exceeds the net asset value per share on that date, we will issue new shares at the net asset value. If the net asset value exceeds the market price of our common stock, the Plan Agent will purchase in the open market such number of shares of our common stock as is necessary to complete the distribution.
 
The Plan Agent will maintain all shareholder accounts in the Plan and furnish written confirmation of all transactions. Shares of our common stock in the Plan will be held in the name of the Plan Agent or its nominee and such shareholder will be considered the beneficial owner of such shares for all purposes.
 
 
111

 
 
There is no charge to shareholders for participating in the Plan or for the reinvestment of dividends and distributions. We will not incur brokerage fees with respect to newly issued shares issued in connection with the Plan. Shareholders will, however, be charged a pro rata share of any brokerage fee charged for open market purchases in connection with the Plan.
 
We may terminate the Plan upon providing written notice to each shareholder participating in the Plan at least 60 days prior to the effective date of such termination. We may also materially amend the Plan at any time upon providing written notice to shareholders participating in the Plan at least 30 days prior to such amendment (except when necessary or appropriate to comply with applicable law or rules and policies of the SEC or other regulatory authority). You may withdraw from the Plan upon providing notice to the Plan Agent. You may obtain additional information about the Plan from the Plan Agent.
 
DESCRIPTION OF SECURITIES
 
The following summary of our capital stock and other securities does not purport to be complete and is subject to, and qualified in its entirety by, our Certificate of Incorporation.
 
Our authorized capital stock is 150,000,000 shares, $0.01 par value.
 
Common Stock
 
At November 1, 2012, there were 28,304,448 shares of common stock outstanding and 4,387,466 shares of common stock in our treasury. To date, no other classes of stock have been issued.
 
 
(1)
Title of Class
(2)
Amount Authorized
(3)
Amount Held by Us or for Our Account
(4)
Amount Outstanding Exclusive of Amounts Shown Under (3)
         
MVC Capital, Inc.
Common Stock
150,000,000
4,387,466
23,916,982

All shares of common stock have equal rights as to earnings, assets, dividends and voting privileges and all outstanding shares of common stock are fully paid and non-assessable. Distributions may be paid to the holders of common stock if and when declared by our Board out of funds legally available therefore. Our common stock has no preemptive, conversion or redemption rights and is freely transferable. In the event of liquidation, each share of common stock is entitled to share ratably in all of our assets that are legally available for distributions after payment of all debts and liabilities and subject to any prior rights of holders of preferred stock, if any, then outstanding. Each share of common stock is entitled to one vote and does not have cumulative voting rights, which means that holders of a majority of the shares, if they so choose, could elect all of the directors, and holders of less than a majority of the shares would, in that case, be unable to elect any director. All shares of common stock offered hereby will be, when issued and paid for, fully paid and non-assessable.
 
Preferred Stock
 
In order to issue preferred stock, it will be necessary for our Board and shareholders to approve an amendment to our certificate of incorporation providing for such issuance. The Board may then authorize the issuance of preferred stock with such preferences, powers, rights and privileges as the Board deems appropriate; except that, such an issuance must adhere to the requirements of the 1940 Act. The 1940 Act requires, among other things, that (i) immediately after issuance and before any distribution is made with respect to common stock, the preferred stock, together with all other senior securities, must not exceed an amount equal to 50% of our total assets; and (ii) the holders of shares of preferred stock, if any are issued, must be entitled as a class to elect two directors at all times and to elect a majority of the directors if dividends on the preferred stock are in arrears by two years or more. We believe the availability of such stock will provide us with increased flexibility in structuring future financings and acquisitions. If we offer preferred stock under this prospectus, we will issue an appropriate prospectus supplement. You should read that prospectus supplement for a description of the preferred stock, including, but not limited to, whether there will be an arrearage in the payment of dividends or sinking fund installments, if any, restrictions with respect to the declaration of dividends, requirements in connection with the maintenance of any ratio or assets, or creation or maintenance of reserves, or provisions for permitting or restricting the issuance of additional securities.
 
 
112

 
 
Warrants
 
We may issue warrants to purchase shares of our common stock. Such warrants may be issued independently or together with shares of common stock and may be attached or separate from such shares of common stock. We will issue each series of warrants under a separate warrant agreement to be entered into between us and a warrant agent. The warrant agent will act solely as our agent and will not assume any obligation or relationship of agency for or with holders or beneficial owners of warrants. Particular terms of any warrants we offer will be described in the prospectus supplement relating to such warrants.
 
Under the 1940 Act, we may generally only offer warrants provided that (i) the warrants expire by their terms within ten years; (ii) the exercise or conversion price is not less than the current market value at the date of issuance; (iii) our shareholders authorize the proposal to issue such warrants, and our Board approves such issuance on the basis that the issuance is in the best interests of MVC Capital and its shareholders; and (iv) if the warrants are accompanied by other securities, the warrants are not separately transferable unless no class of such warrants and the securities accompanying them has been publicly distributed. The 1940 Act also generally provides that the amount of our voting securities that would result from the exercise of all outstanding warrants at the time of issuance may not exceed 25% of our outstanding voting securities.
 
Debt Securities
 
We may issue debt securities that may be senior or subordinated in priority of payment. We will provide a prospectus supplement that describes the ranking, whether senior or subordinated, the specific designation, the aggregate principal amount, the purchase price, the maturity, the redemption terms, the interest rate or manner of calculating the interest rate, the time of payment of interest, if any, the terms for any conversion or exchange, including the terms relating to the adjustment of any conversion or exchange mechanism, the listing, if any, on a securities exchange, the name and address of the trustee and any other specific terms of the debt securities.
 
Limitation on Liability of Directors
 
We have adopted provisions in our certificate of incorporation limiting the liability of our directors for monetary damages. The effect of these provisions in the certificate of incorporation is to eliminate the rights of MVC Capital and its shareholders (through shareholders' derivative suits on our behalf) to recover monetary damages against a director for breach of the fiduciary duty of care as a director or officer (including breaches resulting from negligent behavior) except in certain limited situations. These provisions do not limit or eliminate the rights of MVC Capital or any shareholder to seek non-monetary relief such as an injunction or rescission in the event of a breach of a director's or officer's duty of care. These provisions will not alter the liability of directors or officers under federal securities laws.
 
Delaware Law and Certain Charter And Bylaw Provisions; Anti-Takeover Measures
 
We are subject to the provisions of Section 203 of the General Corporation Law of Delaware. In general, the statute prohibits a publicly held Delaware corporation from engaging in a "business combination" with "interested stockholders" for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A "business combination" includes certain mergers, asset sales and other transactions resulting in a financial benefit to the interested stockholder. Subject to exceptions, an "interested stockholder" is a person who, together with his affiliates and associates, owns, or within three years did own, 15% or more of the corporation's voting stock. Our certificate of incorporation and fifth amended and restated bylaws provide that:
 
 
·
directors may be removed only for cause by the affirmative vote of the holders of at least seventy-five percent of the shares then entitled to vote; and
 
 
113

 
 
 
·
any vacancy on the Board, however the vacancy occurs, including a vacancy due to an enlargement of the Board, may only be filled by vote of the directors then in office.
 
The limitations on removal of directors and filling of vacancies could have the effect of making it more difficult for a third party to acquire us, or of discouraging a third party from acquiring us.
 
Our certificate of incorporation and fifth amended and restated bylaws also provide that:
 
 
·
any action required or permitted to be taken by the stockholders at an annual meeting or special meeting of stockholders may only be taken if it is properly brought before such meeting; and
 
 
·
special meetings of the stockholders may only be called by a majority of our Board, Chairman, Vice Chairman, Chief Executive Officer, President, Secretary and any Vice President.
 
Our fifth amended and restated bylaws provide that, in order for any matter to be considered "properly brought" before a meeting, a stockholder must comply with requirements regarding advance notice to us. These provisions could delay until the next stockholders' meeting stockholder actions which are favored by the holders of a majority of our outstanding voting securities.
 
Delaware's corporation law provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation's certificate of incorporation or bylaws, unless a corporation's certificate of incorporation or bylaws requires a greater percentage. Our certificate of incorporation permits our Board to amend or repeal our bylaws. Our bylaws generally can be amended with the approval of at least sixty-six and two-thirds percent (66 2/3%) of the total number of authorized directors subject to certain exceptions, which provisions will require the vote of seventy-five percent (75%) of the total number of authorized directors to be amended. The affirmative vote of the holders of at least sixty-six and two-thirds percent (66 2/3%) of the voting power of all of the then outstanding shares of stock entitled to vote is required to amend or repeal any of the provisions of our fifth amended and restated bylaws. Generally our certificate of incorporation may be amended by holders of a majority of the shares of our stock issued and outstanding and entitled to vote. However, the vote of at least sixty-six and two-thirds percent (66 2/3%) of the shares of our stock entitled to vote is required to amend or repeal any provision pertaining to the Board, limitation of liability, indemnification or stockholder action..
 
PLAN OF DISTRIBUTION
 
We may sell the securities in any of three ways (or in any combination): (i) through underwriters or dealers; (ii) directly to a limited number of purchasers or to a single purchaser; or (iii) through agents. The securities may be sold "at-the-market" to or through a market maker or into an existing trading market for the securities, on an exchange or otherwise. The prospectus supplement will set forth the terms of the offering of such securities, including:
 
 
·
the name or names of any underwriters, dealers or agents and the amounts of securities underwritten or purchased by each of them;
 
 
·
the offering price of the securities and the proceeds to us and any discounts, commissions or concessions allowed or reallowed or paid to dealers; and
 
 
·
any securities exchanges on which the securities may be listed.
 
Any offering price and any discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time.
 
If underwriters are used in the sale of any securities, the securities will be acquired by the underwriters for their own account and may be resold from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. The securities may be either offered to the public through underwriting syndicates represented by managing underwriters, or directly by underwriters. Generally, the underwriters' obligations to purchase the securities will be subject to certain conditions precedent.
 
 
114

 
 
We may sell the securities through agents from time to time. The prospectus supplement will name any agent involved in the offer or sale of the securities and any commissions we pay to them. Generally, any agent will be acting on a best efforts basis for the period of its appointment.
 
We may authorize underwriters, dealers or agents to solicit offers by certain purchasers to purchase the securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. The contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth any commissions we pay for soliciting these contracts.  The maximum aggregate commission or discount to be received by any member of FINRA or independent broker-dealer will not be greater than 8% of the gross proceeds of the sale of securities offered pursuant to this prospectus and any applicable prospectus supplement.
 
Agents and underwriters may be entitled to indemnification by us against certain civil liabilities, including liabilities under the Securities Act or to contribution with respect to payments which the agents or underwriters may be required to make in respect thereof. Agents and underwriters may be customers of, engage in transactions with, or perform services for us in the ordinary course of business.
 
We may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter identified in the applicable prospectus supplement. We may loan or pledge securities to a financial institution or other third party that in turn may sell the securities using this prospectus. Such financial institution or third party may transfer its short position to investors in our securities or in connection with a simultaneous offering of other securities offered by this prospectus or otherwise.
 
LEGAL COUNSEL
 
Kramer Levin Naftalis & Frankel LLP, 1177 Avenue of the Americas, New York, New York 10036, acts as legal counsel to the Company.

SAFEKEEPING, TRANSFER AND DIVIDEND PAYING AGENT AND REGISTRAR
 
Pursuant to an agreement with the Company, US Bank National Association acts as the Company's custodian with respect to the safekeeping of its securities. The principal business office of the custodian is 1555 North River Center Drive, Suite 302, Milwaukee, WI 53212.
 
The Company employs Computershare Ltd. as its transfer agent to record transfers of the shares, maintain proxy records, process distributions and to act as agent for each participant in the Company's Plan. Computershare's principal business office is 250 Royall Street, Canton, Massachusetts 02021.
 
BROKERAGE ALLOCATION AND OTHER PRACTICES
 
Since we generally acquire and dispose of our investments in privately negotiated transactions, we infrequently use brokers in the normal course of business.
 
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
The audited financial statements and schedules included in this prospectus and elsewhere in the registration statement to the extent and for the periods indicated in their reports have been audited by Ernst & Young LLP for the years ended October 31, 2012, October 31, 2011, October 31, 2010, October 31, 2009 and October 31, 2008, as set forth in its reports thereon and included elsewhere herein and are included in reliance upon such reports given on the authority of said firm as experts in accounting and auditing.
 
 
115

 

MVC CAPITAL, INC.
 
CONSOLIDATED FINANCIAL STATEMENTS
 
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
Page
Consolidated Balance Sheets
 
October 31, 2012 and October 31, 2011
F-1
   
Consolidated Schedule of Investments
 
October 31, 2012
F-2
October 31, 2011
F-4
   
Consolidated Statement of Operations
 
For the Year Ended October 31, 2012,
 
the Year Ended October 31, 2011 and
 
the Year Ended October 31, 2010
F-7
   
Consolidated Statement of Cash Flows
 
For the Year Ended October 31, 2012,
 
the Year Ended October 31, 2011 and
 
the Year Ended October 31, 2010
F-9
   
Consolidated Statement of Changes in Net Assets
 
For the Year Ended October 31, 2012,
 
the Year Ended October 31, 2011 and
 
the Year Ended October 31, 2010
F-11
   
Consolidated Selected Per Share Data and Ratios
 
For the Year Ended October 31, 2012,
 
the Year Ended October 31, 2011,
 
the Year Ended October 31, 2010,
 
the Year Ended October 31, 2009 and
 
the Year Ended October 31, 2008
F-12
   
Notes to Consolidated Financial Statements
F-13
 
 
Reports of Independent Registered Public Accounting Firm
F-44
 
 
Schedule 12-14
F-46
 
 
 

 
 
CONSOLIDATED FINANCIAL STATEMENTS
 
MVC Capital, Inc.
 
Consolidated Balance Sheets
                 
 
  
October 31,
2012
   
October 31,
2011
 
ASSETS
  
Assets
  
             
Cash and cash equivalents
  
$
36,160,558
  
 
$
28,317,460
  
Restricted cash and cash equivalents
  
 
6,480,000
  
   
6,925,000
  
Investments at fair value
  
             
Non-control/Non-affiliated investments (cost $54,629,419 and $90,292,464)
  
 
34,197,990
  
   
51,182,558
  
Affiliate investments (cost $128,521,214 and $126,356,770)
  
 
178,396,856
  
   
187,953,099
  
Control investments (cost $149,281,248 and $141,569,773)
  
 
191,575,802
  
   
213,079,430
  
 
  
             
Total investments at fair value (cost $332,431,881 and $358,219,007)
  
 
404,170,648
  
   
452,215,087
  
Dividends and interest receivables, net of reserves
  
 
4,559,703
  
   
3,277,126
  
Fee and other receivables
  
 
3,314,116
  
   
4,595,741
  
Escrow receivables
  
 
991,563
  
   
1,146,899
  
Prepaid expenses
  
 
753,501
  
   
629,868
  
Prepaid taxes
  
 
591
  
   
  
 
  
             
Total assets
  
$
456,430,680
  
 
$
497,107,181
  
 
  
             
LIABILITIES AND SHAREHOLDERS’ EQUITY
  
Liabilities
  
             
Term loan
  
$
50,000,000
  
 
$
50,000,000
  
Provision for incentive compensation (Note 5)
  
 
15,655,438
  
   
23,938,058
  
Management fee payable
  
 
2,027,571
  
   
2,303,655
  
Management fee payable — Asset Management
  
 
1,054,433
  
   
297,250
  
Professional fees payable
  
 
767,835
  
   
703,293
  
Other accrued expenses and liabilities
  
 
734,501
  
   
288,111
  
Portfolio fees payable — Asset Management
  
 
140,293
  
   
  
Consulting fees payable
  
 
34,476
  
   
64,999
  
Taxes payable
  
 
  
   
2,099
  
 
  
             
Total liabilities
  
 
70,414,547
  
   
77,597,465
  
 
  
             
     
Shareholders’ equity
  
             
Common stock, $0.01 par value; 150,000,000 shares authorized; 23,916,982 and 23,916,982 shares outstanding, respectively
  
 
283,044
  
   
283,044
  
Additional paid-in-capital
  
 
425,651,660
  
   
428,428,139
  
Accumulated earnings
  
 
64,524,665
  
   
40,499,006
  
Dividends paid to stockholders
  
 
(92,010,775
   
(80,171,868
Accumulated net realized loss
  
 
(46,401,983
   
(25,755,440
Net unrealized appreciation
  
 
71,738,767
  
   
93,996,080
  
Treasury stock, at cost, 4,387,466 and 4,387,466 shares held, respectively
  
 
(37,769,245
   
(37,769,245
 
  
             
Total shareholders’ equity
  
 
386,016,133
  
   
419,509,716
  
 
  
             
Total liabilities and shareholders’ equity
  
$
456,430,680
  
 
$
497,107,181
  
 
  
             
Net asset value per share
  
$
16.14
  
 
$
17.54
  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-1

 
 
MVC Capital, Inc.
 
Consolidated Schedule of Investments
October 31, 2012
                                 
Company
 
Industry
 
Investment
 
Principal
   
Cost
   
Fair Value
 
Non-control/Non-affiliated investments — 8.86% (a, c, f, g)
  
Actelis Networks, Inc.
 
Technology Investments
 
Preferred Stock (150,602 shares) (d, j)
         
$
5,000,003
  
   
  
Biovation Holdings, Inc.
 
Manufacturer of Laminate Material & Composites
 
Bridge Loan 6.0000% Cash, 6.0000% PIK, 02/28/2014 (b, h)
 
$
1,500,000
  
   
1,500,000
  
 
$
1,500,000
  
BPC II, LLC
 
Apparel
 
Limited Liability Company Interest (d)
           
180,000
  
   
  
DPHI, Inc.
 
Technology Investments
 
Preferred Stock (602,131 shares) (d, j)
           
4,520,355
  
   
  
FOLIOfn, Inc.
 
Technology Investments
 
Preferred Stock (5,802,259 shares) (d, j)
           
15,000,000
  
   
10,790,000
  
Freshii USA, Inc.
 
Food Services
 
Senior Secured Loan 6.0000% Cash, 6.0000% PIK, 01/11/2017 (b, h)
   
1,044,304
  
   
1,009,230
  
   
1,017,224
  
       
Warrants (d, m)
           
33,873
  
   
33,873
  
                                 
                     
1,043,103
  
   
1,051,097
  
Lockorder Limited
 
Technology Investments
 
Common Stock (21,064 shares) (d, e, j)
           
2,007,701
  
   
  
MainStream Data, Inc.
 
Technology Investments
 
Common Stock (5,786 shares) (d, j)
           
3,750,000
  
   
  
NPWT Corporation
 
Medical Device Manufacturer
 
Series B Common Stock (281 shares) (d)
           
1,236,364
  
   
25,000
  
       
Series A Convertible Preferred Stock (5,000 shares) (d)
           
  
   
440,000
  
                                 
                     
1,236,364
  
   
465,000
  
Prepaid Legal Services, Inc.
 
Consumer Services
 
Tranche A Term Loan 7.5000% Cash, 01/1/2017 (h)
   
3,024,390
  
   
2,989,832
  
   
2,989,832
  
       
Tranche B Term Loan 11.0000% Cash, 01/1/2017 (h)
   
4,000,000
  
   
3,908,589
  
   
3,908,589
  
                                 
                     
6,898,421
  
   
6,898,421
  
SGDA Sanierungsgesellschaft
fur Deponien und Altlasten GmbH
 
Soil Remediation
 
Term Loan 7.0000% Cash, 08/31/2014 (e, h)
   
6,547,350
  
   
6,547,350
  
   
6,547,350
  
Teleguam Holdings, LLC
 
Telecommunications
 
Second Lien Loan 9.7500% Cash, 06/09/2017 (h)
   
7,000,000
  
   
6,946,122
  
   
6,946,122
  
Sub Total Non-control/Non-affiliated investments
           
54,629,419
  
   
34,197,990
  
       
Affiliate investments — 46.21% (a, c, f, g)
                       
Centile Holdings B.V.
 
Software
 
Common Equity Interest (d, e)
           
3,174,376
  
   
3,140,000
  
Custom Alloy Corporation
 
Manufacturer of Pipe Fittings
 
Unsecured Subordinated Loan 7.0000% Cash, 7.0000% PIK, 06/18/2013 (b, h)
   
15,623,348
  
   
15,623,348
  
   
15,623,348
  
       
Convertible Series A Preferred Stock (9 shares) (d)
           
44,000
  
   
44,000
  
       
Convertible Series B Preferred Stock (1,991 shares) (d)
           
9,956,000
  
   
9,956,000
  
                                 
                     
25,623,348
  
   
25,623,348
  
Harmony Health & Beauty, Inc.
 
Health & Beauty - Retail
 
Common Stock (147,621 shares) (d)
           
6,700,000
  
   
100,000
  
JSC Tekers Holdings
 
Real Estate Management
 
Common Stock (2,250 shares) (d, e)
           
4,500
  
   
4,500
  
       
Secured Loan 8.0000% Cash, 06/30/2014 (e, h)
   
4,000,000
  
   
4,000,000
  
   
4,000,000
  
                                 
                     
4,004,500
  
   
4,004,500
  
Marine Exhibition Corporation
 
Theme Park
 
Senior Subordinated Debt 7.0000% Cash, 4.0000% PIK, 08/30/2017 (b, h)
   
11,842,742
  
   
11,829,348
  
   
11,842,742
  
       
Convertible Preferred Stock (20,000 shares) (b)
           
3,274,219
  
   
3,274,219
  
                                 
                     
15,103,567
  
   
15,116,961
  
Octagon Credit Investors, LLC
 
Financial Services
 
Limited Liability Company Interest
           
2,364,745
  
   
6,221,796
  
RuMe Inc.
 
Consumer Products
 
Common Stock (999,999 shares) (d)
           
160,000
  
   
160,000
  
       
Series B-1 Preferred Stock (4,999,076 shares) (d)
           
999,815
  
   
1,417,000
  
                                 
                     
1,159,815
  
   
1,577,000
  
Security Holdings B.V.
 
Electrical Engineering
 
Common Equity Interest (d, e)
           
40,186,620
  
   
24,011,000
  
SGDA Europe B.V.
 
Soil Remediation
 
Common Equity Interest (d, e)
           
20,084,599
  
   
7,915,000
  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-2

 
 
MVC Capital, Inc.
 
Consolidated Schedule of Investments — (Continued)
October 31, 2012
                                 
Company
 
Industry
 
Investment
 
Principal
   
Cost
   
Fair Value
 
U.S. Gas & Electric, Inc.
 
Energy Services
 
Second Lien Loan 9.0000% Cash, 5.0000% PIK , 07/25/2015 (b, h)
 
$
9,619,644
  
 
$
9,619,644
  
 
$
9,619,644
  
       
Convertible Series I Preferred Stock 
(32,200 shares) (d, l)
           
500,000
  
   
81,067,607
  
       
Convertible Series J Preferred Stock (8,216 shares) (d)
           
  
   
  
                                 
                     
10,119,644
  
   
90,687,251
  
Sub Total Affiliate investments
           
128,521,214
  
   
178,396,856
  
Control Investments — 49.63% (a, c, f, g)
                       
MVC Automotive Group B.V.
 
Automotive Dealerships
 
Common Equity Interest (d, e)
           
34,736,939
  
   
33,519,000
  
       
Bridge Loan 10.0000% Cash, 12/31/2012 (e, h)
   
3,643,557
  
   
3,643,557
  
   
3,643,557
  
                                 
                     
38,380,496
  
   
37,162,557
  
MVC Private Equity Fund LP
 
Private Equity
 
Limited Partnership Interest (d, k)
           
8,013,749
  
   
8,072,249
  
       
General Partnership Interest (d, k)
           
204,432
  
   
205,924
  
                                 
                     
8,218,181
  
   
8,278,173
  
Ohio Medical Corporation
 
Medical Device Manufacturer
 
Common Stock (5,620 shares) (d)
           
15,763,636
  
   
  
       
Series A Convertible Preferred Stock
(21,176 shares) (b)
           
30,000,000
  
   
31,100,000
  
       
Guarantee - Series B Preferred (d)
           
  
   
(825,000
                                 
                     
45,763,636
  
   
30,275,000
  
SIA Tekers Invest
 
Port Facilities
 
Common Stock (68,800 shares) (d, e)
           
2,300,000
  
   
1,247,000
  
Summit Research Labs, Inc.
 
Specialty Chemicals
 
Second Lien Loan 7.0000% Cash, 7.0000% PIK , 09/30/2017 (b, h)
   
11,868,017
  
   
11,842,665
  
   
11,868,017
  
       
Common Stock (1,115 shares)
           
16,000,000
  
   
62,500,000
  
                                 
                     
27,842,665
  
   
74,368,017
  
Turf Products, LLC
 
Distributor - Landscaping and Irrigation Equipment
 
Senior Subordinated Debt 9.0000% Cash,
4.0000% PIK , 01/31/2014 (b, h)
   
8,395,261
  
   
8,395,261
  
   
8,395,261
  
       
Junior Revolving Note 6.0000%
Cash, 01/31/2014 (h)
   
1,000,000
  
   
1,000,000
  
   
1,000,000
  
       
Limited Liability Company Interest (d)
           
3,535,694
  
   
2,874,794
  
       
Warrants (d)
           
  
   
  
                                 
                     
12,930,955
  
   
12,270,055
  
Velocitius B.V.
 
Renewable Energy
 
Common Equity Interest (d, e)
           
11,395,315
  
   
21,725,000
  
Vestal Manufacturing Enterprises, Inc.
 
Iron Foundries
 
Senior Subordinated Debt 12.0000% Cash, 04/29/2013 (h)
   
600,000
  
   
600,000
  
   
600,000
  
       
Common Stock (81,000 shares) (d)
           
1,850,000
  
   
5,650,000
  
                                 
                     
2,450,000
  
   
6,250,000
  
Sub Total Control Investments
               
149,281,248
  
   
191,575,802
  
TOTAL INVESTMENT ASSETS — 104.70% (f)
         
$
332,431,881
  
 
$
404,170,648
  
 

(a)
These securities are restricted from public sale without prior registration under the Securities Act of 1933. The Company negotiates certain aspects of the method and timing of the disposition of these investments, including registration rights and related costs.

(b)
These securities accrue a portion of their interest/dividends in “payment in kind” interest/dividends which is capitalized to the investment.

(c)
All of the Company’s equity and debt investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, except Lockorder Limited, MVC Automotive Group B.V., Security Holdings B.V., SGDA Europe B.V., SGDA Sanierungsgesellschaft fur Deponien und Altlasten mbH, SIA Tekers Invest, JSC Tekers Holdings, Centile Holdings B.V., Velocitius B.V. and Freshii USA, Inc. The Company makes available significant managerial assistance to all of the portfolio companies in which it has invested.

(d)
Non-income producing assets.

(e)
The principal operations of these portfolio companies are located in Europe which represents approximately 23% of the total assets. The remaining portfolio companies are located in North America which represents approximately 65% of the total assets.

(f)
Percentages are based on net assets of $386,016,133 as of October 31, 2012.

(g)
See Note 3 for further information regarding “Investment Classification.”

(h)
All or a portion of these securities have been committed as collateral for the Guggenheim Corporate Funding, LLC Credit Facility.

(i)
All or a portion of the accrued interest on these securities have been reserved against.

(j)
Legacy Investments.

(k)
MVC Private Equity Fund, LP is a private equity fund focused on control equity investments in the lower middle market. The fund currently holds three investments, two located in the United States and one in Gibraltar, which are in the energy, services, and industrial sectors, respectively.

(l)
Upon a liquidity event, the Company may receive additional ownership in U.S. Gas & Electric, Inc.

(m)
Includes a warrant in Freshii One LLC, an affiliate of Freshii USA, Inc.

PIK
— Payment-in-kind.

Denotes zero cost or fair value.
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-3

 
 
MVC Capital, Inc.
 
Consolidated Schedule of Investments
October 31, 2011
                                 
Company
 
Industry
 
Investment
 
Principal
   
Cost
   
Fair Value
 
Non-control/Non-affiliated investments — 12.20% (a, c, f, g)
  
Actelis Networks, Inc.
 
Technology Investments
 
Preferred Stock (150,602 shares) (d, j)
         
$
5,000,003
  
   
  
BP Clothing, LLC
 
Apparel
 
Second Lien Loan 12.5000% Cash, 4.0000% PIK, 7/18/2012 (b, h, i)
 
$
20,362,135
  
   
19,579,285
  
   
  
       
Term Loan A 8.0000% Cash, 7/18/2011 (h, i)
   
1,987,500
  
   
1,987,500
  
 
$
280,000
  
       
Term Loan B 11.0000% Cash, 7/18/2011 (h, i)
   
2,000,000
  
   
2,000,000
  
   
  
                                 
                     
23,566,785
  
   
280,000
  
DPHI, Inc.
 
Technology Investments
 
Preferred Stock (602,131 shares) (d, j)
           
4,520,355
  
   
  
FOLIOfn, Inc.
 
Technology Investments
 
Preferred Stock (5,802,259 shares) (d, j)
           
15,000,000
  
   
10,790,000
  
GDC Acquisition, LLC
 
Electrical Distribution
 
Senior Subordinated Debt 12.5000% Cash, 4.5000% PIK%, 8/31/2011 (b, h, i)
   
3,348,160
  
   
3,237,952
  
   
  
       
Warrants (d)
           
  
   
  
                                 
                     
3,237,952
  
   
  
Integrated Packaging Corporation
 
Manufacturer of Packaging Material
 
Warrants (d)
           
  
   
  
Lockorder Limited
 
Technology Investments
 
Common Stock (21,064 shares) (d, e, j)
           
2,007,701
  
   
  
MainStream Data, Inc.
 
Technology Investments
 
Common Stock (5,786 shares) (d, j)
           
3,750,000
  
   
  
NPWT Corporation
 
Medical Device Manufacturer
 
Series B Common Stock (281 shares) (d)
           
1,236,364
  
   
56,364
  
       
Series A Convertible Preferred Stock (5,000 shares) (d)
           
  
   
1,000,000
  
                                 
                     
1,236,364
  
   
1,056,364
  
Octagon High Income Cayman Fund Ltd.
 
Investment Company
 
Series 1 Participating Non-Voting Shares (3,014 shares) (e, k)
           
3,013,952
  
   
2,804,543
  
Prepaid Legal Services, Inc.
 
Consumer Services
 
Tranche A Term Loan 7.5000% Cash, 12/31/2016 (h)
   
4,000,000
  
   
3,943,303
  
   
3,943,303
  
       
Tranche B Term Loan 11.0000% Cash, 12/31/2016 (h)
   
4,000,000
  
   
3,886,607
  
   
3,886,607
  
                                 
                     
7,829,910
  
   
7,829,910
  
SafeStone Technologies Limited
 
Technology Investments
 
Common Stock (21,064 shares) (d, e, j)
           
2,007,701
  
   
  
SGDA Sanierungsgesellschaft fur Deponien und Altlasten GmbH
 
Soil Remediation
 
Term Loan 7.0000% Cash, 8/31/2012 (e, h)
   
6,187,350
  
   
6,187,350
  
   
6,187,350
  
SHL Group Limited
 
Talent Management Assessment
 
Common Stock (1,518,762 shares) (d, e)
           
6,000,000
  
   
15,300,000
  
Teleguam Holdings, LLC
 
Telecommunications
 
Second Lien Loan 9.7500% Cash, 6/9/2017 (h)
   
7,000,000
  
   
6,934,391
  
   
6,934,391
  
Sub Total Non-control/Non-affiliated investments
           
90,292,464
  
   
51,182,558
  
       
Affiliate investments — 44.80% (a, c, f, g)
                       
Centile Holding B.V.
 
Software
 
Common Equity Interest (d, e)
           
3,001,376
  
   
3,001,376
  
Custom Alloy Corporation
 
Manufacturer of Pipe Fittings
 
Unsecured Subordinated Loan 7.0000% Cash, 7.0000% PIK, 9/18/2012 (b, h)
   
14,559,236
  
   
14,485,213
  
   
14,559,236
  
       
Convertible Series A Preferred Stock (9 shares) (d)
           
44,000
  
   
44,000
  
       
Convertible Series B Preferred Stock (1,991 shares) (d)
           
9,956,000
  
   
9,956,000
  
                                 
                     
24,485,213
  
   
24,559,236
  
Harmony Health & Beauty, Inc.
 
Health and Beauty - Retail
 
Common Stock (147,621 shares) (d)
           
6,700,000
  
   
1,000,000
  
JSC Tekers Holdings
 
Real Estate Management
 
Common Stock (2,250 shares) (d, e)
           
4,500
  
   
4,500
  
       
Secured Loan 8.0000% Cash, 6/30/2014 (e, h)
   
4,000,000
  
   
4,000,000
  
   
4,000,000
  
                                 
                     
4,004,500
  
   
4,004,500
  
Marine Exhibition Corporation
 
Theme Park
 
Senior Subordinated Debt 7.0000% Cash, 4.0000% PIK, 10/26/2017 (b, h)
   
11,958,188
  
   
11,921,592
  
   
11,958,188
  
       
Convertible Preferred Stock (20,000 shares) (b)
           
3,024,872
  
   
3,024,872
  
                                 
                     
14,946,464
  
   
14,983,060
  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-4

 
 
MVC Capital, Inc.
 
Consolidated Schedule of Investments — (Continued)
October 31, 2011
                                 
Company
 
Industry
 
Investment
 
Principal
   
Cost
   
Fair Value
 
Octagon Credit Investors, LLC
 
Financial Services
 
Limited Liability Company Interest
         
$
2,176,607
  
 
$
5,333,657
  
RuMe Inc.
 
Consumer Products
 
Common Stock (999,999 shares) (d)
           
160,000
  
   
160,000
  
       
Series B-1 Preferred Stock (4,999,076 shares) (d)
           
999,815
  
   
999,815
  
                                 
                     
1,159,815
  
   
1,159,815
  
Security Holdings B.V.
 
Electrical Engineering
 
Common Equity Interest (d, e)
           
40,186,620
  
   
33,200,000
  
SGDA Europe B.V.
 
Soil Remediation
 
Common Equity Interest (d, e)
           
20,084,598
  
   
10,500,000
  
U.S. Gas & Electric, Inc.
 
Energy Services
 
Second Lien Loan 9.0000% Cash, 5.0000% PIK%, 7/26/2012 (b, h)
 
$
9,143,848
  
   
9,111,577
  
   
9,143,848
  
       
Convertible Series I Preferred Stock (32,200 shares) (d)
           
500,000
  
   
78,515,749
  
       
Convertible Series J Preferred Stock (8,216 shares) (d)
           
  
   
2,551,858
  
                                 
                     
9,611,577
  
   
90,211,455
  
Sub Total Affiliate investments
               
126,356,770
  
   
187,953,099
  
Control Investments — 50.79% (a, c, f, g)
                           
MVC Automotive Group B.V.
 
Automotive Dealerships
 
Common Equity Interest (d, e)
           
34,736,939
  
   
42,450,000
  
       
Bridge Loan 10.0000% Cash, 12/31/2011 (e, h)
   
3,643,557
  
   
3,643,557
  
   
3,643,557
  
                                 
                     
38,380,496
  
   
46,093,557
  
MVC Partners, LLC
 
Private Equity
 
Limited Liability Company Interest (d)
           
1,350,253
  
   
1,133,729
  
Ohio Medical Corporation
 
Medical Device Manufacturer
 
Common Stock (5,620 shares) (d)
  
   
15,763,636
  
   
  
       
Series A Convertible Preferred Stock (18,102 shares) (b)
  
   
30,000,000
  
   
39,500,000
  
                                 
                     
45,763,636
  
   
39,500,000
  
SIA Tekers Invest
 
Port Facilities
 
Common Stock (68,800 shares) (d, e)
           
2,300,000
  
   
1,525,000
  
Summit Research Labs, Inc.
 
Specialty Chemicals
 
Second Lien Loan 7.0000% Cash, 7.0000% PIK, 8/31/2013 (b, h)
   
11,055,089
  
   
10,999,118
  
   
11,055,089
  
       
Common Stock (1,115 shares) (d)
           
16,000,000
  
   
74,500,000
  
                                 
                     
26,999,118
  
   
85,555,089
  
Turf Products, LLC
 
Distributor - Landscaping and Irrigation Equipment
 
Senior Subordinated Debt 9.0000% Cash, 4.0000% PIK, 1/31/2014 (b, h)
   
8,395,261
  
   
8,395,261
  
   
8,395,261
  
       
Junior Revolving Note 6.0000% Cash, 1/31/2014 (h)
   
1,000,000
  
   
1,000,000
  
   
1,000,000
  
       
Limited Liability Company Interest (d)
           
3,535,694
  
   
2,721,794
  
       
Warrants (d)
           
  
   
  
                                 
                     
12,930,955
  
   
12,117,055
  
Velocitius B.V.
 
Renewable Energy
 
Common Equity Interest (d, e)
           
11,395,315
  
   
25,100,000
  
Vestal Manufacturing Enterprises, Inc.
 
Iron Foundries
 
Senior Subordinated Debt 12.0000% Cash, 4/29/2013 (h)
   
600,000
  
   
600,000
  
   
600,000
  
       
Common Stock (81,000 shares) (d)
           
1,850,000
  
   
1,455,000
  
                                 
                     
2,450,000
  
   
2,055,000
  
Sub Total Control Investments
                   
141,569,773
  
   
213,079,430
  
TOTAL INVESTMENT ASSETS — 107.79% (f)
             
$
358,219,007
  
 
$
452,215,087
  
 

(a)
These securities are restricted from public sale without prior registration under the Securities Act of 1933. The Company negotiates certain aspects of the method and timing of the disposition of these investments, including registration rights and related costs.

(b)
These securities accrue a portion of their interest/dividends in “payment in kind” interest/dividends which is capitalized to the investment.

(c)
All of the Company’s equity and debt investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, except Lockorder Limited, MVC Automotive Group B.V., Octagon High Income Cayman Fund Ltd., SafeStone Technologies Limited, Security Holdings B.V., SGDA Europe B.V., SGDA Sanierungsgesellschaft fur Deponien und Altlasten mbH, SIA Tekers Invest, JSC Tekers Holdings, Centile Holding B.V. and Velocitius B.V. The Company makes available significant managerial assistance to all of the portfolio companies in which it has invested.
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-5

 
 
(d)
Non-income producing assets.

(e)
The principal operations of these portfolio companies are located in Europe.

(f)
Percentages are based on net assets of $419,509,716 as of October 31, 2011.

(g)
See Note 3 for further information regarding “Investment Classification.”

(h)
All or a portion of these securities have been committed as collateral for the Guggenheim Corporate Funding, LLC Credit Facility.

(i)
All or a portion of the accrued interest on these securities have been reserved against.

(j)
Legacy Investments.

(k)
Octagon High Income Cayman Fund Ltd., which seeks to maximize current income consistent with the preservation of capital through the leveraged loan market and offers monthly liquidity after the initial six months of the investment with a 15-day notice.

PIK
— Payment-in-kind.

Denotes zero cost or fair value.
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-6

 
 
MVC Capital, Inc.
 
Consolidated Statements of Operations
                         
 
  
For the Year Ended
October 31, 2012
 
  
For the Year Ended
October 31, 2011
 
  
For the Year Ended
October 31, 2010
 
Operating Income:
  
     
  
     
  
     
Dividend income
  
     
  
     
  
     
Non-control/Non-affiliated investments
  
$
7,755
  
  
$
246,234
  
  
$
  
Affiliate investments
  
 
2,481,234
  
  
 
341,043
  
  
 
1,893,133
  
Control investments
  
 
12,000,000
  
  
 
  
  
 
  
 
  
     
  
     
  
     
Total dividend income
  
 
14,488,989
  
  
 
587,277
  
  
 
1,893,133
  
 
  
     
  
     
  
     
Payment-in-kind dividend income
  
     
  
     
  
     
Affiliate investments
  
 
249,347
  
  
 
230,358
  
  
 
382,398
  
 
  
     
  
     
  
     
Total payment-in-kind dividend income
  
 
249,347
  
  
 
230,358
  
  
 
382,398
  
 
  
     
  
     
  
     
Interest income
  
     
  
     
  
     
Non-control/Non-affiliated investments
  
 
2,050,801
  
  
 
2,356,210
  
  
 
6,720,255
  
Affiliate investments
  
 
3,111,318
  
  
 
2,978,289
  
  
 
2,751,668
  
Control investments
  
 
2,423,174
  
  
 
2,353,376
  
  
 
2,388,872
  
 
  
     
  
     
  
     
Total interest income
  
 
7,585,293
  
  
 
7,687,875
  
  
 
11,860,795
  
 
  
     
  
     
  
     
Payment-in-kind interest income
  
     
  
     
  
     
Non-control/Non-affiliated investments
  
 
44,304
  
  
 
268,423
  
  
 
1,972,985
  
Affiliate investments
  
 
2,024,462
  
  
 
1,920,686
  
  
 
2,256,028
  
Control investments
  
 
812,929
  
  
 
755,254
  
  
 
949,897
  
 
  
     
  
     
  
     
Total payment-in-kind interest income
  
 
2,881,695
  
  
 
2,944,363
  
  
 
5,178,910
  
 
  
     
  
     
  
     
Fee income
  
     
  
     
  
     
Non-control/Non-affiliated investments
  
 
68,056
  
  
 
1,086,961
  
  
 
352,679
  
Affiliate investments
  
 
1,105,226
  
  
 
1,130,131
  
  
 
2,717,090
  
Control investments
  
 
766,631
  
  
 
566,426
  
  
 
626,780
  
 
  
     
  
     
  
     
Total fee income
  
 
1,939,913
  
  
 
2,783,518
  
  
 
3,696,549
  
 
  
     
  
     
  
     
Fee income — Asset Management1
  
     
  
     
  
     
Portfolio fees
  
 
1,290,160
  
  
 
  
  
 
  
Management fees
  
 
1,009,577
  
  
 
396,333
  
  
 
  
 
  
     
  
     
  
     
Total fee income — Asset Management
  
 
2,299,737
  
  
 
396,333
  
  
 
  
 
  
     
  
     
  
     
Other income
  
 
442,138
  
  
 
1,341,241
  
  
 
509,712
  
 
  
     
  
     
  
     
Total operating income
  
 
29,887,112
  
  
 
15,970,965
  
  
 
23,521,497
  
 
  
     
  
     
  
     
Operating Expenses:
  
     
  
     
  
     
Management fee
  
 
8,587,992
  
  
 
8,844,572
  
  
 
9,329,809
  
Interest and other borrowing costs
  
 
3,366,756
  
  
 
3,082,125
  
  
 
2,824,788
  
Portfolio fees — Asset Management1
  
 
967,620
  
  
 
  
  
 
  
Management fee — Asset Management1
  
 
757,183
  
  
 
297,250
  
  
 
  
Audit & tax preparation fees
  
 
769,500
  
  
 
560,800
  
  
 
548,500
  
Legal fees
  
 
635,238
  
  
 
884,472
  
  
 
487,000
  
Other expenses
  
 
590,859
  
  
 
1,209,693
  
  
 
832,391
  
Consulting fees
  
 
384,104
  
  
 
550,271
  
  
 
366,200
  
Directors’ fees
  
 
348,833
  
  
 
329,000
  
  
 
346,800
  
Insurance
  
 
333,752
  
  
 
348,027
  
  
 
353,135
  
Administration
  
 
261,914
  
  
 
268,146
  
  
 
273,986
  
Printing and postage
  
 
129,942
  
  
 
80,280
  
  
 
103,396
  
 
 
F-7

 
 
MVC Capital, Inc.
 
Consolidated Statements of Operations — (Continued)
                         
 
  
For the Year Ended
October 31, 2012
   
For the Year Ended
October 31, 2011
   
For the Year Ended
October 31, 2010
 
Public relations fees
  
 
119,700
  
   
89,800
  
   
84,000
  
Net Incentive compensation (Note 5)
  
 
(5,937,431
   
1,947,744
  
   
2,479,167
  
 
  
                     
Total operating expenses
  
 
11,315,962
  
   
18,492,180
  
   
18,029,172
  
 
  
                     
Less: Voluntary Expense Waiver by Adviser2
  
 
(150,000
   
(150,000
   
(150,000
Less: Voluntary Management Fee Waiver by Adviser3
  
 
(58,728
   
(100,635
   
  
Less: Voluntary Incentive Fee Waiver by Adviser4
  
 
(2,345,189
   
  
   
  
 
  
                     
Total waivers
  
 
(2,553,917
   
(250,635
   
(150,000
 
  
                     
Net operating income (loss) before taxes
  
 
21,125,067
  
   
(2,270,580
   
5,642,325
  
 
  
                     
Tax Expenses:
  
                     
Current tax expense
  
 
3,997
  
   
13,557
  
   
8,476
  
 
  
                     
Total tax expense
  
 
3,997
  
   
13,557
  
   
8,476
  
 
  
                     
Net operating income (loss)
  
 
21,121,070
  
   
(2,284,137
   
5,633,849
  
 
  
                     
Net Realized and Unrealized Gain (Loss) on
  
                     
Investments and foreign currency:
  
                     
Net realized (loss) gain on investments and foreign currency
  
                     
Non-control/Non-affiliated investments
  
 
(19,209,277
   
(16,339,803
   
(205,245
Affiliate investments
  
 
  
   
(10,081,806
   
36,111,253
  
Control investments
  
 
(1,309,156
   
  
   
(3,717,209
Foreign currency
  
 
  
   
  
   
(389
 
  
                     
Total net realized (loss) gain on investments and foreign currency
  
 
(20,518,433
   
(26,421,609
   
32,188,410
  
Net change in unrealized (depreciation) appreciation on investments
  
 
(22,257,313
   
35,676,725
  
   
(21,689,497
 
  
                     
Net realized (loss) gain and net change in unrealized (depreciation) appreciation on investments and foreign currency
  
 
(42,775,746
   
9,255,116
  
   
10,498,913
  
 
  
                     
Net (decrease) increase in net assets resulting from operations
  
$
(21,654,676
 
$
6,970,979
  
 
$
16,132,762
  
 
  
                     
Net (decrease) increase in net assets per share resulting from operations
  
$
(0.90
 
$
0.30
  
 
$
0.66
  
 
  
                     
Dividends declared per share
  
$
0.495
  
 
$
0.480
  
 
$
0.480
  
 

1
These items are related to the management of the MVC Private Equity Fund, L.P. (“PE Fund”). Please see Note 4 “Management” for more information.

2
Reflects TTG Advisers’ voluntary waiver of $150,000 of expenses for the 2012, 2011 and 2010 fiscal years that the Company would otherwise be obligated to reimburse TTG Advisers under the Advisory Agreement. Please see Note 4 “Management” for more information.

3
Reflects TTG Advisers’ voluntary agreement that any assets of the Company invested in exchange-traded funds or the Octagon High Income Cayman Fund Ltd. would not be taken into the calculation of the base management fee due to TTG Advisers under the Advisory Agreement. Please see Note 4 “Management” for more information.

4
Reflects TTG Advisers’ voluntary waiver of the Incentive Fee associated with pre-incentive fee net operationg income for the fiscal year ended October 31, 2012. Please see Note 4 “Management” for more information.
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-8

 
 
MVC Capital, Inc.
 
Consolidated Statements of Cash Flows
                         
 
  
For the Year Ended
October 31, 2012
   
For the Year Ended
October 31, 2011
   
For the Year Ended
October 31, 2010
 
Cash flows from Operating Activities:
  
                     
Net (decrease) increase in net assets resulting from operations
  
$
(21,654,676
 
$
6,970,979
  
 
$
16,132,762
  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
  
                     
Net realized loss (gain)
  
 
20,518,433
  
   
26,421,609
  
   
(32,188,410
Net change in unrealized depreciation (appreciation)
  
 
22,257,313
  
   
(35,676,725
   
21,689,497
  
Amortization of discounts and fees
  
 
(62,602
   
(34,327
   
(15,517
Increase in accrued payment-in-kind dividends and interest
  
 
(3,131,042
   
(3,174,721
   
(5,561,308
Increase in allocation of flow through income
  
 
(188,138
   
(589,371
   
(298,058
Changes in assets and liabilities:
  
                     
Dividends, interest and fees receivable
  
 
(952
   
(1,498,553
   
(988,981
Escrow receivables
  
 
155,336
  
   
916,521
  
   
(2,063,420
Prepaid expenses
  
 
(123,633
   
934,438
  
   
(292,953
Prepaid taxes
  
 
(591
   
78,463
  
   
299,420
  
Incentive compensation (Note 5)
  
 
(8,282,620
   
1,947,744
  
   
2,479,167
  
Other liabilities
  
 
1,099,702
  
   
271,525
  
   
(1,190,987
Purchases of equity investments
  
 
(8,439,513
   
(39,507,490
   
(6,456,751
Purchases of debt instruments
  
 
(2,860,000
   
(25,909,586
   
(2,500,000
Proceeds from equity investments
  
 
18,187,072
  
   
20,630,017
  
   
71,987,346
  
Proceeds from debt instruments
  
 
1,762,916
  
   
39,526,996
  
   
22,244,985
  
 
  
                     
Net cash provided by (used in) operating activities
  
 
19,237,005
  
   
(8,692,481
   
83,276,792
  
 
  
                     
Cash flows from Financing Activities:
  
                     
Repurchase of common stock
  
 
  
   
(966,655
   
(3,999,128
Distributions paid to shareholders
  
 
(11,838,907
   
(11,489,032
   
(11,594,909
Net repayments under revolving credit facility
  
 
  
   
  
   
(12,300,000
 
  
                     
Net cash used in financing activities
  
 
(11,838,907
   
(12,455,687
   
(27,894,037
 
  
                     
Net change in cash and cash equivalents for the year
  
 
7,398,098
  
   
(21,148,168
   
55,382,755
  
 
  
                     
Unrestricted and restricted cash and cash equivalents, beginning of year
  
$
35,242,460
  
 
$
56,390,628
  
 
$
1,007,873
  
 
  
                     
Unrestricted and restricted cash and cash equivalents, end of year
  
$
42,640,558
  
 
$
35,242,460
  
 
$
56,390,628
  
 
During the year ended October 31, 2012, 2011 and 2010 MVC Capital, Inc. paid $2,968,757, $2,898,949 and $2,205,644 in interest expense, respectively.
 
During the year ended October 31, 2012, 2011 and 2010 MVC Capital, Inc. paid $6,815, $2,134 and $2,039 in income taxes, respectively.
 
Non-cash activity:
 
During the year ended October 31, 2012, 2011 and 2010, MVC Capital, Inc. recorded payment in kind dividend and interest of $3,131,042, $3,174,721 and $5,561,308, respectively. This amount was added to the principal balance of the investments and recorded as dividend/interest income.
 
 
F-9

 
 
During the year ended October 31, 2012, 2011 and 2010, MVC Capital, Inc. was allocated $442,138, $1,335,755 and $509,712, respectively, in flow-through income from its equity investment in Octagon Credit Investors, LLC. Of these amounts, $254,000, $746,384 and $211,654, respectively, was received in cash and the balance of $188,138, $589,371 and $298,058, respectively, was undistributed and therefore increased the cost of the investment. The fair value was then increased by $188,138, $589,371 and $298,058, respectively, by the Company’s Valuation Committee.
 
On March 17, 2010, MVC Capital, Inc. transferred its equity interest in SGDA Sanierungsgesellschaft fur Deponien und Altlasten GmbH to their equity interest in SGDA Europe B.V. The Company owned 70% of the common stock of SGDA Sanierungsgesellschaft fur Deponien und Altlasten GmbH and a majority economic ownership in SGDA Europe B.V. SGDA Europe B.V. increased its shareholders’ equity by $4.2 million as a result of the cashless transaction.
 
On July 2, 2010, MVC Capital, Inc. sold its common and preferred shares of Vendio Services, Inc. As part of this transaction, there was approximately $180,020 deposited in an escrow account subject to a reduction over an 18 month period in accordance with a specified schedule. This escrow is currently carried at $232,603 on the Company’s consolidated balance sheet.
 
On November 30, 2010, a public Uniform Commercial Code (“UCC”) sale of Harmony Pharmacy’s assets took place. Prior to this sale, the Company formed a new entity, Harmony Health & Beauty, Inc. (“HH&B”). The Company assigned its secured debt interest in Harmony Pharmacy of approximately $6.4 million to HH&B in exchange for a majority of the economic ownership. At the UCC sale, HH&B submitted a successful credit bid of approximately $5.9 million for all of the assets of Harmony Pharmacy. On December 21, 2010, Harmony Pharmacy filed for dissolution in the states of California, New Jersey and New York. As a result, the Company realized an $8.4 million loss on its investment in Harmony Pharmacy.
 
On January 11, 2011, SHL Group Limited acquired the Company’s portfolio company PreVisor. The Company received 1,518,762 common shares of SHL Group Limited for its investment in PreVisor. The cost basis and market value of the Company’s investment remained unchanged as a result of the transaction.
 
On April 29, 2011, assets from a division of Ohio Medical were distributed to Ohio Medical shareholders on a pro-rata basis. The Company received 281 shares of common stock in NPWT Corporation as part of this transaction.
 
On October 17, 2011, MVC Capital, Inc. converted the SGDA Europe B.V. senior secured loan of $1.5 million to additional common equity interest.
 
On December 12, 2011, BP Clothing, LLC (“BP”) filed for Chapter 11 protection in New York with agreement to turn ownership over to secured lenders under a bankruptcy reorganization plan. On June 20, 2012, BP completed the bankruptcy process which resulted in a realized loss of approximately $23.4 million on the second lien loan, term loan A and term loan B. As a result of the bankruptcy process, the Company received limited liability company interest in BPC II, LLC (“BPC”).
 
On January 13, 2012, the Company received free warrants related to their debt investment in Freshii USA, Inc. The Company allocated the cost basis in the investment between the senior secured loan and the warrant at the time the investment was made. The Company will amortize the discount associated with the warrant over the four year life of the loan. During the year ended October 31, 2012, the Company recorded $6,793 of amortization.
 
On March 23, 2012, the Company sold its shares in the Octagon High Income Cayman Fund Ltd. (“Octagon Fund”). As part of this transaction, there was $152,000 held back until Octagon Fund’s fiscal year 2012 audit is complete.
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-10

 
 
MVC Capital, Inc.
 
Consolidated Statements of Changes in Net Assets
                         
 
  
For the Year Ended
October 31, 2012
   
For the Year Ended
October 31, 2011
   
For the Year Ended
October 31, 2010
 
Operations:
  
                     
Net operating income (loss)
  
$
21,121,070
  
 
$
(2,284,137
 
$
5,633,849
  
Net realized (loss) gain on investments and foreign currencies
  
 
(20,518,433
   
(26,421,609
   
32,188,410
  
Net change in unrealized (depreciation) appreciation on investments
  
 
(22,257,313
   
35,676,725
  
   
(21,689,497
 
  
                     
Net (decrease) increase in net assets from operations
  
 
(21,654,676
   
6,970,979
  
   
16,132,762
  
 
  
                     
Shareholder Distributions from:
  
                     
Income
  
 
(11,838,907
   
  
   
(5,633,849
Realized gain
  
 
  
   
  
   
(1,910,585
Return of capital
  
 
  
   
(11,489,032
   
(4,050,475
 
  
                     
Net decrease in net assets from shareholder distributions
  
 
(11,838,907
   
(11,489,032
   
(11,594,909
 
  
                     
Capital Share Transactions:
  
                     
Repurchase of common stock
  
 
  
   
(966,655
   
(3,999,128
 
  
                     
Net decrease in net assets from capital share transactions
  
 
  
   
(966,655
   
(3,999,128
 
  
                     
Total (decrease) increase in net assets
  
 
(33,493,583
   
(5,484,708
   
538,725
  
 
  
                     
Net assets, beginning of year
  
 
419,509,716
  
   
424,994,424
  
   
424,455,699
  
 
  
                     
Net assets, end of year
  
$
386,016,133
  
 
$
419,509,716
  
 
$
424,994,424
  
 
  
                     
Common shares outstanding, end of year
  
 
23,916,982
  
   
23,916,982
  
   
23,990,987
  
 
  
                     
Undistributed net operating income
  
$
9,282,163
  
 
$
  
 
$
  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-11

 
 
MVC Capital, Inc.
 
Consolidated Selected Per Share Data and Ratios
                                         
   
For the
Year  Ended
October 31,
2012
   
For the
Year Ended
October 31,
2011
   
For the
Year Ended
October 31,
2010
   
For the
Year Ended
October 31,
2009
   
For the
Year Ended
October 31,
2008
 
Net asset value, beginning of year
 
$
17.54
  
 
$
17.71
  
 
$
17.47
  
 
$
17.36
  
 
$
15.21
  
Gain from operations:
                                       
Net operating income (loss)
   
0.88
  
   
(0.10
   
0.23
  
   
0.19
  
   
0.24
  
Net realized and unrealized (loss) gain on investments
   
(1.78
   
0.40
  
   
0.43
  
   
0.40
  
   
2.39
  
                                         
Total (loss) gain from investment operations
   
(0.90
   
0.30
  
   
0.66
  
   
0.59
  
   
2.63
  
                                         
Less distributions from:
                                       
Income
   
(0.50
   
  
   
(0.23
   
(0.19
   
(0.09
Realized gain
   
  
   
  
   
(0.08
   
  
   
  
Return of capital
   
  
   
(0.48
   
(0.17
   
(0.29
   
(0.39
                                         
Total distributions
   
(0.50
   
(0.48
   
(0.48
   
(0.48
   
(0.48
                                         
Capital share transactions
                                       
Anti-dilutive effect of share repurchase program
   
  
   
0.01
  
   
0.06
  
   
  
   
  
                                         
Total capital share transactions
   
  
   
0.01
  
   
0.06
  
   
  
   
  
                                         
Net asset value, end of year
 
$
16.14
  
 
$
17.54
  
 
$
17.71
  
 
$
17.47
  
 
$
17.36
  
                                         
Market value, end of year
 
$
12.36
  
 
$
12.93
  
 
$
13.35
  
 
$
9.18
  
 
$
12.30
  
                                         
Market premium (discount)
   
(23.42
)% 
   
(26.28
)% 
   
(24.62
)% 
   
(47.45
%) 
   
(29.15
%) 
Total Return — At NAV (a)
   
(5.21
)% 
   
1.80
   
4.16
   
3.50
   
17.49
Total Return — At Market (a)
   
0.44
   
0.35
   
50.86
   
(21.48
%) 
   
(25.44
%) 
Ratios and Supplemental Data:
                                       
Portfolio turnover ratio
   
3.31
   
13.90
   
3.15
   
3.51
   
26.13
Net assets, end of year (in thousands)
 
$
386,016
  
 
$
419,510
  
 
$
424,994
  
 
$
424,456
  
 
$
421,871
  
Ratios to average net assets:
                                       
Expenses excluding tax expense
   
2.17
   
4.38
   
4.19
   
4.88
   
7.00
Expenses including tax expense
   
2.17
   
4.39
   
4.19
   
5.21
   
6.77
Net operating income (loss) before tax expense
   
5.22
   
(0.54
)% 
   
1.32
   
1.42
   
0.54
Net operating income (loss) after tax expense
   
5.22
   
(0.55
)% 
   
1.32
   
1.09
   
0.77
Ratios to average net assets excluding waivers:
                                       
Expenses excluding tax expense
   
2.80
   
4.44
   
4.22
   
N/A
  
   
N/A
  
Expenses including tax expense
   
2.80
   
4.45
   
4.22
   
N/A
  
   
N/A
  
Net operating income (loss) before tax expense
   
4.59
   
(0.60
)% 
   
1.29
   
N/A
  
   
N/A
  
Net operating income (loss) after tax expense
   
4.59
   
(0.61
)% 
   
1.29
   
N/A
  
   
N/A
  
 
(a)    Total annual return is historical and assumes changes in share price, reinvestments of all dividends and distributions, and no sales charge for the year.
        
(b)    Supplemental Ratio information
       
 
Ratios to average net assets: (b)
                                       
Expenses excluding incentive compensation
   
4.21
   
3.92
   
3.61
   
4.31
   
4.05
Expenses excluding incentive compensation, interest and other borrowing costs
   
3.38
   
3.18
   
2.95
   
3.56
   
2.93
Net operating income (loss) before incentive compensation
   
3.18
   
(0.08
)% 
   
1.90
   
1.99
   
3.49
Net operating income before incentive compensation, interest and other borrowing costs
   
4.01
   
0.66
   
2.56
   
2.74
   
4.61
Ratios to average net assets excluding waivers: (b)
                                       
Expenses excluding incentive compensation
   
4.27
   
3.98
   
3.64
   
N/A
  
   
N/A
  
Expenses excluding incentive compensation, interest and other borrowing costs
   
3.44
   
3.24
   
2.98
   
N/A
  
   
N/A
  
Net operating income (loss) before incentive compensation
   
3.12
   
(0.14
)% 
   
1.87
   
N/A
  
   
N/A
  
Net operating income before incentive compensation, interest and other borrowing costs
   
3.95
   
0.60
   
2.53
   
N/A
  
   
N/A
  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-12

 
 
MVC Capital, Inc.
 
Notes to Consolidated Financial Statements
October 31, 2012
 
1.
Organization and Business Purpose
 
MVC Capital, Inc. and its wholly-owned subsidiaries, MVC Financial Services, Inc. and MVC Cayman (the “Company”), formerly known as meVC Draper Fisher Jurvetson Fund I, Inc., is a Delaware corporation organized on December 2, 1999 which commenced operations on March 31, 2000. On December 2, 2002, the Company announced that it would begin doing business under the name MVC Capital, Inc. The Company’s investment objective is to seek to maximize total return from capital appreciation and/or income. The Company seeks to achieve its investment objective by providing equity and debt financing to companies that are, for the most part, privately owned (“Portfolio Companies”). The Company’s current investments in Portfolio Companies consist principally of senior and subordinated loans, venture capital, mezzanine and preferred instruments and private equity investments.
 
The Company has elected to be treated as a business development company under the 1940 Act. The shares of the Company commenced trading on the NYSE under the symbol MVC on June 26, 2000.
 
The Company had entered into an advisory agreement with meVC Advisers, Inc. (the “Former Advisor”) which had entered into a sub-advisory agreement with Draper Fisher Jurvetson MeVC Management Co., LLC (the “Former Sub-Advisor”). On June 19, 2002, the Former Advisor resigned without prior notice to the Company as the Company’s investment advisor. This resignation resulted in the automatic termination of the advisory agreement between the Former Advisor and the Former Sub-Advisor to the Company. As a result, the Company’s board internalized the Company’s operations, including management of the Company’s investments.
 
At the February 28, 2003 Annual Meeting of Shareholders, a new board of directors (the “Board”) replaced the former board of directors of the Company (the “Former Board”) in its entirety. On March 6, 2003, the results of the election were certified by the Inspector of Elections, whereupon the Board terminated John M. Grillos, the Company’s previous CEO. Shortly thereafter, other members of the Company’s senior management team, who had previously reported to Mr. Grillos, resigned. With these significant changes in the Board and management of the Company, the Company operated in a transition mode and, as a result, no portfolio investments were made from early March 2003 through the end of October 2003 (the end of the Fiscal Year). During this period, the Board explored various alternatives for a long-term management plan for the Company. Accordingly, at the September 16, 2003 Special Meeting of Shareholders, the Board voted and approved the Company’s revised business plan.
 
On November 6, 2003, Michael Tokarz assumed his position as Chairman, Portfolio Manager and Director of the Company.
 
On March 29, 2004 at the Annual Shareholders meeting, the shareholders approved the election of Emilio Dominianni, Robert S. Everett, Gerald Hellerman, Robert C. Knapp and Michael Tokarz to serve as members of the Board of Directors of the Company and adopted an amendment to the Company’s Certificate of Incorporation authorizing the changing of the name of the Company from “meVC Draper Fisher Jurvetson Fund I, Inc.” to “MVC Capital, Inc.”
 
On July 7, 2004, the Company’s name change from “meVC Draper Fisher Jurvetson Fund I, Inc.” to “MVC Capital, Inc.” became effective.
 
On July 16, 2004, the Company commenced the operations of MVC Financial Services, Inc. (“MVCFS”). MVCFS is incorporated in Delaware and its principal purpose is to provide advisory, administrative and other
 
 
F-13

 
 
services to the Company and the Company’s Portfolio Companies. The Company does not hold MVCFS for investment purposes and does not intend to sell MVCFS. On October 14, 2011, the Company formed a wholly-owned subsidiary, MVC Cayman, an exempted company incorporated in the Cayman Islands, to hold certain of its investments. During the fiscal year ended October 31, 2012, MVC Partners was consolidated with the operations of the Company as MVC Partners’ limited partnership interest in the PE Fund is a substantial portion of MVC Partners operations. The consolidation of MVC Partners has not had any material effect on the financial position or net results of operations of the Company.
 
On September 7, 2006, the stockholders of MVC Capital approved the adoption of the investment advisory and management agreement (the “Advisory Agreement”). The Advisory Agreement, which was entered into on October 31, 2006, provides for external management of the Company by TTG Advisers, which is led by Michael Tokarz. The agreement took effect on November 1, 2006. Upon the effectiveness of the Advisory Agreement, Mr. Tokarz’s employment agreement with the Company terminated. All of the individuals (including the Company’s investment professionals) that had been previously employed by the Company as of the fiscal year ended October 31, 2006 became employees of TTG Advisers.
 
On December 11, 2008, our Board of Directors, including all of the directors who are not “interested persons,” as defined under the 1940 Act, of the Company (the “Independent Directors”), at their in-person meeting approved an amended and restated investment advisory and management agreement (also, the “Advisory Agreement”), which was approved by stockholders of the Company on April 14, 2009. The renewal of the Advisory Agreement was last approved by the Independent Directors at their in-person meeting held on October 22, 2012.
 
2.
Consolidation
 
On July 16, 2004, the Company formed a wholly owned subsidiary company, MVCFS. On October 14, 2011, the Company formed a wholly-owned subsidiary, MVC Cayman, an exempted company incorporated in the Cayman Islands, to hold certain of its investments. The results of MVCFS and MVC Cayman are consolidated into the Company and all inter-company accounts have been eliminated in consolidation.
 
During the fiscal year ended October 31, 2012, MVC Partners was consolidated with the operations of the Company as MVC Partners’ limited partnership interest in the PE Fund is a substantial portion of MVC Partners operations. Previously, MVC Partners was presented as a Portfolio Company on the Consolidated Schedule of Investments. The consolidation of MVC Partners has not had any material effect on the financial position or net results of operations of the Company. There are additional disclosures resulting from this consolidation.
 
3.
Significant Accounting Policies
 
The following is a summary of significant accounting policies followed by the Company in the preparation of its consolidated financial statements:
 
The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the consolidated financial statements. Actual results could differ from those estimates.
 
Recent Accounting Pronouncements — On May 12, 2011, the FASB issued Accounting Standards Update No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (“ASU 2011-04”). ASU 2011-04 amends the Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820, which requires entities to change the wording used to describe the requirements in GAAP for measuring fair value and for disclosing information about fair value measurements. ASU 2011-04 clarifies the application of existing fair value measurement and disclosure requirements related to the application of the highest and best use and valuation premise concepts for
 
 
F-14

 
 
financial and nonfinancial instruments, measuring the fair value of an instrument classified in equity, and disclosures about fair value measurements. ASU 2011-04 requires additional disclosures about fair value measurements categorized within Level 3 of the fair value hierarchy, including the valuation processes used by the reporting entity, the sensitivity of the fair value to changes in unobservable inputs, and the interrelationships between those unobservable inputs, if any. All the amendments to ASC 820 made by ASU 2011-04 are effective for interim and annual periods beginning after December 15, 2011. The adoption of this new guidance has not had a material effect on the financial position or results of operations of the Company and has resulted in additional disclosures.
 
Valuation of Investments — ASC 820 defines fair value in terms of the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The price used to measure the fair value is not adjusted for transaction costs while the cost basis of our investments may include initial transaction costs. Under ASC 820, the fair value measurement also assumes that the transaction to sell an asset occurs in the principal market for the asset or, in the absence of a principal market, the most advantageous market for the asset. The principal market is the market in which the reporting entity would sell or transfer the asset with the greatest volume and level of activity for the asset to which the reporting entity has access to as of the measurement date. If no market for the asset exists or if the reporting entity does not have access to the principal market, the reporting entity should use a hypothetical market.
 
Pursuant to our Valuation Procedures, the Valuation Committee (which is comprised of three Independent Directors) determines fair values of Portfolio Company investments on a quarterly basis (or more frequently, if deemed appropriate under the circumstances). Any changes in valuation are recorded in the consolidated statements of operations as “Net change in unrealized appreciation (depreciation) on investments.”
 
Currently, NAV per share is calculated and published on a quarterly basis. The Company calculates NAV per share by subtracting all liabilities from the total value of portfolio securities and other assets and dividing the result by the total number of outstanding shares of common stock on the date of valuation. Fair values of foreign investments determined as of quarter end reflect exchange rates, as applicable, in effect on the last business day of the quarter. Exchange rates fluctuate on a daily basis, sometimes significantly. Exchange rate fluctuations following the most recent fiscal year end are not reflected in the valuations reported in this Annual Report.
 
At October 31, 2012, approximately 88.77% of total assets represented portfolio investments in Portfolio Companies and escrow receivables recorded at fair value (“Fair Value Investments”).
 
Under most circumstances, at the time of acquisition, fair value investments are carried at cost (absent the existence of conditions warranting, in management’s and the Valuation Committee’s view, a different initial value). During the period that an investment is held by the Company, its original cost may cease to approximate fair value as the result of market and investment specific factors. No pre-determined formula can be applied to determine fair value. Rather, the Valuation Committee analyzes fair value measurements based on the value at which the securities of the Portfolio Company could be sold in an orderly disposition over a reasonable period of time between willing parties, other than in a forced or liquidation sale. The liquidity event whereby the Company ultimately exits an investment is generally the sale, the merger, the recapitalization or, in some cases, the initial public offering of the Portfolio Company.
 
There is no one methodology to determine fair value and, in fact, for any portfolio security, fair value may be expressed as a range of values, from which the Company derives a single estimate of fair value. To determine the fair value of a portfolio security, the Valuation Committee analyzes the Portfolio Company’s financial results and projections, publicly traded comparable companies when available, comparable private transactions when available, precedent transactions in the market when available, third-party real estate and asset appraisals if appropriate and available, discounted cash flow analysis, if appropriate, as well as other factors. The Company generally requires, where practicable, Portfolio Companies to provide annual audited and more regular unaudited financial statements, and/or annual projections for the upcoming fiscal year.
 
 
F-15

 
 
The fair value of our portfolio securities is inherently subjective. Because of the inherent uncertainty of fair valuation of portfolio securities and escrow receivables that do not have readily ascertainable market values, our estimate of fair value may significantly differ from the fair value that would have been used had a ready market existed for the securities. Such values also do not reflect brokers’ fees or other selling costs, which might become payable on disposition of such investments.
 
Our investments are carried at fair value in accordance with the 1940 Act and Accounting Standards Codification, ASC 820. In accordance with the 1940 Act, unrestricted minority-owned publicly traded securities for which market quotations are readily available are valued at the closing market quote on the valuation date and majority-owned publicly traded securities and other privately held securities are valued as determined in good faith by the Valuation Committee of the Board of Directors. For legally or contractually restricted securities of companies that are publicly traded, the value is based on the closing market quote on the valuation date minus a discount for the restriction. At October 31, 2012, we did not hold restricted or unrestricted securities of publicly traded companies for which we have a majority-owned interest.
 
ASC 820 provides a framework for measuring the fair value of assets and liabilities and provides guidance regarding a fair value hierarchy which prioritizes information used to measure value. In determining fair value, the Valuation Committee primarily uses the level 3 inputs referenced in ASC 820.
 
If a security is publicly traded, the fair value is generally equal to market value based on the closing price on the principal exchange on which the security is primarily traded unless restricted and a restrict discount is applied.
 
For equity securities of Portfolio Companies, the Valuation Committee estimates the fair value based on market and/or income approach with value then attributed to equity or equity like securities using the enterprise value waterfall (“Enterprise Value Waterfall”) valuation methodology. Under the Enterprise Value Waterfall valuation methodology, the Valuation Committee estimates the enterprise fair value of the Portfolio Company and then waterfalls the enterprise value over the Portfolio Company’s securities in order of their preference relative to one another. To assess the enterprise value of the Portfolio Company, the Valuation Committee weighs some or all of the traditional market valuation methods and factors based on the individual circumstances of the Portfolio Company in order to estimate the enterprise value. The methodologies for performing assets may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the Portfolio Company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the Portfolio Company, and third-party asset and real estate appraisals. For non-performing assets, the Valuation Committee may estimate the liquidation or collateral value of the Portfolio Company’s assets. The Valuation Committee also takes into account historical and anticipated financial results.
 
In assessing enterprise value, the Valuation Committee considers the mergers and acquisitions (“M&A”) market as the principal market in which the Company would sell its investments in Portfolio Companies under circumstances where the Company has the ability to control or gain control of the board of directors of the Portfolio Company (“Control Companies”). This approach is consistent with the principal market that the Company would use for its Portfolio Companies if the Company has the ability to initiate a sale of the Portfolio Company as of the measurement date, i.e., if it has the ability to control or gain control of the board of directors of the Portfolio Company as of the measurement date. In evaluating if the Company can control or gain control of a Portfolio Company as of the measurement date, the Company takes into account its equity securities on a fully diluted basis, as well as other factors.
 
For non-Control Companies, consistent with ASC 820, the Valuation Committee considers a hypothetical secondary market as the principal market in which it would sell investments in those companies.
 
 
F-16

 
 
For loans and debt securities of non-Control Companies (for which the Valuation Committee has identified the hypothetical secondary market as the principal market), the Valuation Committee determines fair value based on the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield (“Market Yield”) valuation methodology. In applying the Market Yield valuation methodology, the Valuation Committee determines the fair value based on such factors as third party broker quotes and market participant assumptions, including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date.
 
Estimates of average life are generally based on market data of the average life of similar debt securities. However, if the Valuation Committee has information available to it that the debt security is expected to be repaid in the near term, the Valuation Committee would use an estimated life based on the expected repayment date.
 
The Valuation Committee determines fair value of loan and debt securities of Control Companies based on the estimate of the enterprise value of the Portfolio Company. To the extent the enterprise value exceeds the remaining principal amount of the loan and all other debt securities of the company, the fair value of such securities is generally estimated to be their cost. However, where the enterprise value is less than the remaining principal amount of the loan and all other debt securities, the Valuation Committee may discount the value of such securities to reflect an impairment.
 
For the Company’s or its subsidiary’s investment in the PE Fund, for which an indirect wholly-owned subsidiary of the Company serves as the GP of the PE Fund, the Valuation Committee relies on the GP’s determination of the Fair Value of the PE Fund which will be generally valued, as a practical expedient, utilizing the net asset valuations provided by the GP, which will be made: (i) no less frequently than quarterly as of the Company’s fiscal quarter end and (ii) with respect to the valuation of PE Fund investments in Portfolio Companies, will be based on methodologies consistent with those set forth in the valuation procedures. The determination of the net asset value of the Company’s or its subsidiary’s investment in the PE Fund will follow the methodologies described for valuing interests in private investment funds (“Investment Vehicles”) described below. Additionally, when both the Company and the PE Fund hold investments in the same Portfolio Company, the GP’s Fair Value determination shall be based on the Valuation Committee’s determination of the Fair Value of the Company’s portfolio security in that Portfolio Company.
 
As permitted under GAAP, the Company’s interests in private investment funds are generally valued, as a practical expedient, utilizing the net asset valuations provided by management of the underlying Investment Vehicles, without adjustment, unless TTG Advisers is aware of information indicating that a value reported does not accurately reflect the value of the Investment Vehicle, including any information showing that the valuation has not been calculated in a manner consistent with GAAP. Net unrealized appreciation (depreciation) of such investments is recorded based on the Company’s proportionate share of the aggregate amount of appreciation (depreciation) recorded by each underlying Investment Vehicle. The Company’s proportionate investment interest includes its share of interest and dividend income and expense, and realized and unrealized gains and losses on securities held by the underlying Investment Vehicles, net of operating expenses and fees. Realized gains and losses on distributions from Investment Vehicles are generally recognized on a first in, first out basis.
 
The Company applies the practical expedient to interests in Investment Vehicles on an investment by investment basis, and consistently with respect to the Company’s entire interest in an investment. The Company may adjust the valuation obtained from an Investment Vehicle with a premium, discount or reserve if it determines that the net asset value is not representative of fair value.
 
If the Company intends to sell all or a portion of its interest in an Investment Vehicle to a third-party in a privately negotiated transaction near the valuation date, the Company will consider offers from third parties to buy the interest in an Investment Vehicle in valuations, which may be discounted for both probability of close and time.
 
 
F-17

 
 
When the Company receives nominal cost warrants or free equity securities (“nominal cost equity”) with a debt security, the Company typically allocates its cost basis in the investment between debt securities and nominal cost equity at the time of origination.
 
Interest income, adjusted for amortization of premium and accretion of discount on a yield to maturity methodology, is recorded on an accrual basis to the extent that such amounts are expected to be collected. Origination and/or closing fees associated with investments in Portfolio Companies are accreted into income over the respective terms of the applicable loans. Upon the prepayment of a loan or debt security, any prepayment penalties and unamortized loan origination, closing and commitment fees are recorded as income. Prepayment premiums are recorded on loans when received. Dividend income, if any, is recognized on an accrual basis on the ex-dividend date to the extent that the Company expects to collect such amounts.
 
For loans, debt securities, and preferred securities with contractual payment-in-kind interest or dividends, which represent contractual interest/dividends accrued and added to the loan balance or liquidation preference that generally becomes due at maturity, the Company will not ascribe value to payment-in-kind interest/dividends, if the Portfolio Company valuation indicates that the payment-in-kind interest is not collectible. However, the Company may ascribe value to payment-in-kind interest if the health of the Portfolio Company and the underlying securities are not in question. All payment-in-kind interest that has been added to the principal balance or capitalized is subject to ratification by the Valuation Committee.
 
Escrows from the sale of a Portfolio Company are generally valued at an amount which may be expected to be received from the buyer under the escrow’s various conditions discounted for both risk and time.
 
ASC 460, Guarantees, requires the Company to estimate the fair value of the guarantee obligation at its inception and requires the Company to assess whether a probable loss contingency exists in accordance with the requirements of ASC 450, Contingencies. The Valuation Committee typically will look at the pricing of the security in which the guarantee provided support for the security and compare it to the price of a similar or hypothetical security without guarantee support. The difference in pricing will be discounted for time and risk over the period in which the guarantee is expected to remain outstanding.
 
Investment Classification — We classify our investments by level of control. As defined in the 1940 Act, “Control Investments” are investments in those companies that we are deemed to “Control.” “Affiliate Investments” are investments in those companies that are “Affiliated Companies” of us, as defined in the 1940 Act, other than Control Investments. “Non-Control/Non-Affiliate Investments” are those that are neither Control Investments nor Affiliate Investments. Generally, under that 1940 Act, we are deemed to control a company in which we have invested if we own 25% or more of the voting securities of such company or have greater than 50% representation on its board. We are deemed to be an affiliate of a company in which we have invested if we own 5% or more and less than 25% of the voting securities of such company.
 
Investment Transactions and Related Operating Income — Investment transactions and related revenues and expenses are accounted for on the trade date. The cost of securities sold is determined on a first-in, first-out basis, unless otherwise specified. Dividend income and distributions on investment securities is recorded on the ex-dividend date. The tax characteristics of such distributions received from our Portfolio Companies will be determined by whether or not the distribution was made from the investment’s current taxable earnings and profits or accumulated taxable earnings and profits from prior years. Interest income, which includes accretion of discount and amortization of premium, if applicable, is recorded on the accrual basis to the extent that such amounts are expected to be collected. Fee income includes fees for guarantees and services rendered by the Company or its wholly-owned subsidiary to Portfolio Companies and other third parties such as due diligence, structuring, transaction services, monitoring services, and investment advisory services. Guaranty fees are recognized as income over the related period of the guaranty. Due diligence, structuring, and transaction services fees are generally recognized as income when services are rendered or when the related transactions are
 
 
F-18

 
 
completed. Monitoring and investment advisory services fees are generally recognized as income as the services are rendered. Any fee income determined to be loan origination fees, original issue discount, and market discount are capitalized and then amortized into income using the effective interest method. Upon the prepayment of a loan or debt security, any unamortized loan origination fees are recorded as income and any unamortized original issue discount or market discount is recorded as a realized gain. For investments with PIK interest and dividends, we base income and dividend accrual on the valuation of the PIK notes or securities received from the borrower. If the Portfolio Company indicates a value of the PIK notes or securities that is not sufficient to cover the contractual interest or dividend, the Company does not accrue interest or dividend income on the notes or securities.
 
The functional currency of the Company is the U.S. Dollar. Assets and liabilities denominated in a currency other than the U.S. Dollar are translated into U.S. Dollars at the closing rates of exchange on the date of determination. Purchases and sales of investments and income and expenses denominated in currencies other than U.S. Dollars are translated at the rates of exchange on the respective dates of the transactions. The resulting gains and losses from such currency translation are included in the Consolidated Statement of Operations. The Company does not isolate the portion of the results of operations resulting from the changes in foreign exchange rates on investments from the fluctuation arising from changes in fair values of securities held. Such fluctuations are included with the Net Realized and Unrealized Gain (Loss) on Investments and foreign currency in the Consolidated Statement of Operations.
 
Cash Equivalents — For the purpose of the Consolidated Balance Sheets and Consolidated Statements of Cash Flows, the Company considers all money market and all highly liquid temporary cash investments purchased with an original maturity of less than three months to be cash equivalents. As of October 31, 2012, the Company had approximately $26.8 million in cash equivalents of the total cash and cash equivalents of approximately $42.6 million.
 
Restricted Cash and Cash Equivalents Cash and cash equivalent accounts that are not available to the Company for day to day use are classified as restricted cash. Restricted cash and cash equivalents are carried at cost, which approximates fair value. On April 26, 2011, the Company agreed to collateralize a 5.0 million Euro letter of credit from JPMorgan Chase Bank, N.A., which is classified as restricted cash on the Company’s consolidated balance sheet (equivalent to approximately $6.5 million at October 31, 2012).
 
Restricted Securities — The Company may invest in privately placed restricted securities. These securities may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and a prompt sale at an acceptable price may be difficult.
 
Reclassifications — Certain amounts from prior years have been reclassified to conform to the current year presentation.
 
Distributions to Shareholders — Distributions to shareholders are recorded on the ex-dividend date.
 
Income Taxes — It is the policy of the Company to meet the requirements for qualification as a regulated investment company (“RIC”) under Subchapter M of the Code. The Company is not subject to income tax to the extent that it distributes all of its investment company taxable income and net realized gains for its taxable year. The Company is also exempt from excise tax if it distributes most of its ordinary income and/or capital gains during each calendar year.
 
Our consolidated operating subsidiary, MVCFS, is subject to federal and state income tax. We use the liability method in accounting for income taxes. Deferred tax assets and liabilities are recorded for temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, using statutory tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized.
 
 
F-19

 
 
ASC 740, Income Taxes, provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statement of operations. During the fiscal year ended October 31, 2012, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal for the Company and MVCFS. The fiscal years 2009, 2010, 2011 and 2012 for the Company and the fiscal years 2009, 2010, 2011 and 2012 for MVCFS remain subject to examination by the IRS.
 
4.
Management
 
On November 6, 2003, Michael Tokarz assumed his positions as Chairman, Portfolio Manager and Director of the Company. From November 6, 2003 to October 31, 2006, the Company was internally managed. Effective November 1, 2006, Mr. Tokarz’s employment agreement with the Company terminated and the obligations under Mr. Tokarz’s agreement were superseded by those under the Advisory Agreement entered into with TTG Advisers. Under the terms of the Advisory Agreement, the Company pays TTG Advisers a base management fee and an incentive fee for its provision of investment advisory and management services.
 
Our Board of Directors, including all of the directors who are not “interested persons,” as defined under the 1940 Act, of the Company (the “Independent Directors”), last approved a renewal of the Advisory Agreement at their in-person meeting held on October 23, 2012.
 
Under the terms of the Advisory Agreement, TTG Advisers determines, consistent with the Company’s investment strategy, the composition of the Company’s portfolio, the nature and timing of the changes to the Company’s portfolio and the manner of implementing such changes. TTG Advisers also identifies and negotiates the structure of the Company’s investments (including performing due diligence on prospective Portfolio Companies), closes and monitors the Company’s investments, determines the securities and other assets purchased, retains or sells and oversees the administration, recordkeeping and compliance functions of the Company and/or third parties performing such functions for the Company. TTG Advisers’ services under the Advisory Agreement are not exclusive, and it may furnish similar services to other entities. Pursuant to the Advisory Agreement, the Company is required to pay TTG Advisers a fee for investment advisory and management services consisting of two components—a base management fee and an incentive fee. The base management fee is calculated at 2.0% per annum of the Company’s total assets excluding cash, the value of any investment in a Third-Party Vehicle covered by a Separate Agreement (as defined in the Advisory Agreement) and the value of any investment by the Company not made in portfolio companies (“Non-Eligible Assets”) but including assets purchased with borrowed funds that are not Non-Eligible Assets. The incentive fee consists of two parts: (i) one part is based on our pre-incentive fee net operating income; and (ii) the other part is based on the capital gains realized on our portfolio of securities acquired after November 1, 2003.
 
The Advisory Agreement provides for an expense cap pursuant to which TTG Advisers will absorb or reimburse operating expenses of the Company, to the extent necessary to limit the Company’s expense ratio (the consolidated expenses of the Company, including any amounts payable to TTG Advisers under the base management fee, but excluding the amount of any interest and other direct borrowing costs, taxes, incentive compensation and extraordinary expenses taken as a percentage of the Company’s average net assets) to 3.5% in each of the 2009 and 2010 fiscal years.
 
On October 25, 2010, October 26, 2011 and October 23, 2012, TTG Advisers and the Company entered into an agreement to extend the expense cap of 3.5% to the 2011, 2012 and 2013 fiscal years, respectively (“Expense Limitation Agreement”). The amount of any payments made by the GP of the PE Fund to TTG Advisers pursuant
 
 
F-20

 
 
to the Portfolio Management Agreement between the GP and TTG Advisers respecting the PE Fund is excluded from the calculation of the Company’s expense ratio under the Expense Limitation Agreement. In addition, for fiscal years 2010 through 2013, TTG Advisers has voluntarily agreed to waive $150,000 of expenses that the Company is obligated to reimburse to TTG Advisers under the Advisory Agreement (the “Voluntary Waiver”). TTG Advisers has also voluntarily agreed that any assets of the Company that are invested in exchange-traded funds or the Octagon Fund would not be taken into account in the calculation of the base management fee due to TTG Advisers under the Advisory Agreement.
 
On October 29, 2010, through MVC Partners and MVCFS, the Company committed to invest approximately $20.1 million in the PE Fund. The PE Fund has closed on approximately $104 million of capital commitments. The Company’s Board of Directors authorized the establishment of, and investment in, the PE Fund for a variety of reasons, including the Company’s ability to make additional investments that represent more than 5% of its total assets or more than 10% of the outstanding voting securities of the issuer (“Non-Diversified Investments”) through the PE Fund. As previously disclosed, the Company is currently restricted from making Non-Diversified Investments. For services provided to the PE Fund, the GP and MVC Partners are together entitled to receive 25% of all management fees and other fees paid by the PE Fund and its portfolio companies and up to 30% of the carried interest generated by the PE Fund. Further, at the direction of the Board of Directors, the GP retained TTG Advisers to serve as the portfolio manager of the PE Fund. In exchange for providing those services, and pursuant to the Board of Directors’ authorization and direction, TTG Advisers is entitled to receive the balance of the fees generated by the PE Fund and its portfolio companies and a portion of any carried interest generated by the PE Fund. Given this separate arrangement with the GP and the PE Fund (the “PM Agreement”), under the terms of the Company’s Advisory Agreement with TTG Advisers, TTG Advisers is not entitled to receive from the Company a management fee or an incentive fee on assets of the Company that are invested in the PE Fund. During the fiscal year ended October 31, 2012, MVC Partners was consolidated with the operations of the Company as MVC Partners’ limited partnership interest in the PE Fund is a substantial portion of MVC Partners operations. Previously, MVC Partners was presented as a Portfolio Company on the Consolidated Schedule of Investments. The consolidation of MVC Partners has not had any material effect on the financial position or net results of operations of the Company. There are additional disclosures resulting from this consolidation.
 
Management and portfolio fees (e.g., closing or monitoring fees) generated by the PE Fund (including its portfolio companies) that are paid to the GP are classified on the consolidated statements of operations as Management fee income — Asset Management and Portfolio fee income — Asset Management, respectively. The portion of such fees that the GP pays to TTG Advisers (in accordance with its PM Agreement described above) are classified on the consolidated statements of operations as Management fee — Asset Management and Portfolio fees — Asset Management. Under the PE Fund’s agreements, a significant portion of the portfolio fees that are paid by the PE Fund’s portfolio companies to the GP and TTG Advisers is subject to recoupment by the PE Fund in the form of an offset to future management fees paid by the PE Fund.
 
5.
Incentive Compensation
 
Effective November 1, 2006, Mr. Tokarz’s employment agreement with the Company terminated and the obligations under Mr. Tokarz’s agreement were superseded by those under the Advisory Agreement entered into with TTG Advisers. Pursuant to the Advisory Agreement, the Company pays an incentive fee to TTG Advisers which is generally: (i) 20% of pre-incentive fee net operating income and (ii) 20% of cumulative aggregate net realized capital gains less aggregate unrealized depreciation (on our portfolio securities acquired after November 1, 2003). TTG Advisers is entitled to an incentive fee with respect to our pre-incentive fee net operating income in each fiscal quarter as follows: no incentive fee in any fiscal quarter in which our pre-incentive fee net operating income does not exceed the lower hurdle rate of 1.75% of net assets, 100% of our pre-incentive fee net operating income with respect to that portion of such pre-incentive fee net operating income, if any, that exceeds the lower hurdle amount but is less than 2.1875% of net assets in any fiscal quarter
 
 
F-21

 
 
and 20% of the amount of our pre-incentive fee net operating income, if any, that exceeds 2.1875% of net assets in any fiscal quarter. Under the Advisory Agreement, the accrual of the provision for incentive compensation for net realized capital gains is consistent with the accrual that was required under the employment agreement with Mr. Tokarz.
 
At October 31, 2009, the provision for estimated incentive compensation was approximately $19.5 million. During the fiscal year ended October 31, 2010, this provision for incentive compensation was increased by a net amount of approximately $2.5 million to $22.0 million. The increase in the provision for incentive compensation reflects both increases and decreases by the Valuation Committee in the fair values of certain Portfolio Companies and the sale of Vitality for a realized gain of $13.9 million. The difference between the amount received from the sale and Vitality’s carrying value at October 31, 2009 was an increase of $3.0 million. The amount of the provision also reflects the Valuation Committee’s determination to increase the fair values of eight of the Company’s portfolio investments (Octagon, Summit, Velocitius, LHD Europe, PreVisor, U.S. Gas, Vestal and Dakota Growers) by a total of $54.2 million. The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $6.8 million due to PIK distributions, which were treated as a return of capital. The net increase in the provision also reflects the Valuation Committee’s determination to decrease the fair values of ten of the Company’s portfolio investments (Amersham, BP, Ohio Medical, MVC Automotive, Security Holdings, Harmony Pharmacy, GDC, SGDA Europe, Turf and SGDA) by a total of $50.5 million and the Valuation Committee determination not to increase the fair values of the Harmony Pharmacy revolving credit facility, the Amersham loan, the BP second lien loan and the GDC senior subordinated loan for the accrued PIK interest totaling approximately $656,000. As of October 31, 2010, the Company does not anticipate an incentive compensation payment being made to TTG Advisers for fiscal year 2010 because 20% of cumulative aggregate net realized capital gains was than less than the aggregate unrealized depreciation (on our portfolio securities acquired after November 1, 2003) based on the terms of the Advisory Agreement. During the fiscal year ended October 31, 2010, there was no provision recorded for the net operating income portion of the incentive fee as pre-incentive fee net operating income did not exceed the hurdle rate.
 
At October 31, 2010, the provision for estimated incentive compensation was approximately $22.0 million. During the fiscal year ended October 31, 2011, this provision for incentive compensation was increased by a net amount of approximately $1.9 million to approximately $23.9 million. The increase in the provision for incentive compensation during the fiscal year ended October 31, 2011 reflects both increases and decreases by the Valuation Committee in the fair values of certain Portfolio Companies. The provision also reflects the sale of the SPDR Barclays Capital High Yield Bond Fund and the iShares S&P U.S. Preferred Stock Index Fund for a realized gain of approximately $106,000, a realized gain of approximately $55,000 from the Octagon Fund, a realized gain of approximately 317,000 from LHD Europe and a realized loss from the sale of HuaMei of $2.0 million. Specifically, it reflects the Valuation Committee’s determination to increase the fair values of six of the Company’s portfolio investments (Summit, SHL Group Limited, Security Holdings, Total Safety, U.S. Gas, and Velocitius) by a total of approximately $39.7 million. The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $1.9 million due to PIK distributions, which were treated as a return of capital. The net increase in the provision also reflects the Valuation Committee’s determination to decrease the fair values of eleven of the Company’s portfolio investments (BP, Ohio Medical common and preferred stock, MVC Automotive, HuaMei, Tekers, Octagon Fund, NPWT, SGDA Europe, Vestal and HH&B) by a total of $32.1 million. During the fiscal year ended October 31, 2011, there was no provision recorded for the net operating income portion of the incentive fee as pre-incentive fee net operating income did not exceed the hurdle rate.
 
At October 31, 2011, the provision for estimated incentive compensation was approximately $23.9 million. During the fiscal year ended October 31, 2012, this provision for incentive compensation was decreased by a net amount of approximately $8.2 million to approximately $15.7 million. The decrease in the provision for incentive compensation during the fiscal year ended October 31, 2012 reflects both increases and decreases by the Valuation Committee in the fair values of certain Portfolio Companies. Specifically, it reflects the Valuation Committee’s determination to decrease the fair values of eleven portfolio investments (BP, HH&B, MVC
 
 
F-22

 
 
Automotive, Security Holdings, SGDA Europe, NPWT, Tekers, Velocitius, BPC, Centile and Ohio Medical) by a total of $35.4 million and the dividend distribution of $12.0 million received from Summit. The net decrease in the provision also reflects the Valuation Committee’s determination to increase the fair values of five portfolio investments (Octagon Fund, Vestal, Octagon, Turf and RuMe) by a total of approximately $5.7 million. The Valuation Committee also increased the fair value of the Company’s escrow receivable related to Vitality by $130,000. For the year ended October 31, 2012, a provision of approximately $2.3 million was recorded for the net operating income portion of the incentive fee as pre-incentive fee net operating income exceeded the hurdle rate for the quarter ended April 30, 2012. TTG Advisers has voluntarily agreed to waive the income-related incentive fee payment of approximately $2.3 million that the Company would otherwise be obligated to pay to TTG Advisers under the Advisory Agreement.
 
6.
Dividends and Distributions to Shareholders
 
As a RIC, the Company is required to distribute to its shareholders, in a timely manner, at least 90% of its investment company taxable income and tax-exempt income each year. If the Company distributes, in a calendar year, at least 98% of its income and 98.2% of its capital gains of such calendar year (as well as any portion of the respective 2% balances not distributed in the previous year), it will not be subject to the 4% non-deductible federal excise tax on certain undistributed income of RICs.
 
Dividends and capital gain distributions, if any, are recorded on the ex-dividend date. Dividends and capital gain distributions are generally declared and paid quarterly according to the Company’s policy established on July 11, 2005. An additional distribution may be paid by the Company to avoid imposition of federal income tax on any remaining undistributed net investment income and capital gains. Distributions can be made payable by the Company either in the form of a cash distribution or a stock dividend. The amount and character of income and capital gain distributions are determined in accordance with income tax regulations which may differ from U.S. generally accepted accounting principles. These differences are due primarily to differing treatments of income and gain on various investment securities held by the Company, differing treatments of expenses paid by the Company, timing differences and differing characterizations of distributions made by the Company. Key examples of the primary differences in expenses paid are the accounting treatment of MVCFS (which is consolidated for GAAP purposes, but not income tax purposes) and the variation in treatment of incentive compensation expense. Permanent book and tax basis differences relating to shareholder distributions will result in reclassifications and may affect the allocation between net operating income, net realized gain (loss) and paid-in capital.
 
All of our shareholders who hold shares of common stock in their own name will automatically be enrolled in our dividend reinvestment plan (the “Plan”). All such shareholders will have any cash dividends and distributions automatically reinvested by the Plan Agent in additional shares of our common stock. Of course, any shareholder may elect to receive his or her dividends and distributions in cash. Currently, the Company has a policy of seeking to pay quarterly dividends to shareholders. For any of our shares that are held by banks, brokers or other entities that hold our shares as nominees for individual shareholders, the Plan Agent will administer the Plan on the basis of the number of shares certified by any nominee as being registered for shareholders that have not elected to receive dividends and distributions in cash. To receive your dividends and distributions in cash, shareholders must notify the Plan Agent, broker or other entity that holds the shares.
 
For the Fiscal Year Ended October 31, 2012
 
On December 16, 2011, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on January 6, 2012 to shareholders of record on December 30, 2011. The total distribution amounted to $2,870,038.
 
During the quarter ended January 31, 2012, as part of the Company’s dividend reinvestment plan for our common stockholders, the Plan Agent purchased 1,108 shares of common stock at an average price of $11.98, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
 
F-23

 
 
On April 13, 2012, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on April 30, 2012 to shareholders of record on April 23, 2012. The total distribution amounted to $2,870,038.
 
During the quarter ended April 30, 2012, as part of the Company’s dividend reinvestment plan for our common stockholders, the Plan Agent purchased 648 shares of common stock at an average price of $12.95, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
On July 13, 2012, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on July 31, 2012 to shareholders of record on July 24, 2012. The total distribution amounted to $2,870,038.
 
During the quarter ended July 31, 2012, as part of the Company’s dividend reinvestment plan for our common stockholders, the Plan Agent purchased 671 shares of common stock at an average price of $12.55, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
On October 15, 2012, the Company’s Board of Directors declared a dividend of $0.135 per share. The dividend was payable on October 31, 2012 to shareholders of record on October 25, 2012 and represents a 12.5% increase over the prior dividend. The total distribution amounted to $3,228,793.
 
During the quarter ended October 31, 2012, as part of the Company’s dividend reinvestment plan for our common stockholders, the Plan Agent purchased 766 shares of common stock at an average price of $12.29, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
For the Fiscal Year Ended October 31, 2011
 
On December 17, 2010, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on January 7, 2011 to shareholders of record on December 31, 2010. The total distribution amounted to $2,878,918.
 
During the quarter ended January 31, 2011, as part of the Company’s dividend reinvestment plan for our common stockholders, the Company purchased 1,211 shares of common stock at an average price of $14.86, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
On April 15, 2011, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on April 29, 2011 to shareholders of record on April 25, 2011. The total distribution amounted to $2,870,038.
 
During the quarter ended April 30, 2011, as part of the Company’s dividend reinvestment plan for our common stockholders, the Company purchased 1,252 shares of common stock at an average price of $13.70, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
On July 15, 2011, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on July 29, 2011 to shareholders of record on July 25, 2011. The total distribution amounted to $2,870,038.
 
 
F-24

 
 
During the quarter ended July 31, 2011, as part of the Company’s dividend reinvestment plan for our common stockholders, the Company purchased 1,693 shares of common stock at an average price of $12.56, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
On October 14, 2011, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on October 31, 2011 to shareholders of record on October 24, 2011. The total distribution amounted to $2,870,038.
 
During the quarter ended October 31, 2011, as part of the Company’s dividend reinvestment plan for our common stockholders, the Company purchased 1,492 shares of common stock at an average price of $12.82, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
For the Fiscal Year Ended October 31, 2010
 
On December 18, 2009, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on January 8, 2010 to shareholders of record on December 31, 2009. The total distribution amounted to $2,915,650.
 
During the quarter ended January 31, 2010, as part of the Company’s dividend reinvestment plan for our common stockholders, the Company purchased 1,890 shares of common stock at an average price of $12.27, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
On April 16, 2010, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on April 30, 2010 to shareholders of record on April 27, 2010. The total distribution amounted to $2,915,650.
 
During the quarter ended April 30, 2010, as part of the Company’s dividend reinvestment plan for our common stockholders, the Company purchased 1,315 shares of common stock at an average price of $14.75, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
On July 16, 2010, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on July 30, 2010 to shareholders of record on July 27, 2010. The total distribution amounted to $2,884,691.
 
During the quarter ended July 31, 2010, as part of the Company’s dividend reinvestment plan for our common stockholders, the Company purchased 1,377 shares of common stock at an average price of $12.93, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
On October 15, 2010, the Company’s Board of Directors declared a dividend of $0.12 per share. The dividend was payable on October 29, 2010 to shareholders of record on October 25, 2010. The total distribution amounted to $2,878,918.
 
During the quarter ended October 31, 2010, as part of the Company’s dividend reinvestment plan for our common stockholders, the Company purchased 1,337 shares of common stock at an average price of $13.43, including commission, in the open market in order to satisfy the reinvestment portion of our dividends under the Plan.
 
 
F-25

 
 
7.
Transactions with Other Parties
 
The Company has procedures in place for the review, approval and monitoring of transactions involving the Company and certain persons related to the Company. For example, the Company has a code of ethics that generally prohibits, among others, any officer or director of the Company from engaging in any transaction where there is a conflict between such individual’s personal interest and the interests of the Company. As a business development company, the 1940 Act also imposes regulatory restrictions on the Company’s ability to engage in certain related-party transactions. However, the Company is permitted to co-invest in certain Portfolio Companies with its affiliates to the extent consistent with applicable law or regulation and, if necessary, subject to specified conditions set forth in an exemptive order obtained from the SEC. During the past four fiscal years, no transactions were effected pursuant to the exemptive order. As a matter of policy, our Board of Directors has required that any related-party transaction (as defined in Item 404 of Regulation S-K) must be subject to the advance consideration and approval of the Independent Directors, in accordance with applicable procedures set forth in Section 57(f) of the 1940 Act.
 
The principal equity owner of TTG Advisers is Mr. Tokarz, our Chairman. Our senior officers and Mr. Holtsberg, a Director of the Company, have other financial interests in TTG Advisers (i.e., based on TTG Advisers’ performance). In addition, our officers and the officers and employees of TTG Advisers may serve as officers, directors or principals of entities that operate in the same or related line of business as we do or of investment funds managed by TTG Advisers or our affiliates. However, TTG Advisers intends to allocate investment opportunities in a fair and equitable manner. Our Board of Directors has approved a specific policy in this regard which is set forth in this Form 10-K.
 
8.
Concentration of Market and Credit Risk
 
Financial instruments that subjected the Company to concentrations of market risk consisted principally of equity investments, subordinated notes, debt instruments and escrow receivables (other than cash equivalents), which represented approximately 88.77% of the Company’s total assets at October 31, 2012. As discussed in Note 9, these investments consist of securities in companies with no readily determinable market values and as such are valued in accordance with the Company’s fair value policies and procedures. The Company’s investment strategy represents a high degree of business and financial risk due to the fact that the investments (other than cash equivalents) are generally illiquid, in small and middle market companies, and include entities with little operating history or entities that possess operations in new or developing industries. These investments, should they become publicly traded, would generally be (i) subject to restrictions on resale, if they were acquired from the issuer in private placement transactions; and (ii) susceptible to market risk. Additionally, we are classified as a non-diversified investment company within the meaning of the 1940 Act, and therefore may invest a significant portion of our assets in a relatively small number of Portfolio Companies in a limited number of industries. At this time, the Company’s investments in short-term securities are in 90-day Treasury Bills, which are federally guaranteed securities, or other high quality, highly liquid investments. The Company’s cash balances, if not large enough to be invested in 90-day Treasury Bills or other high quality, highly liquid investments, are swept into designated money market accounts or other interest bearing accounts.
 
 
F-26

 
 
The following table shows the portfolio composition by industry grouping at fair value as a percentage of net assets as of October 31, 2012 and October 31, 2011.
                 
Industry
  
2012
   
2011
 
Energy Services
  
 
23.49
   
21.50
Specialty Chemical
  
 
19.26
   
20.39
Automotive Dealerships
  
 
9.63
   
10.99
Medical Devices Manufacturer
  
 
7.96
   
9.67
Manufacturer of Pipe Fittings
  
 
6.64
   
5.85
Electrical Engineering
  
 
6.22
   
7.91
Renewable Energy
  
 
5.63
   
5.98
Theme Park
  
 
3.92
   
3.57
Soil Remediation
  
 
3.75
   
3.98
Distributor — Landscaping and Irrigation Equipment
  
 
3.18
   
2.89
Technology
  
 
2.79
   
2.57
Private Equity
  
 
2.14
   
0.27
Telecommunications
  
 
1.80
   
1.65
Consumer Services
  
 
1.79
   
1.87
Iron Foundries
  
 
1.62
   
0.49
Financial Services
  
 
1.61
   
1.27
Real Estate Management
  
 
1.04
   
0.95
Software
  
 
0.81
   
0.72
Consumer Products
  
 
0.41
   
0.28
Manufacturer of Laminate Material
  
 
0.39
   
  
Port Facilities
  
 
0.32
   
0.36
Food Services
  
 
0.27
   
  
Health & Beauty — Retail
  
 
0.03
   
0.23
Investment Company
  
 
  
   
0.67
Talent Management Assessment
  
 
  
   
3.65
Apparel
  
 
  
   
0.07
 
  
             
 
  
 
104.70
   
107.79
 
The Company is classified as a non-diversified investment company within the meaning of the 1940 Act, and therefore we may invest a significant portion of our assets in a relatively small number of portfolio companies in a limited number of industries. As of October 31, 2012 and October 31, 2011, the fair values of our two largest investments, Summit and U.S. Gas, comprised 19.26% and 23.49% and 20.39% and 21.50% of our net assets, respectively. Beyond the asset diversification requirements associated with our qualification as a RIC, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, relatively few industries may continue to be significantly represented among our investments. To the extent that we have large positions in the securities of a small number of portfolio companies, we are subject to an increased risk of significant loss should the performance or financial condition of these portfolio companies or their respective industries deteriorate. We may also be more susceptible to any single economic or regulatory occurrence as a result of holding large positions in a small number of portfolio companies.
 
9.
Portfolio Investments
 
Pursuant to the requirements of the 1940 Act and ASC 820, we value our portfolio securities at their current market values or, if market quotations are not readily available, at their estimates of fair values. Because our Portfolio Company investments generally do not have readily ascertainable market values, we record these investments at fair value in accordance with Valuation Procedures adopted by our Board of Directors. As
 
 
F-27

 
 
permitted by the SEC, the Board of Directors has delegated the responsibility of making fair value determinations to the Valuation Committee, subject to the Board of Directors’ supervision and pursuant to our Valuation Procedures.
 
The levels of fair value inputs used to measure our investments are characterized in accordance with the fair value hierarchy established by ASC 820. Where inputs for an asset or liability fall in more than one level in the fair value hierarchy, the investment is classified in its entirety based on the lowest level input that is significant to that investment’s fair value measurement. We use judgment and consider factors specific to the investment in determining the significance of an input to a fair value measurement. The three levels of the fair value hierarchy and investments that fall into each of the levels are described below:
 
 
 
Level 1:    Level 1 inputs are unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. We use Level 1 inputs for investments in publicly traded unrestricted securities for which we do not have a controlling interest. Such investments are valued at the closing price on the measurement date. We did not value any of our investments using Level 1 inputs as of October 31, 2012.
 
 
 
Level 2:    Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly or other inputs that are observable or can be corroborated by observable market data. Additionally, the Company’s interests in Investment Vehicles that can be withdrawn by the Company at the net asset value reported by such Investment Vehicle as of the measurement date, or within six months of the measurement date, are generally categorized as Level 2 investments. We did not value any of our investments using Level 2 inputs as of October 31, 2012.
 
 
 
Level 3:    Level 3 inputs are unobservable and cannot be corroborated by observable market data. Additionally, included in Level 3 are the Company’s interests in Investment Vehicles from which the Company cannot withdraw at the net asset value reported by such Investment Vehicles as of the measurement date, or within six months of the measurement date. We use Level 3 inputs for measuring the fair value of substantially all of our investments. See Note 3 for the investment valuation policies used to determine the fair value of these investments.
 
As noted above, the interests in Investment Vehicles are included in Level 2 or 3 of the fair value hierarchy. In determining the appropriate level, the Company considers the length of time until the investment is redeemable, including notice and lock-up periods and any other restriction on the disposition of the investment. The Company also considers the nature of the portfolios of the underlying Investment Vehicles and such vehicles’ ability to liquidate their investment.
 
The following fair value hierarchy table sets forth our investment portfolio by level as of October 31, 2012 and October 31, 2011 (in thousands):
                                 
 
  
October 31, 2012
 
 
  
Level 1
 
  
Level 2
 
  
Level 3
   
Total
 
Senior/Subordinated Loans and credit facilities
  
$
      —
  
  
$
      —
  
  
$
89,502
  
 
$
89,502
  
Common Stock
  
 
  
  
 
  
  
 
69,686
  
   
69,686
  
Preferred Stock
  
 
  
  
 
  
  
 
138,089
  
   
138,089
  
Warrants
  
 
  
  
 
  
  
 
34
  
   
34
  
Other Equity Investments
  
 
  
  
 
  
  
 
107,685
  
   
107,685
  
Guarantees
  
 
  
  
 
  
  
 
(825
   
(825
Escrow receivables
  
 
  
  
 
  
  
 
991
  
   
991
  
 
  
     
  
     
  
             
Total Investments, net
  
$
  
  
$
  
  
$
405,162
  
 
$
405,162
  
 
 
F-28

 
 
   
 
  
October 31, 2011
 
 
  
Level 1
 
  
Level 2
 
  
Level 3
 
  
Total
 
Senior/Subordinated Loans and credit facilities
  
$
      —
  
  
$
  
  
$
85,587
  
  
$
85,587
  
Common Stock
  
 
  
  
 
  
  
 
94,001
  
  
 
94,001
  
Preferred Stock
  
 
  
  
 
  
  
 
146,382
  
  
 
146,382
  
Other Equity Investments
  
 
  
  
 
2,805
  
  
 
123,441
  
  
 
126,246
  
Escrow receivables
  
 
  
  
 
  
  
 
1,147
  
  
 
1,147
  
 
  
     
  
     
  
     
  
     
Total Investments, net
  
$
  
  
$
2,805
  
  
$
450,558
  
  
$
453,363
  
 
The following tables sets forth a summary of changes in the fair value of investment assets and liabilities measured using Level 3 inputs for the fiscal years ended October 31, 2012 and 2011 (in thousands):
 
   
Balances,
November 1,
2011
   
Realized
Gains
(Losses)(1)
   
Reversal of
Prior Period
(Appreciation)
Depreciation on
Realization(2)
   
Unrealized
Appreciation
(Depreciation)(3)
   
Purchases(4)
   
Sales(5)
   
Transfers
In & Out
of Level 3
   
Balances,
October 31,
2012
 
Senior/ Subordinated Loans and credit facilities
 
$
85,587
  
 
$
(26,650
 
$
26,525
  
 
$
(111
 
$
5,924
  
 
$
(1,773
   
$      —
  
 
$
89,502
  
Common Stock
   
94,001
  
   
7,235
  
   
(7,293
   
(9,014
   
48
  
   
(15,291
   
  
   
69,686
  
Preferred Stock
   
146,382
  
   
  
   
  
   
(8,543
   
250
  
   
  
   
  
   
138,089
  
Warrants
   
  
   
  
   
  
   
  
   
34
  
   
  
   
  
   
34
  
Other Equity Investments
   
123,441
  
   
(1,309
   
1,350
  
   
(24,557
   
8,760
  
   
  
   
  
   
107,685
  
Guarantees
   
  
   
  
   
  
   
(825
   
  
   
  
   
  
   
(825
Escrow receivables
   
1,147
  
   
143
  
   
  
   
  
   
286
  
   
(585
   
  
   
991
  
                                                                 
Total
 
$
450,558
  
 
$
(20,581
 
$
20,582
  
 
$
(43,050
 
$
15,302
  
 
$
(17,649
   
$      —
  
 
$
405,162
  
                                                                 
   
Balances,
November 1,
2010
   
Realized
Gains
(Losses) (1)
   
Reversal of
Prior Period
(Appreciation)
Depreciation on
Realization (2)
   
Unrealized
Appreciation
(Depreciation) (3)
   
Purchases (4)
   
Sales (5)
   
Transfers
In & Out
of Level 3
   
Balances,
October 31,
2011
 
Senior/ Subordinated Loans and credit facilities
 
$
111,244
  
 
$
(14,189
 
$
14,215
  
 
$
(7,689
 
$
27,233
  
 
$
(45,227
   
$      —
  
 
$
85,587
  
Common Stock
   
78,865
  
   
(12,433
   
12,433
  
   
7,485
  
   
8,101
  
   
(450
   
  
   
94,001
  
Preferred Stock
   
148,995
  
   
  
   
  
   
(2,608
   
1,731
  
   
(1,736
   
  
   
146,382
  
Warrants
   
  
   
  
   
  
   
  
   
  
   
  
   
  
   
  
Other Equity Investments
   
94,798
  
   
  
   
  
   
12,055
  
   
16,790
  
   
(202
   
  
   
123,441
  
Escrow receivables
   
2,063
  
   
40
  
   
  
   
  
   
  
   
(956
   
  
   
1,147
  
                                                                 
Total
 
$
435,965
  
 
$
(26,582
 
$
26,648
  
 
$
9,243
  
 
$
53,855
  
 
$
(48,571
   
$      —
  
 
$
450,558
  
 
(1)
Included in net realized gain (loss) on investments in the Consolidated Statement of Operations.
 
(2)
Included in net unrealized appreciation (depreciation) of investments in the Consolidated Statement of Operations related to securities disposed of during the fiscal years ended October 31, 2012 and October 31, 2011, respectively.
 
(3)
Included in net unrealized appreciation (depreciation) of investments in the Consolidated Statement of Operations related to securities held at October 31, 2012 and October 31, 2011, respectively.
 
(4)
Includes increases in the cost basis of investments resulting from new portfolio investments, PIK interest or dividends, the amortization of discounts, premiums and closing fees and the exchange of one or more existing securities for one or more new securities.
 
(5)
Includes decreases in the cost basis of investments resulting from principal repayments or sales.
 
 
F-29

 
 
In accordance with ASU 2011-04, the following table summarizes information about the Company’s Level 3 fair value measurements as of October 31, 2012 (Fair Value is disclosed in thousands):
 
Quantitative Information about Level 3 Fair Value Measurements*
 
                                         
 
  
Fair value
as of
10/31/2012
   
 
Valuation technique
  
 
Unobservable input
  
Range
   
Weighted
average (a)
 
 
  
 
  
  
 
Low
   
 
High
   
Common Stock (c) (d)
  
$
69,686
  
 
Adjusted Net Asset Approach
  
Discount to Net Asset Value
  
 
0.0
   
50.0
   
3.7
 
  
         
  
Real Estate Appraisals
  
 
N/A
  
   
N/A
  
   
N/A
  
 
  
       
Income Approach
  
Discount Rate
  
 
14.5
   
15.0
   
14.5
 
  
       
Market Approach
  
Revenue Multiple
  
 
2.0x
  
   
2.0x
  
   
2.0x
  
 
  
         
  
EBITDA Multiple
  
 
5.0x
  
   
9.0x
  
   
7.3x
  
Senior/Subordinated loans and credit facilities (b) (d)
  
$
89,502
  
 
Adjusted Net Asset Approach
  
Discount to Net Asset Value
  
 
0.0
   
10.3
   
2.8
 
  
         
  
Real Estate Appraisals
  
 
N/A
  
   
N/A
  
   
N/A
  
 
  
       
Market Approach
  
EBITDA Multiple
  
 
2.8x
  
   
8.8x
  
   
6.1x
  
 
  
         
  
Market Quotes
  
 
97.0
   
98.5
   
97.7
 
  
       
Income Approach
  
Discount Rate
  
 
14.5
   
20.9
   
18.1
Other Equity Investments (d)
  
$
107,685
  
 
Adjusted Net Asset Approach
  
Discount to Net Asset Value
  
 
0.0
   
0.0
   
0.0
 
  
         
  
Real Estate Appraisals
  
 
N/A
  
   
N/A
  
   
N/A
  
 
  
       
Market Approach
  
EBIT Multiple
  
 
8.0x
  
   
8.0x
  
   
8.0x
  
 
  
         
  
Discount to notional value of CLO equity
  
 
20.0
   
20.0
   
20.0
 
  
         
  
Revenue Multiple
  
 
2.0x
  
   
2.0x
  
   
2.0x
  
 
  
         
  
EBITDA Multiple
  
 
5.0x
  
   
8.5x
  
   
6.3x
  
 
  
         
  
Euros per TTM MWhr
  
0.70
  
 
0.70
  
 
0.70
  
 
  
         
  
Euros per Expected MWhr original P50
  
0.70
  
 
0.70
  
 
0.70
  
 
  
         
  
Euros per Expected MWhr new P50
  
0.70
  
 
0.70
  
 
0.70
  
 
  
       
Income Approach
  
Discount Rate
  
 
11.9
   
27.3
   
13.1
Preferred Stock (c)
  
$
138,089
  
 
Market approach
  
Revenue Multiple
  
 
2.0x
  
   
2.9x
  
   
2.8x
  
 
  
         
  
EBITDA Multiple
  
 
6.0x
  
   
9.0x
  
   
6.8x
  
 
  
         
  
% of AUM
  
 
1.0
   
1.0
   
1.0
 
  
         
  
Illiquidity Discount
  
 
20.0
   
20.0
   
20.0
 
  
       
Income Approach
  
Discount Rate
  
 
15.0
   
15.0
   
15.0
Warrants
  
$
34
  
 
Market approach
  
EBITDA Multiple
  
 
8.8x
  
   
8.8x
  
   
8.8x
  
 
  
       
Income Approach
  
Discount Rate
  
 
16.0
   
16.0
   
16.0
Guarantees
  
$
(825
 
Income Approach
  
Discount Rate
  
 
16.0
   
16.0
   
16.0
Escrow Receivables
  
$
991
  
 
Adjusted Net Asset Approach
  
Discount to Net Asset Value
  
 
0.0
   
50.0
   
26.7
Total
  
$
405,162
  
   
  
 
  
                     
 
Notes:
(a)
Calculated based on fair values.

(b)
Certain investments are priced using non-binding broker or dealer quotes.

(c)
Certain common and preferred stock investments are fair valued based on liquidation-out preferential rights held by the Company.

(d)
Real estate appraisals are performed by independent third parties and the Company does not have reasonable access to the underlying unobservable inputs.

 *
The above table excludes certain investments whose fair value is zero due to certain specific situations at the portfolio company level.
 
ASC 820, which requires entities to change the wording used to describe the requirements in GAAP for measuring fair value and for disclosing information about fair value measurements. ASU 2011-04 clarifies the application of existing fair value measurement and disclosure requirements related to the application of the highest and best use and valuation premise concepts for financial and nonfinancial instruments, measuring the fair value of an instrument classified in equity, and disclosures about fair value measurements. ASU 2011-04 requires additional disclosures about fair value measurements categorized within Level 3 of the fair value hierarchy, including the valuation processes used by the reporting entity, the sensitivity of the fair value to changes in unobservable inputs, and the interrelationships between those unobservable inputs, if any.
 
Following are descriptions of the sensitivity of the Level 3 recurring fair value measurements to changes in the significant unobservable inputs presented in the above table. For securities utilizing the income approach valuation technique, a significant increase (decrease) in the discount rate, risk premium or discount for lack of marketability would result in a significantly lower (higher) fair value measurement. The discount for lack of marketability used to determine fair value may include other factors such
 
 
F-30

 
 
as liquidity or credit risk. Generally, a change in the discount rate is accompanied by a directionally similar change in the risk premium and discount for lack of marketability. For securities utilizing the market approach valuation technique, a significant increase (decrease) in the EBITDA, revenue multiple or other key unobservable inputs listed in the above table would result in a significantly higher (lower) fair value measurement. A significant increase (decrease) in the discount for lack of marketability would result in a significantly lower (higher) fair value measurement. The discount for lack of marketability used to determine fair value may include other factors such as liquidity or credit risk. For securities utilizing an adjusted net asset approach valuation technique, a significant increase (decrease) in the price to book value ratio, discount rate or other key unobservable inputs listed in the above table would result in a significantly higher (lower) fair value measurement. During the fiscal year ended October 31, 2012, a valuation technique was changed related to one portfolio company in which the Company holds securities within the senior/subordinated loans and credit facilities and other equity investments categories. Specifically, the Company used a different technique within the market approach as compared to a prior period based on the results of a sales process completed by a subsidiary of that portfolio company.
 
For the Fiscal Year Ended October 31, 2012
 
During the fiscal year ended October 31, 2012, the Company made two new investments, committing capital totaling $2.5 million. The investments were made in Freshii ($1.0 million) and Biovation ($1.5 million).
 
During the fiscal year ended October 31, 2012, the Company made nine follow-on investments in five existing Portfolio Companies totaling approximately $8.8 million. The Company, through MVC Partners Limited Partnership interest and MVCFS’ General Partnership interest, contributed approximately $8.2 million of its $20.1 million capital commitment to the PE Fund, which as of October 31, 2012, has invested in Plymouth Rock Energy, LLC, Gibdock Limited and Focus Pointe Holdings, Inc. On February 1, 2012, the Company made an equity investment in SHL Group Limited of approximately $48,000 for an additional 9,568 shares of common stock. On September 17, 2012, the Company loaned SGDA $360,000, increasing the term loan to approximately $6.5 million at October 31, 2012 and extended the maturity date to August 31, 2014. On October 3, 2012, the Company increased its common equity interest in Centile by approximately $173,000, which was fair valued at $3.1 million as of October 31, 2012.
 
On November 30, 2011, as part of the Ohio Medical debt refinancing, the Company agreed to guarantee a series B preferred stock tranche of equity. As of October 31, 2012, the amount guaranteed was approximately $21.1 million and the guarantee obligation was fair valued at $825,000 by the Valuation Committee.
 
On December 12, 2011, BP filed for Chapter 11 protection in New York with agreement to turn ownership over to secured lenders under a bankruptcy reorganization plan. On June 20, 2012, BP completed the bankruptcy process which resulted in a realized loss of approximately $23.4 million on the Company’s second lien loan, term loan A and term loan B. As a result of the bankruptcy process, the Company received a limited liability company interest in BPC.
 
On December 28, 2011, the Company received its third scheduled disbursement from the Vitality escrow of approximately $585,000. The escrow was fair valued at approximately $472,000 as of October 31, 2012.
 
On March 7, 2012, the board of directors of Summit approved a recapitalization and declared a $15.0 million dividend, of which $12.0 million was paid to the Company, resulting in a $12.0 million reduction in the fair value of the common stock.
 
On March 23, 2012, the Company sold its shares in the Octagon Fund for approximately $3.0 million resulting in a realized gain of approximately $18,000. The Company received approximately $2.9 million of the $3.0 million with the remaining proceeds of approximately $152,000 to be distributed when the Octagon Fund’s fiscal year audit is complete. The Company received additional proceeds of approximately $86,000 over the life of the investment.
 
 
F-31

 
 
On June 27, 2012, IPC completed the liquidation process filed under Chapter 7. There was no realized gain or loss as a result of the liquidation.
 
On July 10, 2012, the Company sold its 21,064 common shares of Safestone Limited, a Legacy Investment, which had a fair value of $0. The amount received from the sale was approximately $50,000 and resulted in a realized loss of approximately $2.0 million.
 
On August 9, 2012, the Company sold its common shares of SHL Group Limited and received gross proceeds of approximately $15.3 million, resulting in a realized gain of approximately $9.2 million. The $15.3 million in proceeds includes all transaction expenses and approximately $225,000 held in escrow, which had a fair value of $135,000 as of October 31, 2012.
 
On October 12, 2012, the Company received a dividend from U.S. Gas of approximately $2.4 million. U.S. Gas’ board approved an initial dividend to its shareholders, with future distributions projected to be paid quarterly. The Company anticipates receiving dividends from U.S. Gas for as long as it maintains its equity investment in U.S. Gas, and its cash flows can support the dividend. Each quarterly dividend must be approved by U.S. Gas’s board of directors and be permissible under its gas and electric supply credit agreement.
 
During the fiscal year ended October 31, 2012, Marine Exhibition Corporation (“Marine”) made principal payments totaling $600,000 on its senior subordinated loan. As of October 31, 2012, the balance of the loan was approximately $11.8 million.
 
During the fiscal year ended October 31, 2012, Pre-Paid Legal made principal payments on its tranche A term loan totaling approximately $976,000. The outstanding balance of the tranche A term loan was approximately $3.0 million.
 
During the fiscal year October 31, 2012, the Company realized a loss on its investment in MVC Partners of approximately $1.4 million. Please see Note 2 above for more information.
 
During the quarter ended January 31, 2012, the Valuation Committee increased the fair value of the Company’s investments in Octagon Fund by approximately $84,000, SGDA Europe equity interest by $265,000, Turf equity interest by $500,000 and Security Holdings equity interest by $205,000. The Valuation Committee also increased the fair values of the Company’s escrow receivables related to Vitality by $130,000 and Vendio by approximately $13,000. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $759,466. The Valuation Committee also decreased the fair value of the Company’s investments in BP term loan A by $100,000, HH&B common stock by $500,000, MVC Automotive equity interest by approximately $7.5 million, MVC Partners equity interest by approximately $326,000, MVCFS’ General Partnership interest in the PE Fund by approximately $8,000, NPWT common and preferred stock by approximately $6,000 and $120,000, respectively, Tekers common stock by $280,000, Velocitius equity interest by approximately $1.9 million. The Valuation Committee also determined to value the liability associated with the Ohio Medical guarantee at $700,000. Also, during the quarter ended January 31, 2012, the undistributed allocation of flow through losses from the Company’s equity investment in Octagon decreased the cost basis and fair value of this investment by approximately $112,000.
 
During the quarter ended April 30, 2012, the Valuation Committee increased the fair value of the Company’s investments in Vestal common stock by $1.2 million, MVC Automotive equity interest by $106,000, Security Holdings equity interest by $101,000, SGDA Europe equity interest by $33,000, Tekers common stock by $4,000 and Octagon Fund by approximately $143,000. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit, U.S. Gas, Freshii and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $775,585. The Valuation Committee also decreased the fair value of the Company’s investments in HH&B common stock by $100,000, MVC Partners equity interest by
 
 
F-32

 
 
approximately $113,000, MVCFS’ General Partnership interest in the PE Fund by approximately $3,000, and Velocitius equity interest by approximately $2.1 million. Also, during the quarter ended April 30, 2012, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $94,000.
 
During the quarter ended July 31, 2012, the Valuation Committee increased the fair value of the Company’s investments in Vestal common stock by approximately $1.2 million and RuMe preferred stock by approximately $417,000. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit, U.S. Gas, Freshii and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $759,887. The Valuation Committee also decreased the fair value of the Company’s investments in BPC equity interest by $180,000, HH&B common stock by $150,000, MVC Automotive equity interest by approximately $1.1 million, MVC Partners equity interest by approximately $565,000, Security Holdings equity interest by approximately $6.5 million, SGDA Europe equity interest by approximately $3.1 million, Tekers common stock by $141,000, Turf equity interest by $618,000 and Velocitius equity interest by approximately $1.9 million. Also, during the quarter ended July 31, 2012, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $107,000.
 
During the quarter ended October 31, 2012, the Valuation Committee increased the fair value of the Company’s investments in Vestal common stock by approximately $1.8 million, Octagon equity interest by $700,000, Velocitius equity interest by approximately $2.5 million, Turf equity interest by $271,000, SGDA Europe equity interest by $239,000, Tekers common stock by $139,000 and MVCFS’ General Partnership interest in the PE Fund by approximately $13,000. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit, U.S. Gas, Freshii and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $836,104. The Valuation Committee also decreased the fair value of the Company’s investments in HH&B common stock by $150,000, MVC Automotive equity interest by $362,000, MVC Partners equity interest by approximately $71,000, Security Holdings equity interest by approximately $3.0 million, Ohio Medical preferred stock and guarantee by $8.4 million and $125,000, respectively, NPWT common and preferred stock by approximately $25,000 and $440,000, respectively, and Centile equity interest by approximately $34,000. Also, during the quarter ended October 31, 2012, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $99,000.
 
During the fiscal year ended October 31, 2012, the Valuation Committee increased the fair value of the Company’s investments in Octagon Fund by approximately $227,000, RuMe preferred stock by approximately $417,000, Turf equity interest by approximately $153,000, MVCFS’ General Partnership interest in the PE Fund by approximately $1,000, Octagon equity interest by $700,000 and Vestal common stock by approximately $4.2 million. The Valuation Committee also increased the fair values of the Company’s escrow receivables related to Vitality by $130,000 and Vendio by approximately $13,000. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit U.S. Gas, and Freshii and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $3,131,042. The Valuation Committee also decreased the fair value of the Company’s investments in BP term loan A by $100,000, HH&B common stock by $900,000, MVC Automotive equity interest by approximately $8.9 million, SGDA Europe equity interest by approximately $2.6 million, Security Holdings equity interest by approximately $9.2 million, BPC equity interest by $180,000, MVC Partners equity interest by approximately $1.1 million, NPWT common and preferred stock by approximately $31,000 and $560,000, respectively, Tekers common stock by $278,000, Velocitius equity interest by approximately $3.4 million, Ohio Medical preferred stock by $8.4 million, Centile equity interest by approximately $34,000 and valued the liability associated with the Ohio Medical guarantee at $825,000. Also, during the fiscal year ended October 31, 2012, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $188,000.
 
 
F-33

 
 
At October 31, 2012, the fair value of all portfolio investments, exclusive of short-term investments, was $404.2 million with a cost basis of $332.4 million. At October 31, 2012, the fair value and cost basis of portfolio investments of the Legacy Investments were $10.8 million and $30.3 million, respectively, and the fair value and cost basis of portfolio investments made by the Company’s current management team were $393.4 million and $303.5 million, respectively. At October 31, 2011, the fair value of all portfolio investments, exclusive of short-term securities, was $452.2 million, with a cost basis of $358.2 million. At October 31, 2011, the fair value and cost basis of portfolio investments of the Legacy Investments was $10.8 million and $32.3 million, respectively, and the fair value and cost basis of portfolio investments made by the Company’s current management team was $441.4 million and $325.9 million, respectively.
 
For the Fiscal Year Ended October 31, 2011
 
During the fiscal year ended October 31, 2011, the Company made six new investments, committing capital totaling approximately $26.1 million. The investments were made in Octagon Fund ($3.0 million), JSC Tekers ($4.0 million), Teleguam ($7.0 million), Pre-Paid Legal ($8.0 million), RuMe ($1.2 million) and Centile ($3.0 million).
 
During the fiscal year ended October 31, 2011, the Company made seven follow-on investments in four existing Portfolio Companies totaling approximately $17.1 million. On January 27, 2011, the Company invested $3.3 million in Security Holdings in the form of an additional equity interest. On January 28, 2011, the Company loaned an additional $5.0 million to Security Holdings in the form of a bridge loan with an annual interest rate of 3%. This bridge loan allowed Security Holdings to secure project guarantees. On May 4, 2011, the Company invested $500,000 in NPWT to acquire 5,000 shares of convertible preferred stock. On May 26, 2011 and September 14, 2011, the Company invested an additional $150,000 on each date into HH&B to acquire an additional 47,612 shares of common stock. On September 6, 2011, the Company invested $7.0 million in Security Holdings in the form of an additional equity interest. On October 17, 2011, the Company invested $1.0 million in SGDA Europe in the form of additional equity interest. In addition, during the fiscal year ended October 31, 2011, the Company invested approximately $10.0 million in the SPDR Barclays Capital High Yield Bond Fund and approximately $10.0 million in the iShares S&P U.S. Preferred Stock Index Fund. These investments were sold during the fiscal year ended October 31, 2011, resulting in a realized gain of approximately $106,000. The investments in these exchange traded funds were intended to provide the Company with higher yielding investments than cash and cash equivalents while awaiting deployment into Portfolio Companies pursuant to the Company’s principal investment strategy. TTG Advisers had voluntarily agreed that any assets of the Company that are invested in exchange-traded funds would not be subject to the base management fee due to TTG Advisers under the Advisory Agreement.
 
Effective November 4, 2010, the interest rate on the Turf senior subordinated loan was reduced from 15% to 13% and the maturity date on the senior subordinated loan and junior revolving note was extended to January 31, 2014.
 
On November 30, 2010, the Company loaned an additional $700,000 to Harmony Pharmacy, which was the remaining portion of the $1.3 million demand note committed on September 23, 2010.
 
On November 30, 2010, a public Uniform Commercial Code (“UCC”) sale of Harmony Pharmacy’s assets took place. Prior to this sale, the Company formed a new entity, HH&B. The Company assigned its secured debt interest in Harmony Pharmacy of approximately $6.4 million to HH&B in exchange for a majority of the economic ownership. At the UCC sale, HH&B submitted a successful credit bid of approximately $5.9 million for all of the assets of Harmony Pharmacy. On December 21, 2010, Harmony Pharmacy filed for dissolution in the states of California, New Jersey and New York. As a result, the Company realized an $8.4 million loss on its investment in Harmony Pharmacy.
 
On December 1, 2010, Amersham filed for dissolution in the State of California as all operating divisions were sold in 2010. As a result, the Company realized a $6.5 million loss on its investment in Amersham. The
 
 
F-34

 
 
Company may be eligible to receive proceeds from an earnout related to the sale of an operating division once the senior lender is repaid in full. At this time, it is not likely that any proceeds will be received by the Company.
 
On January 11, 2011, SHL Group Limited, which provides workplace talent assessment solutions, including ability and personality tests, and psychometric assessments, acquired the Company’s portfolio company PreVisor. The Company received 1,518,762 common shares of SHL Group Limited for its investment in PreVisor. The cost basis and market value of the Company’s investment remained unchanged at the time as a result of the transaction.
 
On January 25, 2011, the Company sold its common stock in LHD Europe and received approximately $542,000 in proceeds, which resulted in a realized gain of approximately $317,000.
 
On March 1, 2011, SP repaid its first lien and second lien loans in full including all accrued interest. The Company received a $500,000 termination fee associated with the repayment of the loans.
 
On April 29, 2011, assets from a division of Ohio Medical were distributed to Ohio Medical shareholders on a pro-rata basis. The Company received 281 shares of common stock in NPWT as a result of this transaction.
 
On May 26, 2011, Security Holdings repaid its bridge loan in full, including all accrued interest.
 
On August 1, 2011, as part of a restructuring of the Company’s investment in HuaMei, the Company sold its shares to HuaMei, resulting in a realized loss of $2.0 million.
 
On August 31, 2011, Sonexis, a Legacy Investment, completed the dissolution of its operations and the sales of its assets. The Company realized a loss of $10.0 million as a result of this dissolution.
 
On October 3, 2011, Storage Canada repaid its term loan in full including all accrued interest.
 
On October 17, 2011, the Company converted SGDA Europe’s $1.5 million senior secured loan and all accrued interest to additional common equity interest.
 
On October 28, 2011, Total Safety repaid its first and second lien loans in full including all accrued interest.
 
On October 31, 2011, the Company received a distribution from NPWT of $500,000, which was treated as a return of capital and returned all cash invested into NPWT to the Company.
 
During the fiscal year ended October 31, 2011, Marine made principal payments totaling $450,000 on its senior subordinated loan. The balance of the loan as of October 31, 2011 was approximately $12.0 million.
 
During the fiscal year ended October 31, 2011, Octagon borrowed and repaid $1.5 million on its revolving line of credit. Octagon cancelled the revolving line of credit effective June 30, 2011. As of October 31, 2011, the revolving credit facility was no longer a commitment of the Company.
 
During the quarter ended January 31, 2011, the Valuation Committee increased the fair value of the Company’s investments in Summit common stock by $7.5 million and U.S. Gas preferred stock by $2.5 million. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, SP, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of payment in kind (“PIK”) interest/dividends totaling $980,119. The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $1.9 million due to PIK distributions, which were treated as a return of capital. Also, during the quarter ended January 31, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $229,000. The Valuation Committee also decreased the fair value of the Company’s investments in BP second lien loan by $3.9
 
 
F-35

 
 
million and term loan A and B by a combined $2.0 million, Ohio Medical common stock by $500,000 and preferred stock by $8.2 million, MVC Automotive equity interest by $3.1 million, HuaMei stock by $325,000 and HH&B by $1.9 million during the quarter ended January 31, 2011.
 
During the quarter ended April 30, 2011, the Valuation Committee increased the fair value of the Company’s investments in Summit common stock by $2.0 million, MVC Automotive equity interest by $3.0 million, SHL Group Limited common stock by $2.5 million, Security Holdings equity interest by approximately $2.0 million, Tekers common stock by $590,000, Total Safety first lien loan by approximately $74,000 and Velocitius equity interest by $2.6 million. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, SP, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $714,247. In addition, during the quarter ended April 30, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $28,000. The Valuation Committee also decreased the fair value of the Company’s investments in BP term loan A by approximately $1.2 million, Ohio Medical preferred stock by approximately $164,000, HuaMei common stock by approximately $1.0 million, SGDA Europe equity interest by $3.9 million and HH&B by $3.8 million during the quarter ended April 30, 2011.
 
During the quarter ended July 31, 2011, the Valuation Committee increased the fair value of the Company’s investments in SHL Group Limited common stock by $1.0 million, Octagon Fund by approximately $25,000 and Security Holdings equity interest by approximately $2.5 million. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $731,374. In addition, during the quarter ended July 31, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $139,000. The Valuation Committee also decreased the fair value of the Company’s investments in HuaMei common stock by $250,000, SGDA Europe equity interest by $400,000, MVC Automotive by $2.3 million, Tekers common stock by $180,000, Velocitius equity interest by $2.3 million and Vestal common stock by $670,000 during the quarter ended July 31, 2011.
 
During the quarter ended October 31, 2011, the Valuation Committee increased the fair value of the Company’s investments in SHL Group Limited common stock by $1.4 million, Security Holdings equity interest by approximately $13.1 million, Summit common stock by $5.0 million, Ohio Medical preferred stock by $400,000 and MVC Automotive equity interest by $750,000. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $748,981. In addition, during the quarter ended October 31, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $193,000. The Valuation Committee also decreased the fair value of the Company’s investments in Octagon Fund by approximately $234,000, Tekers common stock by $2.7 million, NPWT common and preferred stock by a net amount of approximately $200,000, Velocitius equity interest by $100,000 and Vestal common stock by $75,000 during the quarter ended October 31, 2011.
 
During the fiscal year ended October 31, 2011, the Valuation Committee increased the fair value of the Company’s investments in Summit common stock by $14.5 million, SHL Group Limited common stock by $4.9 million, Security Holdings equity interest by approximately $17.6 million, Total Safety first lien loan by approximately $74,000, U.S. Gas preferred stock by $2.5 million and Velocitius equity interest by $200,000. In addition, increases in the cost basis and fair value of the loans to Custom Alloy, SP, Marine, Summit and U.S. Gas and the Marine preferred stock were due to the capitalization of PIK interest/dividends totaling $3,174,721. The Valuation Committee also increased the fair value of the Ohio Medical preferred stock by approximately $1.9 million due to PIK distributions, which were treated as a return of capital. Also, during the fiscal year ended October 31, 2011, the undistributed allocation of flow through income from the Company’s equity investment in Octagon increased the cost basis and fair value of this investment by approximately $589,000. The Valuation
 
 
F-36

 
 
Committee also decreased the fair value of the Company’s investments in MVC Automotive equity interest by approximately $1.7 million, Tekers common stock by approximately $2.3 million, Octagon Fund by $209,000, BP second lien loan by $3.9 million and term loan A and B by a combined $3.2 million, Ohio Medical common stock by $500,000 and preferred stock by approximately $8.0 million, NPWT common and preferred stock by a net amount of approximately of $200,000, HuaMei common stock by approximately $1.5 million, SGDA Europe equity interest by approximately $4.3 million, Vestal common stock by $745,000 and HH&B by $5.7 million during the fiscal year ended October 31, 2011.
 
At October 31, 2011, the fair value of all portfolio investments, exclusive of short-term investments, was $452.2 million with a cost basis of $358.2 million. At October 31, 2011, the fair value and cost basis of portfolio investments of the Legacy Investments was $10.8 million and $32.3 million, respectively, and the fair value and cost basis of portfolio investments made by the Company’s current management team was $441.4 million and $325.9 million, respectively. At October 31, 2010, the fair value of all portfolio investments, exclusive of short-term securities, was $433.9 million, with a cost basis of $375.6 million. At October 31, 2010, the fair value and cost basis of portfolio investments of the Legacy Investments was $10.8 million and $42.3 million, respectively, and the fair value and cost basis of portfolio investments made by the Company’s current management team was $423.1 million and $333.3 million, respectively.
 
10.
Commitments and Contingencies
 
Commitments to/for Portfolio Companies:
 
At October 31, 2012, the Company’s existing commitments to Portfolio Companies consisted of the following:
 
Portfolio Company
  
Amount Committed
 
  
Amount Funded at October 31, 2012
 
Turf
  
$
1.0 million
  
  
$
1.0 million
  
MVC Partners/MVCFS
  
$
20.1 million
  
  
$
8.2 million
  
 
  
     
  
     
Total
  
$
21.1 million
  
  
$
9.2 million
  
 
Guarantees
 
As of October 31, 2012, the Company had the following commitments to guarantee various loans and mortgages:
 
Guarantee
  
Amount Committed
 
  
Amount Funded at October 31, 2012
 
MVC Automotive
  
$
5.2 million
  
  
 
                                         —
  
Tekers
  
$
194,000
  
  
 
  
Ohio Medical
  
$
21.1 million
  
  
 
  
 
  
     
  
     
Total
  
$
26.5 million
  
  
 
  
 
ASC 460, Guarantees, requires the Company to estimate the fair value of the guarantee obligation at its inception and requires the Company to assess whether a probable loss contingency exists in accordance with the requirements of ASC 450, Contingencies. At October 31, 2012, the Valuation Committee estimated the fair values of the guarantee obligations noted above to be $825,000.
 
These guarantees are further described below, together with the Company’s other commitments.
 
On June 30, 2005, the Company pledged its common stock of Ohio Medical to Guggenheim to collateralize a loan made by Guggenheim to Ohio Medical.
 
 
F-37

 
 
On July 19, 2007, the Company agreed to guarantee a 1.4 million Euro mortgage for Tekers. The guarantee had a commitment of approximately 150,000 euros at October 31, 2012, equivalent to approximately $194,000.
 
On January 15, 2008, the Company agreed to guarantee a 6.5 million Euro mortgage for MVC Automotive. The guarantee had a commitment of approximately 5.9 million euros at October 31, 2011, equivalent to approximately $8.2 million. On July 31, 2012, the mortgage that was guaranteed was repaid by MVC Automotive, resulting in the release of the guarantee. As of October 31, 2012, the guarantee was no longer a commitment of the Company.
 
On January 16, 2008, the Company agreed to support a 4.0 million Euro mortgage for a Ford dealership owned and operated by MVC Automotive (equivalent to approximately $5.2 million at October 31, 2012) through making financing available to the dealership and agreeing under certain circumstances not to reduce its equity stake in MVC Automotive. The Company has consistently reported the amount of the guarantee as 4.0 million Euro. The Company and MVC Automotive continue to view this amount as the full amount of our commitment. Erste Bank, the bank extending the mortgage to MVC Automotive, believes, based on a different methodology, that the balance of the guarantee as of October 31, 2012 is approximately 6.3 million Euro (equivalent to approximately $8.2 million).
 
On July 31, 2008, the Company extended a $1.0 million loan to Turf in the form of a secured junior revolving note. The note bears annual interest at 6.0% and expires on January 31, 2014. On July 31, 2008, Turf borrowed $1.0 million from the secured junior revolving note. At October 31, 2011 and October 31, 2012, the outstanding balance of the secured junior revolving note was $1.0 million.
 
On March 31, 2010, the Company pledged its Series I and Series J preferred stock of U.S. Gas to Macquarie Energy, LLC (“Macquarie Energy”) as collateral for Macquarie Energy’s trade supply credit facility to U.S. Gas.
 
On October 29, 2010, through MVC Partners and MVCFS, the Company committed to invest approximately $20.1 million in the PE Fund, for which an indirect wholly-owned subsidiary of the Company serves as GP. The PE Fund closed on approximately $104 million of capital commitments. During the fiscal year ended October 31, 2012, MVC Partners was consolidated with the operations of the Company as MVC Partners’ limited partnership interest in the PE Fund is a substantial portion of MVC Partners operations. As of October 31, 2012, $8.2 million of the Company’s commitment was contributed.
 
On April 26, 2011, the Company agreed to collateralize a 5.0 million Euro letter of credit from JPMorgan Chase Bank, N.A., which is classified as restricted cash on the Company’s consolidated balance sheet. This letter of credit is being used as collateral for a project guarantee by AB DnB NORD bankas to Security Holdings.
 
On November 30, 2011, as part of Ohio Medical’s refinancing of their debt, the Company agreed to guarantee a series B preferred stock tranche of equity with a 12% coupon for the first 18 months it is outstanding. After that initial period, the rate increases by 400bps to 16% for the next 6 months and increases by 50 bps (.5%) each 6 month period thereafter. As of October 31, 2012, the amount guaranteed was approximately $21.1 million and the guarantee obligation was fair valued at $825,000 by the Valuation Committee.
 
Commitments of the Company
 
Effective November 1, 2006, under the terms of the Investment Advisory and Management Agreement with TTG Advisers, which has since been amended and restated (the “Advisory Agreement”) and described in Note 9 of the consolidated financial statements, “Management”, TTG Advisers is responsible for providing office space to the Company and for the costs associated with providing such office space. The Company’s offices continue to be located on the second floor of 287 Bowman Avenue, Purchase, New York 10577.
 
 
F-38

 
 
On April 27, 2006, the Company and MVCFS, as co-borrowers, entered into a four-year, $100 million Credit Facility, consisting of $50.0 million in term debt and $50.0 million in revolving credit, with Guggenheim as administrative agent for the lenders. On April 13, 2010, the Company renewed the Credit Facility for three years. The Credit Facility consists of a $50.0 million term loan with an interest rate of LIBOR plus 450 basis points with a 1.25% LIBOR floor. As of October 31, 2012, there was $50.0 million in term debt outstanding under the Credit Facility and approximately $9,000 of interest payable. The Credit Facility will expire on April 27, 2013, at which time the outstanding amount under the Credit Facility will be due and payable. During the year ended October 31, 2012, the Company requested Guggenheim’s consent to waive compliance with a particular covenant of the Credit Facility. In order to obtain this waiver, the Company agreed to increase the interest rate on the Credit Facility if the Company did not meet a newly established covenant level that was more stringent than required in the Company’s Credit Facility documents. The covenant level for an event of default remained the same. As of October 31, 2012, the Company has met all of its original covenant levels and is not in default, but was unable to meet the increased covenant level required by Guggenheim as part of the waiver obtained earlier in the year. As a result, the interest rate on the Credit Facility has increased to LIBOR plus 525 basis points with a 1.25% LIBOR floor. The increased rate will be effective until the Company demonstrates that it has passed the higher covenant level. The Company paid a closing fee, legal and other costs associated with obtaining and renewing the Credit Facility. These costs are being amortized evenly over the life of the facility. The prepaid expenses on the consolidated balance sheet include the unamortized portion of these costs. Borrowings under the Credit Facility are secured, by among other things, cash, cash equivalents, debt investments, accounts receivable, equipment, instruments, general intangibles, the capital stock of MVCFS, and any proceeds from all the aforementioned items, as well as all other property except for equity investments made by the Company.
 
At October 31, 2012, the carrying amount of our Credit Facility approximates the fair value, using Level 3 inputs under the fair value hierarchy, of our Credit Facility, which was $50.0 million. The fair value of our debt obligation is determined in accordance with ASC 820, which defines fair value in terms of the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The fair value of our Credit Facility is estimated based upon market interest rates for our own borrowings or entities with similar credit risk, adjusted for nonperformance risk, if any.
 
The Company enters into contracts with Portfolio Companies and other parties that contain a variety of indemnifications. The Company’s maximum exposure under these arrangements is unknown. However, the Company has not experienced claims or losses pursuant to these contracts and believes the risk of loss related to indemnifications to be remote.
 
A summary of our contractual payment obligations as of October 31, 2012 is as follows:
 
 
  
Payments Due by Period
 
  
Total
 
  
Less than
1 year
  
1-3 years
  
4-5 years
  
After
5 years
Credit Facility I
  
$
50,000,000
  
  
$50,000,000
  
N/A
  
N/A
  
N/A
Total Debt
  
$
50,000,000
  
  
$50,000,000
  
N/A
  
N/A
  
N/A
 
11.
Certain Issuances of Equity Securities by the Issuer and Share Repurchase Program
 
On April 23, 2010, the Company’s Board of Directors approved a share repurchase program authorizing up to $5.0 million for share repurchases. The share repurchase program was substantially completed during the quarter ended April 30, 2011. Under the program, 380,105 shares were repurchased at an average price of $13.06, including commission, with a total cost of approximately $5.0 million. The Company’s net asset value per share was increased by approximately $0.07 as a result of the share repurchases. The following table represents our stock repurchase program for the fiscal year ended October 31, 2011.
 
 
F-39

 
 
 
Period
 
 
Total Number of
Shares  Purchased
   
Average Price Paid  per
Share including
commission
   
Total Number of  Shares
Purchased as Part of
Publicly Announced
Program
   
Approximate Dollar Value
of Shares that May Yet Be
Purchased Under the
Program
 
As of October 30, 2011
   
306,100
  
 
$
13.06
  
   
306,100
  
 
$
1,000,872
  
April 1, 2011 — April 30, 2011
   
74,005
  
 
$
13.06
  
   
74,005
  
 
$
34,217
  
                                 
Total
   
380,105
  
 
$
13.06
  
   
380,105
  
 
$
34,217
  
 
On July 19, 2011, the Company’s Board of Directors approved another share repurchase program authorizing up to $5.0 million for additional share repurchases. No shares were repurchased under this new repurchase program during the year ended October 31, 2012. Implementation of the program, as well as the timing thereof, depends on a variety of factors, including, among others, the availability of capital, the Company’s current share price and the ability to conduct the offer under its Credit Facility.
 
We had no unregistered sales of equity securities for the fiscal year ended October 31, 2012.
 
12.
Tax Matters
 
Return of Capital Statement of Position (ROCSOP) Adjustment:    During the year ended October 31, 2012, the Company recorded a reclassification for permanent book to tax differences. These differences were primarily due to book/tax treatment of partnership income. These differences resulted in a net decrease in accumulated losses of $2,904,589, an increase in accumulated net realized loss of $128,110, and a decrease in additional paid-in capital of $2,776,479. This reclassification had no effect on net assets.
 
Distributions to Shareholders:    The table presented below includes MVC Capital, Inc. only. The Company’s wholly-owned subsidiary MVCFS has not been included. As of October 31, 2012, the components of accumulated earnings/ (deficit) on a tax basis were as follows:
 
Tax Basis Accumulated Earnings (Deficit)
  
   
Accumulated capital and other losses
  
$
(45,108,864
Undistributed Net investment Income
  
 
  
Undistributed Long-Term Capital Gain
  
 
  
Gross unrealized appreciation
  
 
147,616,889
  
Gross unrealized depreciation
  
 
(77,417,977
 
  
     
Net unrealized appreciation
  
$
70,198,912
  
 
  
     
Total tax basis accumulated earnings
  
$
25,090,048
  
Tax cost of investments
  
$
333,767,304
  
Current year distributions to shareholders on a tax basis
  
     
Ordinary income
  
$
11,152,071
  
Return of Capital
  
$
686,835
  
Prior year distributions to shareholders on a tax basis
  
     
Ordinary income
  
$
8,257,244
  
Long Term Capital Gain
  
$
2,200,450
  
Return of Capital
  
$
1,031,338
  
 
On October 31, 2012, the Company had a net capital loss carryforward of $45,108,864 of which $26,318,783 will expire in the year 2019 and $18,790,081 has no expiration. To the extent future capital gains are offset by capital loss carryforwards, such gains need not be distributed.
 
 
F-40

 
 
Qualified Dividend Income Percentage
 
The Company designated 100% of dividends declared and paid during the year ending October 31, 2012 from net operating income as qualified dividend income under the Jobs Growth and Tax Relief Reconciliation Act of 2003.
 
Corporate Dividends Received Deduction Percentage
 
Corporate shareholders may be eligible for the dividends received deduction for certain ordinary income distributions paid by the Company. The Company designated 100% of dividends declared and paid during the year ending October 31, 2012 from net operating income as qualifying for the dividends received deduction. The deduction is a pass through of dividends paid by domestic corporations (i.e. only equities) subject to taxation.
 
13.
Income Taxes
 
The Company’s wholly-owned subsidiary MVCFS is subject to federal and state income tax. For the fiscal year ended October 31, 2012, the Company recorded a tax provision of $3,997. For the fiscal year ended October 31, 2011, the Company recorded a tax provision of $13,557. For the fiscal year ended October 31, 2010, the Company recorded a tax benefit of $8,476. The provision for income taxes was comprised of the following:
 
 
  
Fiscal Year ended
 
 
  
October 31, 2012
 
  
October 31, 2011
 
  
October 31, 2010
 
Current tax (benefit) expense:
  
     
  
     
  
     
Federal
  
$
  
  
$
11,363
  
  
$
  
State
  
 
3,997
  
  
 
2,194
  
  
 
8,476
  
 
  
     
  
     
  
     
Total current tax (benefit) expense
  
 
3,997
  
  
 
13,557
  
  
 
8,476
  
Deferred tax expense (benefit):
  
     
  
     
  
     
Federal
  
 
  
  
 
  
  
 
  
State
  
 
  
  
 
  
  
 
  
 
  
     
  
     
  
     
Total deferred tax expense (benefit)
  
 
  
  
 
  
  
 
  
Total tax (benefit) provision
  
$
3,997
  
  
$
13,557
  
  
$
8,476
  
 
The following table summarizes the significant differences between the U.S. federal statutory tax rate and the Company’s effective tax rate for financial statement purposes for the fiscal years ended October 31, 2012, 2011 and 2010:
 
 
  
Fiscal Year Ended
 
 
  
October 31,
2012
   
October 31,
2011
   
October 31,
2010
 
Federal income tax benefit at statutory rate
  
($
1,328,162
   
($1,503,159
 
($
940,558
State income taxes, net of federal benefit
  
 
(213,286
   
(244,827
   
(152,979
Other
  
 
  
   
11,363
  
   
5,593
  
Net change to valuation allowance
  
 
1,545,445
  
   
1,750,180
  
   
1,096,420
  
 
  
                     
 
  
$
3,997
  
 
$
13,557
  
 
$
8,476
  
 
 
F-41

 
 
The Company generated a net operating loss of approximately $3.7 million in the current year for federal and New York state purposes. The net operating loss will be carried forward to offset federal taxable income in future years. As of October 31, 2012, the Company has the following NOL available to be carried forward:
 
NOL — Federal
  
NOL — New York State
  
Fiscal Year of NOL
  
Expiration
$           —
  
$29,673
  
October 31, 2007
  
October 31, 2027
$1,411,365
  
$2,284,298
  
October 31, 2008
  
October 31, 2028
$2,585,262
  
$2,780,861
  
October 31, 2009
  
October 31, 2029
$3,969,891
  
$3,968,135
  
October 31, 2010
  
October 31, 2030
$5,286,401
  
$5,284,207
  
October 31, 2011
  
October 31, 2031
$3,660,070
  
$3,656,073
  
October 31, 2012
  
October 31, 2032
 
Due to the uncertainty surrounding the ultimate utilization of these net operating losses, the Company has recorded a 100% valuation allowance against the current year federal deferred benefit of approximately $1,329,000 as well as against prior years federal deferred tax asset of approximately $4,599,000. Additionally, a 100% valuation allowance has been recorded for current year state and local deferred benefit of approximately $216,000 and against prior years state and local deferred tax asset of approximately $826,000
 
Deferred income tax balances for MVCFS reflect the impact of temporary difference between the carrying amount of assets and liabilities and their tax bases and are stated at tax rates expected to be in effect when taxes are actually paid or recovered. The components of our deferred tax assets and liabilities for MVCFS as of October 31, 2012, October 31, 2011 and October 31, 2010 were as follows:
 
 
  
October 31, 2012
   
October 31, 2011
   
October 31, 2010
 
Deferred tax assets:
  
                     
Deferred revenues
  
$
165,003
  
 
$
99,118
  
 
$
362,391
  
Net operating loss
  
 
6,763,864
  
   
5,317,308
  
   
3,229,077
  
Others
  
 
41,962
  
   
8,895
  
   
85,102
  
 
  
                     
Total deferred tax assets
  
$
6,970,829
  
 
$
5,425,321
  
 
$
3,676,570
  
 
  
                     
Valuation allowance on Deferred revenues and Net operating loss
  
($
6,970,829
 
($
5,425,321
 
($
3,676,570
 
  
                     
Net deferred tax assets
  
$
  
 
$
  
 
$
  
Deferred tax liabilities:
  
                     
Deferred tax liabilities
  
 
  
   
  
   
  
 
  
                     
Total deferred tax liabilities
  
 
  
   
  
   
  
Net deferred taxes
  
$
  
 
$
  
 
$
  
 
14.
Segment Data
 
The Company’s reportable segments are its investing operations as a business development company, MVC Capital, which includes MVC Cayman and MVCFS.
 
 
F-42

 
 
The following table presents book basis segment data for the fiscal year ended October 31, 2012:
 
 
  
MVC
   
MVCFS
   
Consolidated
 
Interest and dividend income
  
$
25,205,231
  
 
$
93
  
 
$
25,205,324
  
Fee income
  
 
  
   
1,939,913
  
   
1,939,913
  
Fee income — asset management
  
 
  
   
2,299,737
  
   
2,299,737
  
Other income
  
 
442,138
  
   
  
   
442,138
  
Total operating income
  
 
25,647,369
  
   
4,239,743
  
   
29,887,112
  
Total operating expenses
  
 
3,126,647
  
   
8,189,315
  
   
11,315,962
  
Less: Waivers by Adviser
  
 
(2,513,218
   
(40,699
   
(2,553,917
Total net operating expenses
  
 
613,429
  
   
8,148,616
  
   
8,762,045
  
Net operating income (loss) before taxes
  
 
25,033,940
  
   
(3,908,873
   
21,125,067
  
Tax expense
  
 
  
   
3,997
  
   
3,997
  
Net operating income (loss)
  
 
25,033,940
  
   
(3,912,870
   
21,121,070
  
Net realized (loss) gain on investments
  
 
(20,519,455
   
1,022
  
   
(20,518,433
Net change in unrealized (depreciation) appreciation on investments
  
 
(22,258,805
   
1,492
  
   
(22,257,313
Net decrease in net assets resulting from operations
  
 
(17,744,320
   
(3,910,356
   
(21,654,676
 
In all periods prior to July 16, 2004, all business was conducted through MVC Capital, Inc.
 
15.
Subsequent Events
 
On November 26, 2012, the Company loaned an additional $8.0 million to JSC Tekers, increasing the secured loan amount to $12.0 million. The interest rate remains at 8% per annum and the maturity date was extended to December 31, 2014.
 
On December 14, 2012, the Company loaned an additional $500,000 to Biovations, increasing the loan amount to $2.0 million.
 
On December 17, 2012, the Company declared a dividend of $0.135 per share, or a total of approximately $3.2 million. The dividend is payable on January 7, 2013 to shareholders of record on December 31, 2012.
 
On December 17, 2012, the Company received a dividend from Vestal of approximately $426,000 dividend from Vestal.
 
On December 19, 2012, MVC Automotive made a principal payment of approximately $2.0 million on its bridge loan.
 
 
F-43

 
 
Report of Independent Registered Public Accounting Firm
 
To the Board of Directors and Shareholders of MVC Capital, Inc.
 
We have audited the accompanying consolidated balance sheets of MVC Capital, Inc. (the “Company”), including the consolidated schedules of investments, as of October 31, 2012 and 2011, and the related consolidated statements of operations, cash flows and changes in net assets for each of the three years in the period ended October 31, 2012, and the consolidated selected per share data and ratios for each of the five years in the period ended October 31, 2012. Our audit also included the financial statement schedule listed in the Index at Item 15(a)(2). These financial statements, the selected per share data and ratios and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements, selected per share data and ratios and schedule based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of October 31, 2012, by correspondence with the custodians and management of the underlying investments. We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the financial statements and selected per share data and ratios referred to above present fairly, in all material respects, the consolidated financial position of MVC Capital, Inc. as of October 31, 2012 and 2011, and the consolidated results of its operations, its cash flows and its changes in net assets for each of the three years in the period ended October 31, 2012 and the consolidated selected per share data and ratios for each of the five years in the period ended October 31, 2012 in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
 
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), MVC Capital, Inc.’s internal control over financial reporting as of October 31, 2012, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated December 26, 2012 expressed an unqualified opinion thereon.
 
 
 
 
 
New York, New York
December 26, 2012
 
 
F-44

 
 
Report of Independent Registered Public Accounting Firm
 
The Board of Directors and Shareholders of MVC Capital, Inc.
 
We have audited MVC Capital Inc.’s internal control over financial reporting as of October 31, 2012, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). MVC Capital, Inc.’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Controls and Procedures. Our responsibility is to express an opinion on the company’s internal control over financial reporting based on our audit.
 
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
 
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.
 
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 
In our opinion, MVC Capital, Inc. maintained, in all material respects, effective internal control over financial reporting as of October 31, 2012, based on the COSO criteria.
 
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of MVC Capital, Inc., including the consolidated schedules of investments, as of October 31, 2012 and 2011, and the related consolidated statements of operations, cash flows and changes in net assets for each of the three years in the period ended October 31, 2012, and the consolidated selected per share data and ratios for each of the five years in the period ended October 31, 2012, and our report dated December 26, 2012 expressed an unqualified opinion thereon.
 
   
New York, New York
December 26, 2012
 
 
F-45

 
 
Schedule 12-14
 
MVC Capital, Inc. and Subsidiaries
 
Schedule of Investments in and Advances to Affiliates
 
                                                     
       
Amount of Interest
or Dividends Credited
   
October  31,
2011
Fair Value
   
Gross
Additions (3)
   
Gross
Reductions (4)
   
October  31,
2012
Fair Value
 
 
Portfolio Company
 
 
Investment (1)
 
to Income (5)
   
Other (2)
         
Companies More than 25% owned
                                                   
MVC Automotive Group
 
Common Stock
   
  
   
  
   
42,450,000
  
   
  
   
(8,931,000
   
33,519,000
  
(Automotive Dealership)
 
Bridge Loan
   
364,356
  
   
  
   
3,643,557
  
   
  
   
  
   
3,643,557
  
MVC Partners, LLC
 
Common Equity Interest
   
  
   
  
   
1,133,729
  
   
8,013,749
  
   
(1,075,229
   
8,072,249
  
(Private Equity Firm)
                                                   
MVC Private Equity Fund LP
 
General Partnership
Interest
   
  
   
  
   
  
   
205,924
  
   
  
   
205,924
  
(Private Equity Firm)
 
Bridge Loan
   
8,350
  
   
  
   
  
   
  
   
  
   
  
Ohio Medical Corporation
 
Common Stock
   
  
   
  
   
  
   
  
   
  
   
  
(Medical Device Manufacturer)
 
Preferred Stock
   
  
   
  
   
39,500,000
  
   
  
   
(8,400,000
   
31,100,000
  
   
Guarantee
   
  
   
  
   
  
   
  
   
(825,000
   
(825,000
SIA Tekers Invest
 
Common Stock
   
  
   
  
   
1,525,000
  
   
  
   
(278,000
   
1,247,000
  
(Port Facilities)
                                                   
Summit Research Labs, Inc.
 
Loan
   
1,635,659
  
   
  
   
11,055,089
  
   
812,928
  
   
  
   
11,868,017
  
(Specialty Chemical)
 
Preferred Stock
   
12,000,000
  
   
  
   
74,500,000
  
   
  
   
(12,000,000
   
62,500,000
  
Turf Products, LLC
 
Loan
   
1,154,538
  
   
  
   
8,395,261
  
   
  
   
  
   
8,395,261
  
(Distributor — Landscaping & Irrigation Equipment)
 
LLC Interest
   
  
   
  
   
2,721,794
  
   
153,000
  
   
  
   
2,874,794
  
   
Revolver
   
  
   
  
   
1,000,000
  
   
  
   
  
   
1,000,000
  
   
Warrant
   
  
   
  
   
  
   
  
   
  
   
  
Velocitius B.V.
 
Common Equity Interest
   
  
   
  
   
25,100,000
  
   
  
   
(3,375,000
   
21,725,000
  
(Renewable Energy)
                                                   
Vestal Manufacturing Enterprises, Inc.
 
Loan
   
73,200
  
   
  
   
600,000
  
   
  
   
  
   
600,000
  
(Iron Foundries)
 
Common Stock
   
  
   
  
   
1,455,000
  
   
4,195,000
  
   
  
   
5,650,000
  
Total companies more than 25% owned
     
$
15,236,103
  
                                 
$
191,575,802
  
Companies More than 5% owned, but less than 25%
                                                   
Centile Holding B.V.
 
Common Stock
   
  
   
  
   
3,001,376
  
   
173,000
  
   
(34,376
   
3,140,000
  
(Software)
                                                   
Custom Alloy Corporation
 
Loan
   
2,141,055
  
   
  
   
14,559,236
  
   
1,064,112
  
   
  
   
15,623,348
  
(Manufacturer of Tubular Goods for the Energy Industry)
 
Preferred Stock
   
  
   
  
   
44,000
  
   
  
   
  
   
44,000
  
   
Preferred Stock
   
  
   
  
   
9,956,000
  
   
  
   
  
   
9,956,000
  
Harmony Health & Beauty, Inc.
 
Common Stock
   
  
   
  
   
1,000,000
  
   
  
   
(900,000
   
100,000
  
(Healthcare — Retail)
                                                   
JSC Tekers Holdings
 
Common Stock
   
  
   
  
   
4,500
  
   
  
   
  
   
4,500
  
(Automotive Dealerships)
 
Loan
   
325,333
  
   
  
   
4,000,000
  
   
  
   
  
   
4,000,000
  
Marine Exhibition Corporation
 
Loan
   
1,331,430
  
   
  
   
11,958,188
  
   
484,554
  
   
(600,000
   
11,842,742
  
(Theme Park)
 
Preferred Stock*
   
374,020
  
   
  
   
3,024,872
  
   
249,347
  
   
  
   
3,274,219
  
Octagon Credit Investors, LLC
 
LLC Interest
   
  
   
  
   
5,333,657
  
   
888,139
  
   
  
   
6,221,796
  
(Financial Services)
                                                   
RuMe Inc.
 
Common Stock
   
  
   
  
   
160,000
  
   
  
   
  
   
160,000
  
(Consumer Products)
 
Preferred Stock
   
  
   
  
   
999,815
  
   
417,185
  
   
  
   
1,417,000
  
Security Holdings, B.V.
 
Common Equity Interest
   
  
   
  
   
33,200,000
  
   
  
   
(9,189,000
   
24,011,000
  
(Technology Services)
                                                   
SGDA Europe B.V.
 
Common Equity Interest
   
  
   
  
   
10,500,000
  
   
  
   
(2,585,000
   
7,915,000
  
(Soil Remediation)
                                                   
U.S. Gas & Electric, Inc.
 
Loan
   
1,337,963
  
   
  
   
9,143,848
  
   
475,796
  
   
  
   
9,619,644
  
(Energy Services)
 
Preferred Stock
   
2,356,560
  
   
  
   
78,515,749
  
   
  
   
  
   
78,515,749
  
   
Preferred Stock
   
  
   
  
   
2,551,858
  
   
  
   
  
   
2,551,858
  
Total companies more than 5% owned, but less than 25%
     
$
7,866,361
  
                                 
$
178,396,856
  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F-46

 
 

This schedule should be read in conjunction with the Company’s consolidated statements as of and for the year ended October 31, 2012, including the consolidated schedule of investments.
 
(1)
Common stock, preferred stock, warrants, options and equity interests are generally non-income producing and restricted. The principal amount for loans and debt securities and the number of shares of common and preferred stock are shown in the consolidated schedule of investments as of October 31, 2012.
 
(2)
Other includes interest, dividend, or other income which was applied to the principal of the investment and therefore reduced the total investment. These reductions are also included in the Gross Reductions for the investment, as applicable.
 
(3)
Gross additions include increases in the cost basis of investments resulting from new portfolio investments, paid-in-kind interest or dividends, the amortization of discounts and closing fees, and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation.
 
(4)
Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales and the exchange of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation.
 
(5)
Represents the total amount of interest or dividends credited to income for a portion of the year an investment was included in the companies more than 25% owned.
 
*
All or a portion of the dividend income on this investment was or will be paid in the form of additional securities or by increasing the liquidation preference. Dividends paid-in-kind are also included in the Gross Additions for the investment, as applicable.
 
The accompanying notes are an integral part of these consolidated financial statements.

 
F-47

 
 
 
 
 
$70,000,000

 
7.25% Senior Notes due 2023
 

 
 
PROSPTECTUS SUPPLEMENT
 

 
UBS INVESTMENT BANK
 
MORGAN STANLEY
 
BB&T CAPITAL MARKETS
 
JMP SECURITIES
 
MLV & CO.
 
STERNE AGEE
 
 
 

 
 
February 19, 2013